Apta_index,Sequence,Aptamer description,Aptamer Chemistry,Length,GC content,Molecular weight,Molarity of 1 ¦Ìg/¦Ìl solution,Number of tetrads,G-Score,Function,Applications,Assay
Apta_1,ACGAAGCUUGAUCCCGUUUGCCGGUCGAUCGCUUCGA,RNA Tat,RNA,37 nt,0.568,"11,783.98 Da",84.86 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Determination of equilibrium dissociation constants (Kd) for binding of TAR-1 and of RNATat to CQ. Representative autoradiograms obtained from gel-shift assays for analysis of binding of TAR-1 and RNATat to CQ (A and B, respectively)"
Apta_2,GGGCUUCUCUGGUUAGACCAGAUUUGAGCCUGGGAGCUCUCUGGCUAACUAGGGAACCC,TAR-1,RNA,59 nt,0.559,"18,943.21 Da",52.79 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Determination of equilibrium dissociation constants (Kd) for binding of TAR-1 and of RNATat to CQ. Representative autoradiograms obtained from gel-shift assays for analysis of binding of TAR-1 and RNATat to CQ (A and B, respectively)"
Apta_3,CCTGCCTTTGGCAGCCGGGCGAAGGCAACCCGACACCGACAGC,Aptamer A14,DNA,43 nt,0.698,"13,169.44 Da",75.93 ¦ÌM,No QGRS found,N/A,Target recognition,Binds specifically to H3N2 subtype of influenza virus,N/A
Apta_4,CCTGCCTTTGGAACCGACCGCCAGGCCGAGGAAAGGCACCGACAGC,Aptamer A1,DNA,46 nt,0.674,"14,125.06 Da",70.80 ¦ÌM,No QGRS found,N/A,Target recognition,Binds specifically to H3N2 subtype of influenza virus,N/A
Apta_5,GGGAGAGCCAUACCUGACAAAGACGCUAGCGAAUUGGUUCCUCACUCAAAAGUAGGGGAAAGCGUUAUUAAGAAACCAAAAUUUGACAGGUUACGCAUCCUGCAUCCUCCAGGUUACGCAUCC,Family II,RNA,123 nt,0.472,"39,558.58 Da",25.28 ¦ÌM,No QGRS found,N/A,Targeted binding,Regulated kinase 2 (ERK2),"Dissociation constants of family II RNA. Trace, 5P-end labeled family II RNA was incubated with diphosphorylated or unphosphorylated ERK2 over a protein concentration range from 2 WM to 5.6 pM. RNA-protein complexes were captured on nitrocellulose membranes and data were analyzed as described"
Apta_6,GGAAAGACGCUAGCGAAUUGGUUCCUCGAAAGGGGAAAGCGUUAUUAAGAAACCAAAAUUUCC,Family II-Truncated,RNA,63 nt,0.429,"20,370.21 Da",49.09 ¦ÌM,No QGRS found,N/A,Targeted binding,Regulated kinase 2 (ERK2),"Dissociation constants of family II RNA. Trace, 5P-end labeled family II RNA was incubated with diphosphorylated or unphosphorylated ERK2 over a protein concentration range from 2 WM to 5.6 pM. RNA-protein complexes were captured on nitrocellulose membranes and data were analyzed as described"
Apta_7,CCAGTCTCCCGTTTACCGCGCCTACACATGTCTGAATGCC,Gli4,DNA,40 nt,0.575,"12,103.77 Da",82.62 ¦ÌM,No QGRS found,N/A,Targeted binding,"Detect hordeins and secalins as well as avenins withlower affinity and discriminates them from rice, soya, and maize proteins",Competitive assay curve. Analytical signals expressed as percentage of the maximum intensity current as a function of the PWG concentration in the presence of [gli4] = 250 nM
Apta_8,TGTGGGGGTGGACGGGCCGGGTAGA,VEap121,DNA,25 nt,0.72,"8,243.94 Da",121.30 ¦ÌM,2,21,Aptasensor,VEGF-detection,Detection of VEGF by plate assay
Apta_9,TGAGGGGGCGGCGGGGCCGGGCAGG,1R01,DNA,25 nt,0.88,"7,911.05 Da",126.41 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_10,GGGGGGGGTGGCTGGGCGGGGTGGG,1R02,DNA,25 nt,0.88,"8,013.10 Da",124.80 ¦ÌM,3,62,Aptasensor,VEGF-detection,N/A
Apta_11,AGAGGGGGGGGTCGGGGTGGGTCGC,1R03,DNA,25 nt,0.8,"7,941.08 Da",125.93 ¦ÌM,3,64,Aptasensor,VEGF-detection,N/A
Apta_12,TGAGGGGGTGGGTGGGACGGGTTGG,1R04,DNA,25 nt,0.72,"7,971.10 Da",125.45 ¦ÌM,3,63,Aptasensor,VEGF-detection,N/A
Apta_13,AGGGGGGGGGGAGGGGTCGGGGTGG,1R05,DNA,25 nt,0.84,"8,046.14 Da",124.28 ¦ÌM,4,83,Aptasensor,VEGF-detection,N/A
Apta_14,AGCGGGGGGGGCTGGGCTGGGTGGG,1R09,DNA,25 nt,0.84,"7,957.07 Da",125.67 ¦ÌM,3,64,Aptasensor,VEGF-detection,N/A
Apta_15,TGAGGGGGGGGGAGGGCGGGGCTGC,1R10,DNA,25 nt,0.84,"7,966.09 Da",125.53 ¦ÌM,3,64,Aptasensor,VEGF-detection,N/A
Apta_16,AGGGGGGGGGGACGGGACGGGTATA,2R06,DNA,25 nt,0.72,"7,958.11 Da",125.66 ¦ÌM,3,64,Aptasensor,VEGF-detection,N/A
Apta_17,AGGGGGGGGGGTGGGGGTGGGTCCC,2R07,DNA,25 nt,0.84,"7,957.07 Da",125.67 ¦ÌM,3,64,Aptasensor,VEGF-detection,N/A
Apta_18,TGGGGGGTTGGACGGGCGGGGCTGC,2R12,DNA,25 nt,0.8,"7,892.04 Da",126.71 ¦ÌM,3,60,Aptasensor,VEGF-detection,N/A
Apta_19,TGAGGGGGGGGGAGGTCGGGCCTGC,2R17,DNA,25 nt,0.8,"7,901.05 Da",126.57 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_20,AGAGGGGGGGGTGGGGGTGGCCTGC,2R18,DNA,25 nt,0.8,"7,941.08 Da",125.93 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_21,TGTGGGGGAGGACGGGCGGGGATGC,3R01,DNA,25 nt,0.76,"7,925.08 Da",126.18 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_22,TGTGGGGGTGGACTGGGTGGGTACC,3R02,DNA,25 nt,0.68,"7,866.04 Da",127.13 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_23,TGTGGGGGTGGACGGGCCGAGTACG,3R03,DNA,25 nt,0.72,"7,860.04 Da",127.23 ¦ÌM,2,20,Aptasensor,VEGF-detection,N/A
Apta_24,TGTGGGGATGGATGGGCCGGGCTGC,3R08,DNA,25 nt,0.72,"7,851.03 Da",127.37 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_25,TGTGGGGGTGGTTGGGCGGGGCTGC,3R09,DNA,25 nt,0.76,"7,898.04 Da",126.61 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_26,AGGGGGGGGGGTAAGGGTGGGTAGA,3R12,DNA,25 nt,0.68,"8,013.15 Da",124.79 ¦ÌM,3,62,Aptasensor,VEGF-detection,N/A
Apta_27,AGGGGGAGGGGTGGGGCCGGGCAGA,3R14,DNA,25 nt,0.8,"7,959.10 Da",125.64 ¦ÌM,3,64,Aptasensor,VEGF-detection,N/A
Apta_28,AGTGGGGGGGGTGGAGCCGGGTAGA,3R16,DNA,25 nt,0.72,"7,949.10 Da",125.80 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_29,AGAGGGGGGGGACGGCCCGGGTAGA,3R17,DNA,25 nt,0.76,"7,903.08 Da",126.53 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_30,AGAGGGGGGGGTGGAGGGGGCTAGA,3R18,DNA,25 nt,0.72,"7,998.14 Da",125.03 ¦ÌM,2,21,Aptasensor,VEGF-detection,N/A
Apta_31,ATACCAGTCTATTCAATTGGGCCCGTCCGTATGGTGGGTGTGCTGGCCAGATAGTATGTGCAATCA,VEa5,DNA,66 nt,0.5,"20,406.06 Da",49.01 ¦ÌM,No QGRS found,N/A,Aptasensor,Identifying high affinity aptamer sequences for the biological molecules and targeting them as antagonist for cancer cell detection,N/A
Apta_32,CGGTAAACTGCGTCCGAAGGGGCTGCAGTGACCCGAATGGGTCCG,aptamer 1,DNA,45 nt,0.644,"13,952.93 Da",71.67 ¦ÌM,No QGRS found,N/A,Targeted binding,"Biological experiments using cultured cells revealed that our stabilized aptamers efficiently inhibited the interaction between VEGF165 and its receptor, with the same or slightly higher efficiency than that of the pegaptanib RNA aptamer",Binding analysis of anti-VEGF165 aptamers by a BIAcore T200 at 25 ©} or 37 ©}
Apta_33,GCGGTAAACTGCGTCCGAAGGGGCTGCAGTGACCCGAATGGGTCCGCCGCGAAGCG,aptamer 4,DNA,56 nt,0.679,"17,382.10 Da",57.53 ¦ÌM,No QGRS found,N/A,Targeted binding,"Biological experiments using cultured cells revealed that our stabilized aptamers efficiently inhibited the interaction between VEGF165 and its receptor, with the same or slightly higher efficiency than that of the pegaptanib RNA aptamer",Binding analysis of anti-VEGF165 aptamers by a BIAcore T200 at 25 ©} or 37 ©}
Apta_34,TGTCACAATTTCCCCCCTCGCACATTTTGCAAGTAACTGA,Lep1,DNA,40 nt,0.45,"12,125.82 Da",82.47 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Determination of binding affinities using fluorescence intensity. A constant concentration of protein was immobilized onto a 96-well plate and blocked with 5% BSA. Each well was incubated with a different concentration of aptamer (0-5000 nM). After several washing steps, the fluorescence intensity of the DNA was measured in each well surface and the corrected signal was normalized using the BSA-only control. Fluorescence intensities (in relative fluorescence units, RFU) were plotted against the aptamer concentration (in lM), and the binding affinity KD was calculated using nonlinear regression on GraphPad Prism 5. Experiments were performed in triplicate"
Apta_35,TGGGTGGCCTCCCGTTTATTCGAGATTTGGTTGAATTTGT,Lep2,DNA,40 nt,0.45,"12,360.92 Da",80.90 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Determination of binding affinities using fluorescence intensity. A constant concentration of protein was immobilized onto a 96-well plate and blocked with 5% BSA. Each well was incubated with a different concentration of aptamer (0-5000 nM). After several washing steps, the fluorescence intensity of the DNA was measured in each well surface and the corrected signal was normalized using the BSA-only control. Fluorescence intensities (in relative fluorescence units, RFU) were plotted against the aptamer concentration (in lM), and the binding affinity KD was calculated using nonlinear regression on GraphPad Prism 5. Experiments were performed in triplicate"
Apta_36,GTTAATGGGGGATCTCGCGGCCGTTCTTGTTGCTTATACA,Lep3,DNA,40 nt,0.5,"12,339.91 Da",81.04 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Determination of binding affinities using fluorescence intensity. A constant concentration of protein was immobilized onto a 96-well plate and blocked with 5% BSA. Each well was incubated with a different concentration of aptamer (0-5000 nM). After several washing steps, the fluorescence intensity of the DNA was measured in each well surface and the corrected signal was normalized using the BSA-only control. Fluorescence intensities (in relative fluorescence units, RFU) were plotted against the aptamer concentration (in lM), and the binding affinity KD was calculated using nonlinear regression on GraphPad Prism 5. Experiments were performed in triplicate"
Apta_37,TCTATAAACTCTGTCCGGTTTTATAATAATAACATTTTAC,Lep4,DNA,40 nt,0.25,"12,192.90 Da",82.01 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Determination of binding affinities using fluorescence intensity. A constant concentration of protein was immobilized onto a 96-well plate and blocked with 5% BSA. Each well was incubated with a different concentration of aptamer (0-5000 nM). After several washing steps, the fluorescence intensity of the DNA was measured in each well surface and the corrected signal was normalized using the BSA-only control. Fluorescence intensities (in relative fluorescence units, RFU) were plotted against the aptamer concentration (in lM), and the binding affinity KD was calculated using nonlinear regression on GraphPad Prism 5. Experiments were performed in triplicate"
Apta_38,GGUAGAUACGAUGGAUACCCCCUGUGGCCCGUCAACACAGGGGAAGUGGCAUGACGCGCAGCCA,Family-1,RNA,64 nt,0.609,"19,805.68 Da",50.49 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to TLR3 ECD,Binding curves of selected RNA aptamers for TLR3-ECD. Data points were obtained by a filter binding assay (Family-II closed squares] and Family-II [closed trianglesJ). The values represent means of three independent experiments. RNA binding shows the percentage of input RNA retained on the filter in protein/RNA complex
Apta_39,GGUAGAUACGAUGGACUACCGCCACCCCGGGUCCGGGUGACGUUAAUUGAGGGCCCAUGACGCGCAGCCA,Family-2,RNA,70 nt,0.629,"21,626.82 Da",46.24 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to TLR3 ECD,Binding curves of selected RNA aptamers for TLR3-ECD. Data points were obtained by a filter binding assay (Family-II closed squares] and Family-II [closed trianglesJ). The values represent means of three independent experiments. RNA binding shows the percentage of input RNA retained on the filter in protein/RNA complex
Apta_40,UGUUCAUGUCCUACUGUUCAAACAAAAAAACUGUGCACAAAAAUAAAUUGGGGCAUGGACA,A9,RNA,61 nt,0.361,"18,820.16 Da",53.13 ¦ÌM,No QGRS found,N/A,Targeted binding,Suppressed pgRNA packaging and DNA synthesis,N/A
Apta_41,CGGTCGCTCCGTGTGGCTTGGGTTGGGTGTGGCAGTGAC,VI-2,DNA,39 nt,0.667,"12,149.74 Da",82.31 ¦ÌM,2,20,Targeted therapy,The inhibitory aptamers were capable of completely abolishing the action of an antisense oligonucleotide in a rabbit reticulocyte lysate supplemented with human RNase H1,N/A
Apta_42,GCTGGTCTCTGCGGGTTGTTGCGCCGCGGCACCCTTGGCA,V-2,DNA,40 nt,0.7,"12,303.84 Da",81.28 ¦ÌM,No QGRS found,N/A,Targeted therapy,The inhibitory aptamers were capable of completely abolishing the action of an antisense oligonucleotide in a rabbit reticulocyte lysate supplemented with human RNase H1,N/A
Apta_43,GGGAGAGCGGAAGCGUGCUGGGCCACCAUCCGUAACUAGCUAAUACUUGUUAUCUUUUUAUUUUCAUAACCCAGAGGUCGAUGGAUCCCCCC,CL9,RNA,92 nt,0.5,"29,424.39 Da",33.99 ¦ÌM,No QGRS found,N/A,Targeted therapy,To be an antiviral agent that specifically boosts the RIG-I-dependent signaling cascade,The binding affinity (Kd) of AP-treated CL9 aptamer to full length RIG-I measured by filter assay
Apta_44,TCTCGGACGCGTGTGGTCGGGTGGGAGTTGTGGGGGGGGGTGGGAGGGTTCTTTGTTTGATCTTTCTCGCTGCCTGGCCCTAGAGTG,C14B,DNA,87 nt,0.621,"27,207.25 Da",36.75 ¦ÌM,3,64,Aptasensor,Selective and sensitive detection of AGR2,N/A
Apta_45,CGGGTGGGAGTTGTGGGGGGGGGTGGGAGGGTTCTTTGTTTGATCTTTCTCGCTGCCTGGCCCTAGAGTG,C14B0,DNA,70 nt,0.614,"21,911.91 Da",45.64 ¦ÌM,3,64,Aptasensor,Selective and sensitive detection of AGR2,N/A
Apta_46,CGGGTGGGAGTTGTGGGGGGGGGTGGGAGGGTT,C14B1,DNA,33 nt,0.727,"10,554.72 Da",94.74 ¦ÌM,3,64,Aptasensor,Selective and sensitive detection of AGR2,The binding constants of C14B1 in the buffer w/ and w/o K+. The data were the average of triplicate experiment results
Apta_47,GACCTAGCAGTGGACATGTGGCAGGGTGAAGTGGCATCGTC,CAT 1,DNA,41 nt,0.585,"12,771.19 Da",78.30 ¦ÌM,2,19,Targeted binding,Aptamer exhibited a distinct specificity toward bovine catalase,N/A
Apta_48,ACTGGGCAGATTAACGGTCCTATATTTTCGGTTCTGGAAA,CAT 2,DNA,40 nt,0.425,"12,340.95 Da",81.03 ¦ÌM,No QGRS found,N/A,Targeted binding,Aptamer exhibited a distinct specificity toward bovine catalase,N/A
Apta_49,CTTCCATGTTGAGGCGTTTATACCAGTTATCATCGGACTA,CAT 3,DNA,40 nt,0.425,"12,251.89 Da",81.62 ¦ÌM,No QGRS found,N/A,Targeted binding,Aptamer exhibited a distinct specificity toward bovine catalase,N/A
Apta_50,AGTGGCGAGGGGGGTAGGTAAAGTATCCTTAGTGTGTTG,CAT 4,DNA,39 nt,0.513,"12,253.86 Da",81.61 ¦ÌM,No QGRS found,N/A,Targeted binding,Aptamer exhibited a distinct specificity toward bovine catalase,N/A
Apta_51,GCCUUAGUAACGUGCUUUGAUGUCGAUUCGACAGGAGGC,CL4,RNA,39 nt,0.513,"12,053.74 Da",82.96 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibits EGFR-mediated signal pathways causing selective cell death,"Binding isotherm for CL4:EC-EGFR complexes. Kd value was derived by fitting bound CL4 versus the protein concentration to the equation Y = BmaxX/(Kd+X), where Bmax is the extrapolated maximal amount of RNA:protein complex bound. The specific binding was determined by subtracting the background values obtained with CL4sc from the values obtained with CL4"
Apta_52,ACUGUCCUCCCUUCAGAGAGCGCGGGACCCUUAACUUGGGGCCCACGAACAGCUUCAGUUCCGUCUCGGCGU,F1-1,RNA,72 nt,0.611,"22,975.60 Da",43.52 ¦ÌM,No QGRS found,N/A,Target recognition,Recognition of colicin E3,"Inhibition of the colicin E3 activity by the aptamers in poly(U)-dependent poly(Phe) synthesis. As a control, a randomly selected RNA fragment from the initial pool was used, with a Kd of 147 nM"
Apta_53,UCCCUGGCCCAAGAUCCUAAUAAAGUUUUUUCGGACCGGAGCGAAACCACUAUCCUCUUAAGCAAUCUGU,F2-1,RNA,70 nt,0.457,"22,256.20 Da",44.93 ¦ÌM,No QGRS found,N/A,Target recognition,Recognition of colicin E3,"Inhibition of the colicin E3 activity by the aptamers in poly(U)-dependent poly(Phe) synthesis. As a control, a randomly selected RNA fragment from the initial pool was used, with a Kd of 147 nM"
Apta_54,GUACAACACAUCAUUACGGCUGCUAUUGGCUCCAAGCGUCUUUCUCCCUGGUCAAUAGUCCAGCCACCACG,F3-1,RNA,71 nt,0.521,"22,528.34 Da",44.39 ¦ÌM,No QGRS found,N/A,Target recognition,Recognition of colicin E3,"Inhibition of the colicin E3 activity by the aptamers in poly(U)-dependent poly(Phe) synthesis. As a control, a randomly selected RNA fragment from the initial pool was used, with a Kd of 147 nM"
Apta_55,GACAUCUGUAAGUAAGAUUCUAUCUGCAAAGCGGUUAGGAGGGCUCGGACUCUGAUUGCCUCCCCGCACC,F4-1,RNA,70 nt,0.529,"22,422.30 Da",44.60 ¦ÌM,2,20,Target recognition,Recognition of colicin E3,"Inhibition of the colicin E3 activity by the aptamers in poly(U)-dependent poly(Phe) synthesis. As a control, a randomly selected RNA fragment from the initial pool was used, with a Kd of 147 nM"
Apta_56,GCAGCTAAGCAGGCGGCTCACAAAACCATTCGCATGCGGC,Apta1,DNA,40 nt,0.6,"12,284.91 Da",81.40 ¦ÌM,No QGRS found,N/A,Targeted binding,Against other egg white proteins,"In the SPR measurement, Apta1 was biotinylated and immobilized onto a streptavidin coated SPR chip"
Apta_57,GCGGGTCGGTTGCTCGCTTCGCCCGATCGGTCTAAGGGTG,Apta3,DNA,40 nt,0.675,"12,367.88 Da",80.85 ¦ÌM,No QGRS found,N/A,Targeted binding,Against other egg white proteins,N/A
Apta_58,GCACCTTGATGACATGATAGTCGTTGTGTATGCAGTTGGC,Apta8,DNA,40 nt,0.475,"12,372.95 Da",80.82 ¦ÌM,No QGRS found,N/A,Targeted binding,Against other egg white proteins,N/A
Apta_59,GGACCUCGGCGAAAGCUAACGUCUCAUGGCUAAAUUGCCAUGUUGCUACAAAUGAUAUGACUAGAGAGGUUAGGUGCCUCGUGAUGUCCAGUCGC,cyt7-2,RNA,95 nt,0.495,"30,571.12 Da",32.71 ¦ÌM,No QGRS found,N/A,Target recognition,Recognize the structures of the native proteins,N/A
Apta_60,GGAATGAGTGCCCTGCAAGCGAGGGCTAGC,Clone 6,DNA,30 nt,0.633,"9,322.00 Da",107.27 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,Cells that are incubated with lysozyme and the Clone 1 aptamer (blue) demonstrate no discernable decrease in absorbance while cells incubated with the same amount of unselected RNA (red) are efficiently lysed
Apta_61,AGCAGCACAGAGGTCAGATGGCAGGTAAGCAGGCGGCTCACAAAACCATTCGCATGCGGCCCTATGCGTGCTACCGTGAA,Apt 80,DNA,80 nt,0.575,"24,741.85 Da",40.42 ¦ÌM,2,18,Aptasensor,Assay of human salivary lysozyme,N/A
Apta_62,AGTCCGTGGTAGGGCAGGTTGGGGTGACT,60-18,DNA,29 nt,0.577,"24,339.58 Da",41.09 ¦ÌM,2,20,Targeted binding,Inhibits thrombin-catalyzed fibrinclot formation in vitro,N/A
Apta_63,GACCCGTGGTAGGGTAGGATGGGGTGGTC,30-38[29],DNA,29 nt,0.655,"9,110.84 Da",109.76 ¦ÌM,2,20,Targeted binding,Inhibits thrombin-catalyzed fibrinclot formation in vitro,N/A
Apta_64,ACCGTGTGGAGGGTGTT,30-38[27],DNA,17 nt,0.588,"5,297.43 Da",188.77 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibits thrombin-catalyzed fibrinclot formation in vitro,N/A
Apta_65,CTACCGTGGTAGGGAAGGTTGGAGTGTAG,30-16[29],DNA,29 nt,0.552,"9,093.85 Da",109.96 ¦ÌM,2,20,Targeted binding,Inhibits thrombin-catalyzed fibrinclot formation in vitro,N/A
Apta_66,TACCGTGGTAGGGAAGGTTGGAGTGTA,30-16[27],DNA,27 nt,0.519,"8,715.40 Da",114.74 ¦ÌM,2,20,Targeted binding,Inhibits thrombin-catalyzed fibrinclot formation in vitro,N/A
Apta_67,AGATGCCTGTCGAGCATGCTGTTGTGGTAGGGTTAGGGATGGTAGCGGTTGTAGCTAAACTGCTTTGTCGACGGG,30-14,DNA,75 nt,0.533,"23,669.89 Da",42.25 ¦ÌM,2,21,Targeted binding,Inhibits thrombin-catalyzed fibrinclot formation in vitro,N/A
Apta_68,AGATGCCTGTCGAGCATGCTGTGAATAGGTAGGGTCGGATGGGCTACGGTGTAGCTAAACTGCTTTGTCGACGGG,8ˆÙ30?,DNA,75 nt,0.547,"23,632.88 Da",42.31 ¦ÌM,2,20,Targeted binding,Inhibits thrombin-catalyzed fibrinclot formation in vitro,N/A
Apta_69,AGCGAGTAGGTTGGTGTGGTTGGGGCTCGCT,D2-5,DNA,31 nt,0.613,"9,950.15 Da",100.50 ¦ÌM,2,20,Targeted binding,Thrombin inhibiting,N/A
Apta_70,AGGTCGTAGGTTGGTGTGGTTGGGGCGACCT,D3-9,DNA,31 nt,0.613,"9,950.15 Da",100.50 ¦ÌM,2,20,Targeted binding,Thrombin inhibiting,N/A
Apta_71,GGCGAGTAGGTTGGTGTGGTTGGGGCTCGCC,D4-7,DNA,31 nt,0.677,"9,951.14 Da",100.49 ¦ÌM,2,20,Targeted binding,Thrombin inhibiting,N/A
Apta_72,AGTCAGTAGGTTGGTGTGGTTGGGGCTGACT,D1-9,DNA,31 nt,0.548,"9,949.16 Da",100.51 ¦ÌM,2,20,Targeted binding,Thrombin inhibiting,N/A
Apta_73,GGGGAGTAGGTTGGTGTGGTTGGGGCTCCCC,D4-2,DNA,31 nt,0.677,"9,951.14 Da",100.49 ¦ÌM,2,20,Targeted binding,Thrombin inhibiting,N/A
Apta_74,GGACAGTAGGTTGGTGTGGTTGGGGCTGTCC,D4-5,DNA,31 nt,0.613,"9,950.15 Da",100.50 ¦ÌM,2,20,Targeted binding,Thrombin inhibiting,N/A
Apta_75,CACTGGTAGGTTGGTGTGGTTGGGGCCAGTG,Original,DNA,31 nt,0.613,"9,950.15 Da",100.50 ¦ÌM,2,20,Targeted binding,Thrombin inhibiting,N/A
Apta_76,CAGCGCTAGGGCTTTTAGCGTAATGGGTAGGGTGGTGCGGTGCAGATATCGGAATTGGTG,Thrombin 03,DNA,60 nt,0.55,"19,033.94 Da",52.54 ¦ÌM,2,20,Targeted binding,Binds specifically to thrombin,Highest affinity aptamers obtained via particle display for four protein targets
Apta_77,GGTGTGGGCGACATGGGGGTTGGTGGTGTAGGAGCGCCAT,Tb-L8,DNA,40 nt,0.65,"12,840.98 Da",77.88 ¦ÌM,2,20,Aptasensor,Application of the selected SSA in fluorescent detection of HSA in urine with diagnostic required sensitivity and dynamic range,Using a magnetic bead-based qPCR assay.Error bars show standard deviation from three repeat experiments
Apta_78,ATCTCGACTAGTCATAGGGGGCGCGAACATACGCGGTTGGTGTGGTTGGCTGACAATACTCGT,CTBA4T,DNA,63 nt,0.54,"19,789.44 Da",50.53 ¦ÌM,2,20,Targeted therapy,Excellent anticoagulation activity,"Fraction of the shifted band (aptamer/thrombin complex) vs. [thrombin] for CTBA4T, CTBA4T-B1, and CTBA4MT, respectively. The data was fitted with the Origin software to a saturation 1:1 binding curve using nonlinear regression, resulting in a Kd value provided in each graph"
Apta_79,ATCTCGAGTCATAGGGGGCGCGAACATACGCGGTTGGTGTGGTTGGCTGACTCGT,CTBA4T-B1,DNA,55 nt,0.582,"17,349.87 Da",57.64 ¦ÌM,2,20,Targeted therapy,Excellent anticoagulation activity,"Fraction of the shifted band (aptamer/thrombin complex) vs. [thrombin] for CTBA4T, CTBA4T-B1, and CTBA4MT, respectively. The data was fitted with the Origin software to a saturation 1:1 binding curve using nonlinear regression, resulting in a Kd value provided in each graph"
Apta_80,GCAAUGGUACGGUACUUCCUUUGGAAGAUAGCUGGAGAACUAACCAAAAGUGCACGCUACUUUGCUAA,T705,RNA,68 nt,0.441,"21,242.44 Da",47.08 ¦ÌM,No QGRS found,N/A,Targeted binding,Both RNA aptamers inhibit only bovine thrombin-catalyzed fibrin clot formation in vitro,"Binding curves for RNA aptamers following seven rounds of SELEX. Binding curves for T-05RNA, T+10RNA and the starting bulk 25N RNA population are shown"
Apta_81,GCAAUGGUACGGUACUUCCAAGUGCGGGGGGGAGGUGGUGGUUCCAAAAGUGCACGCUACUUUGCUAA,T710,RNA,68 nt,0.544,"21,403.48 Da",46.72 ¦ÌM,2,21,Targeted binding,Both RNA aptamers inhibit only bovine thrombin-catalyzed fibrin clot formation in vitro,"Binding curves for RNA aptamers following seven rounds of SELEX. Binding curves for T-05RNA, T+10RNA and the starting bulk 25N RNA population are shown"
Apta_82,GGCTTTACACTTTATGCTTCCGAAACAACGCAGAAAGTCTTTACAACATTACATAACAATTTCACACAGGAAACAG,BnFIX1,DNA,76 nt,0.368,"23,537.98 Da",42.48 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibition of catalytic activity of target proteins,"Binding of BnFIX1, BnFIX2, BnFIX3, and their natural counterparts to factor IXa. Data are average ºô SD of three independent determinations"
Apta_83,GGCTTTACACTTTATGCTTCCGTAAAAACACAAACACACGCACATACATAAAATAACAATTTCACACAGGAAACAG,BnFIX2,DNA,76 nt,0.355,"23,508.99 Da",42.54 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibition of catalytic activity of target proteins,"Binding of BnFIX1, BnFIX2, BnFIX3, and their natural counterparts to factor IXa. Data are average ºô SD of three independent determinations"
Apta_84,GGCTTTACACTTTATGCTTCCGTTGCAATTTTAATGGGAGGTACATGGCGGAATAACAATTTCACACAGGAAACAG,BnFIX3,DNA,76 nt,0.408,"23,719.03 Da",42.16 ¦ÌM,2,18,Targeted binding,Inhibition of catalytic activity of target proteins,"Binding of BnFIX1, BnFIX2, BnFIX3, and their natural counterparts to factor IXa. Data are average ºô SD of three independent determinations"
Apta_85,UGCGACUGUUAUAACCUAACAGCGACGUAAAGAUA,upanap-12,RNA,35 nt,0.4,"11,459.69 Da",87.26 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_86,GAAACGACUCGACAACCUCGAGCGACGUGAAUCAU,upanap-79,RNA,35 nt,0.514,"11,472.73 Da",87.16 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_87,UACCGACUAGCAAAACCUGCUGGCGACGUUUAGAU,upanap-84,RNA,35 nt,0.486,"11,427.64 Da",87.51 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_88,AAUAACCUUAAUGCGACGUUGGUUUGUCAACAACG,upanap-21(6),RNA,35 nt,0.4,"11,413.61 Da",87.61 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_89,AAUAACCUUAAUGCGACGUUGGUUCGUCAACAUGG,upanap-71,RNA,35 nt,0.429,"11,429.61 Da",87.49 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_90,ACAACCUAAAUGCGACGUUGGGUCAAAAACGUGAA,upanap-28,RNA,35 nt,0.429,"11,521.77 Da",86.79 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_91,GAUAACCUCGAUGCGACGUUCGGCCUCAAAAUCAA,upanap-25,RNA,35 nt,0.486,"11,410.66 Da",87.64 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_92,ACAACUUAAUGCGACGUUGGUAAAGCAUAUCAAAC,upanap-78,RNA,35 nt,0.371,"11,443.69 Da",87.38 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_93,CUCCGCUAUCUAACGUAUGAUAGAAUGGAUGACUA,upanap-26,RNA,35 nt,0.4,"11,413.61 Da",87.61 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_94,AUGACAGGAUGCAGAGCUCCACUGUCUAGUGUUUA,upanap-68,RNA,35 nt,0.457,"11,445.61 Da",87.37 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_95,CCGCGACAGUCGUAAGUUUUGACUGACUGAACGUU,upanap-24,RNA,35 nt,0.486,"11,421.58 Da",87.55 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_96,UCGCUAAUUAUAGGCGGAGUGCGACGUUAUAAAUA,upanap-88,RNA,35 nt,0.4,"11,493.66 Da",87.00 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_97,UUGUCGUCUUCUCCAGUUAGUCAACGAACUUGUGU,upanap-27,RNA,35 nt,0.429,"11,297.43 Da",88.52 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations,N/A
Apta_98,CGAUGCGGUCUCAUGCGUCGAGUGUGAGUUUACCUUCG,C5C6,RNA,38 nt,0.553,"12,387.10 Da",80.73 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited zymosan-induced generation of C5a,"Aptamers from the biased .SELEX experiment were assayed and representative binding curves are shown. Most aptamers bound with Kd between 10 and 20 nM. The best aptamer, YL-13, bound with K between 2-5 nM, which is 10-fold better than the template aptamer C5C6"
Apta_99,AGCAGCACAGAGGTCAGATGTCGGGCGGTTCGGGACCTTGCTGCGACATATGCGTATTATCCTATGCGTGCTACCGTGAA,4.3,DNA,80 nt,0.55,"25,006.77 Da",39.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_100,AGCAGCACAGAGGTCAGATGATTCAAGGGTAACACATCCAGGGGAACGGAATTGCAGCCCCCTATGCGTGCTACCGTGAA,4.9,DNA,80 nt,0.538,"25,004.82 Da",39.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_101,AGCAGCACAGAGGTCAGATGTGTTAGGCTGGGACACGTATTACACTTACCGTAAATATTTCCTATGCGTGCTACCGTGAA,4.13,DNA,80 nt,0.463,"24,956.79 Da",40.07 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_102,AGCAGCACAGAGGTCAGATGCGTTTTTTACGGCTGGCAACGGAAGTCAGTTTATTCTTCACCTATGCGTGCTACCGTGAA,4.2,DNA,80 nt,0.488,"24,939.75 Da",40.10 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_103,AGCAGCACAGAGGTCAGATGCATCGCATTATTCGCGGCCGGCCAACGAGAGTATGTTTCTCCTATGCGTGCTACCGTGAA,4.21,DNA,80 nt,0.538,"24,919.73 Da",40.13 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_104,AGCAGCACAGAGGTCAGATGCAAACCACAGCCTGAGTGGTTAGCGTATGTCATTTACGGACCTATGCGTGCTACCGTGAA,4.31,DNA,80 nt,0.513,"24,976.80 Da",40.04 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_105,AGCAGCACAGAGGTCAGATGATGCTCTAGGCGAAAGACTTGGCGTAGAACGACGGGAGGCCCTATGCGTGCTACCGTGAA,6.1,DNA,80 nt,0.563,"25,116.87 Da",39.81 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_106,AGCAGCACAGAGGTCAGATGGAGCCAGGAGTCGGCCTACAGAAGATTCTGATGTACCTCACCTATGCGTGCTACCGTGAA,6.11,DNA,80 nt,0.538,"24,986.80 Da",40.02 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_107,AGCAGCACAGAGGTCAGATGTTCATTTCAGTTGACCGATAGCATTGAGCAATGATCTATTCCTATGCGTGCTACCGTGAA,6.14,DNA,80 nt,0.45,"24,931.78 Da",40.11 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_108,AGCAGCACAGAGGTCAGATGCTTTGCCACGGCAACGTCCCAAAACTAATGGTAACTATACCCTATGCGTGCTACCGTGAA,6.18,DNA,80 nt,0.5,"24,849.74 Da",40.24 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_109,AGCAGCACAGAGGTCAGATGTGCGACCACCTGGATAGACGAGGGTAGTAAGGAGTGTGTTCCTATGCGTGCTACCGTGA,6.21,DNA,79 nt,0.544,"24,824.67 Da",40.28 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_110,AGCAGCACAGAGGTCAGATGGTTAGGAAGGTGAATAGGTACGACTGCAGGTCTATCGCAGCCTATGCGTGCTACCGTGAA,6.26,DNA,80 nt,0.525,"25,121.88 Da",39.81 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_111,AGCAGCACAGAGGTCAGATGCAAACCACAGCCTGAGTGGTTAGCGTATGTCATTTACGGACCTATGCGTGCTACCGTGAA,4.31,DNA,80 nt,0.513,"24,976.80 Da",40.04 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_112,AGCAGCACAGAGGTCAGATGTCGGGCGGTTCGGGACCTTGCTGCGACATATGCGTATTATCCTATGCGTGCTACCGTGAA,4.3,DNA,80 nt,0.55,"25,006.77 Da",39.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_113,AGCAGCACAGAGGTCAGATGATTCAAGGGTAACACATCCAGGGGAACGGAATTGCAGCCCCCTATGCGTGCTACCGTGAA,4.9,DNA,80 nt,0.538,"25,004.82 Da",39.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_114,AGCAGCACAGAGGTCAGATGTGTTAGGCTGGGACACGTATTACACTTACCGTAAATATTTCCTATGCGTGCTACCGTGAA,4.13,DNA,80 nt,0.463,"24,956.79 Da",40.07 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_115,AGCAGCACAGAGGTCAGATGCGTTTTTTACGGCTGGCAACGGAAGTCAGTTTATTCTTCACCTATGCGTGCTACCGTGAA,4.2,DNA,80 nt,0.488,"24,939.75 Da",40.10 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_116,AGCAGCACAGAGGTCAGATGCATCGCATTATTCGCGGCCGGCCAACGAGAGTATGTTTCTCCTATGCGTGCTACCGTGAA,4.21,DNA,80 nt,0.538,"24,919.73 Da",40.13 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_117,AGCAGCACAGAGGTCAGATGATGCTCTAGGCGAAAGACTTGGCGTAGAACGACGGGAGGCCCTATGCGTGCTACCGTGAA,6.1,DNA,80 nt,0.563,"25,116.87 Da",39.81 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_118,AGCAGCACAGAGGTCAGATGGAGCCAGGAGTCGGCCTACAGAAGATTCTGATGTACCTCACCTATGCGTGCTACCGTGAA,6.11,DNA,80 nt,0.538,"24,986.80 Da",40.02 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_119,AGCAGCACAGAGGTCAGATGTTCATTTCAGTTGACCGATAGCATTGAGCAATGATCTATTCCTATGCGTGCTACCGTGAA,6.14,DNA,80 nt,0.45,"24,931.78 Da",40.11 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_120,AGCAGCACAGAGGTCAGATGCTTTGCCACGGCAACGTCCCAAAACTAATGGTAACTATACCCTATGCGTGCTACCGTGAA,6.18,DNA,80 nt,0.5,"24,849.74 Da",40.24 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_121,AGCAGCACAGAGGTCAGATGTGCGACCACCTGGATAGACGAGGGTAGTAAGGAGTGTGTTCCTATGCGTGCTACCGTGA,6.21,DNA,79 nt,0.544,"24,824.67 Da",40.28 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_122,AGCAGCACAGAGGTCAGATGGTTAGGAAGGTGAATAGGTACGACTGCAGGTCTATCGCAGCCTATGCGTGCTACCGTGAA,6.26,DNA,80 nt,0.525,"25,121.88 Da",39.81 ¦ÌM,2,20,Targeted binding,Binding to target proteins,N/A
Apta_123,GGGAGAAAGGGAAGCUUGAGCAGCAGGAGGGCCGGCGUUAGGGUUAGCGAGCCGAUUGAAAGAAGAAGGAACGAGCGUACGGAUCCGAUC,DP3,RNA,90 nt,0.578,"29,784.69 Da",33.57 ¦ÌM,3,56,Targeted binding,Binding to target proteins,N/A
Apta_124,GGTGGTGGGGGGGGTTGGTAGGGTGTCTTC,IBA,DNA,30 nt,0.667,"9,732.99 Da",102.74 ¦ÌM,2,21,Target detection,Detection of insulin,N/A
Apta_125,TGGTGGATGGCGCAGTCGGCGACAA,VR11,DNA,25 nt,0.64,"8,027.96 Da",124.56 ¦ÌM,2,17,Targeted binding,Binding specififically to TNFa,Binding curves of immobilized aptamer VR11 associated with increasing concentrations of TNF›¥
Apta_126,TCCTCATATAGAGTGCGGGGCGTGT,VR20,DNA,25 nt,0.56,"7,968.92 Da",125.49 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding specififically to TNFa,Binding curves of immobilized aptamer VR20 associated with increasing concentrations of TNF›¥
Apta_127,GGTATTGAGGGTCGCATCCACTGGTCGTTGTTGTCTGTTGTCTGTTATGTTGTTTCGTGATGGCTCTAACTCTCCTCT,APT_SEB1,DNA,78 nt,0.474,"24,262.24 Da",41.22 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_128,GGTATTGAGGGTCGCATCCCGTAGTGTGTTCTTATTCGTGTCTGTGTGTGTTCTGTCGGATGGCTCTAACTCTCCTCT,APT_SEB2,DNA,78 nt,0.5,"24,272.24 Da",41.20 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_129,GGGAGGACGAUGCGGACACCGUUAAUCUGAGGCCCUGUCCUAUUCCUUCACGCCUCAGA,2'F-1,RNA,59 nt,0.576,"19,125.16 Da",52.29 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_130,GGGAGGACGAUGCGGUGGUAGCGCGAUAUAGCGCUGGUAGGGUUGCCGGUGAUCAGACGACUCGCCCGA,2'NH2-17,RNA,69 nt,0.638,"22,720.33 Da",44.01 ¦ÌM,2,17,Targeted binding,Binding to target proteins,N/A
Apta_131,GGGAGGACGAUGCGGUCCUGUCGUCUGUUCGUCCCCAGACGACUCGCCCGA,Tr-1,RNA,51 nt,0.667,"16,600.65 Da",60.24 ¦ÌM,No QGRS found,N/A,Targeted binding,Determine the fraction of soluble CD25,An ELISA-based assay demonstrating the EC50 of the IL2-CD25 interaction (N=3). A representative plot from three independent sets of experiments is shown
Apta_132,GGGAGGACGAUGCGGCGUUUCCUCUGGUUCGUCCCCAGACGACUCGCCCGA,Tr-6,RNA,51 nt,0.667,"16,600.65 Da",60.24 ¦ÌM,No QGRS found,N/A,Targeted binding,Determine the fraction of soluble CD25,An ELISA-based assay demonstrating the EC50 of the IL2-CD25 interaction (N=3). A representative plot from three independent sets of experiments is shown
Apta_133,GGGAGGACGAUGCGGUGAGUCGUUCCCUUCGUCCCCAGACGACUCGCCCGA,Tr-7,RNA,51 nt,0.667,"16,623.69 Da",60.16 ¦ÌM,No QGRS found,N/A,Targeted binding,Determine the fraction of soluble CD25,An ELISA-based assay demonstrating the EC50 of the IL2-CD25 interaction (N=3). A representative plot from three independent sets of experiments is shown
Apta_134,GGGAGGACGAUGCGGGCCGUUGUUGUGUGCCGCCCCAGACGACUCGCCCGA,Tr-8,RNA,51 nt,0.706,"16,718.76 Da",59.81 ¦ÌM,No QGRS found,N/A,Targeted binding,Determine the fraction of soluble CD25,An ELISA-based assay demonstrating the EC50 of the IL2-CD25 interaction (N=3). A representative plot from three independent sets of experiments is shown
Apta_135,GGGAGGACGAUGCGGAUUCUGGUUACUGGCCGCCCCAGACGACUCGCCCGA,Tr-11,RNA,51 nt,0.667,"16,686.76 Da",59.93 ¦ÌM,2,19,Targeted binding,Determine the fraction of soluble CD25,An ELISA-based assay demonstrating the EC50 of the IL2-CD25 interaction (N=3). A representative plot from three independent sets of experiments is shown
Apta_136,CGUGUCGUCCUGGUACGAUUUGGUAUAUAACCGUGGCUUUUCGACA,7,RNA,46 nt,0.478,"14,904.56 Da",67.09 ¦ÌM,No QGRS found,N/A,Targeted binding,Stained CD4+ T cells in a preparation of human peripheral blood mononuclear cells,Binding analysis of a representative aptamer from each of the four classes. Biotinylated RNA aptamer sequences complexed to SA-PE were incubated with CD4 presented on L200 beads and then analyzed by flow cytometry. The mean fluoresence of beads was plotted against the concentration of Aptamer:SA-PE complex
Apta_137,GGGAGACAAGAAUAAACGCUCAAGUGACGUCCUGAUCGAUUGUGCAUUCGGUGUGACGAUCUUUCGACAGGAGGCUCACAACAGGC,aptamer 12,RNA,86 nt,0.512,"28,018.49 Da",35.69 ¦ÌM,No QGRS found,N/A,Targeted binding,Stained CD4+ T cells in a preparation of human peripheral blood mononuclear cells,Binding analysis of a representative aptamer from each of the four classes. Biotinylated RNA aptamer sequences complexed to SA-PE were incubated with CD4 presented on L200 beads and then analyzed by flow cytometry. The mean fluoresence of beads was plotted against the concentration of Aptamer:SA-PE complex
Apta_138,GGAGGUGCUCCGAAAGGAACUCC,Apt8-2,RNA,23 nt,0.609,"7,664.44 Da",130.47 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognize and bind to human IgG with high specificity and affinity,N/A
Apta_139,GATAAACGCCTTGATTAAAGGCCCAGTTCTTTAGGCCTACACGTGCTGCGACATTAATT,ApoE 06,DNA,59 nt,0.441,"18,359.59 Da",54.47 ¦ÌM,No QGRS found,N/A,Targeted binding,Binds specifically to thrombin,Highest affinity aptamers obtained via particle display for four protein targets
Apta_140,GGCAGGAAGACAAACACGATGGGGGGGTATGATTTGATGTGGTTGTTGCATGATCGTGGTCTGTGGTGCTGT,clone 1,DNA,72 nt,0.514,"22,811.35 Da",43.84 ¦ÌM,No QGRS found,N/A,Target recognition,Recognition molecule for the detection of CRP,N/A
Apta_141,GTTGACGGGCGATTGGTCTT,PF-aptamer,DNA,20 nt,0.55,"6,434.93 Da",155.40 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,Representative duplicated results of dissociation constant of selected PFaptamer
Apta_142,CGCACATCAGTTTAGCAGCGCCAAAGGCGGAAGCGCA,CRP-Ugu4-3,DNA,37 nt,0.595,"11,642.29 Da",85.89 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,Representative SPR sensorgrams showing the interaction between the CRP and the aptamer CRP-Ugu4-3
Apta_143,GGTGCGGTTCGTGCGGTTGTAGTACTCGTGGCCGATAGAGGTAGTTTCG,G8,DNA,49 nt,0.571,"15,517.69 Da",64.44 ¦ÌM,No QGRS found,N/A,Target detection,Detection of GHSA,N/A
Apta_144,GGTGCGGTTCGTGCGGTTGTAGTACTCGTGGCCGATAGAGGTAG,Del5,DNA,44 nt,0.591,"13,986.72 Da",71.50 ¦ÌM,No QGRS found,N/A,Target detection,Detection of GHSA,N/A
Apta_145,GGTGCGGTTCGTGCGGTTGTAGTACTCGTGGCCGATAGA,Del10,DNA,39 nt,0.59,"12,381.70 Da",80.76 ¦ÌM,No QGRS found,N/A,Target detection,Detection of GHSA,N/A
Apta_146,GGTGCGGTTCGTGCGGTTGTAGTACTCGTGGCCG,Del15,DNA,34 nt,0.647,"10,808.68 Da",92.52 ¦ÌM,No QGRS found,N/A,Target detection,Detection of GHSA,N/A
Apta_147,TGCGGTTGTAGTACTCGTGGCCG,5del11 and 3del15,DNA,23 nt,0.609,"7,342.50 Da",136.19 ¦ÌM,No QGRS found,N/A,Target detection,Detection of GHSA,N/A
Apta_148,CCGTAGGTTCGGGGTCGGAGTGGTCCGGAAGGTGGCGTGG,A3,DNA,40 nt,0.7,"12,801.95 Da",78.11 ¦ÌM,2,21,Targeted binding,Specificity to ricin toxin,N/A
Apta_149,CCGTAGGTTCGGGGTCGGAGTGGTCCGGAAGATGGCGTGG,C1,DNA,40 nt,0.675,"12,785.95 Da",78.21 ¦ÌM,2,21,Targeted binding,Specificity to ricin toxin,N/A
Apta_150,CCGTAGGTTCGGGGCGGAGTGGTCCGGAAGGTGGCGTGG,C5,DNA,39 nt,0.718,"12,497.75 Da",80.01 ¦ÌM,2,21,Targeted binding,Specificity to ricin toxin,N/A
Apta_151,GCAATGGTACGGTACTTCCGCGGTCCGGGGTGGGTGGGTGGTGGGGGGTGCGGGGGGGCGGCCGCAAAAGTGCACGCTACTTTGCTAA,NS1-aptamer,DNA,88 nt,0.67,"27,810.46 Da",35.96 ¦ÌM,3,64,Targeted therapy,Induce IFN-b by suppressing the function of NS1,"Affinity measurement of the selected aptamer specific to NS1 by ELISA. The immobilized 50-biotinylated aptamer was incubated with increasing concentrations of GST-tagged NS1. After addition of GST antibody-conjugated HRP, the amount of the NS1-aptamer complex was calculated and graphed as a function of NS1 concentration. The graph was fit to the Michaelis-Menten equation and the Kd was calculated (18.91 ºô 3.95 nM)"
Apta_152,UUACCACGCGCUCUUAACUGCUAGCGCCAUGGC,m.1.1,RNA,33 nt,0.576,"10,681.15 Da",93.62 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibition of cDNA Synthesis and RNase H Activity,N/A
Apta_153,CCACAGUUCAGAGGCACCGCGAACAAAACGCAAGACAGAGUGCCGACAAGAAC,aptER-1,RNA,53 nt,0.547,"17,380.37 Da",57.54 ¦ÌM,No QGRS found,N/A,Targeted binding,Effectively inhibited ER-mediated transcriptional activation in a breast cancer cell line,Binding curves of the aptamers for ERa determined using filter-binding assays. The apparent Kd determined from binding curves is shown next to the title of each curve. Each experiment was repeated at least three times and the standard deviation was shown as error bars
Apta_154,ACACGCGAGAUAGAGCGAGGCCUCCAAAAAUGGCCACGCCAGGAAGCAAGU,aptER-2,RNA,51 nt,0.569,"16,778.97 Da",59.60 ¦ÌM,No QGRS found,N/A,Targeted binding,Effectively inhibited ER-mediated transcriptional activation in a breast cancer cell line,Binding curves of the aptamers for ERa determined using filter-binding assays. The apparent Kd determined from binding curves is shown next to the title of each curve. Each experiment was repeated at least three times and the standard deviation was shown as error bars
Apta_155,GACCCAGGGCCGGGACGCAAAGCAGCCAAAACAGACGGCCCCAGUCAGGGAGUU,aptER-3,RNA,54 nt,0.648,"17,765.55 Da",56.29 ¦ÌM,No QGRS found,N/A,Targeted binding,Effectively inhibited ER-mediated transcriptional activation in a breast cancer cell line,Binding curves of the aptamers for ERa determined using filter-binding assays. The apparent Kd determined from binding curves is shown next to the title of each curve. Each experiment was repeated at least three times and the standard deviation was shown as error bars
Apta_156,GGGAGAAUUCCGACCAGAAGGGUUAGCAGUCGGCAUGCGGUACAGACAGACCUUUCCUCUCUCCUUCCUCUUCU,P30-10-16,RNA,74 nt,0.541,"23,860.91 Da",41.91 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited HA-mediated membrane fusion,N/A
Apta_157,GGGUUCACUGCAGACUUGACGAAGCUUACAAACAAGAGCAAAAAGGGAGUUGACGUAGACUGUGCGGAAUGGAUCCACAUCUACGAAUUC,HAS15-5,RNA,90 nt,0.467,"29,343.34 Da",34.08 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Blocking and inhibiting the receptor-binding domain of viral HA, can be developed as a novel antiviral agent against type H5 avian influenza virus",N/A
Apta_158,CACAGGCTACGGCACGTAGAGCATCACCATGATCCTGTG,36t,DNA,39 nt,0.564,"12,201.64 Da",81.96 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibitory effect on PDGF dependent [3H]thymidine incorporation in PAE cells expressing the PDGF receptors,Binding of minimal DNA ligands to PDGF
Apta_159,GCGTGCAGCATGACCACCGATGTCACACTTAATGAGAAT,TK1_apta69,DNA,39 nt,0.487,"12,224.67 Da",81.80 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic assays,N/A
Apta_160,CGGTGCAGTGGATACATGCCAGCCGTAGCCATCGTGGATA,TK1_apta37,DNA,40 nt,0.575,"12,601.88 Da",79.35 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic assays,N/A
Apta_161,GTGTGCAGATCTGATTGCCTGCGTCAACCTACATACAAC,TK1_apta3,DNA,39 nt,0.487,"12,166.62 Da",82.19 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic assays,N/A
Apta_162,CCGTACATACTACGTACGTACGTGAACAGAGGCAGAG,TK1_apta39,DNA,37 nt,0.514,"11,656.31 Da",85.79 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic assays,N/A
Apta_163,GCGCATGACCATTGATGTCTGCACCATCAGAGGCAGAG,TK1_apta9,DNA,38 nt,0.553,"11,952.48 Da",83.66 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic assays,N/A
Apta_164,TATAGACCACAGCCTGAGATTAACCACCAACCCAGGACT,VWF R9.4,DNA,39 nt,0.487,"12,122.63 Da",82.49 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit platelet aggregation in PFA-100 and ristocetin-induced platelet aggregation assays,Binding affinities of VWF aptamers
Apta_165,TGGACGAACTGCCCTCAGCTACTTTCATGTTGCTGACGCA,VWF R9.14,DNA,40 nt,0.525,"12,462.79 Da",80.24 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit platelet aggregation in PFA-100 and ristocetin-induced platelet aggregation assays,Binding affinities of VWF aptamers
Apta_166,ATCGCGCTCTCCTGCTTAAGCAGCTATCAAATAGCCCACT,VWF R9.3,DNA,40 nt,0.5,"12,375.76 Da",80.80 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit platelet aggregation in PFA-100 and ristocetin-induced platelet aggregation assays,Binding affinities of VWF aptamers
Apta_167,TGCTCCTTGGCCTTAGCCCTGGAACCATCAATCCTCTTCG,VWF R9.18,DNA,40 nt,0.55,"12,349.71 Da",80.97 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit platelet aggregation in PFA-100 and ristocetin-induced platelet aggregation assays,N/A
Apta_168,AAUUAACCCUCACUAAAGGGAACUGUUGUGAGUCUCAUGUCGAAGAGCGGUUAAGGGAGAUUUAGGCAGCAGCUUGGACAGUGUAUCGGCUGAGUUGAGCGUCUAGUCUUGUCU,B4,RNA,114 nt,0.474,"37,033.67 Da",27.00 ¦ÌM,2,18,Targeted therapy,Neutralizing antibody,N/A
Apta_169,GGGAGACAAGACUAGACGCUCAAUGUGGGCCACGCCCGAUUUUACGCUUUUACCCGCACGCGAUUGGUUUGUUUUCGACAUGAGACUCACAACAGUUCCCUUUAGUGAGGGUUAAUU,B40,RNA,117 nt,0.487,"37,726.05 Da",26.51 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind specifically to the surface glycoprotein (gp120) of the R5 strain,The titration yielded an equilibrium dissociation constant (Kd) of 21 ºô 2 nM and 31 ºô 2 nM for the aptamer B40 and B40t77 respectively
Apta_170,GGGAGACAAGACUAGACGCUCAAUGUGGGCCACGCCCGAUUUUACGCUUUUACCCGCACGCGAUUGGUUUGUUUCCC,B40t77,RNA,77 nt,0.545,"24,857.49 Da",40.23 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind specifically to the surface glycoprotein (gp120) of the R5 strain,The titration yielded an equilibrium dissociation constant (Kd) of 21 ºô 2 nM and 31 ºô 2 nM for the aptamer B40 and B40t77 respectively
Apta_171,GGGAGCUCAGAAUAAACGCUCAACCAGUCUUGUGGCUUUGAAAGAGAGGAGUGUUCGACAUGAGGCCCGGAUCCGGC,P5,RNA,77 nt,0.545,"25,172.81 Da",39.73 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,Nitrocell Jlose binding curves for F5 and 3CN RNAs in bufer containing s0 mw Nacl. HIv integrase concentrations are giva in molarity. Data points are averages of triplicate experiments
Apta_172,GGAGACAUCCCUCUUGUUGGUGGUGCCGUGUGGAUGUCUC,selpsi,RNA,40 nt,0.575,"13,054.47 Da",76.60 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit HIV replication,"Binding data I. Filter binding for NC with SelPsi, SelPsi 46 and pool 0. All of the filter binding experiments were done at least twice"
Apta_173,AGCAGCACAGAGGTCAGATGGCAGGTTTCGACGTACAATGCTATGGAGGCTTTATGATCGCCTATGCGTGCTACCGTGAA,4.3,DNA,80 nt,0.513,"25,038.82 Da",39.94 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to HIV reverse transcriptase (HIVRT),N/A
Apta_174,AGCAGCACAGAGGTCAGATGTCGGTCTTGTGTATACATACCCGTGTGTTTTCATCTCAGGCCTATGCGTGCTACCGTGAA,4.5,DNA,80 nt,0.5,"24,906.72 Da",40.15 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to HIV reverse transcriptase (HIVRT),N/A
Apta_175,AGCAGCACAGAGGTCAGATGAGGACTGTCGATAAGTATAATGGCAAGTAGCTCGATACATCCTATGCGTGCTACCGTGAA,4.14,DNA,80 nt,0.475,"25,048.87 Da",39.92 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to HIV reverse transcriptase (HIVRT),N/A
Apta_176,AGCAGCACAGAGGTCAGATGTATGGTACATTCGAGCGAGCTAAACTAGGATTAAACTCACCCTATGCGTGCTACCGTGAA,4.19,DNA,80 nt,0.475,"24,968.82 Da",40.05 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to HIV reverse transcriptase (HIVRT),N/A
Apta_177,AGCAGCACAGAGGTCAGATGCCATAGGTGCCTGAATTGTCCCAAACATTCGCATGATCGACCTATGCGTGCTACCGTGAA,4.2,DNA,80 nt,0.513,"24,896.75 Da",40.17 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to HIV reverse transcriptase (HIVRT),N/A
Apta_178,AGCAGCACAGAGGTCAGATGCGGTATGCTGGGTCATCTAACTGGGGATATTCTGATATTGCCTATGCGTGCTACCGTGAA,4.25,DNA,80 nt,0.5,"25,044.81 Da",39.93 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to HIV reverse transcriptase (HIVRT),N/A
Apta_179,TCGGTTGAGTGAGATTAGTCAAATGTTTAGAAGACAACCTC,WT62,DNA,41 nt,0.39,"12,927.13 Da",77.36 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,"IC50 values were calculated by fitting the data for the aptamers¨Ù titration to a sigmoidal dose-response curve giving the values at 127.9 ºô 10.33, 162.2 ºô 10.02, 90.03 ºô 6.49, 110.6 ºô 9.89, and 84.81 ºô 8.54 nM for WT3, WT7 WT12, WT48, and WT62, respectively (Figure 3 and Table 1). Whereas NVP gave the IC50 value at 688.6 ºô 6.48 nM. All of the data indicated that the selected DNA aptamers inhibited the WT HIV-1 RT function in the nanomolar range"
Apta_180,GGTCCCCCGTAAATTGAGAATTTGGGCGTTTTGGTTCTA,WT48,DNA,39 nt,0.462,"12,274.67 Da",81.47 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,"IC50 values were calculated by fitting the data for the aptamers¨Ù titration to a sigmoidal dose-response curve giving the values at 127.9 ºô 10.33, 162.2 ºô 10.02, 90.03 ºô 6.49, 110.6 ºô 9.89, and 84.81 ºô 8.54 nM for WT3, WT7 WT12, WT48, and WT62, respectively (Figure 3 and Table 1). Whereas NVP gave the IC50 value at 688.6 ºô 6.48 nM. All of the data indicated that the selected DNA aptamers inhibited the WT HIV-1 RT function in the nanomolar range"
Apta_181,CCGTGTAAGGTTTCAGTGGCTTATCCGAAGTAACCCGAGA,WT12,DNA,40 nt,0.5,"12,575.88 Da",79.52 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,"IC50 values were calculated by fitting the data for the aptamers¨Ù titration to a sigmoidal dose-response curve giving the values at 127.9 ºô 10.33, 162.2 ºô 10.02, 90.03 ºô 6.49, 110.6 ºô 9.89, and 84.81 ºô 8.54 nM for WT3, WT7 WT12, WT48, and WT62, respectively (Figure 3 and Table 1). Whereas NVP gave the IC50 value at 688.6 ºô 6.48 nM. All of the data indicated that the selected DNA aptamers inhibited the WT HIV-1 RT function in the nanomolar range"
Apta_182,AAAAAAGCCCCCCCTTCGACCGTATACCAGGGTACGGAATG,WT7,DNA,41 nt,0.537,"12,797.04 Da",78.14 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,"IC50 values were calculated by fitting the data for the aptamers¨Ù titration to a sigmoidal dose-response curve giving the values at 127.9 ºô 10.33, 162.2 ºô 10.02, 90.03 ºô 6.49, 110.6 ºô 9.89, and 84.81 ºô 8.54 nM for WT3, WT7 WT12, WT48, and WT62, respectively (Figure 3 and Table 1). Whereas NVP gave the IC50 value at 688.6 ºô 6.48 nM. All of the data indicated that the selected DNA aptamers inhibited the WT HIV-1 RT function in the nanomolar range"
Apta_183,TAGCACTGTGCGGCGCGTATTGTTCTAATCTGATTACATT,WT3,DNA,40 nt,0.425,"12,522.84 Da",79.85 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,"IC50 values were calculated by fitting the data for the aptamers¨Ù titration to a sigmoidal dose-response curve giving the values at 127.9 ºô 10.33, 162.2 ºô 10.02, 90.03 ºô 6.49, 110.6 ºô 9.89, and 84.81 ºô 8.54 nM for WT3, WT7 WT12, WT48, and WT62, respectively (Figure 3 and Table 1). Whereas NVP gave the IC50 value at 688.6 ºô 6.48 nM. All of the data indicated that the selected DNA aptamers inhibited the WT HIV-1 RT function in the nanomolar range"
Apta_184,AGGAAGGCTTTAGGTCTGAGATCTCGGAAT,PF1,DNA,30 nt,0.467,"9,565.96 Da",104.54 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,Inhibition of HIV RT primer extension in the presence of various amounts of PF1 and starting material
Apta_185,ACCAAGGCTTTAGGTCTGAGATCTCCCAAT,PF1-terminal GG > CC,DNA,30 nt,0.467,"9,405.87 Da",106.32 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_186,AGGAACGCTTTAGGTCTGAGATCTCGGAAT,PF1-C6,DNA,30 nt,0.467,"9,525.94 Da",104.98 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_187,ACCAACCCTTTACCTCTGAGATCTCCCAAT,PF1-GG > CC,DNA,30 nt,0.467,"9,245.77 Da",108.16 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_188,AAAAAAACTTTAAATCTGAGATCTCAAAAT,PF1-GG > AA,DNA,30 nt,0.2,"9,437.97 Da",105.96 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_189,AGGAACCCTTTACCTCTGAGATCTCGGAAT,PF1-GCmid,DNA,30 nt,0.467,"9,405.87 Da",106.32 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_190,AGGAACCCTTTAGGTCTGAGATCTCGGAAT,PF1C6-7,DNA,30 nt,0.467,"9,485.91 Da",105.42 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_191,AGGAAGGCTTTACCTCTGAGATCTCGGAAT,PF1C13-14,DNA,30 nt,0.467,"9,485.91 Da",105.42 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_192,AGGAAGGCTTTAGCTCTGAGATCTCGGAAT,PF1-C14,DNA,30 nt,0.467,"9,525.94 Da",104.98 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_193,AGGAAGGCTTTAGGGTCTGAGATCTCGGAAT,PF1-3G,DNA,31 nt,0.484,"9,895.17 Da",101.06 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_194,AGGAAGGCTTTAGGGTCTGAGATCTCGGGAAT,PF1-3G2,DNA,32 nt,0.5,"10,224.37 Da",97.81 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_195,AGGAAGGCTTTAGGGGTCTGAGATCTCGGAAT,PF1-4G,DNA,32 nt,0.5,"10,224.37 Da",97.81 ¦ÌM,2,17,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_196,AGGAAGGCTTTAGGTCTGAGATCTC,PF1-25nt3' cut,DNA,25 nt,0.48,"7,976.94 Da",125.36 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_197,GGCTTTAGGTCTGAGATCTCGGAAT,PF1-25nt5' cut,DNA,25 nt,0.48,"7,967.93 Da",125.50 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_198,AGGAAGGCTTTAGGTCTGAG,PF1-20nt3' cut,DNA,20 nt,0.5,"6,476.99 Da",154.39 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_199,TAGGTCTGAGATCTCGGAAT,PF1-20nt5' cut,DNA,20 nt,0.45,"6,411.95 Da",155.96 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_200,AGGAAGGCTTTAGGT,PF1-15nt3' cut,DNA,15 nt,0.467,"4,911.99 Da",203.58 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_201,CTGAGATCTCGGAAT,PF1-15nt5' cut,DNA,15 nt,0.467,"4,831.94 Da",206.96 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_202,AAGGCTTTAGGTCTGAGATCTCGGAAT,PF1-27nt5' cut,DNA,27 nt,0.444,"8,594.34 Da",116.36 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_203,GGAAGGCTTTAGGTCTGAGATCTCGG,PF1-26ntG,DNA,26 nt,0.538,"8,322.15 Da",120.16 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_204,CCAAGGCTTTAGGTCTGAGATCTCCC,PF1-26ntC,DNA,26 nt,0.538,"8,162.05 Da",122.52 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_205,TTAAGGCTTTAGGTCTGAGATCTCTT,PF1-26ntT,DNA,26 nt,0.385,"8,222.10 Da",121.62 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_206,AGGAAGGGGTCTGAGATCTCGGAAT,PF1-D (8-12),DNA,25 nt,0.52,"8,050.99 Da",124.21 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_207,AGGAAGGCTTTAGGTGGAAT,PF1-D (16-25),DNA,20 nt,0.45,"6,501.01 Da",153.82 ¦ÌM,2,18,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_208,AGGAAGGGGTGGAAT,PF1-D (8-12/16-25),DNA,15 nt,0.533,"4,986.04 Da",200.56 ¦ÌM,2,19,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_209,AAGGCTTTAGGTCTG,PF1-15ntmidG,DNA,15 nt,0.467,"4,862.95 Da",205.64 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_210,AGGTTGGTTGGTTGGAAT,PF1-18ntTlinkG,DNA,18 nt,0.444,"5,880.60 Da",170.05 ¦ÌM,2,21,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_211,GGTTGGTGTGGTTGG,TBA (thrombin aptamer),DNA,15 nt,0.6,"4,965.99 Da",201.37 ¦ÌM,2,20,Targeted binding,Binds specifically to thrombin,N/A
Apta_212,AGGAAGGCUUUAGGUCUGAGAUCUCGGAAU,PF1-RNA,RNA,30 nt,0.467,"9,565.96 Da",104.54 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_213,AGGAAGGCAAAAGGAAAAAAAAAAAGGAAA,PF1A,DNA,30 nt,0.3,"9,678.15 Da",103.33 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_214,AGGAAGGCTTTAGGTTTCCTAAAGCCTTCC,PF1Flip,DNA,30 nt,0.467,"9,436.88 Da",105.97 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_215,AGGAAGGCTTTAGGTCCGAGATCTCGGAAT,PF1Loop,DNA,30 nt,0.5,"9,550.95 Da",104.70 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_216,TGGTTGGTTTTTGGTTTTTTTTTTTGGTTT,PF1T,DNA,30 nt,0.267,"9,503.87 Da",105.22 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting function against the WT HIV-1 RT,N/A
Apta_217,CGCCTGATTAGCGATACTCAGGCGTTGGGTGGGTGGGTGGG,R1T,DNA,41 nt,0.634,"13,065.13 Da",76.54 ¦ÌM,3,64,Targeted therapy,Inhibiting function against the WT HIV-1 RT,"Inhibition of HIV-1 RT DDDP activity by aptamer R1T. Aptamer concentrations (nM) are indicated above the lanes. RT and primer/template concentrations used in these assays are 3 nM and 30 nM, respectively. Open and filled arrows on the left indicate positions of unextended primer and full-length product bands, respectively"
Apta_218,AGCCGCGAGGGGAGGGAUAGGGUAGGGCGCGGCU,SE15-8min,RNA,34 nt,0.735,"10,959.80 Da",91.24 ¦ÌM,3,63,Target recognition,Specific recognition of various breast cancer cell lines,N/A
Apta_219,AACCGCCCAAATCCCTAAGAGTCTGCACTTGTCATTTTGTATATGTATTTGGTTTTTGGCTCTCACAGACACACTACACACGCACA,HB5,DNA,86 nt,0.43,"26,510.80 Da",37.72 ¦ÌM,No QGRS found,N/A,Targeted therapy,Targeting ligand for delivering doxorubicin (Dox) to breast cancer cells in vitro,Quantitative assay of HB5¨Ùs binding affinity
Apta_220,ATCAACTCACCGTAGGTCTAGTGAGAACTTCAAGTCTACT,R9chWT-15,DNA,40 nt,0.425,"12,478.84 Da",80.14 ¦ÌM,No QGRS found,N/A,Targeted therapy,Adjuvant to traditional chemotherapy for breast cancer,N/A
Apta_221,GTCCTAGCAGACACTCGGCCATCACGCCCATTGGTTTGCA,R9chWT-1,DNA,40 nt,0.575,"12,432.77 Da",80.43 ¦ÌM,No QGRS found,N/A,Targeted therapy,Adjuvant to traditional chemotherapy for breast cancer,N/A
Apta_222,AGCGACTGACGATCTTGAGTAAACCGCTCATCCACGTAGT,R9chSM-20,DNA,40 nt,0.5,"12,504.84 Da",79.97 ¦ÌM,No QGRS found,N/A,Targeted therapy,Adjuvant to traditional chemotherapy for breast cancer,N/A
Apta_223,CATTGAGATAGCTAGTTGTAGCTGCGTCATAGGCTGGGTTGGGTCTAGTGGTTGGGTGTG,PAI-1 01,DNA,60 nt,0.517,"19,005.92 Da",52.62 ¦ÌM,2,19,Targeted binding,Binds specifically to thrombin,Highest affinity aptamers obtained via particle display for four protein targets
Apta_224,GGGGCCACCAACGACAUUGAACCACGUAGGCUCGUUUCUGAGCCGAUCUCGAUGUUGAUAUAAAUAGUGCCCAUGGAUC,paionap-5,RNA,79 nt,0.506,"25,586.99 Da",39.08 ¦ÌM,No QGRS found,N/A,Targeted binding,Compete with high-affinity protein-protein interactions,PAI-1 binding aptamers inhibit PAI-1-vitronectin binding
Apta_225,GGGGCCACCAACGACAUUUAUCGAAUUGAUAACCUUACGCGAGAGCGUAGUUCGUUGAUAUAAAUAGUGCCCAUGGAUC,paionap-40,RNA,79 nt,0.456,"25,620.02 Da",39.03 ¦ÌM,No QGRS found,N/A,Targeted binding,Compete with high-affinity protein-protein interactions,PAI-1 binding aptamers inhibit PAI-1-vitronectin binding
Apta_226,GGGAGATCACTTACGGCACCGTATAGTCGTACATGAA-CGAGTGTGAGTGTTAAGCCTTTG-GCGACAGGGCTCGGAACC,Aptamer-19,DNA,80 nt,0.538,"24,446.43 Da",40.91 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,Aptamer-19(12-74) is 100-fold more specific for binding cJun/cJun compared to cJun/cFos. Data from EMSAs were quantified and fit to binding curves; the equilibrium dissociation constant of the aptamer for cJun/cJun is 0.5 nM and for cJun/cFos is 0.85 nM
Apta_227,ACGCGCCTATGGTGCATCGCATGCCGACC,Kit-129,DNA,29 nt,0.655,"9,079.62 Da",110.14 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Recognizes c-kit endogenously expressed by a mast cell line or hematopoietic progenitor cells, and specifically blocks binding of the c-kit ligand stem cell factor (SCF)",Kit-129 has high specificity for BJAB c-kit cells. Shown are mean fluorescence values of Alexa-647-labeled Kit-129 aptamer tested in serial dilutions from 0 to 100 nM by flow cytometry
Apta_228,AGCAGCACAGAGGTCAGATGCGGCGCGGGGTCTTTTACAAATAGTTGTCCTAGCCACGCCTATGCGTGCTACCGTGAA,4.4.2,DNA,78 nt,0.551,"24,342.36 Da",41.08 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target human IgG,N/A
Apta_229,GGGGCACGTTTATCCGTCCCTCCTAGTGGCGTGCCCC,D17.4,DNA,37 nt,0.676,"11,525.15 Da",86.77 ¦ÌM,No QGRS found,N/A,Targeted binding,IGEL1.2 and D17.4 competitively inhibit the interaction of human IgE with FceRI,"Representative binding curves of oligonucleotide ligands to IgE. The fraction of P-labeled oligonucleotides bound to nitrocellulose filters is plotted as a function of total protein concentration, and the data points were fitted as described"
Apta_230,GGGAGGACGAUGCGGGCGUGAAUGGUGUUGUGAGG,lGELl.2,RNA,35 nt,0.629,"11,770.82 Da",84.96 ¦ÌM,2,17,Targeted binding,IGEL1.2 and D17.4 competitively inhibit the interaction of human IgE with FceRI,"Representative binding curves of oligonucleotide ligands to IgE. The fraction of P-labeled oligonucleotides bound to nitrocellulose filters is plotted as a function of total protein concentration, and the data points were fitted as described"
Apta_231,GGGAGGACGAUGCGGGUGUGGGGCG,ICEL2.2,RNA,25 nt,0.76,"8,522.92 Da",117.33 ¦ÌM,2,17,Targeted binding,IGEL1.2 and D17.4 competitively inhibit the interaction of human IgE with FceRI,"Representative binding curves of oligonucleotide ligands to IgE. The fraction of P-labeled oligonucleotides bound to nitrocellulose filters is plotted as a function of total protein concentration, and the data points were fitted as described"
Apta_232,AGCAGCACAGAGGTCAGATGCTATGAGCAGATCCGATAGAAAGTTAATGCCCTAGAACATCCTATGCGTGCTACCGTGAA,4.4.10,DNA,80 nt,0.475,"24,977.84 Da",40.04 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target human IgG,N/A
Apta_233,AGCAGCACAGAGGTCAGATGTGAAACATAGCATATTTACTTATGTCGCCTTGCCGGTTCCTATGCGTGCTACCGTGAA,4.4.12,DNA,78 nt,0.474,"24,290.36 Da",41.17 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target human IgG,N/A
Apta_234,AGCAGCACAGAGGTCAGATGAAATTTTGCACTTACTTGACGTTTCCTCGATAGCCACAAGCCTATGCGTGCTACCGTGAA,4.4.16,DNA,80 nt,0.475,"24,861.73 Da",40.22 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target human IgG,N/A
Apta_235,AGCAGCACAGAGGTCAGATGTGGTTCGATGCTGCAAGGTGTTGTCATTTGGCATATGTTACCTATGCGTGCTACCGTGAA,4.4.20,DNA,80 nt,0.488,"25,050.81 Da",39.92 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target human IgG,N/A
Apta_236,AGCAGCACAGAGGTCAGATGAGATGGTTGACCGGTTGATGTGATTAAGGAGACGTCGATTCCTATGCGTGCTACCGTGAA,4.4.27,DNA,80 nt,0.5,"25,142.89 Da",39.77 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target human IgG,N/A
Apta_237,UUCAACGCUGUGAAGGGCUUAUACGAGCGGAUUACCC,Clone 17.16,RNA,37 nt,0.514,"12,095.01 Da",82.68 ¦ÌM,No QGRS found,N/A,Targeted therapy,Block endothelial adhesion molecules to prevent or treat vaso-occlusion in SCD,N/A
Apta_238,CACACATTCCCGTCCTCGATACGTCTAGGCTTAGTGCCACTTGCTTAATC,›¥V-1,DNA,50 nt,0.5,"15,422.68 Da",64.84 ¦ÌM,No QGRS found,N/A,Target recognition,Recognize the ›¥V and Ø¶3 subunits,Affiinity measurement of aptamers ›¥V-1 and Ø¶3-1
Apta_239,CCCAGATTACTGTGGAGTGGTTGTCTGCGAATCCTTCGTCCACCCAATAG,Ø¶3-1,DNA,50 nt,0.52,"15,567.77 Da",64.24 ¦ÌM,No QGRS found,N/A,Target recognition,Recognize the ›¥V and Ø¶3 subunits,Affiinity measurement of aptamers ›¥V-1 and Ø¶3-1
Apta_240,TTTTTAATTAAAGCTCGCCATCAAATAGCTTT,PSap4#5,DNA,32 nt,0.281,"9,987.26 Da",100.13 ¦ÌM,No QGRS found,N/A,Aptasensor,Sensing PSA concentrations between 40 and 100 nM,N/A
Apta_241,GCUUGACGGAGAUCAAGGGCGAGUCUCAUACCAAGUUGAUGGGG,HA12-16,RNA,44 nt,0.545,"14,519.47 Da",68.87 ¦ÌM,No QGRS found,N/A,Targeted therapy,HA12-16 RNA aptamer suppressed viral infection in host cells by enhancing cell viability,"The antiviral effect of selected aptamers on the viability of MDCK cells infected by the influenza virus was evaluated using the MTT method. MDCK cells were infected with influenza virus H3N2 at an MOI of 0.1 TCID50 and then treated with the selected RNA aptamers (5 pmol). The highest protective activity was observed by HA12-16, as compared with other selected RNA aptamers"
Apta_242,GCUUCCAGGAAGAGAAGUGUCAUGUGAUCAGUCCUGGUGGGUGG,HA12-5,RNA,44 nt,0.545,"14,513.42 Da",68.90 ¦ÌM,No QGRS found,N/A,Targeted therapy,Suppressed viral infection,"The antiviral effect of selected aptamers on the viability of MDCK cells infected by the influenza virus was evaluated using the MTT method. MDCK cells were infected with influenza virus H3N2 at an MOI of 0.1 TCID50 and then treated with the selected RNA aptamers (5 pmol). The highest protective activity was observed by HA12-16, as compared with other selected RNA aptamers"
Apta_243,GCUUGAAGCUAGCAGUAAGACUAGCGCUACGGAUGGGUGUGCG,HA12-8,RNA,43 nt,0.558,"14,190.27 Da",70.47 ¦ÌM,No QGRS found,N/A,Targeted therapy,Suppressed viral infection,"The antiviral effect of selected aptamers on the viability of MDCK cells infected by the influenza virus was evaluated using the MTT method. MDCK cells were infected with influenza virus H3N2 at an MOI of 0.1 TCID50 and then treated with the selected RNA aptamers (5 pmol). The highest protective activity was observed by HA12-16, as compared with other selected RNA aptamers"
Apta_244,GCUUCCGGAGAGAAGGGUCAAAGUUGUGCGGGAGUGUGUUGUGG,HA12-14,RNA,44 nt,0.568,"14,609.47 Da",68.45 ¦ÌM,No QGRS found,N/A,Targeted therapy,Suppressed viral infection,"The antiviral effect of selected aptamers on the viability of MDCK cells infected by the influenza virus was evaluated using the MTT method. MDCK cells were infected with influenza virus H3N2 at an MOI of 0.1 TCID50 and then treated with the selected RNA aptamers (5 pmol). The highest protective activity was observed by HA12-16, as compared with other selected RNA aptamers"
Apta_245,ACAGGGGTGTGGGGACAGGGGTGTGGGG,ILPR2,DNA,28 nt,0.714,"9,151.65 Da",109.27 ¦ÌM,4,84,Target detection,In vivo detection and sensing of insulin as well as its isolation and purification from biological samples,N/A
Apta_246,GGCTTTACACTTTATGCTTCCGGCCCGCGGAAATGATAACGCGTATGGTGGTATAACAATTTCACACAGGAAACAG,BnHNE1,DNA,76 nt,0.461,"23,689.99 Da",42.21 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Binding of BnHNE1, BnHNE2, BnHNE3, and their natural counterparts to HNE. Data are average ºô SD of three independent determinations"
Apta_247,GGCTTTACACTTTATGCTTCCGTACCAGAACATATCGAGTGATCCTGGGAGGATAACAATTTCACACAGGAAACAG,BnHNE2,DNA,76 nt,0.434,"23,658.00 Da",42.27 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Binding of BnHNE1, BnHNE2, BnHNE3, and their natural counterparts to HNE. Data are average ºô SD of three independent determinations"
Apta_248,GGCTTTACACTTTATGCTTCCGGCCGAGGATTTTCATACCCCGCACGAACGCATAACAATTTCACACAGGAAACAG,BnHNE3,DNA,76 nt,0.474,"23,514.89 Da",42.53 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Binding of BnHNE1, BnHNE2, BnHNE3, and their natural counterparts to HNE. Data are average ºô SD of three independent determinations"
Apta_249,CCCTGTTCCCCCTCCGCCGCTTGACTCTCC,2mHNE-1,DNA,30 nt,0.7,"9,157.64 Da",109.20 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_250,CCCTGGCCGCCCTCTGGCGCGCTGATGT,2mHNE-2,DNA,28 nt,0.75,"8,749.38 Da",114.29 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_251,GCCCTACATTCTGTGCGACTCCCCCCCCCGC,2mHNE-3,DNA,31 nt,0.71,"9,504.88 Da",105.21 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_252,CCCTTACCTACTCTGCTCCCCCCCCCCCTCGGCTGC,2mHNE-4,DNA,36 nt,0.722,"10,916.76 Da",91.60 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_253,CCCTGTTCGCTATCCCCCATCCCCCGATTGC,2mHNE-5,DNA,31 nt,0.645,"9,494.88 Da",105.32 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_254,CCCGCTGTTCTCCCCCCCCCGCTGAGATCCCTGT,2mHNE-6,DNA,34 nt,0.706,"10,418.45 Da",95.98 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_255,TAGCGATACTGCGTGGGTTGGGGCGGGTAGGGCCAGCAGTCTCGT,DNA-I,DNA,45 nt,0.644,"14,285.90 Da",70.00 ¦ÌM,3,64,Targeted binding,Vehicle for molecular delivery,Binding curves of peptide-conjugated (solid circles; Kd = 7 ºô 2 nM) and unconjugated (open circles; Kd = 17 ºô 6 nM) DNA-I obtained by nitrocellulose filter binding
Apta_256,GGGCGCUAAGUCCUCGCUCAUGCGCGUCCCAUGGGGUAUAGAGGGGUCGAAGUGGACGCGCGACUCGGAUCCU,TR-D20,RNA,73 nt,0.644,"23,838.95 Da",41.95 ¦ÌM,No QGRS found,N/A,Targeted therapy,Controlled blocking of signaling pathways in vivo,N/A
Apta_257,GGCAGAAGAAATATCGAAACCCAGAATGGTCGGCCAGGCG,CLN0015,DNA,40 nt,0.55,"12,661.96 Da",78.98 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_258,CACTGCGGGGGTCTATACGTGAGGAAGAAGTGGGCAGGTC,CLN0020,DNA,40 nt,0.6,"12,746.96 Da",78.45 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,Fitted CLN0020 binding to both CD16 allotypes and minor binding to CD16. Enlarged symbols represent calculated KD values
Apta_259,GCAAGTATGAGCGCAGGAGTTAGGTCCCGTGGCGATGGGT,CLN0021,DNA,40 nt,0.6,"12,737.95 Da",78.51 ¦ÌM,2,20,Targeted binding,Binding to target proteins,N/A
Apta_260,GACGTTAAGCTAGCAGGTGTTAGGTCCCGTGGTGATGAAT,CLN0023,DNA,40 nt,0.5,"12,686.94 Da",78.82 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_261,TAAACCCCAAAACAGTGCAACTAGGTGTAGGTCCCGTGGT,CLN0030,DNA,40 nt,0.5,"12,553.88 Da",79.66 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,N/A
Apta_262,ACGGACTCGCAAAAGGTGGAACAGGAGTGGGCCCCGCGGC,CLN0118,DNA,40 nt,0.675,"12,670.92 Da",78.92 ¦ÌM,2,19,Targeted binding,Binding to target proteins,N/A
Apta_263,AGAGGGGAGGGTCGGGTATCGGCGTGTTCGGGGGATCTGC,CLN0123,DNA,40 nt,0.675,"12,825.97 Da",77.97 ¦ÌM,3,56,Targeted binding,Binding to target proteins,N/A
Apta_264,GGCGTTGTCGGGCGCAGGTGTAGGCCTCGTGGTGGTGGGT,CLN0126,DNA,40 nt,0.7,"12,783.92 Da",78.22 ¦ÌM,2,19,Targeted binding,Binding to target proteins,N/A
Apta_265,CCACTGCGGGGGTCTATACGTGAGGAAGAAGTGGGCAGGTCGCAGGTCGGAGGGAAAAGTTATCAGGCTGGATGGTAGCTCGGTCGGGGTGGGTGGGTTGGCAAGTCTGATTAGTTTTGGAGTACTCGCTCC,bsA17,DNA,132 nt,0.576,"41,577.26 Da",24.05 ¦ÌM,2,21,Targeted binding,Binding to target proteins,N/A
Apta_266,TGGATGGTAGCTCGGTCGGGGTGGGTGGGTTGGCAAGTCT,CLN0003,DNA,40 nt,0.625,"12,806.96 Da",78.08 ¦ÌM,2,21,Targeted binding,Binding to target proteins,N/A
Apta_267,GAGTGCGTAATGGTACGATTTGGGAAGTGGCTTGGGGTGG,CLN0004,DNA,40 nt,0.55,"12,839.01 Da",77.89 ¦ÌM,2,20,Targeted binding,Binding to target proteins,N/A
Apta_268,CUUAUAGGGGAGGCUGUGGUGAGGGAAUAUUAAGAGAAUUAACGGUCUAGUUCACCUCGA,AIR-3,RNA,60 nt,0.45,"19,673.49 Da",50.83 ¦ÌM,2,20,Targeted binding,"To deliver bulky cargos, exemplified by fluorescently labeled streptavidin, into IL-6R presenting cells, thereby setting the stage for an aptamer-mediated escort of drug molecules to diseased cell populations or tissues",Aptamer AIR-3 binds the soluble IL-6 receptor (sIL-6R) with high affinity. Filter retention assays. Constant amounts (1 nM) of 32P-radioactively labeled aptamer AIR-3 (red diamonds) and RNA starting library R1 (black circles) were incubated with increasing amounts of sIL-6R (0·ª300 nM). Protein-bound RNA was visualized by autoradiography. Fractions of bound RNA molecules were plotted against the concentration of sIL-6R (logarithmic scale). Data points represent mean values of 10 independent measurements
Apta_269,AACGCUCAACGUCAGAAGGCAACGUAUAGGCAAGCACACUUCGACAUGAGGC,26A,RNA,52 nt,0.519,"17,007.06 Da",58.80 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibit the first step in the signaling pathway of basic fibroblast growth factor: binding of the growth factor to Its cell-surface receptors,Representative binding curves for high-affinity RNA ligands
Apta_270,CUGUCGAACAUGCUGAGGGUAACGUACUGGCAAGCUCACCUCAGCGUAGCUAa,22B,RNA,53 nt,0.528,"17,260.10 Da",57.94 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibit the first step in the signaling pathway of basic fibroblast growth factor: binding of the growth factor to Its cell-surface receptors,Representative binding curves for high-affinity RNA ligands
Apta_271,CUGUCGAGCAUGCUCAGGGUAACGUAUAGUCAAGACACCUCAAGUGUAACU,28B,RNA,51 nt,0.471,"16,594.70 Da",60.26 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibit the first step in the signaling pathway of basic fibroblast growth factor: binding of the growth factor to Its cell-surface receptors,Representative binding curves for high-affinity RNA ligands
Apta_272,GGGAGACAAGAAUAAACGCUCAACACAGAACGCGGUCCCCACACAGGACAGGAGCCAGCCCCGGUUCGACAGGAGGCUCACAACAGGC,SRP19,RNA,88 nt,0.602,"28,737.16 Da",34.80 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to SRP19 protein,N/A
Apta_273,ATAAGCTGAGCATCTTAGATCCCCGTCAAGGGCAGCGTAA,Aptamer ID1,DNA,40 nt,0.5,"12,553.88 Da",79.66 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to PDGF-BB protein,The three most highly enriched sequences from QSAS R3?R2 were tested for their affinity
Apta_274,GATACTGAGCATCGTACATGATCCCGCAACGGGCAGTATT,Aptamer ID2,DNA,40 nt,0.5,"12,544.87 Da",79.71 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to PDGF-BB protein,The three most highly enriched sequences from QSAS R3?R2 were tested for their affinity
Apta_275,AGTTGAATGGTGTGGTCACTTCCAGTCCCGCAGGGCACAC,Aptamer ID3,DNA,40 nt,0.575,"12,552.84 Da",79.66 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to PDGF-BB protein,The three most highly enriched sequences from QSAS R3?R2 were tested for their affinity
Apta_276,GGACCGAGAAGUUACCCUGUAAUCUUAGGAUGAAUCGCAUGCUCUAGCGACCUUUUCGGCUUCGGCGUACGCACAUCGCAGCAAC,class?-1,RNA,85 nt,0.529,"27,459.08 Da",36.42 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Enhanced the amber suppression efficiency in the presence of an anticodon_x0002_adjusted (CUA) suppressor tRNA without practically damaging the protein translation machinery of the cell-free extract of E.coli, as confirmed by the translation of amber-mutated (gfpamber141 or gfpamber178) and wild-type (gfpwild) genes of GFP","Overlay of SPR sensorgrams showing the specific affinity of class II-1 aptamer for E. coli RF-1. Various concentrations of E. coli RF-1 (10·ª100 nM) or E. coli RF-2 (100 nM) were injected (total 60 lL, 180 s) at a flow rate of 20 lL/min over a sensor chip SA precoated with class II-1-bio aptamer. The arrow indicates the end of injection"
Apta_277,TTTTTTGGTCAGATGAGGCCTGGTGATCGTGCCCAGGCCATATGAGCAAGGAACCCCTATGCGTGCT,A-9S,DNA,67 nt,0.537,"20,936.17 Da",47.76 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding assay for HBeAg,Determination of the dissociation constants (Kd) for aptamers A-9 and A-9S bound to HBeAg. Varying concentrations (0-8 nM) of HBeAg were incubated with 10 pM aptamer at room temperature for 1 h. The aptamer bound to the HBeAg protein was measured using the affinity real-time qPCR assay. A negative control of affinity assay was performed in parallel using an oligonucleotide sequence unable to bind to HBeAg (Table S1). Error bars represent one standard deviation from six analyses involving duplicate experiments
Apta_278,AGCAGCACAGAGGTCAGATGAGGCCTGGTGATCGTGCCCAGGCCATATGAGCAAGGAACCCCTATGCGTGCTACCGTGAA,A-9,DNA,80 nt,0.575,"25,012.80 Da",39.98 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding assay for HBeAg,Determination of the dissociation constants (Kd) for aptamers A-9 and A-9S bound to HBeAg. Varying concentrations (0-8 nM) of HBeAg were incubated with 10 pM aptamer at room temperature for 1 h. The aptamer bound to the HBeAg protein was measured using the affinity real-time qPCR assay. A negative control of affinity assay was performed in parallel using an oligonucleotide sequence unable to bind to HBeAg (Table S1). Error bars represent one standard deviation from six analyses involving duplicate experiments
Apta_279,TTTTTTTTGGGCGAAGACCGGGACGGGAGGAAAGAGATGTTTGGTTTT,EAg3-Py,DNA,48 nt,0.458,"15,259.57 Da",65.53 ¦ÌM,2,17,Targeted binding,Binding assay for HBeAg,"Comparison of the binding of HBeAg to three aptamers, EAg0, EAg3, and EAg3-Py, containing modification of pyrrolo-dC. Varying concentrations (0-8nM) of HBeAg were incubated with 10 pM of each aptamer at room temperature for 1 h. The amount of aptamers bound to HBeAg was measured using the affinity real-time qPCR assay. A negative control of affinity assay was performed in parallel using an oligonucleotide sequence unable to bind to HBeAg (Table S1). Error bars represent one standard deviation from six analyses involving duplicate experiments"
Apta_280,GAUAAUACGACUCACUAUAGGGUUCACUGCAGACUUGACGAAGCUUGCAGAAAAGGGGGAAGAAGAGGGUGAUUCAGGCGAGAGAAUGGAUCCACAUCUACGAAUUC,ES15-1,RNA,107 nt,0.467,"34,958.69 Da",28.61 ¦ÌM,No QGRS found,N/A,Targeted therapy,Efficiently inhibit double-stranded DNA unwinding activity of the helicase by up to 85% with an IC50 value of 1.2 nM,Inhibition of the helicase activity of the SCV helicase in the presence of various concentrations of the ES15 RNA
Apta_281,CCGTAATACGACTCACTATAGGGGAGCTCGGTACCGAATTCATGTTGGTAGTTGGCTTGTGTTCGTGTGTTAAGCTTTCAGAGAGGATCCTT,NG8,DNA,92 nt,0.467,"28,730.15 Da",34.81 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit SARS-CoV replication,Effect of modified aptamers on the ATPase activity of SCV helicase
Apta_282,ATCCATGGGGCGGAGATGAGGGGGAGGAGGGCGGGTACCCGGTTGAT,A8,DNA,47 nt,0.66,"15,051.40 Da",66.44 ¦ÌM,3,58,Aptasensor,Biosensor for specific detection of Listeria monocytogenes,Analysis of interaction of aptamer A8 with protein preparations from different bacterial cultures. Proteins were vacuumimmobilized on the PVDF membrane using a slot blot and reacted with biotinylated-A8 (10 pmol L**-1) and developed using streptavidinconjugated HRP (100 ng ml)**-1) and a substrate. Bands marked with a dotted circle show positive reactions. Anti-InlA antibody also showed a very weak reaction with L. monocytogenes cells
Apta_283,ACTCCGTCATCTTTAGTGGCCCCAATGTCGTTATCACCGA,HA68,DNA,40 nt,0.5,"12,397.75 Da",80.66 ¦ÌM,No QGRS found,N/A,Target detection,Be used in rapid detection and typing protocols for fifield applications,The dissociation constant (Kd) of each DNA aptamer was used to describe the strength of the binding affinity between aptamer and recombinant swH3 protein. The Kd was calculated from the dot blot chemiluminescence intensity based on a nonlinear regression equation
Apta_284,CACTCCGTCACTTTAGTGGATCTTTATAAAACCGATGCTG,HA7,DNA,40 nt,0.425,"12,460.82 Da",80.25 ¦ÌM,No QGRS found,N/A,Target detection,Be used in rapid detection and typing protocols for fifield applications,The dissociation constant (Kd) of each DNA aptamer was used to describe the strength of the binding affinity between aptamer and recombinant swH3 protein. The Kd was calculated from the dot blot chemiluminescence intensity based on a nonlinear regression equation
Apta_285,GCCACTCCGTCACTTTAGTGGTTTTTTTTATAAATGCTTC,HA2a,DNA,40 nt,0.375,"12,423.77 Da",80.49 ¦ÌM,No QGRS found,N/A,Target detection,Be used in rapid detection and typing protocols for fifield applications,The dissociation constant (Kd) of each DNA aptamer was used to describe the strength of the binding affinity between aptamer and recombinant swH3 protein. The Kd was calculated from the dot blot chemiluminescence intensity based on a nonlinear regression equation
Apta_286,TACTCCGTCACTTTAGTGGATATAACAACCTCCCTATGGG,HA2b,DNA,40 nt,0.45,"12,445.80 Da",80.35 ¦ÌM,No QGRS found,N/A,Target detection,Be used in rapid detection and typing protocols for fifield applications,The dissociation constant (Kd) of each DNA aptamer was used to describe the strength of the binding affinity between aptamer and recombinant swH3 protein. The Kd was calculated from the dot blot chemiluminescence intensity based on a nonlinear regression equation
Apta_287,CAGCACCGACCTTGTGCTTTGGGAGTGCTGGTCCAAGGGCGTTAATGGACA,CoV2-RBD-1C aptamer,DNA,51 nt,0.569,"16,027.05 Da",62.39 ¦ÌM,2,20,Targeted binding,Binding to SARS-CoV-2 RBD,The binding affinity of the CoV2-RBD-1C aptamer
Apta_288,ATCCAGAGTGACGCAGCATTTCATCGGGTCCAAAAGGGGCTGCTCGGGATTGCGGATATGGACACGT,CoV2-RBD-4C aptamer,DNA,67 nt,0.552,"21,028.25 Da",47.56 ¦ÌM,2,19,Targeted binding,Binding to SARS-CoV-2 RBD,The binding affinity of the CoV2-RBD-4C aptamer
Apta_289,GGGGGCUUAUCAUUCCAUUUAGUGUUAUGAUAACC,8A-35,RNA,35 nt,0.4,"11,384.51 Da",87.84 ¦ÌM,No QGRS found,N/A,Targeted therapy,Development of effective therapeutic agents against inflammatory diseases,"Each aptamer (0.001 w 1000 nM) was pre-incubated with 0.1 nM [125I]-IL-8 at room temperature for 40 min, followed by the addition of 1x10**6 human neutrophils and incubation at 4 ©} for 90 min. The inhibitory activities of 8A-44, 8A-44COM, 8A-35 and 8A-30 were analyzed by measuring the radioactivity of the cell surface-bound [125I]-IL-8 using a g-scintillation counter"
Apta_290,GAACTCACCGGGAAGAAGCCCGTTCCGTCACAGACATGTT,ADR7,DNA,41 nt,0.55,"12,514.84 Da",79.91 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognise MCP-1 in different ways,Aptamer inhibition of heparin binding. Binding measurements were carried out by surface plasmon resonance using a Biacore 2000 instrument at 25 ©}
Apta_291,AAAAATCTAGGCGCTGAAGCCCCGCTTCCTTACCTTCAC,ADR22,DNA,39 nt,0.513,"12,071.56 Da",82.84 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognise MCP-1 in different ways,Aptamer inhibition of heparin binding. Binding measurements were carried out by surface plasmon resonance using a Biacore 2000 instrument at 25 ©}
Apta_292,CUACGAACUCAUGACACAAGGAUGCAAUCUCAUCCCGCCAGCCCACCGU,SAF-93,RNA,49 nt,0.551,"15,796.28 Da",63.31 ¦ÌM,No QGRS found,N/A,Targeted binding,Diagnostic and therapeutic approaches to TSEs,Affinity of aptamer SAF-93 for proteinase K-treated and untreated scrapie-associated fibrils
Apta_293,CGGCCACAGAAUGAAAAACCUCAUCGAUGUUGCAUAGUUG,OPN-R3,RNA,40 nt,0.45,"13,066.63 Da",76.53 ¦ÌM,No QGRS found,N/A,Targeted therapy,Decreases local progression and distant metastases,"OPN-R3 and adhesion, migration, and invasion of MDA-MB-231 cells"
Apta_294,AUACCAGCUUAUUCAAUUGCCUGAUUAGCGGUAUCACGAUUACUUACCUUCGUUGCUGAGAUAGUAAGUGCAAUCU,SQ-1,RNA,76 nt,0.395,"24,438.19 Da",40.92 ¦ÌM,No QGRS found,N/A,Targeted binding,The aptamer-mediated identification of ALPPL-2 on the cell surface and cell secretions of pancreatic cancer cells supports its potential use in the serum and membrane-based diagnosis of PDAC,N/A
Apta_295,AUACCAGCUUAUUCAAUUGCCUGAAAAGCUAUCGCCCAAUUCGCAGUGAUAUCCUUUAAGAUAGUAAGUGCAAUCU,SQ-2,RNA,76 nt,0.382,"24,451.29 Da",40.90 ¦ÌM,No QGRS found,N/A,Targeted binding,The aptamer-mediated identification of ALPPL-2 on the cell surface and cell secretions of pancreatic cancer cells supports its potential use in the serum and membrane-based diagnosis of PDAC,Binding affinity of chemically synthesized SQ-2(6-30)-TAMRA was calculated by nucleocytometer
Apta_296,AUACCAGCUUAUUCAAUUGCCUGAAAACCUGGUCUCUCUGUCAGCAAAGACUAUGTUGAGAUAGUAAGUGCAAUCU,SQ-3,RNA,76 nt,0.395,"24,507.31 Da",40.80 ¦ÌM,No QGRS found,N/A,Targeted binding,The aptamer-mediated identification of ALPPL-2 on the cell surface and cell secretions of pancreatic cancer cells supports its potential use in the serum and membrane-based diagnosis of PDAC,N/A
Apta_297,AUACCAGCUUAUUCAAUUGCCUGAGUAGCUGGGUCCGUCCCCACACAUUACCAUUUGUAGAUAGUAAGUGCAAUCU,SQ-4,RNA,76 nt,0.434,"24,435.24 Da",40.92 ¦ÌM,No QGRS found,N/A,Targeted binding,The aptamer-mediated identification of ALPPL-2 on the cell surface and cell secretions of pancreatic cancer cells supports its potential use in the serum and membrane-based diagnosis of PDAC,N/A
Apta_298,AUACCAGCUUAUUCAAUUGCCUGAAAACUGGUGUACCUCUUUGCCCUAUCUUAUCUGGAGAUAGUAAGUGCAAUCU,SQ-5,RNA,76 nt,0.395,"24,398.17 Da",40.99 ¦ÌM,No QGRS found,N/A,Targeted binding,The aptamer-mediated identification of ALPPL-2 on the cell surface and cell secretions of pancreatic cancer cells supports its potential use in the serum and membrane-based diagnosis of PDAC,N/A
Apta_299,AUACCAGCUUAUUCAAUUGCCUGAAGACUGGAUAUACUCUUAAGCAUUUCUAUAAUCGAGAUAGUAAGUGCAAUCU,SQ-6,RNA,76 nt,0.342,"24,477.28 Da",40.85 ¦ÌM,No QGRS found,N/A,Targeted binding,The aptamer-mediated identification of ALPPL-2 on the cell surface and cell secretions of pancreatic cancer cells supports its potential use in the serum and membrane-based diagnosis of PDAC,N/A
Apta_300,AUACCAGCUUAUUCAAUUGCCUGAAACUGCUGCAUCGUCUCCCACGUAUUACACAUGAAGAUAGUAAGUGCAAUCU,SQ-7,RNA,76 nt,0.408,"24,426.28 Da",40.94 ¦ÌM,No QGRS found,N/A,Targeted binding,The aptamer-mediated identification of ALPPL-2 on the cell surface and cell secretions of pancreatic cancer cells supports its potential use in the serum and membrane-based diagnosis of PDAC,N/A
Apta_301,AUACCAGCUUAUUCAAUUGCCUGAAAAGUUGAACUCCAAAUACGCGCUGAGAUAGUAAGUGCAAUCU,SQ-8,RNA,67 nt,0.388,"21,675.71 Da",46.13 ¦ÌM,No QGRS found,N/A,Targeted binding,The aptamer-mediated identification of ALPPL-2 on the cell surface and cell secretions of pancreatic cancer cells supports its potential use in the serum and membrane-based diagnosis of PDAC,N/A
Apta_302,ATCCTGTGAGGAATGCTCATGCATAGCAAGGGCT,A6,DNA,34 nt,0.5,"10,746.71 Da",93.05 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Abrin toxin,Binding curve of TA6 (1 nM) with increasing concentrations of abrin in selection buffer. FP changes refer to the difference in steady-state polarization from the 5-FAM-labeled DNA in the absence and presence of abrin at RT. The line is a nonlinear least square fit using GraphPad Prism software and the fitted dissociation constant is 28 ºô 9 nM
Apta_303,CCUCCGGCUCAUACCUUUUCGAAGACAAGCUUCGACAGGAGG,Oligo569,RNA,42 nt,0.548,"13,644.94 Da",73.29 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of Lipocalin-2,The mLcn2 aptamer (oligo569) was titrated into 5 ×SM 6xHis-mLcn2 by ITC
Apta_304,CGGCCGAUAGAAAGACUACUUGAGCCCUUAAAUGAGGUUAUGUGCGGCCG,A10,RNA,50 nt,0.52,"16,360.56 Da",61.12 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to GnRH,N/A
Apta_305,GGGAGGACGAUGCGGAUCGCCCUGAACCGGCCCAGCAGACUGCUGACGGCACGAUCCGCAUCGUCCUCCC,ADR58,RNA,70 nt,0.686,"22,742.38 Da",43.97 ¦ÌM,No QGRS found,N/A,Targeted therapy,Antagonize OSM binding to the gp130 receptor and specifically antagonize OSM mediated signaling,Effect of aptamers on LIF-and OSM-induced interleukin 6 release from KB cells
Apta_306,CAAGGTAACCAGTACAAGGTGCTAAACGTAATGGCTTCG,LD201,DNA,39 nt,0.462,"12,288.72 Da",81.38 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin binding to immobilized SLex in static assays and inhibit L-selectin-mediated rolling of human lymphocytes and neutrophils on cytokine-activated endothelial cells in flow-based assays,N/A
Apta_307,CATTCACCATGGCCCCTTCCTACGTATGTTCTGCGGGTG,LD174,DNA,39 nt,0.564,"12,116.55 Da",82.53 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin binding to immobilized SLex in static assays and inhibit L-selectin-mediated rolling of human lymphocytes and neutrophils on cytokine-activated endothelial cells in flow-based assays,N/A
Apta_308,TGGCGGTACGGGCCGTGCACCCACTTACCTGGGAAGTGA,LD196,DNA,39 nt,0.641,"12,289.66 Da",81.37 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin binding to immobilized SLex in static assays and inhibit L-selectin-mediated rolling of human lymphocytes and neutrophils on cytokine-activated endothelial cells in flow-based assays,N/A
Apta_309,TAGCCAAGGTAACCAGTACAAGGTGCTAAACGTAATGGCTTCGGCTTAC,LD201t1,DNA,49 nt,0.469,"15,353.67 Da",65.13 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin binding to immobilized SLex in static assays and inhibit L-selectin-mediated rolling of human lymphocytes and neutrophils on cytokine-activated endothelial cells in flow-based assays,N/A
Apta_310,GCGCCAGCTTTGCTGATGGGTGGCCACCCTTGCCCTGGGTTTGAATTTCGATCCTATCG,H38-15,DNA,59 nt,0.576,"18,358.49 Da",54.47 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Inhibited the biological activities of HGF including the stimulation of scattering, migration, and invasion of pancreatic can_x0002_cer KP-3 cells",Dose-dependent inhibition of HGF-induced migration of cells on the addition of H38-15 or H38-21. The concentration of HGF was 100 pM. The relative ratios of migrating cells for DNA/HGF (assigned as 100%) versus for each DNA are indicated. The means of the results obtained for 10 randomly selected microscopic fields in each well are shown with SD. The data shown are representative of three experiments
Apta_311,GTGGGGTTGGGTGGGTTTGGGTTATGGGCGCTCCGGCCCGGCGTCTTGCGTCCCTTCCAT,H38-21,DNA,60 nt,0.667,"18,847.74 Da",53.06 ¦ÌM,3,62,Targeted therapy,"Inhibited the biological activities of HGF including the stimulation of scattering, migration, and invasion of pancreatic can_x0002_cer KP-3 cells",Dose-dependent inhibition of HGF-induced migration of cells on the addition of H38-15 or H38-21. The concentration of HGF was 100 pM. The relative ratios of migrating cells for DNA/HGF (assigned as 100%) versus for each DNA are indicated. The means of the results obtained for 10 randomly selected microscopic fields in each well are shown with SD. The data shown are representative of three experiments
Apta_312,GGGAAAAGAGACGGCCGGCGCCAUAGCCGAGAUCCGAGGUGUUGCCGAGAA,Aptamer 15,RNA,51 nt,0.627,"16,883.98 Da",59.23 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibits enzymatic activity,Arachidonic acid-mediated contractions of guinea pig lung pleural strips in the presence of aptamer 15
Apta_313,UGCCCUGCCCUCACCCGUUAGCCUGAGCGCCCCGCA,F3Bomf,RNA,36 nt,0.722,"11,586.70 Da",86.31 ¦ÌM,No QGRS found,N/A,Targeted binding,Used for ex vivo imaging slices of human brain tumors,N/A
Apta_314,GGUUACCAGCCUUCACUGCUCCCGGACGCGUCUGUAUCCGCUACCCGCCGCACCACGGUCGGUCACAC,F3,RNA,68 nt,0.662,"21,823.74 Da",45.82 ¦ÌM,No QGRS found,N/A,Targeted binding,Used for ex vivo imaging slices of human brain tumors,N/A
Apta_315,GGGAGGACGAUGCGGUCGUAUUAUCCGCUGCACGCCAGACGACUCGCCCGA,C4-3,RNA,51 nt,0.647,"16,670.76 Da",59.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Identification of aptamer-based ago_x0002_nists for a variety of cell-surface signaling receptors,"C4-3 is specifically internalized by TrkB-expressing HEK cells. TrkB-expressing or TrkB-negative HEK cells were incubated with 100 nM FAM-labeled C4-3 or control RNA for 1 h at 37 ¨FC. Surface-bound RNA was stripped from the cells with a salt/acid wash, and then cells were fixed with formaldehyde, permeabilized, and labeled with anti-FAM and fluorescent secondary antibodies. A, TrkB-expressing HEK cells incubated with C4-3. B, HEK cells incubated with C4-3. C, TrkB-expressing HEK cells incubated with control RNA. Note evidence of C4-3 immunoreactivity signal within TrkB-expressing HEK cells [punctate (e.g., see arrows) and diffuse fluorescence in A] and signal absence in cells lacking TrkB (B). Signal detected with control RNA in TrkB-expressing HEK cells (C) provides a measure of nonspecific uptake of RNA molecules of the size of C4-3 in these cells"
Apta_316,CCGCCCAAATCCCTAAGAGAAGACTGTAATGACATCAAACCAGACACACTACACACGCA,B1·ª4,DNA,59 nt,0.475,"18,241.58 Da",54.82 ¦ÌM,No QGRS found,N/A,Targeted binding,Assay of intracellular IFN-c,Evaluation of B1-4¨Ùs affinity to IFN-c. The affinity between FITC-labeled B1-4 and IFN-c was quantitatively assayed by plotting the fluorescence against the DNA concentration
Apta_317,GGTTGGTGTGGTTGGTTTTTTTTTTTTTTTTTTTTAGTCCGTGGTAGGGCAGGTTGGGGTGACT,15mer-29-mer dimer with 20T linker,DNA,64 nt,0.422,"20,197.64 Da",49.51 ¦ÌM,2,20,Targeted binding,Improves the affinities,N/A
Apta_318,CCCGTCTTCCAGACAAGAGTGCAGGG,Apt,DNA,26 nt,0.615,"8,221.09 Da",121.64 ¦ÌM,No QGRS found,N/A,Targeted therapy,Block proteins,N/A
Apta_319,ACCCUGAUGGUAGACGCCGGGGUG,NX-178,RNA,24 nt,0.667,"8,002.61 Da",124.96 ¦ÌM,No QGRS found,N/A,Targeted binding,Binds to VPF/VEGF with high affinity and specificity,N/A
Apta_320,GCACTCTGTGGGGGTGGACGGGCCGGGT,Vap7,DNA,28 nt,0.75,"8,998.54 Da",111.13 ¦ÌM,2,21,Targeted binding,Binding to VEGF,N/A
Apta_321,AACCGCCCAAATCCCTAAGAGTCGGACTGCAACCTATGCTATCGTTGATGTCTGTCCAAGCAACACAGACACACTACACACGCACA,MA3,DNA,86 nt,0.5,"26,505.82 Da",37.73 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Capable of carrying doxorubicin into MUC1-positive tumor cells, while significantly reducing the drug intake by MUC1-negative cells",Quantitative assay of the affinity between FITC-labeled MA3 and the MUC1 epitope (APDTRPAPG)
Apta_322,GAAGTGAAAATGACAGAACACAACA,MUC1-5TR-1,DNA,25 nt,0.36,"7,974.01 Da",125.41 ¦ÌM,No QGRS found,N/A,Aptasensor,"New diagnostic assays against this tumour marker for the early diagnosis of primary or metastatic disease in breast, bladder and other epithelial tumours",Displacement ELISA of the C595 anti-MUC1 antibody from the MUC1-5TR protein using the four aptamer species selected. A scrambled aptamer has been previously shown not to interfere with this interaction
Apta_323,GGCTATAGCACATGGGTAAAACGAC,MUC1-5TR-2,DNA,25 nt,0.48,"7,963.96 Da",125.57 ¦ÌM,No QGRS found,N/A,Aptasensor,"New diagnostic assays against this tumour marker for the early diagnosis of primary or metastatic disease in breast, bladder and other epithelial tumours",Displacement ELISA of the C595 anti-MUC1 antibody from the MUC1-5TR protein using the four aptamer species selected. A scrambled aptamer has been previously shown not to interfere with this interaction
Apta_324,CAAACAATCAAACAGCAGTGGGGTG,MUC1-5TR-3,DNA,25 nt,0.48,"7,972.97 Da",125.42 ¦ÌM,No QGRS found,N/A,Aptasensor,"New diagnostic assays against this tumour marker for the early diagnosis of primary or metastatic disease in breast, bladder and other epithelial tumours",Displacement ELISA of the C595 anti-MUC1 antibody from the MUC1-5TR protein using the four aptamer species selected. A scrambled aptamer has been previously shown not to interfere with this interaction
Apta_325,TACTGCATGCACACCACTTCAACTA,MUC1-5TR-4,DNA,25 nt,0.44,"7,769.84 Da",128.70 ¦ÌM,No QGRS found,N/A,Aptasensor,"New diagnostic assays against this tumour marker for the early diagnosis of primary or metastatic disease in breast, bladder and other epithelial tumours",Displacement ELISA of the C595 anti-MUC1 antibody from the MUC1-5TR protein using the four aptamer species selected. A scrambled aptamer has been previously shown not to interfere with this interaction
Apta_326,GCAACAGGGTATCCAAAGGATCAAA,S1.6,DNA,25 nt,0.44,"7,956.97 Da",125.68 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind to MUC1 Tumour Marker,N/A
Apta_327,GGCTATAGCACATGGGTAAAACGAC,5TRG2,DNA,25 nt,0.48,"7,963.96 Da",125.57 ¦ÌM,No QGRS found,N/A,Targeted therapy,Internalized by epithelial cancer cells and can be precisely activated by light to kill such cells,N/A
Apta_328,GGGTTATATTACTCGGCCGGTGTAA,5TRG1,DNA,25 nt,0.48,"7,967.93 Da",125.50 ¦ÌM,No QGRS found,N/A,Targeted therapy,Internalized by epithelial cancer cells and can be precisely activated by light to kill such cells,N/A
Apta_329,GGCGTACGGTAGGCGGGGTCAACTG,5TRG3,DNA,25 nt,0.68,"8,043.96 Da",124.32 ¦ÌM,2,19,Targeted therapy,Internalized by epithelial cancer cells and can be precisely activated by light to kill such cells,N/A
Apta_330,GCTGGGTAAATAGATGATTCCCGGC,5TRG4,DNA,25 nt,0.52,"7,961.93 Da",125.60 ¦ÌM,No QGRS found,N/A,Targeted therapy,Internalized by epithelial cancer cells and can be precisely activated by light to kill such cells,N/A
Apta_331,GAAGTGAAAATGACAGAACACAACA,5TR1,DNA,25 nt,0.36,"7,974.01 Da",125.41 ¦ÌM,No QGRS found,N/A,Targeted therapy,Internalized by epithelial cancer cells and can be precisely activated by light to kill such cells,N/A
Apta_332,GGCTATAGCACATGGGTAAAACGAC,5TR2,DNA,25 nt,0.48,"7,963.96 Da",125.57 ¦ÌM,No QGRS found,N/A,Targeted therapy,Internalized by epithelial cancer cells and can be precisely activated by light to kill such cells,N/A
Apta_333,CAAACAATCAAACAGCAGTGGGGTG,5TR3,DNA,25 nt,0.48,"7,972.97 Da",125.42 ¦ÌM,No QGRS found,N/A,Targeted therapy,Internalized by epithelial cancer cells and can be precisely activated by light to kill such cells,N/A
Apta_334,TACTGCATGCACACCACTTCAACTA,5TR4,DNA,25 nt,0.44,"7,769.84 Da",128.70 ¦ÌM,No QGRS found,N/A,Targeted therapy,Internalized by epithelial cancer cells and can be precisely activated by light to kill such cells,N/A
Apta_335,ACCGGGCGTACACCGTCGCGGCACATGTCTGAATGCGTTTAGTCTCTGTG,S5,DNA,50 nt,0.58,"15,624.78 Da",64.00 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bind to CD44 with nanomolar affinities and efficiently inhibit the growth of leukemic cancer cells characterized by high expression of CD44,Affinities of s5 and s5rev toward CD44 HABD. Dissociation constants (Kd) were determined by microscale thermophoresis
Apta_336,CATGCTTCCCCAGGGAGATGACCGGGGCGTACACCGTCGCGGCACATGTCTGAATGCGTTTAGTCTCTGTGG,S5rev,DNA,72 nt,0.597,"22,463.12 Da",44.52 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bind to CD44 with nanomolar affinities and efficiently inhibit the growth of leukemic cancer cells characterized by high expression of CD44,Affinities of s5 and s5rev toward CD44 HABD. Dissociation constants (Kd) were determined by microscale thermophoresis
Apta_337,GGGAGGAUAUUUUCUCAGACCGUAAGUACCGAAUGUGCUUUUGGCCGAUUUUUGGCCCCUGCAGUUGCAGCAUCGUGAACUAGGAUCCGGG,F1a,RNA,91 nt,0.516,"29,488.18 Da",33.91 ¦ÌM,No QGRS found,N/A,Targeted therapy,Potent inhibitor of the RNA-dependent DNA polymerase activity of both the recombinant and the virion-derived FIV reverse transcriptase,N/A
Apta_338,GGGCGCGTTCTTCGTGGTTACTTTTAGTCCCG,20t,DNA,32 nt,0.563,"10,060.22 Da",99.40 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibitory effect on PDGF dependent [3H]thymidine incorporation in PAE cells expressing the PDGF receptors,N/A
Apta_339,CACAGGCTACGGCACGTAGAGCATCACCATGATCCTGTGT,36t,DNA,40 nt,0.55,"12,505.83 Da",79.96 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibitory effect on PDGF dependent [3H]thymidine incorporation in PAE cells expressing the PDGF receptors,N/A
Apta_340,TACTCAGGGCACTGCAAGCAATTGTGGTCCCAATGGGCTGAGTA,41t,DNA,44 nt,0.523,"13,836.68 Da",72.27 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibitory effect on PDGF dependent [3H]thymidine incorporation in PAE cells expressing the PDGF receptors,N/A
Apta_341,TCGGGGTTTGGGGGTTCGGGGTCGGTTCGGTTTCTTCTAATGGA,SYL-H2C,DNA,44 nt,0.568,"13,974.69 Da",71.56 ¦ÌM,2,20,Target detection,Detect circulating tumor cells in real cancer patient blood samples with excellent detection accuracy,The dissociation constant of aptamer SYL-H2C against SW480 cells in plasma
Apta_342,GCGACUGGUUACCCGGUCG,EpDT3,RNA,19 nt,0.684,"6,308.58 Da",158.51 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to EpCAM,Determination of equilibrium dissociation constants (K¨Ùd) for the interaction between serially truncated clones of epithelial cell adhesion molecule (EpCAM) aptamers and Kato III human gastric cancer cells
Apta_343,AACAGAGGGACAAACGGGGGAAGATTTGACGTCGACGAC,EP166,DNA,39 nt,0.538,"12,412.80 Da",80.56 ¦ÌM,No QGRS found,N/A,Targeted binding,Stem cell marker or in other applications in both stem cell and cancer studies,"Along with rising aptamer concentration, the binding affinity of EP166 towards HepG2 cells expressing EpCAM was examined by FACS"
Apta_344,CACTACAGAGGTTGCGTCTGTCCCACGTTGTCATGGGGGGTTGGCCTG,SYL3C,DNA,48 nt,0.604,"15,078.41 Da",66.32 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targer cell,Binding affinity determination (Kd) of SYL3 aptamer
Apta_345,ACAGTAACCGCGTGAGGTCGA,Aptamer 110,DNA,21 nt,0.571,"6,720.15 Da",148.81 ¦ÌM,No QGRS found,N/A,Targeted therapy,Neutralize cardiomyopathy,Concentrationdependent effect of 0-100 nM aptamer 110 on beta1-AABs prepared from a patient with DCM
Apta_346,GTACGTTCAGGAGCAGTGCGA,Rapt1,DNA,21 nt,0.571,"6,751.16 Da",148.12 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to toxin B protein,N/A
Apta_347,AAAAAAAAAAAAGTACGTTCAGGAGCAGTGCGA,Rapt2,DNA,33 nt,0.364,"10,509.64 Da",95.15 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to toxin B protein,N/A
Apta_348,ACTTGCTCTGATGCGACAACCTTTTGCCCAGATAGTAAGT,NS13,DNA,40 nt,0.45,"12,485.83 Da",80.09 ¦ÌM,No QGRS found,N/A,Target detection,Detection of N-cadherin protein,Dissociation constant (Kd) curve of NS13 and NC23 for N-cadherin. The standard deviations were obtained from three separate trials
Apta_349,ATACCAGCTTATTCAATTAGACGAGTTTTATTCATTTTCCATGTCGTAGCTTACCGTGAGATAGTAAGTGCAATCT,NC23,DNA,76 nt,0.355,"23,600.95 Da",42.37 ¦ÌM,No QGRS found,N/A,Target detection,Detection of N-cadherin protein,Dissociation constant (Kd) curve of NS13 and NC23 for N-cadherin. The standard deviations were obtained from three separate trials
Apta_350,GGTGGTGGTGGTTGTGGTGGTGGTGG,AS1411,DNA,26 nt,0.654,"8,512.21 Da",117.48 ¦ÌM,2,21,Targeted therapy,Internalize into many different cancer cell-types would increase the utility of aptamer-mediated delivery of therapeutic agents,N/A
Apta_351,TTCTCGGTTGGTCTCTGGCGGAGCGATCATCTCAGAGCATTCTTAGCGTTTTGTTCTTGTGTATGATTCGCTTTTCCC,TQ 21,DNA,78 nt,0.474,"24,191.21 Da",41.34 ¦ÌM,2,18,Targeted binding,Inhibited polymerase activity,Effect of temperature on inhibition
Apta_352,GGGAGGACGAUGCGGUGGUCUCCCAAUUCUAAACUUUCUCCAUCGUAUCUGGGCAGACGACUCGCCCGA,14F,RNA,69 nt,0.565,"21,468.51 Da",46.58 ¦ÌM,2,17,Targeted binding,Binding to keratinocyte growth factor,N/A
Apta_353,GAAUUCCGCGUGUGCCAGCGAAAGUUGCGUAUGGGUCACAUCGCAGGCACAUGUCAUCUGGGCGGUCCGUUCGGGAUCC,A30,RNA,79 nt,0.595,"24,670.52 Da",40.53 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibits hrg-dependent tyrosine phosphorylation of HER2 and the hrg-induced growth response of MCF7 cells,Binding of A30 to HER3ECD and cellular HER3
Apta_354,ATACCAGCTTATTCAATTCTATACTCCACTTTGCTATTTCTCGGTTCCTTCACGCGCCGATCGCAGGCTGATGAATTGAGATAGTAAGTGCAATCT,31,DNA,96 nt,0.427,"29,652.78 Da",33.72 ¦ÌM,No QGRS found,N/A,Targeted binding,Check the surface occupancy of streptavidin-coated magnetic beads with biotinylated molecules after immobilization procedures,"Determination of the dissociation constants (KD) for aptamers 26, 30, 31, and 33"
Apta_355,GATGCAGCCACCTACATTGCAGGTTTTATAATACAACTACGCGCCGTTCGCAGGCTAGTT,26,DNA,60 nt,0.483,"18,649.76 Da",53.62 ¦ÌM,No QGRS found,N/A,Targeted binding,Check the surface occupancy of streptavidin-coated magnetic beads with biotinylated molecules after immobilization procedures,"Determination of the dissociation constants (KD) for aptamers 26, 30, 31, and 33"
Apta_356,CGGGGGGTACGTGCCCGTGTTGCTCGGCGGCCCCCTCGCTTATTTTTGTGTGCCCTTT,30,DNA,58 nt,0.638,"18,044.25 Da",55.42 ¦ÌM,No QGRS found,N/A,Targeted binding,Check the surface occupancy of streptavidin-coated magnetic beads with biotinylated molecules after immobilization procedures,"Determination of the dissociation constants (KD) for aptamers 26, 30, 31, and 33"
Apta_357,ACAATGTCGCTCTCCGCCGCAGGAGCATTGTCTGTCTTTATGCTTCTCTTTTTTGTTGC,33,DNA,59 nt,0.475,"18,248.44 Da",54.80 ¦ÌM,No QGRS found,N/A,Targeted binding,Check the surface occupancy of streptavidin-coated magnetic beads with biotinylated molecules after immobilization procedures,"Determination of the dissociation constants (KD) for aptamers 26, 30, 31, and 33"
Apta_358,GGGAATCGCCACCCGACGCAGGGTTTCCC,StrepApt2,DNA,29 nt,0.69,"9,104.64 Da",109.83 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to streptavidin,N/A
Apta_359,GGGAACGCGTTATTGGGTAACTTCCC,StrepApt1,DNA,26 nt,0.538,"8,242.10 Da",121.33 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to streptavidin,N/A
Apta_360,GGGAACGCATACGCCGCAGTATTTCCC,StrepApt3,DNA,27 nt,0.593,"8,485.26 Da",117.85 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to streptavidin,N/A
Apta_361,GGGAACGCCCGTATTGCTCGGTTCCC,StrepApt4,DNA,26 nt,0.654,"8,179.04 Da",122.26 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to streptavidin,N/A
Apta_362,GGGAACGCACCGATCGCAGGTTTCCC,StrepApt5,DNA,26 nt,0.654,"8,197.07 Da",121.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to streptavidin,N/A
Apta_363,ATTGACCGCTGTGTGACGCAACACTCAAT,St-2-1,DNA,29 nt,0.483,"9,101.67 Da",109.87 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to streptavidin,N/A
Apta_364,TATGGTATGCTGTGTGGTATGGGGTGGCGTGCTCT,B23 aptamer,DNA,35 nt,0.543,"11,166.92 Da",89.55 ¦ÌM,2,19,Aptasensor,Real-time in vivo hormone monitoring,"Affinity study of the B23 aptamer. The concentration-response curve of B23 is shown in black. Two blue lines indicate the negative controls, one is the response of truncated B23 against FSH (red) and the other is the response of a random sequence against LH (blue). Means ºô s.d. from three independent experiments are shown (n = 3)"
Apta_365,GGACCUAUGCAGUAGCCAGUGUGGACUGGGCUGCCCCCCC,M9-5,RNA,40 nt,0.675,"13,056.58 Da",76.59 ¦ÌM,No QGRS found,N/A,Targeted therapy,Discriminated between the sera of pancreatic cancer patients and healthy volunteers with high sensitivity and specificity,N/A
Apta_366,GGUUAGAGGCGACGUCCCGGAAUCCGCGCCCAUUGCCCCC,M9-4,RNA,40 nt,0.7,"13,015.58 Da",76.83 ¦ÌM,No QGRS found,N/A,Targeted therapy,Discriminated between the sera of pancreatic cancer patients and healthy volunteers with high sensitivity and specificity,N/A
Apta_367,CGAGCGUAGAAUGUCUUCCCACUAGACGUCGUUCGGCCCC,M9-6,RNA,40 nt,0.6,"12,722.57 Da",78.60 ¦ÌM,No QGRS found,N/A,Targeted therapy,Discriminated between the sera of pancreatic cancer patients and healthy volunteers with high sensitivity and specificity,N/A
Apta_368,GGTATTGAGGGTCGCATCTCAAAAGGGGTGATTGCTTGCACAATGACAGGGTAGGACAGATGGCTCTAACTCTCCTCT,A,DNA,78 nt,0.5,"24,171.48 Da",41.37 ¦ÌM,No QGRS found,N/A,Targeted binding,"Enzyme-linked assays, western blots and affinity purification",Plot of the steady-state affinity for 'A' using the Req values derived from sensorgrams in (A) fitted locally. The KD = 5.14 Çß 10**-9 M as determined from the steady-state affinity model
Apta_369,GGCTGTTGTGAGCCTCCTCCCAGAGGGAAGACTTTAGGTTCGGTTCACGTCCCGCTTATTCTTACTCCC,GBI-10,DNA,69 nt,0.551,"21,127.48 Da",47.33 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to tenascin-C,Binding of tenascin-C and subdomains of tenascin-C to aptamer GBI-10 is shown
Apta_370,GGGAGGACGCGUCGCCGUAAUGGAUGUUUUGCUCCCUG,TTA1.2,RNA,38 nt,0.605,"12,225.24 Da",81.80 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to TN-C,N/A
Apta_371,GGCAGACCAUACGGGAGAGAAACUUGCC,C13.28,RNA,28 nt,0.571,"9,062.51 Da",110.34 ¦ÌM,No QGRS found,N/A,Targeted binding,Trap a novel conformational state of a protein kinase,N/A
Apta_372,GACCAUACGGGAGAGAAACU,C13.20,RNA,20 nt,0.5,"6,475.97 Da",154.42 ¦ÌM,No QGRS found,N/A,Targeted binding,Trap a novel conformational state of a protein kinase,N/A
Apta_373,CCAUACGGGAGAGAAACU,C13.18,RNA,18 nt,0.5,"5,801.56 Da",172.37 ¦ÌM,No QGRS found,N/A,Targeted binding,Trap a novel conformational state of a protein kinase,N/A
Apta_374,GUCCCGUGCGCAAAAGUUCUUAGCGCUAGCAGUCCUAGUUGC,a.1.1,RNA,42 nt,0.548,"13,398.95 Da",74.63 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibition of cDNA synthesis and RNase H activity,N/A
Apta_375,TTGGGGAGGGGCACTGGGCAGTGTAATTTACGAAAGCGAG,Apt-9,DNA,40 nt,0.55,"12,546.06 Da",79.71 ¦ÌM,2,18,Targeted binding,Specifific Cam recognition,"Saturation curves and determination of dissociation constants (Kd) of the aptamers. Binding reactions were performed using a fixed amount of Cam-coated magnetic beads (2 Çß 10**7) with a concentration series (0 to 600 nM) of the fluorescently labelled aptamers. Based on the amounts of aptamers eluted by heat treatment, saturation curves were obtained by plotting the amount of eluted aptamer verses the amount of total incubated aptamer and the Kd were calculated by nonlinear regression analysis"
Apta_376,GGGAGCUCAGCCUUCACUGCACUCCGGCUGGUGGACGCGGUACGAGCAAUUUGUACCGGAUGGAUGUUCGGGCAGCGGUGUGGCAGGGAUGAGCGGCACCACGGUCGGAUCCAC,class A-20,RNA,114 nt,0.64,"36,950.92 Da",27.06 ¦ÌM,2,19,Targeted therapy,"The aptamer not only distinguished HA derived from the influenza A virus, but also inhibited HA-mediated membrane fusion",SPR-analysis of the binding kinetics of the aptamer-HA complex. The aptamer was injected at a flow rate of 2 ml/min for 10 min (20 ml total volume; 50 nM final concentration). Sensogram runs with HA of B/Johannesburg/05/1999 injected into the flow cell at a flow rate of 20 ml/min for 3 min
Apta_377,CUUCGGGAUUUGAGGGUAGAAUGGGACUA,G9-?,RNA,29 nt,0.483,"9,404.61 Da",106.33 ¦ÌM,No QGRS found,N/A,Targeted binding,Selected aptamers have potential as anti-HCV compounds,"Binding curves of selected RNA aptamers and DNS3. Data points were obtained by filter binding assay (50 mL reaction) as described in Materials and methods (G9-I, circle; G9-II, cross; and G9-III, square). The concentration of labeled aptamers was 5 nm"
Apta_378,UGCUCUUAGAAUGGGACUAAGACACGGGAC,G9-?,RNA,30 nt,0.5,"9,675.82 Da",103.35 ¦ÌM,No QGRS found,N/A,Targeted binding,Selected aptamers have potential as anti-HCV compounds,"Binding curves of selected RNA aptamers and DNS3. Data points were obtained by filter binding assay (50 mL reaction) as described in Materials and methods (G9-I, circle; G9-II, cross; and G9-III, square). The concentration of labeled aptamers was 5 nm"
Apta_379,UACGACACGAUUGGGACGUGUCUAUGGGAC,G9-?,RNA,30 nt,0.533,"9,668.78 Da",103.43 ¦ÌM,No QGRS found,N/A,Targeted binding,Selected aptamers have potential as anti-HCV compounds,"Binding curves of selected RNA aptamers and DNS3. Data points were obtained by filter binding assay (50 mL reaction) as described in Materials and methods (G9-I, circle; G9-II, cross; and G9-III, square). The concentration of labeled aptamers was 5 nm"
Apta_380,GGGAUGCUUCGGCAUCCCCGAAGCCGCUAUGGACCAGUGGCGCGGCUUCGGCCCGACGGAGUGGUACCGCUUCGGCGGUACGUAAGCUUGGG,B.2,RNA,92 nt,0.674,"29,744.63 Da",33.62 ¦ÌM,2,19,Targeted binding,Binding to nonstructural 5B,Assays for the interaction of the B.2 aptamer and the NS5BC55 protein. Assays were performed as described in Materials and Methods with a constant amount of labeled B.2 RNA (0.12 nM) and increasing concentrations of purified protein between 0.19 and 48 nM
Apta_381,AUUCUGUUGGCGAACUGUACGCAAGUACUGGAUGACAGCCUAUCUAU,10G-1,RNA,47 nt,0.447,"15,023.91 Da",66.56 ¦ÌM,No QGRS found,N/A,Targeted binding,The NS3-binding region in 10G-1 can serve as a basis for designing more potential inhibitors of the NS3 protein,The binding of 10G-1 to NS3. Labeled 10G-1 was mixed with different amounts of NS3 and the RNA. protein complexes were separated on filters. The radioactivity retained on the filter was divided by the total number of counts in the reaction mixture. This ratio was plotted against the concentration of NS3 in the mixture
Apta_382,GGCGUGACCUGAUGAGUCACGCAGACGCUAGCGAAUUGGUUCCUCGAAAGGGGAAAGCGUUAUUAAGAAACCAAAAUGUGUUACGAAACGUUCCC,N,RNA,95 nt,0.484,"30,687.30 Da",32.59 ¦ÌM,No QGRS found,N/A,Targeted binding,Monitoring post-translational modification of proteins,N/A
Apta_383,GGCGUGACCUGAUGAGUCACGCUAAGGAGGAUUUCCGAAAGCGGCUACGGUCCGCCAGUGUUACGAAACGUUCCC,N,RNA,75 nt,0.573,"24,170.38 Da",41.37 ¦ÌM,No QGRS found,N/A,Targeted binding,Monitoring post-translational modification of proteins,N/A
Apta_384,AUGAUCAAUCGCCUCAAUUCGACAGGAGGCUCAC,GL21.T,RNA,34 nt,0.5,"10,841.51 Da",92.24 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Inhibits its catalytic activity. GL21.T blocked Axl-dependent transducing events in vitro, including Erk and Akt phosphorylation, cell migration and invasion, as well as in vivo lung tumor formation in mice xenografts",Motility of U87MG and A549 cells was analyzed by Transwell Migration Assay in the presence of GL21.T or the unrelated aptamer for 24 hours toward 10% fetal bovine serum (FBS) or Gas6 as inducers of migration
Apta_385,ACAGATACGGAACTACAGAGGTCAATTACGGTGGCCACGC,P19,DNA,40 nt,0.525,"12,347.97 Da",80.98 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to  GPCRs,"Aptamer P19 interacts with the rat and human neurotensin receptor with high affinity. E. coli membrane nitrocellulose filter binding assay at 4¨FC. The interaction of P19 with the fully tagged rat (filled circles) and human (filled triangles) NTR is compared with that of the fully tagged human adenosine A2a receptor (filled squares); see solid lines throughout. The interaction of the negative control aptamer, G31, with the same three receptor fusion proteins is also shown and is denoted by the corresponding open symbols with a dashed line"
Apta_386,GGAAAAGATGGTATGGGCCCTAGAAAGTCCACCCGGCGCC,P108,DNA,40 nt,0.6,"12,364.95 Da",80.87 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to  GPCRs,N/A
Apta_387,CTTTAATGCCCTTCACTAGGTCTAAGCTACTACTTACCCG,B32,DNA,40 nt,0.45,"12,116.80 Da",82.53 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to  GPCRs,N/A
Apta_388,GCGGAAGCGUGCUGGGCUAGAAUAAUAAUAAGAAAACCAGUACUUUCGU,YJ-1,RNA,49 nt,0.429,"15,831.49 Da",63.17 ¦ÌM,No QGRS found,N/A,Targeted binding,The isolated aptamer bound specifically to CEA-positive cells and inhibited interactions between CEA and heterogeneous nuclear ribonucleoprotein M4,N/A
Apta_389,GCCTGTGGTGTTGGGGCGGGTGCG,T-SO508,DNA,24 nt,0.75,"7,528.81 Da",132.82 ¦ÌM,2,18,Targeted binding,Development of drugs and diagnostic tests for neurodegenerative diseases,ELONA analysis of the binding of FITC-labeled aptamers to AØ¶1-40 oligomer. A 0.43 ×Sg sample of AØ¶1-40 oligomer was immobilized in a 96-well microtiter plate
Apta_390,GGTGCGGCGGGACTAGTGGGTGTG,T-SO530,DNA,24 nt,0.708,"7,561.84 Da",132.24 ¦ÌM,2,18,Targeted binding,Development of drugs and diagnostic tests for neurodegenerative diseases,ELONA analysis of the binding of FITC-labeled aptamers to AØ¶1-40 oligomer. A 0.43 ×Sg sample of AØ¶1-40 oligomer was immobilized in a 96-well microtiter plate
Apta_391,ACCGTGGAGGATAGTTCGGTGGCTGTTCAGGGTCTCCTCCACGGT,TD05,DNA,45 nt,0.6,"13,915.89 Da",71.86 ¦ÌM,2,17,Targeted binding,"Improved kinetic and biochemical features, unique specificity and desirable pharmacological properties, may be useful in biomedical applications",N/A
Apta_392,GGATAGTTCGGTGGCTGTTCAGGGTCTCCTCCT,TD05.18,DNA,33 nt,0.576,"10,158.50 Da",98.44 ¦ÌM,2,17,Targeted binding,"Improved kinetic and biochemical features, unique specificity and desirable pharmacological properties, may be useful in biomedical applications",N/A
Apta_393,AGGAGGATAGTTCGGTGGCTGTTCAGGGTCTCCTCCT,TD05.17,DNA,37 nt,0.568,"11,443.33 Da",87.39 ¦ÌM,2,17,Targeted binding,"Improved kinetic and biochemical features, unique specificity and desirable pharmacological properties, may be useful in biomedical applications",N/A
Apta_394,GGGCGAAUUCAACUGCCAUCUAGGCAGUAACCAGGAGUUAGUAGGACAAGUUUCGUCC,AN58,RNA,58 nt,0.5,"18,676.14 Da",53.54 ¦ÌM,No QGRS found,N/A,Targeted binding,AN58 serves as a unique lead compound for developing watersoluble inhibitors with a nanomolar affinity for GluR2 AMPA receptors,Radioligand displacement assay of AN58 with S1S2. Each point represents the average intensity in arbitrary units of three radioactivity measurements of specific binding
Apta_395,AATCCACGTATCGACTAGCTCAAACCAGCCTGATAGAGCCATTCGCTTTA,clone 7,DNA,50 nt,0.46,"15,257.83 Da",65.54 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibited the interaction of PE with vitronectin,N/A
Apta_396,GGGAGGACGAUGCGGCAGUCUGCAUCGUAGGAAUCGCCACCGUAUACUUUCCCACCAGACGACUCGCUGAGGAUCCGAGA,aptamer 9.8,RNA,80 nt,0.588,"25,783.38 Da",38.78 ¦ÌM,No QGRS found,N/A,Targeted binding,"The OX40 receptor-activating aptamer is able to induce nuclear localization of NF¿ÐB, cytokine production and cell proliferation as well as enhance the potency of dendritic cell-based tumor vaccines when systemically delivered to mice",N/A
Apta_397,GGGAGGACGAUGCGGAUACCAGGAUCACAUCCUGAGGAACCCCGGCUCCCAACCUCAGACGACUCGCUGAGGAUCCGAGA,aptamer 11.2,RNA,80 nt,0.613,"25,827.49 Da",38.72 ¦ÌM,2,17,Targeted binding,"The OX40 receptor-activating aptamer is able to induce nuclear localization of NF¿ÐB, cytokine production and cell proliferation as well as enhance the potency of dendritic cell-based tumor vaccines when systemically delivered to mice",N/A
Apta_398,GGGAGGACGAUGCGGCUUUAAUCCUCGCACUCAGCGCGCAUCACCCUUGACAUCACAGACGACUCGCUGAGGAUCCGAGA,aptamer 11.4,RNA,80 nt,0.588,"25,703.33 Da",38.91 ¦ÌM,No QGRS found,N/A,Targeted binding,"The OX40 receptor-activating aptamer is able to induce nuclear localization of NF¿ÐB, cytokine production and cell proliferation as well as enhance the potency of dendritic cell-based tumor vaccines when systemically delivered to mice",N/A
Apta_399,GGGAGGACGAUGCGGCAAACCAGCUAUUUCCUGAGGUACCCCGGCUCUCCAUGGCAGACGACUCGCUGAGGAUCCGAGA,aptamer 9.3,RNA,79 nt,0.608,"25,493.21 Da",39.23 ¦ÌM,No QGRS found,N/A,Targeted binding,"The OX40 receptor-activating aptamer is able to induce nuclear localization of NF¿ÐB, cytokine production and cell proliferation as well as enhance the potency of dendritic cell-based tumor vaccines when systemically delivered to mice",N/A
Apta_400,GGGAGGACGAUGCGGAUACCAGCGAAUAACUCGCUGAGGAACCCGACUCACAAACAGACGACUCGCUGAGGAUCCGAGA,aptamer 11.8,RNA,79 nt,0.57,"25,617.42 Da",39.04 ¦ÌM,No QGRS found,N/A,Targeted binding,"The OX40 receptor-activating aptamer is able to induce nuclear localization of NF¿ÐB, cytokine production and cell proliferation as well as enhance the potency of dendritic cell-based tumor vaccines when systemically delivered to mice",N/A
Apta_401,ATCCAGAGTGACGCAGCAGATAAGTAGGTATCCGTTTGAAAAACTTTTCTGACCGTCCGACTATGGACACGGTGGCTTAGT,GR-3,DNA,81 nt,0.469,"25,046.06 Da",39.93 ¦ÌM,No QGRS found,N/A,Targeted binding,Aptamer GR-3 against GCGR can be a promising tool with the potential to attenuate hyperglycemia in diabetes mellitus,Dissociation constant (Kd) of GR-3 for CHO-GCGR cells was measured by fow cytometry
Apta_402,GCCUGUAAGGUGGUCGGUGUGGCGAGUGUGUUAGGAGAGAUUGC,cy3-RNA,RNA,44 nt,0.568,"14,346.49 Da",69.70 ¦ÌM,2,19,Aptasensor,Aptasensor for C-reactive protein,N/A
Apta_403,GTCTTGACTAGTTACGCCCCCAAGAACCCGCTTGCCGTGGTGACGTTGATCATGTCGTTTGGTCATTCAGTTGGCGCCTC,IFN›¥-1 aptamer,DNA,80 nt,0.55,"24,561.66 Da",40.71 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Designing of aptamers similar to the IFN›¥-3 aptamer provides a novel approach to assess other inflammatory protein(s) in patients before, during, and after completion of treatment and would denote clinical improvement in successfully treated patients",Binding affinity of selected aptamers. The dissociation constant (Kd) curve derived through nonlinear regression represents the binding affinity of (C) IFN›¥-1 and (D) IFN›¥-3 aptamers to 250 ng of the IFN-›¥ protein
Apta_404,GTCTTGACTAGTTACGCCCACAAGAACCTGCTTGCCATGGTGACGCCGATCATGCTTTTTGGTCATTCAGTTGGCGCCTC,IFN›¥-3 aptamer,DNA,80 nt,0.525,"24,529.66 Da",40.77 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Designing of aptamers similar to the IFN›¥-3 aptamer provides a novel approach to assess other inflammatory protein(s) in patients before, during, and after completion of treatment and would denote clinical improvement in successfully treated patients",Binding affinity of selected aptamers. The dissociation constant (Kd) curve derived through nonlinear regression represents the binding affinity of (C) IFN›¥-1 and (D) IFN›¥-3 aptamers to 250 ng of the IFN-›¥ protein
Apta_405,TCTAGCCCACTGCATAGAGGTAGCCACGTATGTGGGTGTTACCCATTCGTAGCTACCGGTG,hVap1_T1979,DNA,61 nt,0.541,"18,787.02 Da",53.23 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Demonstrated a potent inhibition of capillary tube formation of endothelial cells, comparable to the effect of a clinically approved anti-VEGF antibody drug, bevacizumab",Flow cytometry-based measurement of binding affinity of full-length and truncated aptamers to VEGF
Apta_406,AAAGCCCACTGCATAGAGGCCGCTCAACATGCGAGCCGGT,hVap2_T2160,DNA,40 nt,0.6,"12,284.91 Da",81.40 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Demonstrated a potent inhibition of capillary tube formation of endothelial cells, comparable to the effect of a clinically approved anti-VEGF antibody drug, bevacizumab",Flow cytometry-based measurement of binding affinity of full-length and truncated aptamers to VEGF
Apta_407,GTGAATTGCGTTGAATTATGTTTTTTCAGTCATCACT,G12msi,DNA,37 nt,0.324,"11,365.33 Da",87.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to G12msi,Etermination of binding affinity of G12msi aptamers to GPC3 protein. E
Apta_408,GCAATGGTACGGTACTTCCGTCATCAGCTTGTGATGTGGATGCGAACTGCAAAAGTGCACGCTACTTTGCTAA,A1,DNA,73 nt,0.479,"22,541.44 Da",44.36 ¦ÌM,No QGRS found,N/A,Targeted therapy,Aptamer A1 is a novel specific and potent BACE1 inhibitor and is a promising potential target for the treatment of AD,"Chronic intracerebroventricular injections of aptamer A1 inhibit the protein expression of BACE1 and sAPPb. Western blot detection of the protein expression levels of BACE1 in hippocampal homogenates (n = 4 per group). The data are presented as the mean-SEM. P < 0.01 relative to the A1-scr treated Tg6799 mice. sAPPb, soluble amyloid precursor protein b"
Apta_409,GCAATGGTACGGTACTTCCGGATGCGGAAACTGGCTAATTGGTGAGGCTGGGGCGGTCGTGCAGCAAAAGTGCACGCTACTTTGCTAA,1,DNA,88 nt,0.545,"27,367.49 Da",36.54 ¦ÌM,2,20,Aptasensor,Selected ssDNA aptamer may be a good alternative detection probe for the rapid and sensitive detection of SARS,"Affinity measurement of N protein-selected ssDNA aptamers interaction by ELISA. The N protein was incubated with increasing concentrations of 5©m-biotinylated aptamer 1 and 11. After addition of streptavidin-HRP, the amount of N protein-aptamer complex was calculated andgraphed as a function of aptamer concentration. The graph was fit to the Michaelis-Menten equation and the Kd was calculated (4.93ºô 0.30 nM (aptamer 1) and 9.02ºô1.89 nM (aptamer 11))"
Apta_410,GGGAGAGCGGAAGCGUGCUGGGCCUGUCGUUCGCUGUGUCUUGCUACGUUACGUUACACGGUUGGCAUAACCCAGAGGUCGAUGG,aptamer 1,RNA,85 nt,0.588,"27,476.22 Da",36.40 ¦ÌM,No QGRS found,N/A,Aptasensor,"These aptamer-antibody hybrid immunoassays may be useful for rapid, sensitive detection of SARS-CoV N protein",Detection of the SARS-CoV N protein by an aptamer-based chemiluminescence immunosorbent assay. Serially diluted N protein was captured by aptamer 1 bound to a streptavidin-coated 96-well plate via hybridization between oligo(A)16 tagged to the 30-end of the aptamer and biotinylated oligo(dT)16. Captured N protein was detected using polyclonal anti-N antibody and alkaline phosphatase-conjugated secondary antibody. The luminescence intensities and standard deviations are from triplicate experiments
Apta_411,AGACGTAAGTTAATTGGACTTGGTCGTGTGCGGCACAGCGATTGAAAT,clone 4.20,DNA,48 nt,0.458,"14,926.60 Da",66.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to histone H4 protein,N/A
Apta_412,CACGACTCTCACCTCATAGCtGGTGGGGTTCCCGGGAGGGCGGCTACGGGTTCCGTAATCAGATTTGTGTCTGGTTCTGTAGACGGCTTG,clone 4.33,DNA,90 nt,0.578,"27,852.73 Da",35.90 ¦ÌM,3,60,Targeted binding,Binding to histone H4 protein,N/A
Apta_413,GUGAGACCAGCCGAGUGGUGUCUGGCUAUUCACUGGAGCGUGGGUGGAACCCCUGCGCACUCGUUUGGCUGUCCGGGCCUUCGGGCCGGGAUUAUCUCU,APC99,RNA,99 nt,0.626,"31,864.75 Da",31.38 ¦ÌM,2,19,Targeted binding,Binding to human activated protein C (APC),Determination of Km values by Lineweaver-Burk plot of APC against Boc-Leu-Ser-Thr-Arg-NH-Mec as substrate with APC aptamers
Apta_414,GGGAGGACGAUGCGGCCGAUUAGAACUGGGCUGAGGCGUUCUGCAUUUCGGUGAUCAGACGACUCGCUGAGGAUCCGAGA,DE3A,RNA,80 nt,0.588,"25,977.44 Da",38.49 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Bind hemoglobin, significantly increase the delay time, and reduce the rate of polymerization of HbS",Saturation binding curves for individual aptamers
Apta_415,GGGAGGACGAUGCGGAAACUCAUCGGUAGCCUUCCUGCGGUCAGUCUAUUAGGACCAGACGACUCGCUGAGGAUCCGAGA,OX3B,RNA,80 nt,0.575,"25,864.41 Da",38.66 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Bind hemoglobin, significantly increase the delay time, and reduce the rate of polymerization of HbS",Saturation binding curves for individual aptamers
Apta_416,GGACCUCGGCGAAAGCCGGUAACGCCACAAGUCGGAGGGUAAGAUCUGACAGGAACUGGGUGACGGAGGUUAGGUGC,L1-Rev,RNA,77 nt,0.597,"25,129.05 Da",39.79 ¦ÌM,2,19,Aptasensor,Detection of diverse analytes with an aptazyme ligase array,Response curves for allosteric ribozyme ligases
Apta_417,GGCAGGAAGACAAACACCAGGTGAGGGAGACGACGCGAGTGTTAGATGGTAGCTGTTGGTCTGTGGTGCTGT,Hemoglobin aptamer,DNA,72 nt,0.556,"22,553.42 Da",44.34 ¦ÌM,No QGRS found,N/A,Aptasensor,The detection process of human whole blood,N/A
Apta_418,TGGCAGGAAGACAAACACATCGTCGCGGCCTTAGGAGGGGCGGACGGGGGGGGGCGTGGTCTGTGGTGCTGT,Glycated Hemoglobin Aptamer,DNA,72 nt,0.667,"22,588.38 Da",44.27 ¦ÌM,2,21,Aptasensor,The detection process of human whole blood,N/A
Apta_419,ATCAGGGCTAAAGAGTGCAGAGTTACTTAG,clone1,DNA,30 nt,0.433,"9,319.04 Da",107.31 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"The binding activities for the selected aptamers are shown. Light green bars illustrate percent binding in the absence of protein, while dark green bars show percent binding in the presence of 500 nM lysozyme"
Apta_420,AGGGACGGGCTAAGTAACTGTGGAGGGT,Undefined,DNA,28 nt,0.571,"8,798.67 Da",113.65 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of lysozyme,N/A
Apta_421,ATCTACGAATTCATCAGGGCTAAAGAGTGCAGAGTTACTTAGCCCGTGA,Aptasensor,DNA,49 nt,0.449,"15,128.75 Da",66.10 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of lysozyme,N/A
Apta_422,GGGAGCTCAGAATAAACGCTCAATTCGGGAATGATTATCAAATTTATGCCCTCTGATTTCGACATGAGGCCCGGATC,M64CA,DNA,77 nt,0.455,"23,754.25 Da",42.10 ¦ÌM,No QGRS found,N/A,Aptasensor,Detecting M. tuberculosis,"Map of the sandwich assay to detect the 77 samples. (A) Non-tuberculosis Mycobacterium and BCG Danish; (B) M. tuberculosis including H37Rv and 50 isolations, and M. bovis"
Apta_423,TGGGAGCTGATGTCGCATGGGTTTTGATCACATGA,M64RA,DNA,35 nt,0.486,"10,872.99 Da",91.97 ¦ÌM,No QGRS found,N/A,Aptasensor,Detecting M. tuberculosis,"Map of the sandwich assay to detect the 77 samples. (A) Non-tuberculosis Mycobacterium and BCG Danish; (B) M. tuberculosis including H37Rv and 50 isolations, and M. bovis"
Apta_424,UGCUAGUAUAUCGCACGGAUUUAAUCGCCGUAGAAAAGCAUGUCAAAGCCG,E03,RNA,51 nt,0.451,"16,378.78 Da",61.05 ¦ÌM,No QGRS found,N/A,Targeted binding,Be used to escort other anti-tumor or contrast agents,"Binding constants for Aptamers E03, E04, and E07"
Apta_425,UGCCGCCAUAUCACACGGAUUUAAUCGCCGUAGAAAAGCAUGUCAAAGCCG,E04,RNA,51 nt,0.49,"16,336.79 Da",61.21 ¦ÌM,No QGRS found,N/A,Targeted binding,Be used to escort other anti-tumor or contrast agents,"Binding constants for Aptamers E03, E04, and E07"
Apta_426,UGCCGCUAUAAUGCACGGAUUUAAUCGCCGUAGAAAAGCAUGUCAAAGCCG,E07,RNA,51 nt,0.471,"16,377.80 Da",61.06 ¦ÌM,No QGRS found,N/A,Targeted binding,Be used to escort other anti-tumor or contrast agents,"Binding constants for Aptamers E03, E04, and E07"
Apta_427,GAAGCUUUCACACAACAAGGCCCGGGACUGUAUUAGGGAAAUUAGAGUACAGACAGUCGCCGUGGGUCGAAUUCCGCUCA,R2,RNA,80 nt,0.513,"25,801.40 Da",38.76 ¦ÌM,No QGRS found,N/A,Targeted binding,Anti-NF-kB p65,Average binding isotherms based on electrophoretic gel mobility shift experiments. Error bars represent the standard error of the mean. Fit values of Kd are shown for indicated R1 truncations. Gray trace corresponds to apamer R1
Apta_428,GAAGCUUACAAGAAGGACAGCACGAAUAAAACCUGCGUAAAUCCGCCCCAUUUGUGUAAGGGUAGUGGGUCGAAUUCCGCUCA,R1,RNA,83 nt,0.482,"26,749.97 Da",37.38 ¦ÌM,No QGRS found,N/A,Targeted binding,Anti-NF-kB p65,Average binding isotherms based on electrophoretic gel mobility shift experiments. Error bars represent the standard error of the mean. Fit values of Kd are shown for indicated R1 truncations. Gray trace corresponds to apamer R1
Apta_429,GCAUGCAGUGUCUAUUCUCGAGUAGCGAUCGUUGAAGGGGUAUAAGGUUGGCAGAUCGCUAGCAUGCAACUGACUCGGAUAAGCA,D1,RNA,85 nt,0.494,"27,468.30 Da",36.41 ¦ÌM,2,17,Targeted binding,Anti-NF-kB p65,Average binding isotherms based on electrophoretic gel mobility shift experiments. Error bars represent the standard error of the mean. Fit values of Kd are shown for indicated R1 truncations. Gray trace corresponds to apamer R1
Apta_430,GGGAUAUCCUCGAGCAUAAGAAACAAGAUAGAUCCUGAAACUGUUUUAAGGUUGGCCGAUCUUCUGCUCGAGAAUGCAUGAAGCGUUCCAUAUUUUU,aptamer3,RNA,97 nt,0.412,"31,122.40 Da",32.13 ¦ÌM,No QGRS found,N/A,Targeted binding,Blocks the ability of NF-¿ÐB to bind duplex DNA,Estimation of equilibrium dissociation constants for p502 binding to DNA duplex 1 and RNA aptamer 3
Apta_431,CAGGCAUGCCUAGCUAAGCAGCCCAUGGCUUAUGCGCGGAAUAUUGGCUUCCGUUC,A10-3,RNA,56 nt,0.554,"17,906.61 Da",55.85 ¦ÌM,No QGRS found,N/A,Targeted therapy,Be used clinically as NAALADase inhibitors or be modified to carry imaging agents and therapeutic agents directed to prostate cancer cells,N/A
Apta_432,GGGAGACAAGAAUAAACGCUCAAGGCAUUUCUGCUAGUCUGGUUGUAAGAUAUUCAACACGUGAGUUUCGACAGGAGGCUCACAACAGGC,1G8-14,RNA,90 nt,0.467,"29,057.32 Da",34.41 ¦ÌM,No QGRS found,N/A,Targeted therapy,Be used clinically as NAALADase inhibitors or be modified to carry imaging agents and therapeutic agents directed to prostate cancer cells,ITC raw data and corresponding binding isotherms for 1G8-14 binding to eVP35 IID
Apta_433,GGGAGACAAGAAUAAACGCUCAACGUUCAGUAUAACAGUCCGAGUCUAACACACAAUGGGACACUGAAUUCGACAGGAGGCUCACAACAGGC,2F11-14,RNA,92 nt,0.478,"29,725.87 Da",33.64 ¦ÌM,No QGRS found,N/A,Targeted therapy,Be used clinically as NAALADase inhibitors or be modified to carry imaging agents and therapeutic agents directed to prostate cancer cells,ITC raw data and corresponding binding isotherms for 2F11-14 binding to eVP35 IID
Apta_434,ACACGACGGGAATACTGACTCTCCCCCATGT,PB9,DNA,31 nt,0.548,"9,425.09 Da",106.10 ¦ÌM,No QGRS found,N/A,Targeted binding,Apply fluorescently labelled probes to study the spatiotemporal dynamics and activation of individual endo genous PKC isoforms during various cell signalling processes,Anisotropy changes of 59-TMR labelled PB9 upon addition of PKC’©
Apta_435,CCTTCGTTGTCTGCCTTCGTAGGACCGCAGACATCGACGCAGGGAAATTCCGCAAGTCCAGCCAAATGCCACCCTTCAGAATTCGCACCA,85A,DNA,90 nt,0.556,"27,523.61 Da",36.33 ¦ÌM,No QGRS found,N/A,Target recognition,Recognition of other glycoproducts,"Binding curves of B-TTP-, TTP-, and M-TTP-derived 85A with fibrinogen (left), deglycosylated fibrinogen (middle), and periodated fibrinogen (right)"
Apta_436,CCCCCGCATCACGCCGTGGTGCGATTGACACAATTGCAAT,401,DNA,40 nt,0.575,"12,201.84 Da",81.95 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_437,TCACAGTCCCGGTGCCGCACTAAAACCCATTGTTGTGCGA,402,DNA,40 nt,0.55,"12,216.85 Da",81.85 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_438,AGCCATGACGATGTCGTTACGTAGATGCAGAGACTCCTAA,411,DNA,40 nt,0.475,"12,328.95 Da",81.11 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_439,TAACACTCGATTCTCCTAGCCCGCTAGAAATTCCCCTCCC,436,DNA,40 nt,0.525,"12,031.75 Da",83.11 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_440,AAAGACCGTTTTTTAAAACGCTCAATATACACGACATAAA,446,DNA,40 nt,0.3,"12,247.97 Da",81.65 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_441,TGAATCTCGCGCTCGTTGGTACCCTTAAAATAAAGGCATA,454,DNA,40 nt,0.425,"12,278.93 Da",81.44 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_442,AGCCATGACGATGTCGTTACGTAGATGCAGAGACTCCTAA,#411-J,DNA,40 nt,0.475,"12,328.95 Da",81.11 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_443,GGCCATGACGATGTCGTTACGTAGATGCAGAGACTCCTAA,#411-J-A1G,DNA,40 nt,0.5,"12,344.95 Da",81.00 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_444,AGCCATTACGATGTCGTTACGTAGATGCAGAGACTCCTAA,#411-J-G7T,DNA,40 nt,0.45,"12,303.94 Da",81.27 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_445,AGCCATGACGATGTCGTTACGTAGATGTAGAGACTCCTAA,#411-J-C28T,DNA,40 nt,0.45,"12,343.96 Da",81.01 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_446,AGCCATGACGATGTCGTTACGTAGATGCATAGACTCCTAA,#411-J-G30T,DNA,40 nt,0.45,"12,303.94 Da",81.27 ¦ÌM,No QGRS found,N/A,Targeted binding,Bind human receptors and cross-react with their murine orthologs,N/A
Apta_447,ACGCUCAACGAGCCAGGAACAUCGACGUCAGCAAACGCGAGCGCAACCAGUAACACC,PF377,RNA,57 nt,0.579,"18,338.12 Da",54.53 ¦ÌM,No QGRS found,N/A,Targeted therapy,Potential utility of aptamers to block endothelial adhesion molecules to prevent or treat vaso-occlusion in SCD,N/A
Apta_448,TAACTCACTCCATACTCACTTGCTGATTCGCCAACAACACACCCTTAAACAGTCCC,clone 9,DNA,56 nt,0.464,"16,895.89 Da",59.19 ¦ÌM,No QGRS found,N/A,Targeted therapy,Block toxic effects of AGE on cultured retinal pericytes,N/A
Apta_449,CGCACTATGTTTTACGAGCCGTTTCCTCGGCAGATAGTAAGTGCG,PD4S,DNA,45 nt,0.511,"13,842.88 Da",72.24 ¦ÌM,No QGRS found,N/A,Targeted therapy,Anti-PD-1 aptamer PD4S could be applied as an alternative agent in immunotherapy,N/A
Apta_450,ATACCAGCTTATTCAATTACATGTCCTGAAGGGGAATAATATACAGCTTTGGGTGGGTAGATAGTAAGTGCAATCT,PD2,DNA,76 nt,0.382,"23,558.15 Da",42.45 ¦ÌM,No QGRS found,N/A,Targeted therapy,Antitumor Immunotherapy,N/A
Apta_451,ATACCAGCTTATTCAATTGAGTAAGAGTGCACTATGTTTTACGAGCCGTTTCCTCGGCAGATAGTAAGTGCAATCT,PD4,DNA,76 nt,0.408,"23,421.04 Da",42.70 ¦ÌM,No QGRS found,N/A,Targeted therapy,Antitumor Immunotherapy,N/A
Apta_452,ATACCAGCTTATTCAATTGAAGAGTATAAAAAGAGTGATTATCTTTTGTAGGTTTTTTAGATAGTAAGTGCAATCT,PD27,DNA,76 nt,0.276,"23,536.17 Da",42.49 ¦ÌM,No QGRS found,N/A,Targeted therapy,Antitumor Immunotherapy,N/A
Apta_453,GGGCUAGCUGAUCGUACCAGUAGCGUGGCCUGGGGGGCCUAGUCGUGCGAUACUAACAGCUAACACCC,AptAF42dope1,RNA,68 nt,0.603,"21,920.05 Da",45.62 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibitory tool specifific to IL-17A/F,N/A
Apta_454,AGCTCCAGAAGATAAATTACAGGTGAGGGCGGGCGGGTGGTTGTAATATGATCGAATGGTATATGTGTGTTTGCAACTAGGATACTATGACCCCG,AP65_A1,DNA,95 nt,0.463,"29,610.97 Da",33.77 ¦ÌM,2,21,Aptasensor,Diagnostic assays for the reliable and rapid detection of T. vaginalis in vaginal swabs,Absorbance reading of biotinylated AP65_A1 aptamer binding to AP65 by ELAA and SPR sensogram showing the binding of AP65_A1 to immobilized AP65 represented in RU
Apta_455,AGCTCCAGAAGATAAATTACAGGGGCCGGGGTGGCTCAGGCAAGGGGTTGACCTGTCGTAGGGATTGTTTTAACAACTAGGATACTATGACCCC,AP65_A2,DNA,94 nt,0.511,"29,197.69 Da",34.25 ¦ÌM,3,58,Aptasensor,Diagnostic assays for the reliable and rapid detection of T. vaginalis in vaginal swabs,Affinity dissociation constants KD of the full length aptamer candidates calculated by SPR (ii)
Apta_456,AGCTCCAGAAGATAAATTACAGGTGGGTGGGTGGGCGGTGGAATTTAGCGGCGGAGCTCTGTGTGTGTTAGGGCAACTAGGATACTATGACCCC,AP65_A3,DNA,94 nt,0.532,"29,340.75 Da",34.08 ¦ÌM,2,21,Aptasensor,Diagnostic assays for the reliable and rapid detection of T. vaginalis in vaginal swabs,Affinity dissociation constants KD of the full length aptamer candidates calculated by SPR (ii)
Apta_457,AGCTCCAGAAGATAAATTACAGGGGATCAGTAAGGTTGAGACGGCCTGAATCTATCGTGGAGACCACGCGACGCAACTAGGATACTATGACCCC,AP65_A4,DNA,94 nt,0.5,"29,097.67 Da",34.37 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic assays for the reliable and rapid detection of T. vaginalis in vaginal swabs,Affinity dissociation constants KD of the full length aptamer candidates calculated by SPR (ii)
Apta_458,AGCTCCAGAAGATAAATTACAGGGAGAGTAAACTTTGCAAACACAACAATACCATTCCGGAACGTTCTTAACACAACTAGGATACTATGACCCC,AP65_A5,DNA,94 nt,0.404,"28,895.63 Da",34.61 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic assays for the reliable and rapid detection of T. vaginalis in vaginal swabs,Affinity dissociation constants KD of the full length aptamer candidates calculated by SPR (ii)
Apta_459,AGCTCCAGAAGATAAATTACAGGGGCGGGGGGGCGGGGGAGGCGGAAGGCCTGCTAAAGTCGTTGTGAGCGAACCAACTAGGATACTATGACCCC,AP65_A6,DNA,95 nt,0.579,"29,645.96 Da",33.73 ¦ÌM,3,64,Aptasensor,Diagnostic assays for the reliable and rapid detection of T. vaginalis in vaginal swabs,Affinity dissociation constants KD of the full length aptamer candidates calculated by SPR (ii)
Apta_460,GGAUGGCAGCGGAGAGUUGCUUGGAAUGCGUUAUAGUCUCUUAGGUGUGUACAGCCCACACCACUCUCC,S05,RNA,69 nt,0.536,"22,150.10 Da",45.15 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibits transcription of SP6 RNA polymerase,Estimation of dissociation constant (KD) by filter-binding assay
Apta_461,CGCTCGGCTTCACGAGATTCGTGTCGTTGTGTCCTGTACCCGCCTTGACCAGTCACTCTAGAGCATCCGGACTG,T18_1_3,DNA,74 nt,0.581,"22,662.45 Da",44.13 ¦ÌM,No QGRS found,N/A,Targeted binding,Targeting TGF-b1 protein,Multimerization of thioaptamer T18_1_3
Apta_462,GGTATAGACCCCTGAGTCCTACCGAGGGCACGGCA,1501s,DNA,35 nt,0.629,"10,766.92 Da",92.88 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of a malaria biomarker,"SPR (Biacore) analysis of the interaction between 1501s and PvLDH. PvLDH was immobilized to a Ni-NTA chip, then the response was observed at multiple concentrations of 1501s as shown in the figure. Raw data are shown background with the best fit overlain with a thick solid line. For 1501s binding to PvLDH, the association rate (kon), dissociation rate (koff), and the equilibrium dissociation constant (KD) were 2.2 Çß 10**4 M-1Íðs-1 , 1.4 Çß 10**-2 s-1 , and 670 nM, respectively"
Apta_463,GTTCTCATGCACACTTATAGCGGGGGGATCCAGTACT,M12-23,DNA,37 nt,0.514,"11,380.32 Da",87.87 ¦ÌM,No QGRS found,N/A,Targeted therapy,Costimulated T cell activation in vitro and mediated tumor rejection in mice,Mice without tumors or with tumors that had not reached 12 mm diameter. Differences between the control and treatment groups were statistically significant (P<0.01)
Apta_464,GTCAGATTCCACTATAGTAGGTTGGGTAGGGTGGTCGCAGTGGATGATATGTCGTAGGGG,4-1BB 07,DNA,60 nt,0.517,"18,793.02 Da",53.21 ¦ÌM,2,20,Targeted binding,Binds specifically to thrombin,Highest affinity aptamers obtained via particle display for four protein targets
Apta_465,AGCTGACACAGCAGGTTGGTGGGGGTGGCTTCCAGTTGGGTTGACAATACGTAGGGACACGAAGTCCAACCACGAGTCGAGCAATCTCGAAAT,aptamer 40,DNA,93 nt,0.538,"28,903.50 Da",34.60 ¦ÌM,2,21,Aptasensor,Analysis of the Lup an 1 allergen in foodstuffs,ELONA assay. Detection of ?-conglutin by ELONA using Sequence 40 in SELEX Binding Buffer at 100 nM final concentration
Apta_466,AGCTGACACAGCAGGTTGGTGGGGGTGGCTCACATCATGGTAGAATGACTGAACAGCGTTGATTAAAAGGCACGAGTCGAGCAATCTCGAAAT,aptamer 2,DNA,93 nt,0.495,"28,950.56 Da",34.54 ¦ÌM,2,21,Aptasensor,Analysis of the Lup an 1 allergen in foodstuffs,SPR Sensorgrams of the aptamer sequences obtained
Apta_467,GGGAGGACGAUGCGGCAGUGCCCAACCGGAACAACAACCACCGGCGGCUCCUGCUCAGACGACUCGCUGAGGAUCCGAGA,14-16,RNA,80 nt,0.65,"25,881.54 Da",38.64 ¦ÌM,No QGRS found,N/A,Targeted therapy,Binding to p68,The representative RNA molecules 14-16 and 14-8 were assayed for binding in vitro to tumor extracted protein
Apta_468,CTGTAATTGGCGTATGTAACCCAGGCACCAAACACCCCAT,R5A0,DNA,40 nt,0.5,"12,193.87 Da",82.01 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_469,CTGTAATTGGCGTATGTAACCCAGGCACCAAACACCCCAG,R5A1,DNA,40 nt,0.525,"12,218.88 Da",81.84 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,"Inhibition of IL-10 dependent proliferation of MC/9 cells. MC/9 cells cultured in the presence of 1ng/ml IL-10 were incubated with increasing concentrations of either anti-IL-10 antibodies, tetrameric R5A1 aptamers or tetrameric R5B1 aptamers and proliferation was determined 48 hours later by measuring 3H-thymidine incorporation"
Apta_470,CTGTAATTGGCGTATGTAACCCAGGCACCAAACACCTCAT,R5A2,DNA,40 nt,0.475,"12,208.88 Da",81.91 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_471,CTGTAATTGGCGTATGTAACCCAGGCACCAAACGCCCCAG,R5A3,DNA,40 nt,0.55,"12,234.88 Da",81.73 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_472,CCCCCACATTCAAATGGCCCCCCTACTCAATTACTGCACA,R5B1,DNA,40 nt,0.525,"12,009.75 Da",83.27 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_473,CCCTGCACTCGCAATGGCCCCTCTACACCACAAACGGACA,R5Bw2,DNA,40 nt,0.6,"12,084.79 Da",82.75 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_474,CAAAAAGATAGGTGGATTTTTCCCCGGATCGGTTTGTATG,R5C1,DNA,40 nt,0.425,"12,380.97 Da",80.77 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_475,CAAAAAGATAGGTGGATTTTTCCCCGGGTCGGTTTGTATG,R5C2,DNA,40 nt,0.45,"12,396.97 Da",80.66 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_476,CCTATCTTATTCGTTGCGGACTCCCCGGTCGGTATGTATG,R5Cw1,DNA,40 nt,0.525,"12,235.83 Da",81.73 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_477,CGCGGAAGAATTGCTATGTGTGCCCCGGTTGGTCTGTATA,R5Cw2,DNA,40 nt,0.525,"12,373.93 Da",80.82 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_478,CTTCACTTTCGTGGACGGTGGCGTCGGGGCGGTTTGTATG,R5Cw4,DNA,40 nt,0.6,"12,412.92 Da",80.56 ¦ÌM,2,19,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_479,CGGCCCACCTCGGTCGGTTTGTATGGCGAGCTGGTTTTTT,R5D1,DNA,40 nt,0.575,"12,307.86 Da",81.25 ¦ÌM,2,17,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_480,CGGCACACCTCGGTCGGTTTGTATGGCGAGCTGGTTTTTT,R5D2,DNA,40 nt,0.55,"12,331.88 Da",81.09 ¦ÌM,2,17,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_481,CGGCCCACCTCGGTCGGTTTGTATGGCGAGCTGGTTTTTA,R5D3,DNA,40 nt,0.575,"12,316.87 Da",81.19 ¦ÌM,2,17,Targeted therapy,Bound to IL-10 receptor on the cell surface and blocked IL-10 function in vitro,N/A
Apta_482,AGCAAGGTTTGGTGTTGGTTGGTTGCTGGTTTTGGTTTC,N,DNA,39 nt,0.462,"12,158.77 Da",82.25 ¦ÌM,2,19,Targeted binding,Bound to ASPV,N/A
Apta_483,ATTGGGAGGGATTGGGTGGG,[B7]-3-0,DNA,20 nt,0.6,"6,349.09 Da",157.50 ¦ÌM,3,62,Aptasensor,Peroxidase activity and strong binding affinity to hemin,CD spectra of truncated aptamers (4 ×SM) in PB buffer without (black line) and with (red line) K+
Apta_484,CAGGGAGGGACAGGGCGGGAATTTGTATGATGGTTCGTTTGCTCG,A3,DNA,45 nt,0.556,"14,084.01 Da",71.00 ¦ÌM,3,62,Aptasensor,Peroxidase activity and strong binding affinity to hemin,CD spectra of selected sequences (4 ×SM) in PB buffer without (black line) and with (red line) K+
Apta_485,TGTCGTTGGGGGGGTAGGGAAGGGTGAAACGACAAGCCAGAAGTT,B2,DNA,45 nt,0.556,"14,160.09 Da",70.62 ¦ÌM,3,63,Aptasensor,Peroxidase activity and strong binding affinity to hemin,CD spectra of selected sequences (4 ×SM) in PB buffer without (black line) and with (red line) K+
Apta_486,GGGAGGGATTGGGTGGGCACAGCTCGCTGATAGGTCCTGGTCTCAC.,B7,DNA,47 nt,0.63,"14,319.15 Da",69.84 ¦ÌM,3,62,Aptasensor,Peroxidase activity and strong binding affinity to hemin,CD spectra of truncated aptamers (4 ×SM) in PB buffer without (black line) and with (red line) K+
Apta_487,CGGGGAGTTGGGAGGGGGGGCAAAGCCTGTGTATTTATCTTCTGT,C1,DNA,45 nt,0.556,"14,075.00 Da",71.05 ¦ÌM,3,62,Aptasensor,Peroxidase activity and strong binding affinity to hemin,CD spectra of truncated aptamers (4 ×SM) in PB buffer without (black line) and with (red line) K+
Apta_488,CGACCAGGGTGGGAGGGGGACGGGCTGGCGGCGCGCGGTAATG,C7,DNA,43 nt,0.767,"13,537.63 Da",73.87 ¦ÌM,3,62,Aptasensor,Peroxidase activity and strong binding affinity to hemin,CD spectra of truncated aptamers (4 ×SM) in PB buffer without (black line) and with (red line) K+
Apta_489,GGGGTTAAATATTCCCACATTGCCTGCGCCAGTACAAATAG,DTA-64,DNA,41 nt,0.463,"12,593.12 Da",79.41 ¦ÌM,No QGRS found,N/A,Targeted therapy,Treatment of JIA and other types of arthritis,"Peripheral blood human neutrophils were obtained from healthy donors and plated on glass coverslips. Control or anti-DEK aptamers (DTA-64) were added to neutrophil cultures 15 min prior to PMA stimulation (10 ng ml-1). Neutrophils were incubated for 1 h at 37 ©}, then fixed and stained for NETs with anti-MPO (green), DAPI for DNA (blue) and DEK (red) as shown in representative confocal images from experiments using 5 ng ml -1 of control aptamer or DTA-64 (60 magnification, scale bar 20 mm). The inserts zoom in on the NETs marked by the arrows in the upper panel"
Apta_490,GGGAGACAAGAATAAACGCTCAAGGGCGTGGTGGGTGGGGTACTAATAATGTGCGTTTGTTCGACAGGAGGCTCACAACAGGC,r10/43,DNA,83 nt,0.53,"25,933.61 Da",38.56 ¦ÌM,3,52,Targeted therapy,Inhibition of HCV,"The percentage of aptamer bound is plotted against the concentration of polymerase. Estimated values for KD are also shown. Results are expressed as the means of three replicates, and error bars represent the standard errors of the means"
Apta_491,TTGGGGTCTGCTCGGGATTGCGGAGAACGTGAATCT,r10/47,DNA,36 nt,0.556,"11,203.18 Da",89.26 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibition of HCV,"The percentage of aptamer bound is plotted against the concentration of polymerase. Estimated values for KD are also shown. Results are expressed as the means of three replicates, and error bars represent the standard errors of the means"
Apta_492,GCGAGGTGTTCGAGAGTTAGGGGCGACATGACCAAACGTT,clone 24,DNA,40 nt,0.55,"12,466.01 Da",80.22 ¦ÌM,No QGRS found,N/A,Targeted therapy,Against ›¥-bungarotoxin,Binding specificity of the aptamer obtained from clone 24 & 51 by surface plasmon resonance (SPR) technique using Biacore 3000
Apta_493,GGGGTGGTGGGTTCTTTTTGTGGTATTGGTGTGGGGGGCA,N,DNA,40 nt,0.575,"12,619.04 Da",79.25 ¦ÌM,3,50,Targeted binding,Bound to ASPV,N/A
Apta_494,GGGAGAUACCAGCUUAUUCAAUUCUGGCAAUGGGCUAUCCCAAGUGCUAGGCUUCAGGGAGCGAGGACCAGACGACGUACCUAACCCUAAGGUGAGAUAGUAAGUGCAAUCU,N71yc16,RNA,112 nt,0.5,"36,151.52 Da",27.66 ¦ÌM,No QGRS found,N/A,Targeted binding,Defining the interactions between PTPases and their targets,Binding curves for anti-Yop51* aptamers with Yop51*D162
Apta_495,GGGAATGGATCCACATCTACGTATTACTGCTGGTGACGAGGGCTAGACGACGTACCTTCACTGCAGACTTGACGAAGCTT,N30yc5,DNA,80 nt,0.513,"24,718.83 Da",40.45 ¦ÌM,No QGRS found,N/A,Targeted binding,Defining the interactions between PTPases and their targets,Binding curves for anti-Yop51* aptamers with Yop51*D162
Apta_496,GGGCUAGCUGAUCGUACCCAGUAGCGUGGCAUGGGGUGCCUAGUCGGGCGAUACUAACAGCUAACACCC,APTAF42,RNA,69 nt,0.594,"22,249.25 Da",44.95 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibitory tool specifific to IL-17A/F,N/A
Apta_497,GTTCGATTGGATTGTGCCGGAAGTGCTGGCTCGAAC,pL1,DNA,36 nt,0.556,"11,163.16 Da",89.58 ¦ÌM,No QGRS found,N/A,Aptasensor,"Tool for the diagnosis, monitoring, and surveillance of malaria",Dissociation constants of the pLDH aptamers determined by a fluorescence assay. The fluorescence intensities of FAM-modified aptamers were measured to determine the dissociation constants of the pL1 aptamer and the pL2 aptamer
Apta_498,GAACTCATTGGCTGGAGGCGGCAGTACCGCTTGAGTT,pL2,DNA,37 nt,0.568,"11,461.35 Da",87.25 ¦ÌM,2,20,Aptasensor,"Tool for the diagnosis, monitoring, and surveillance of malaria",Dissociation constants of the pLDH aptamers determined by a fluorescence assay. The fluorescence intensities of FAM-modified aptamers were measured to determine the dissociation constants of the pL1 aptamer and the pL2 aptamer
Apta_499,GGACGCGUGGUACCAGGCCGAUCUAUGGACGCUAUAGGCACACCGGAUACUUUAACGAUUGGCUAAGCUUCCGCGGGGAUC,RNA aptamer for Ø¶-catenin,RNA,81 nt,0.568,"26,107.51 Da",38.30 ¦ÌM,2,18,Targeted therapy,Inhibited B-catenin-dependent transcription of cyclin D1 and c-myc in colon cancer cells,RNA-EMSAs. [32P]UTP-labeled RNA aptamer (80 pmol/L) was incubated with increasing concentrations of recombinant h-catenin
Apta_500,GGGAGAAAGGGAAGCUUGAGGUGCUAUGGAGUGGAGGAGUUGAAGGUGUCGGGGUUGGCAGAAGAAGGCGAGCGUACGGAUCCAUC,DP7,RNA,86 nt,0.57,"28,287.89 Da",35.35 ¦ÌM,2,20,Targeted therapy,Reduces PrPSc formation,Filter-binding studies of full-length prion proteins from various species
Apta_501,GGGAGACAAGAATAAACGCTCAATTTAACGTATTTATTCAAGCTCGTATTCGACAGGAGGCTCACAACAGGC,3.0 M NaSCN selection,DNA,72 nt,0.431,"22,240.32 Da",44.96 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit heparanase,"OC MZ-6 cells cultured in medium supplemented with anti-heparanase antibody, 1.5 M short, 1.5 M long and 3.0 M aptamers"
Apta_502,GGGAGACAAGAATAAACGCTCAAATGGACTTTTGAATGTGGCAACAAATTCGACAGGAGGCTCACAACAGGC,1.5 M NaCl selection,DNA,72 nt,0.458,"22,348.40 Da",44.75 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit heparanase,"OC MZ-6 cells cultured in medium supplemented with anti-heparanase antibody, 1.5 M short, 1.5 M long and 3.0 M aptamers"
Apta_503,ACTTTTGAATGTGGCAACAAATTCGACAGG,1.5 M Short,DNA,30 nt,0.4,"9,254.00 Da",108.06 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit the enzymatic action of heparanase,N/A
Apta_504,TTGCTCCTTATAGAGCCGTCCGAGC,Pink,DNA,25 nt,0.56,"7,608.91 Da",131.42 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit the enzymatic action of heparanase,N/A
Apta_505,CTAAAGTGCCTCACGCTGTTAACTC,Yellow,DNA,25 nt,0.48,"7,576.91 Da",131.98 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit the enzymatic action of heparanase,N/A
Apta_506,AAGCGCGCGAGACTACGTTTGTAGGGATACCGATGTCG,?,DNA,38 nt,0.553,"11,783.57 Da",84.86 ¦ÌM,No QGRS found,N/A,Aptasensor,Biorecognition elements for easy and fast environmental monitoring,"Binding curves and determination of dissociation constants (Kd values) of II, IV, VI, and VIII. Kd values were calculated by nonlinear regression analysis. Error bars represent standard deviations from three repeated experiments"
Apta_507,GGCGGGGCTACGAAGTAGTGATTTTTTCCGATGGCCCGTG,V?,DNA,40 nt,0.575,"12,414.95 Da",80.55 ¦ÌM,No QGRS found,N/A,Aptasensor,Biorecognition elements for easy and fast environmental monitoring,"Binding curves and determination of dissociation constants (Kd values) of II, IV, VI, and VIII. Kd values were calculated by nonlinear regression analysis. Error bars represent standard deviations from three repeated experiments"
Apta_508,GCGGGCGATCGGCGGGGGGTGCGTGCGCTCTGTGCCAGGGGGTGGGACAGATCATATGGGGGTGCT,No.22,DNA,66 nt,0.712,"20,733.17 Da",48.23 ¦ÌM,3,54,Targeted binding,Binding to 8-OHdG,Binding affifinities of the aptamers for 8-OHdG
Apta_509,TCGCGCGAGTCGTCTGGGGGACTAGAGGACTTGTGCGGCCCCGCATCGTCCTCCC,Antibac2,DNA,55 nt,0.691,"16,912.77 Da",59.13 ¦ÌM,No QGRS found,N/A,Aptasensor,Rapid bacteria detection,Binding affinity of Antibac2 aptamer
Apta_510,TGTAATTTGTCTGCAGCGGTTCTTGATCGCTGACACCATATTATGAAGA,S18,DNA,49 nt,0.408,"15,091.70 Da",66.26 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of this pesticides in agricultural products and environmental samples,Specificity and affinity determination for S18
Apta_511,ATCCGTCACACCTGCTCTCAGGGGATCACATTCTTGACGGTGTGATACAGTGCCTGGTGTTGGCTCCCGTAT,ACh 6R,DNA,72 nt,0.542,"22,123.13 Da",45.20 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of acetylcholine,N/A
Apta_512,ATAGGACGATTATCGAAAATCACCAGATTGGACCCTGGTTAACGAT,1.20E+05,DNA,46 nt,0.413,"14,190.17 Da",70.47 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to adenine,Dissociation constant determination for RNA 12 E4
Apta_513,TAGGGAAAACCAACCGCCCAGAACTGCAGCATAAC,5aF1,DNA,35 nt,0.514,"10,720.95 Da",93.28 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to adenine,N/A
Apta_514,ACTCAGCACGCGTGTAGGGAAAACCAACCGCCCACAAGCTGCATGCAACG,5bA8,DNA,50 nt,0.58,"15,336.87 Da",65.20 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to adenine,N/A
Apta_515,CCTGGGGGAGTATTGCGGAGGAAGG,DH25.42,DNA,25 nt,0.64,"7,868.06 Da",127.10 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to adenine,N/A
Apta_516,ACTCATCTGTGAGACTCACTATAGGAAGAGATGTCAACTCGTGCACGAGTTGACATCTCTTCTCCGAGCCGGTCGAAATATTGGAGGAAGCTCGAGCTGGAGGAAAAGTGAGTCTCACAGATGAGT,N,DNA,126 nt,0.484,"39,076.02 Da",25.59 ¦ÌM,No QGRS found,N/A,Aptasensor,Application as a Colorimetric Biosensor,Kinetics of the color change of the colorimetric adenosine sensor in the presence of 5 mM adenosine
Apta_517,ACCTTCGGGGAGTATTGCGGAGGAAGGT,One-site Apt,DNA,28 nt,0.571,"8,749.63 Da",114.29 ¦ÌM,No QGRS found,N/A,Aptasensor,Specifific recognition of adenosine,ITC traces and integrated heat for 20 mM one-site aptamer titrated
Apta_518,GTATTGCGGAGGAAGGTTTTTAACCTTCGGGGA,Res-A10-Right-cut,DNA,33 nt,0.485,"10,279.61 Da",97.28 ¦ÌM,No QGRS found,N/A,Aptasensor,Specifific recognition of adenosine,ITC traces and integrated heat for 20 mM one-site aptamer titrated
Apta_519,GTATTGCGGAGGAAGGTTTTTAACCTTCGGGG,A10-excised Apt,DNA,32 nt,0.5,"9,966.41 Da",100.34 ¦ÌM,No QGRS found,N/A,Aptasensor,Specifific recognition of adenosine,ITC traces and integrated heat for 20 mM one-site aptamer titrated
Apta_520,GGGAGAUCUACGGAUCUCAGGGCUCUUACGGGAGCUACAUGGAAGGAGUCCAUGUGU,1-1min,RNA,57 nt,0.544,"18,458.98 Da",54.17 ¦ÌM,2,20,Targeted binding,Binding to ATP,Binding of the 1-1min aptamer to ATP
Apta_521,GGGUUGGGAAGAAACUGUGGCACUUCGGUGCCAGCAACCC,Jan-40,RNA,40 nt,0.6,"12,928.74 Da",77.35 ¦ÌM,2,17,Targeted binding,Binding to ATP,N/A
Apta_522,GGGCGACCCUGAUGAGCACACGAGGGGGAAACCCCGGACAAUCAGACACGGUGUUCGAAACGGUGAAAGCCGUAGGUUGCCCUUU,Undefined,RNA,85 nt,0.588,"27,540.47 Da",36.31 ¦ÌM,No QGRS found,N/A,Aptasensor,Assay of Protein Kinase Activity,N/A
Apta_523,ATCCGTCACACCTGCTCTGACGCTGGGGTCGACCCGGAGAAATGCATTCCCCTGTGGTGTTGGCTCCCGTAT,AFAS3,DNA,72 nt,0.597,"22,993.57 Da",43.49 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_524,ATCCGTCACACCTGCTCTGGCATTAGTATTCCATAGCCGGCCAAGTCTATGTAGTGGTGTTGGCTCCCGTAT,AFA4,DNA,72 nt,0.514,"22,082.11 Da",45.29 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_525,ATCCGTCACACCTGCTCTCAATCTGAAATATTGCAAGCAGTGCTCACAATTTGTTGGTGTTGGCTCCCGTAT,AFA5,DNA,72 nt,0.458,"22,049.13 Da",45.35 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_526,ATACGGGAGCCAACACCAAGTAACACACGCGGACCAGAAATACATCCCCCCGTAGAGCAGGTGTGACGGAT,AFA7,DNA,71 nt,0.549,"21,887.07 Da",45.69 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_527,ATACGGGAGCCAACACCAACAACCTAGATGTTCTGATAACACGAATCGCTTCGAAGAGCAGGTGTGACGGAT,AFA8,DNA,72 nt,0.486,"22,251.31 Da",44.94 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_528,ATACGGGAGCCAACACCACTTGGTTAACCAATCAAACCGGACAACGAAGGGTCCAGAGCAGGTGTGACGGAT,AFAM3,DNA,72 nt,0.528,"22,286.32 Da",44.87 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_529,ATCCGTCACACCTGCTCTACACTCCGCACGATCTTTTTTAGAACGCGTACCCGTTGGTGTTGGCTCCCGTAT,APM1,DNA,72 nt,0.528,"21,938.02 Da",45.58 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_530,ATCCGTCACACCTGCTCTGTGTACGCCCGTATTTACGTTCCTAGCAATTGCTATGTGGTGTTGGCTCCCGTAT,APM4,DNA,73 nt,0.507,"22,328.26 Da",44.79 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_531,ATACGGGAGCCAACACCACATCGACTTACGAATCAACGCGTTTATTATTGGTTCAGAGCAGGTGTGACGGAT,APM5,DNA,72 nt,0.472,"22,239.28 Da",44.97 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_532,ATCCGTCACACCTGCTCTAACTTACACATAATTCTAGGTTACATCTTGCTCATATGGTGTTGGCTCCCGTAT,APM6,DNA,72 nt,0.431,"21,959.08 Da",45.54 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_533,ATACGGGAGCCAACACCAAAGTAAGATCATCACCCGGACGCGGACATAATAGGAGAGCAGGTGTGACGGAT,APM9,DNA,71 nt,0.521,"22,046.18 Da",45.36 ¦ÌM,2,19,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_534,ATCCGTCACACCTGCTCTTGTAGGGTTCCCACCCAATTCAGTTCCGTTAAACCATGGTGTTGGCTCCCGTAT,APM13,DNA,72 nt,0.514,"21,962.04 Da",45.53 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_535,ATCCGTCACACCTGCTCTTGGGGTTATTACTCGTGAGATTGGGAATAGGTTACATGGTGTTGGCTCCCGTAT,APM16,DNA,72 nt,0.486,"22,232.21 Da",44.98 ¦ÌM,2,19,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_536,ATCCGTCACACCTGCTCTCGAATAGAGTACTCGATACTGACTTTATTTACCGTCTGGTGTTGGCTCCCGTAT,APM19,DNA,72 nt,0.472,"22,016.09 Da",45.42 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_537,ATCCGTCACACCTGCTCTCCTCGAACTAGTTAGACCCTCCTCCAAGTCAACTTGTGGTGTTGGCTCCCGTAT,APM21,DNA,72 nt,0.528,"21,907.01 Da",45.65 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of aflflatoxin M1,N/A
Apta_538,GTGTTGTCTCTCTGTGTCTC,Apt-1bp,DNA,20 nt,0.5,"6,071.91 Da",164.69 ¦ÌM,No QGRS found,N/A,Aptasensor,Sensor for Aflflatoxin B1,Comparison of electrochemical Aptasensors using aptamers with different stem lengths ranging from 1 to 6 bp in responses to AFB1
Apta_539,CGTGTTGTCTCTCTGTGTCTCG,Apt-2bp,DNA,22 nt,0.545,"6,690.29 Da",149.47 ¦ÌM,No QGRS found,N/A,Aptasensor,Sensor for Aflflatoxin B1,Comparison of electrochemical Aptasensors using aptamers with different stem lengths ranging from 1 to 6 bp in responses to AFB1
Apta_540,ACGTGTTGTCTCTCTGTGTCTCGT,Apt-3bp,DNA,24 nt,0.5,"7,307.69 Da",136.84 ¦ÌM,No QGRS found,N/A,Aptasensor,Sensor for Aflflatoxin B1,Comparison of electrochemical Aptasensors using aptamers with different stem lengths ranging from 1 to 6 bp in responses to AFB1
Apta_541,CACGTGTTGTCTCTCTGTGTCTCGTG,Apt-4bp,DNA,26 nt,0.538,"7,926.08 Da",126.17 ¦ÌM,No QGRS found,N/A,Aptasensor,Sensor for Aflflatoxin B1,Comparison of electrochemical Aptasensors using aptamers with different stem lengths ranging from 1 to 6 bp in responses to AFB1
Apta_542,GCACGTGTTGTCTCTCTGTGTCTCGTGC,Apt-5bp,DNA,28 nt,0.571,"8,544.47 Da",117.03 ¦ÌM,No QGRS found,N/A,Aptasensor,Sensor for Aflflatoxin B1,Comparison of electrochemical Aptasensors using aptamers with different stem lengths ranging from 1 to 6 bp in responses to AFB1
Apta_543,GGCACGTGTTGTCTCTCTGTGTCTCGTGCC,Apt-6bp,DNA,30 nt,0.6,"9,162.86 Da",109.14 ¦ÌM,No QGRS found,N/A,Aptasensor,Sensor for Aflflatoxin B1,Comparison of electrochemical Aptasensors using aptamers with different stem lengths ranging from 1 to 6 bp in responses to AFB1
Apta_544,GCGGGCGGTTGTATAGCGG,AMP17,DNA,19 nt,0.684,"5,940.83 Da",168.33 ¦ÌM,No QGRS found,N/A,Aptasensor,Aptasensor for ampicillin,N/A
Apta_545,TTAGTTGGGGTTCAGTTGG,AMP18,DNA,19 nt,0.474,"5,920.82 Da",168.90 ¦ÌM,No QGRS found,N/A,Aptasensor,Aptasensor for ampicillin,N/A
Apta_546,CACGGCATGGTGGGCGTCGTG,AMP4,DNA,21 nt,0.714,"6,519.19 Da",153.39 ¦ÌM,No QGRS found,N/A,Aptasensor,Aptasensor for ampicillin,N/A
Apta_547,GGGAGAAGGCGGCGCGUAGGCGAGCUUUAGGCCCGACAUUCCCCUAAAAAAGCUUGUUCUAUUCGUGGACGAUGCGCAC,LGA11,RNA,79 nt,0.57,"25,496.16 Da",39.22 ¦ÌM,2,19,Aptasensor,Detection of antibiotics,GNP-aptamer sensor detection of aminoglycosides
Apta_548,GGGAGAAGGCGGCGCGUAGGCGAGCUUUACCAGUUUUAUUUGUUUUAUUGUUAUAUGCUUAUUCGUGGACGAUGCGCAC,LS13,RNA,79 nt,0.468,"25,394.90 Da",39.38 ¦ÌM,2,17,Aptasensor,Detection of antibiotics,Promiscuity of aminoglycoside binding by GNP-Aptasensor
Apta_549,GGAGCUCAGCCUUCACUGCAUGAUAAACCGAUGCUGGGCGAUUCUCCUGAAGUAGGGGAAGAGUUGUCAUGUAUGGGGGCACCACGGUCGGAUCCUG,ag.06,RNA,97 nt,0.557,"31,347.58 Da",31.90 ¦ÌM,2,17,Aptasensor,Detection of arginine,Affinity elution of ag.06 RNA from an L-arginine column by L-arginine and competition by arginine analogues
Apta_550,GGTAATACGACTCACTATAGGGAGATACCAGCTTATTCAATTTTACAGAACAACCAACGTCGCTCCGGGTACTTCTTCATCGAGATAGTAAGTGCAATCT,Ars-3,DNA,100 nt,0.42,"30,766.76 Da",32.50 ¦ÌM,No QGRS found,N/A,Aptasensor,Removal of arsenic,"Kd values of Ars-3 to arsenate, arsenite, and nine different metals determined individually"
Apta_551,GGAUGUCCAGUCGCUUGCAAUGCCCUUUUAGACCCUGAUGAGCGGUGCUAGUUAGUUGCAGUUUCGGUUGUUACGCGAAACGGUGAAAGCCGUAGGUCU,S3.asp.E4,RNA,99 nt,0.515,"31,836.74 Da",31.41 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect caffeine or aspartame,Specificity of the aspartame sensor S3.asp.E4
Apta_552,CACCTGGGGGAGTATTGCGGAGGAAGGTTCCAGGTG,ATP-Binding aptamer,DNA,36 nt,0.611,"11,262.22 Da",88.79 ¦ÌM,2,19,Aptasensor,Detection of ATP,"The normalized fluorescent signal change of strips was plotted against ATP (line) or GTP (dotted line) concentrations, and fitted (black line) to a ligand binding  curve"
Apta_553,TGTACCGTCTGAGCGATTCGTACGAACGGCTTTGTACTGTTTGCACTGGCGGATTTAGCCAGTCAGTGTTAAGGAGTGC,R12.23,DNA,79 nt,0.506,"24,464.63 Da",40.88 ¦ÌM,No QGRS found,N/A,Aptasensor,Rapid atrazine detection in environmental samples,N/A
Apta_554,TGTACCGTCTGAGCGATTCGTACCATTAGTGGGTGCTCCTTACCTGATGGTCATCTAGCCAGTCAGTGTTAAGGAGTGC,R12.28,DNA,79 nt,0.506,"24,384.58 Da",41.01 ¦ÌM,No QGRS found,N/A,Aptasensor,Rapid atrazine detection in environmental samples,N/A
Apta_555,TGTACCGTCTGAGCGATTCGTACGGATTGGGTTTGCACTTTACCTGCGGTGCATCGCAGCCAGTCAGTGTTAAGGAGTGC,R12.57,DNA,80 nt,0.538,"24,754.80 Da",40.40 ¦ÌM,No QGRS found,N/A,Aptasensor,Rapid atrazine detection in environmental samples,N/A
Apta_556,GGCTCTCGGGACGACATGGATTTTCCATCAACGAAGTGCGTCCGTCCC,BES.1,DNA,48 nt,0.583,"14,720.43 Da",67.93 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of steroids,Reactivity of the steroid sensors used in the final array
Apta_557,GGAACACUAUCCGAUGGCACCGACCAUAGGCUCGGGUUGCCAGAGGUUCCACACUUUCAUCGAAAAGCCUAUGCUAGGCAAUGACAUGGACUCCUUGGUCAUUAGGAUCG,N,RNA,110 nt,0.518,"35,325.97 Da",28.31 ¦ÌM,2,19,Aptasensor,Detection of biotin,Saturation curve for the binding of the biotin aptamer to immobilized ligand as described in the Materials and Methods
Apta_558,CCGGTGGGTGGTCAGGTGGGATAGCGTTCCGCGTATGGCCCAGCGCATCACGGGTTCGCACCA,#3,DNA,63 nt,0.667,"19,513.43 Da",51.25 ¦ÌM,2,20,Aptasensor,Detection of BPA,Selected aptamers affinity to BPA
Apta_559,GGAUGUCCAGUCGCUUGCAAUGCCCUUUUAGACCCUGAUGAGGAUCAUCGGACUUUGUCCUGUGGAGUAAGAUCGCGAAACGGUGAAAGCCGUAGGUCU,S2.caf.D11,RNA,99 nt,0.515,"31,865.83 Da",31.38 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect caffeine or aspartame,Measurement of fluorescence at 535 nm versus time at various concentrations of caffeine (S2.caf.D11)
Apta_560,GGAAGAGAUGGCGACUAAAACGACUUGUCGC,Undefined,RNA,31 nt,0.516,"10,044.07 Da",99.56 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cAMP,Determination of the KD for the aptamer ligand complex using equilibrium filtration
Apta_561,GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGCCUGUGGAAACAGACGUGGCACAUGACUACGUCGAAACGGUAGCGAGAGCUC,AR4,RNA,90 nt,0.544,"29,204.47 Da",34.24 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cAMP,N/A
Apta_562,GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGCCUUUAGGGCCAAGUGUGGUGAAAGACACACUCGAAACGGUAGCGAGAGCUC,AR3,RNA,90 nt,0.533,"29,205.45 Da",34.24 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cAMP,N/A
Apta_563,GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGAAAGCCAAAGCCGUAGCGCAGAUGAUCUCGCCAUCAGUACCGAAACGGUAGCGAGAGCUC,AR1,RNA,98 nt,0.541,"31,742.02 Da",31.50 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cAMP,N/A
Apta_564,GGGGACTGTTGTGGTATTATTTTTGGTTGTGCAGT,CAP,DNA,35 nt,0.429,"10,915.99 Da",91.61 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of Cd(II),N/A
Apta_565,GCGGGGTTGGGCGGGTGGGTTCGCTGGGCAGGGGGCGAGTG,#16,DNA,41 nt,0.78,"12,988.25 Da",76.99 ¦ÌM,3,63,Aptasensor,Recognition of cellobiose,Specificity of aptamer binding
Apta_566,GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGCCCUGCGAUGCAGAAAGGUGCUGACGACACAUCGAAACGGUAGCGAGAGCUC,AR2,RNA,90 nt,0.556,"29,203.48 Da",34.24 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cAMP,N/A
Apta_567,CCTAAGGGGGGACTCAGCATTTTGTGCGGGCGGCGCTAACACAATCAGATAGAGCGGGGTT,Chi No.52 (61),DNA,61 nt,0.574,"18,975.14 Da",52.70 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of chitin,N/A
Apta_568,CCCAGCAGCACTGGTAGTGAGGCAGTTCACCGGTGGGGCGGTGAGTTTGGCTGCTATTTAT,Chi No. 1 (61) b,DNA,61 nt,0.574,"18,939.09 Da",52.80 ¦ÌM,2,20,Aptasensor,Recognition of chitin,N/A
Apta_569,TGCGCATGTGAAAGGTTGCCTAACTGGACAGGGTTTAGGAGCGACTAGACACAG,Chi No. 23 (54),DNA,54 nt,0.519,"16,799.79 Da",59.52 ¦ÌM,2,17,Aptasensor,Recognition of chitin,N/A
Apta_570,GGCAAGATGTGCCCAGAACAGTTGCTTGTATGGTGGGGAGCGTCCATATTGGCTTAAAC,Chi No. 28 (59),DNA,59 nt,0.508,"18,321.74 Da",54.58 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of chitin,N/A
Apta_571,ACCTGCGATAGGTAGTTTGTTTCTGTTGCCCTAGCGTCCGTCGTAACAAGTCA,Chi No. 35 (52),DNA,53 nt,0.491,"16,280.43 Da",61.42 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of chitin,N/A
Apta_572,CCGTAACCCTGCGGGGGGGGGAGAAGGCAATGGGGGACAACTCGCCGGTAGCCATCCATAT,Chi No. 46 (61),DNA,61 nt,0.639,"18,955.12 Da",52.76 ¦ÌM,2,21,Aptasensor,Recognition of chitin,N/A
Apta_573,CGTACAGTGGGCTATATTGCTGACGTAAGAGCTGCTTTCAATGCATTGGCATAGATGTCA,Chi No. 57 (60),DNA,60 nt,0.45,"18,559.91 Da",53.88 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of chitin,N/A
Apta_574,AUGAAAAGGGCUGGCGAGACAUAUCCGCUGGGCAAUCAGAUUCGGAGCCGCACCACCCUCGAAGUAGACA,70Cm6,RNA,70 nt,0.557,"22,615.58 Da",44.22 ¦ÌM,No QGRS found,N/A,Target detection,Detection of chloramphenicol,N/A
Apta_575,AGAGCUUGACGGUCCCGAGAGUCGAGCCCAAGCUGACACUGGACCUUUGCGGACCACGUGUUGAUCGUCG,70Cm9,RNA,70 nt,0.6,"22,531.39 Da",44.38 ¦ÌM,No QGRS found,N/A,Target detection,Detection of chloramphenicol,N/A
Apta_576,GGCACCAAAGCUGAAGUAGCGGGAUAACUCAAAUUACUUUAGGUGUAUGAAGGUGAAACUAGCAAUGAA,70Cm53,RNA,69 nt,0.406,"22,355.39 Da",44.73 ¦ÌM,No QGRS found,N/A,Target detection,Detection of chloramphenicol,N/A
Apta_577,ACTTCAGTGAGTTGTCCCACGGTCGGCGAGTCGGTGGTAG,Clone 7,DNA,40 nt,0.6,"12,399.93 Da",80.65 ¦ÌM,2,17,Target detection,Detection of chloramphenicol,Saturation curves and determination of dissociation constants (Kd) of the aptamers
Apta_578,CACCAAGCGCAGGGAATTACATTGAAGTGTGGGATTGGCT,Clone 9,DNA,40 nt,0.5,"12,425.00 Da",80.48 ¦ÌM,No QGRS found,N/A,Target detection,Detection of chloramphenicol,Saturation curves and determination of dissociation constants (Kd) of the aptamers
Apta_579,ACTGAGGGCACGGACAGGAGGGGGAGAGATGGCGTGAGGT,Clone 16,DNA,40 nt,0.65,"12,646.11 Da",79.08 ¦ÌM,2,21,Target detection,Detection of chloramphenicol,Saturation curves and determination of dissociation constants (Kd) of the aptamers
Apta_580,ATGCGGGTATATGGTGCGAGAAAACAAGGGGCATACTGGA,Clone 20,DNA,40 nt,0.5,"12,523.07 Da",79.85 ¦ÌM,No QGRS found,N/A,Target detection,Detection of chloramphenicol,Saturation curves and determination of dissociation constants (Kd) of the aptamers
Apta_581,GTACCAGCTTATTCAATTCGCGGAAGACGAATTCCAAGCGCGCGCGGGTCACGCGACTTGGGAATGAGCAAGGGTTGGCCCGAGATAGTATGTTCATCAG,5,DNA,100 nt,0.54,"31,012.83 Da",32.24 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cholic acid,N/A
Apta_582,GTACCAGCTTATTCAATTGGGCGAAGGAACATACGGCAGTTTATGGCCGCTATCGAGATAGACTATCATCTCAACGTCTTCTAGATAGTATGTTCATCAG,7,DNA,100 nt,0.43,"30,844.78 Da",32.42 ¦ÌM,2,19,Aptasensor,Recognition of cholic acid,N/A
Apta_583,GTACCAGCTTATTCAATTGCGAGCAGGGTCAATGGAATTAATGATCAATTGACAGACGCAAGTCTCCTGCGGTCCTGTGTTGAGATAGTATGTTCATCAG,9,DNA,100 nt,0.44,"30,940.83 Da",32.32 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cholic acid,N/A
Apta_584,GTACCAGCTTATTCAATTACACGGACAGAGGGTAGCGGCTCTGCGCATTGAGTTGCTGCGGGCTGAAGCGCGGTACATGGGAGATAGTATGTTCATCAG,11,DNA,99 nt,0.525,"30,760.66 Da",32.51 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cholic acid,N/A
Apta_585,GATCGAGGGCAGCGATAGCTGGGCTAATAAGGTTAGCCCCATCGGTC,ch1-47,DNA,47 nt,0.574,"14,569.34 Da",68.64 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cholic acid,N/A
Apta_586,GGGAGACAAGGAAAATCCTTCAATGAAGTGGGTCGACA,MNS-4.1,DNA,38 nt,0.474,"11,833.65 Da",84.50 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cocaine,N/A
Apta_587,GGAATGGATCCACATCCATGGATGGGCAATGCGGGGTGGAGAATGGTTGCCGCACTTCGGCTTCACTGCAGACTTGACGAAGCTT,Aptamer 15-1,DNA,85 nt,0.553,"26,380.86 Da",37.91 ¦ÌM,2,19,Aptasensor,Detection of cortisol,MST Kd measurement of aptamer 15-1 and cortisol
Apta_588,CCGGUGCGCAUAACCACCUCAGUGCGAGCAAGGAA,N,RNA,35 nt,0.6,"11,263.81 Da",88.78 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of cyanocobalamin,N/A
Apta_589,GGGAATTCGAGCTCGGTACCATCTGTGTAAGGGGTAAGGGGTGGGGGTGGGTACGTCTAGCTGCAGGCATGCAAGCTTGG,10.1,DNA,80 nt,0.588,"25,063.98 Da",39.90 ¦ÌM,3,63,Target recognition,Recognition and targeting therapy of gastric cancer,N/A
Apta_590,ACCATCTGTGTAAGGGGTAAGGGGTGGGGGTGGGTACGTCT,10.10V,DNA,41 nt,0.585,"12,873.24 Da",77.68 ¦ÌM,3,63,Target recognition,Recognition and targeting therapy of gastric cancer,N/A
Apta_591,CTCTCGGGACGACGGCTGGCACGTTTGGTTCAAGAATGTGGGTGTCGTCCC,Fructose-bisboronic acid aptamer-sensor,DNA,51 nt,0.608,"15,770.07 Da",63.41 ¦ÌM,2,17,Aptasensor,Recognition of D-Fructose,The response of sensors
Apta_592,CTCTCGGGACGACCACTACGCATAGTTTCTATCGCCAGGAAGGGTCGTCCC,Galactose-bisboronic acid aptamer-sensor,DNA,51 nt,0.588,"15,612.00 Da",64.05 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of D-Galactose,The response of sensors
Apta_593,CTCTCGGGACGACAGCCGAGTTGATTCAACAGCCGAGTCGTCCC,Glucose-bisboronic acid aptamer-sensor,DNA,44 nt,0.614,"13,478.64 Da",74.19 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of D-Glucose,The response of sensors
Apta_594,GGGCUAUUGCUGGAGGGGCGCCACAUGAAAGUGGUGGUUGGGUGCGGUCGGCGAUAGCUC,DMHBI-binding aptamer,RNA,60 nt,0.633,"19,558.59 Da",51.13 ¦ÌM,2,20,Live-cell imaging,Imaged in living cells,"13-2 enhances the fluorescence of DMHBI. Solutions containing DMHBI, 13-2 RNA, DMHBI with 13-2 RNA, or DMHBI with total HeLa cell RNA were photographed under illumination with 365 nm light"
Apta_595,AGCGAGGGCGGTGTCCAACAGCGGTTTTTTCACGAGGAGGTTGGCGGTGG,D1,DNA,50 nt,0.62,"15,634.98 Da",63.96 ¦ÌM,2,20,Aptasensor,Recognition of digoxin,N/A
Apta_596,GGTGGCTGTTGGTCGAGGCTTATTAGTGTAGTCAATGGAGGCAGGCGACG,D2,DNA,50 nt,0.56,"15,649.01 Da",63.90 ¦ÌM,2,18,Aptasensor,Recognition of digoxin,N/A
Apta_597,TACTGGGCTGGGCTTGGATTAGATCACAGTGGAACATACAGGACACACG,D3,DNA,49 nt,0.51,"15,194.77 Da",65.81 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of digoxin,N/A
Apta_598,GGGAAUUCCGCGUGUGCGCCGCGGAAGACGUUGGAAGGAUAGAUACCUACAACGGGGAAUAUAGAGGCCAGCACAUAGUGAGGCCCUCCUCCC,dopa2/c.1,RNA,93 nt,0.581,"30,111.99 Da",33.21 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of dopamine,N/A
Apta_599,GUCUCUGUGUGCGCCAGAGAACACUGGGGCAGAUAUGGGCCAGCACAGAAUGAGGCCC,dopa1.30/c.30,RNA,58 nt,0.603,"18,784.24 Da",53.24 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of dopamine,N/A
Apta_600,GTCTCTGTGTGCGCCAGAGAACACTGGGGCAGATATGGGCCAGCACAGAATGAGGCCC,DNA version of dopa1.30/c.30,DNA,58 nt,0.603,"17,982.52 Da",55.61 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of dopamine,N/A
Apta_601,GGGAAUUCCGCGUGUGCGCCGCGGAAGAGGGAAUAUAGAGGCCAGCACAUAGUGAGGCCCUCCUCCC,dopa2/c.4,RNA,67 nt,0.627,"21,675.96 Da",46.13 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of dopamine,N/A
Apta_602,GGGCGAGAACAGTGTCCCAGTCGCTAGTTTTCTCTGCCC,DOX 6,DNA,39 nt,0.59,"11,950.66 Da",83.68 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to DOX,Determination of binding affinities of DOX 6 toward DOX using EMSA
Apta_603,CUUGUCUGAACAAUUUCGUCUGCCUUUGCGUUCCGACGGC,DOX 7,RNA,40 nt,0.525,"12,639.42 Da",79.12 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to DOX,N/A
Apta_604,TCCTGACCTTAGCCTATGTTTTCTCTACCGGCTATGTTAC,VA 6,DNA,40 nt,0.45,"12,129.79 Da",82.44 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to DOX,N/A
Apta_605,CUUCUUAAUCCUAAAGUCCCUGGUGUUUCUCUGCGUGGGG,VA 2,RNA,40 nt,0.5,"12,680.43 Da",78.86 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to DOX,N/A
Apta_606,CGGUUGGAUGGGUGUUGGUGGUUUGUUGAGUCCAGGCGGC,VA 22,RNA,40 nt,0.6,"12,990.62 Da",76.98 ¦ÌM,2,19,Aptasensor,Binding to DOX,N/A
Apta_607,TGAGGCGGGTGGGTGGGTTGAATATGCTGATTACCCCATCGGAGAACGTTAAGGCGCTTC,#14.3,DNA,60 nt,0.55,"18,682.95 Da",53.52 ¦ÌM,2,21,Aptasensor,Detection of ethanolamine,Saturation curves and determination of dissociation constants (KD)
Apta_608,TGAGGCGGGTGGGTGGGTTGAATACGCTGATCACCCCATCGGAGAACGTTAAGGCGCTTT,#11.4,DNA,60 nt,0.567,"18,667.94 Da",53.57 ¦ÌM,2,21,Aptasensor,Detection of ethanolamine,Saturation curves and determination of dissociation constants (KD)
Apta_609,GCTGCGAGGTGGGTGGGTGGGAGCAATTGGTCCTCGCTTAGCTTCTACGGTGGGCTATCT,#2.3,DNA,60 nt,0.6,"18,672.89 Da",53.55 ¦ÌM,3,44,Aptasensor,Detection of ethanolamine,Saturation curves and determination of dissociation constants (KD)
Apta_610,GCTGTGAGGTGGGTGGGTGGGAGCAATTGGTCCTCGCTTAGCTTCTACGGTGGGCTATCT,#9.6,DNA,60 nt,0.583,"18,687.90 Da",53.51 ¦ÌM,3,44,Aptasensor,Detection of ethanolamine,Saturation curves and determination of dissociation constants (KD)
Apta_611,GCTGCGAGGTGGGTGGGTGGGAGCAATTGGTCCTTGCTTAGCTTCTACGGTGGGCTATCT,#9.1,DNA,60 nt,0.583,"18,687.90 Da",53.51 ¦ÌM,3,44,Aptasensor,Detection of ethanolamine,Saturation curves and determination of dissociation constants (KD)
Apta_612,GGGCGACCCUGAUGAGCCUUAGGAUAUGCUUCGGCAGAAGGACGUCGAAACGGUGAAAGCCGUAGGUUGCCC,switch,RNA,72 nt,0.583,"23,332.92 Da",42.86 ¦ÌM,No QGRS found,N/A,Targeted binding,Genetic control elements,"Qualitative assessment of the specificity of ligand-induced ribozyme self-cleavage. Internally 32P-labeled constructs were incubated at 23¨FC for 15 min in the absence (2) or presence of FMN (F; 200 mM), theophylline (T; 1 mM), or ATP (A; 1 mM)"
Apta_613,GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGCCUUAGGAUAUGCAUGAUGCAGAAGGACGUCGAAACGGUAGCGAGAGCUC,AR5,RNA,88 nt,0.523,"28,595.09 Da",34.97 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition of FMN,N/A
Apta_614,AATCGCATTACCTTATACCAGCTTATTCAATTACGTCTGCACATACCAGCTTATTCAATT,FB1 39,DNA,60 nt,0.35,"18,236.76 Da",54.83 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to fumonisin B1,Binding curves for the aptamer sequence FB1 39
Apta_615,ACGAAGAAACAGGGCGCTTCGAACGAACATGGGCAGGGTGGGAAGTTTTAAAGTGGTAC,13,DNA,59 nt,0.508,"18,446.86 Da",54.21 ¦ÌM,3,54,Targeted binding,Binding to fumonisin B1,N/A
Apta_616,GGTGCGGGTAGGGATGAGGGCGGGTCGGGTTGAGTGTGAGCTTAGGGGtGGCGGATCTAC,20,DNA,60 nt,0.65,"18,957.06 Da",52.75 ¦ÌM,3,62,Targeted binding,Binding to fumonisin B1,N/A
Apta_617,CAATGGGGTCGGGCGGGCCGGGTGTCATGGTGGACGGAGATGGGACGTAGAGGGCGGT,26,DNA,58 nt,0.69,"18,302.66 Da",54.64 ¦ÌM,3,63,Targeted binding,Binding to fumonisin B1,N/A
Apta_618,GCGGCAAATCAGCATACGAGTGTACAGGGACGGGACGGGTGGGTAAAAGGTGTCGCCTCAG,30,DNA,61 nt,0.59,"19,058.21 Da",52.47 ¦ÌM,3,63,Targeted binding,Binding to fumonisin B1,N/A
Apta_619,CCAACTTGGGCGGAGGGCTAACGGTGGGGGGATATTATGAGGGGTGGAGGTATTAACCATT,32,DNA,61 nt,0.541,"19,125.24 Da",52.29 ¦ÌM,3,60,Targeted binding,Binding to fumonisin B1,N/A
Apta_620,TTCTTTCTTCCCCTTGTTTGTT,N,DNA,22 nt,0.364,"6,590.24 Da",151.74 ¦ÌM,No QGRS found,N/A,Aptasensor,CPCH Aptasensor could screen a wide concentration range of heavy metal ions with high selectivity and reversibility,N/A
Apta_621,AAGCTTGCTTTATAGCCTGCAGCGATTCTTGATCGGAAAAGGCTGAGAGCTACGC,SS2-55,DNA,55 nt,0.491,"16,989.91 Da",58.86 ¦ÌM,No QGRS found,N/A,Aptasensor,Analysis and/or neutralization of the residues of the four organophosphorus pesticides,Specifificity of SS2-55 and SS4-54 aptamers
Apta_622,AAGCTTTTTTGACTGACTGCAGCGATTCTTGATCGCCACGGTCTGGAAAAAGAG,SS4-54,DNA,54 nt,0.463,"16,675.71 Da",59.97 ¦ÌM,No QGRS found,N/A,Aptasensor,Analysis and neutralization of the residues of the four organophosphorus pesticides,Specifificity of SS2-55 and SS4-54 aptamers
Apta_623,GGGAAUGGAUCCACAUCUACGAAUUCACCGCGGGGUUGCGGACCGGGAGCUCCAGCUUCACUGCAGACUUGACGAAGCUU,sla 16,RNA,80 nt,0.575,"25,761.32 Da",38.82 ¦ÌM,2,18,Targeted binding,Binding to aminoglycoside,N/A
Apta_624,GGGAAUGGAUCCACAUCUACGAAUUCGAAUUGCCGUAAUUUCCCGUGGAGCGAUGCUUCACUGCAGACUUGACGAAGCUU,sla 110,RNA,80 nt,0.488,"25,654.20 Da",38.98 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to aminoglycoside,N/A
Apta_625,ATACCAGCTTATTCAATTCAGGGCGGTATGAGGCTCGATCAAGGTCGGAGCGAGAATTTTTTCGCGGAGTCGGCTGGATCAGATAGTAAGTGCAATCT,#13_82,DNA,98 nt,0.48,"30,429.47 Da",32.86 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to aminoglycoside,Specificity tests on the representative of each of the groups of DNA oligonucleotides derived from Capture-SELEX against the mixture of pharmaceuticals
Apta_626,ATACCAGCTTATTCAATTGGTGGTAGGATGGGCTCGATCGAGGTCTTCAGTCGGCTCGGTTTAGTTTATGTTCTCCTGTAGATAGTAAGTGCAATCT,#3_7,DNA,97 nt,0.443,"30,020.19 Da",33.31 ¦ÌM,2,20,Targeted binding,Binding to aminoglycoside,Specificity tests on the representative of each of the groups of DNA oligonucleotides derived from Capture-SELEX against the mixture of pharmaceuticals
Apta_627,ATACCAGCTTATTCAATTATGCGGGGATGAGGCTTGATCTGTGGCTCTGATCCATGATCAGTCGTCTTACGTGCGGTCCAGATAGTAAGTGCAATCT,#11_76,DNA,97 nt,0.464,"29,968.17 Da",33.37 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to aminoglycoside,Specificity tests on the representative of each of the groups of DNA oligonucleotides derived from Capture-SELEX against the mixture of pharmaceuticals
Apta_628,ATACCAGCTTATTCAATTAGCCCGGTATTGAGGTCGATCTCTTATCCTATGGCTTGTCCCCCATGGCTCGGTTATATCCAGATAGTAAGTGCAATCT,#3_19,DNA,97 nt,0.443,"29,758.05 Da",33.60 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to aminoglycoside,Specificity tests on the representative of each of the groups of DNA oligonucleotides derived from Capture-SELEX against the mixture of pharmaceuticals
Apta_629,TGGGGGTTGAGGCTAAGCCGA,ky2,DNA,21 nt,0.619,"6,567.24 Da",152.27 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of kanamycin,A620/A520 ratio and color of the AuNP solution versus kanamycin concentration
Apta_630,GACCAGGGCAAACGGTAGGGAGTGGTC,12-79,DNA,27 nt,0.63,"8,439.44 Da",118.49 ¦ÌM,2,19,Targeted binding,Binding to arginine,Spectra of the isolated G-rich domain from clone 12-79 in the absence (open circles) or presence (closed circles) of 10 mM arginine
Apta_631,GGGATCGAAACGTAGCGCCTTCGATCCC,12-28 hairpin,DNA,28 nt,0.607,"8,574.53 Da",116.62 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to arginine,N/A
Apta_632,GACGAGAAGGAGUGCUGGUUAUACUAGCGGUUAGGUCACUCGUC,44.cit11,RNA,44 nt,0.523,"14,217.46 Da",70.34 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to L-Histidine,N/A
Apta_633,GGCAUCGGAAAGUGGGUUGAUGUAAGUAACAGGCGAUGCC,His945,RNA,40 nt,0.525,"13,017.80 Da",76.82 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to L-Histidine,Affinity chromatography of RNA on 0.6 mM histidine-Sepharose
Apta_634,GGUCUUACGUCGUUCGCGACUAUUGGGAGACC,IL 42-32b,RNA,32 nt,0.563,"10,233.07 Da",97.72 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to isoleucine,Isocratic affinity elution from isoleucine agarose
Apta_635,TAGCCGGATCGCGCTGGCCAGATGATATAAAGGGTCAACCCCCCA,B1,DNA,45 nt,0.578,"13,824.89 Da",72.33 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_636,TAGCCGGATCGCGCTGGCCAGATGATATAAAGGGTCAGCCCCCCA,B2,DNA,45 nt,0.6,"13,840.89 Da",72.25 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_637,TAGCCGGATCGCGTTGGCCAGATGATATAAAGGGTCAACCCCCCA,B3,DNA,45 nt,0.556,"13,839.90 Da",72.25 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_638,TAGCCGGATCGCGCTGGCCAGATGATATAAAGGGTCAACCCCCCG,B4,DNA,45 nt,0.6,"13,840.89 Da",72.25 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_639,CTAAGCACAGGGAAACCAGCTAATGAGTTAGGCCTGTCCCCCACG,B5,DNA,45 nt,0.556,"13,808.89 Da",72.42 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_640,CAATGGACCTATTCGAGTACTGAATAGAACAGTCGGCGCTCTGGG,B6,DNA,45 nt,0.511,"13,909.95 Da",71.89 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_641,TTCAAGACGATGCCTGGCGCGAGTTACACACTTGCATGGAGCTGG,B7,DNA,45 nt,0.556,"13,901.92 Da",71.93 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_642,ATCCAATACCTCAGAACTCAGTTCGAGTCGTAAAGGGGAATCGCA,B8,DNA,45 nt,0.467,"13,846.94 Da",72.22 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_643,ACCGATCCATCGAGTTTCTGAGAAAGGCCCGGAGAAACCGCGAGA,B9,DNA,45 nt,0.556,"13,897.95 Da",71.95 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_644,TCAATCTAACCATGCATGCAGTTTAGGCAGGATTCGTTATCGCAA,B10,DNA,45 nt,0.422,"13,818.91 Da",72.36 ¦ÌM,No QGRS found,N/A,Target detection,Detection of endotoxin,N/A
Apta_645,CUGGACGACGGGGACGCCACUGGACUAGGUAAGCCAGGACCGUACGUCGGGAGCCGUCAGAAUA,Trp70-727,RNA,64 nt,0.625,"20,782.47 Da",48.12 ¦ÌM,2,18,Targeted binding,Binding to L-tryptophan,Affinity chromatography and specificity of tryptophan aptamers
Apta_646,TGGAGCTTGGATTGATGTGGTGTGTGAGTGCGGTGCCC,pe35,DNA,38 nt,0.579,"11,883.59 Da",84.15 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to L-tryptophan,N/A
Apta_647,GGAUCCCGACUGGCGAGAGCCAGGUAACGAAUGGAUCC,MG4,RNA,38 nt,0.605,"12,300.41 Da",81.30 ¦ÌM,No QGRS found,N/A,Live-cell imaging,Binding to MG,Addition of the minimal aptamer RNA induces a shift in the UV absorption maximum of MG from 616 nm to 630 nm. The concentration dependence of the RNA-induced shift suggests a KD 1 mM
Apta_648,GCACACCGATGGCGGTCCTGTTTAGGGGGTGTGC,Rd29C33-T7,DNA,34 nt,0.647,"10,546.75 Da",94.82 ¦ÌM,No QGRS found,N/A,Target detection,Detection of melamine,Affinity characterization of Rd29C33-T7 by using ITC
Apta_649,GCACACCGATGGCGGTCCTGTTTAGGGGGTGTGCGTG,Rd29C33-T6,DNA,37 nt,0.649,"11,509.35 Da",86.89 ¦ÌM,No QGRS found,N/A,Target detection,Detection of melamine,N/A
Apta_650,GCACACCGATGGCGGTCCTGTTTAGGGGGTGTGCGTGGGGAGGTGCGGTTGC,Rd29C33-T5,DNA,52 nt,0.673,"16,276.36 Da",61.44 ¦ÌM,2,19,Target detection,Detection of melamine,N/A
Apta_651,CCTGCACCTCGTCCAGCATGCACACCGATGGCGGTCCTGTTTAGGGGGTGTGCGTG,Rd29C33-T4,DNA,56 nt,0.643,"17,256.00 Da",57.95 ¦ÌM,No QGRS found,N/A,Target detection,Detection of melamine,N/A
Apta_652,CCTGCACCTCGTCCAGCATGCACACCGATGGCGGTCCTGGCAGGGGGTGTGCGTG,Rd29C33-T2,DNA,55 nt,0.691,"16,961.81 Da",58.96 ¦ÌM,2,19,Target detection,Detection of melamine,N/A
Apta_653,CCTGCACCTCGTCCAGCATCCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGGTG,Rd29C33-T1,DNA,63 nt,0.587,"19,428.39 Da",51.47 ¦ÌM,No QGRS found,N/A,Target detection,Detection of melamine,N/A
Apta_654,GCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTG,Rd29C33-primer,DNA,54 nt,0.574,"16,771.71 Da",59.62 ¦ÌM,No QGRS found,N/A,Target detection,Detection of melamine,N/A
Apta_655,CCTGCACCTCGTCCAGCATGCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTG,Rd29C33-P2,DNA,73 nt,0.589,"22,518.36 Da",44.41 ¦ÌM,No QGRS found,N/A,Target detection,Detection of melamine,N/A
Apta_656,GCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTGGGGAGGTGCGGTTGC,Rd29C33-P1,DNA,69 nt,0.609,"21,538.71 Da",46.43 ¦ÌM,2,19,Target detection,Detection of melamine,N/A
Apta_657,CCTGCACCTCGTCCAGCATGCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTGGGGAGGTGCGGTTGC,Rd29C33,DNA,88 nt,0.614,"27,285.36 Da",36.65 ¦ÌM,2,19,Target detection,Detection of melamine,N/A
Apta_658,CUGCGAUCAGGGGUAAAUUUCCGCGCAGGCUCCACGCCGC,M1,RNA,40 nt,0.65,"12,800.64 Da",78.12 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of DNA damaging compounds and ultimately DNA adducts,N/A
Apta_659,CAGAGGGAGUACUGAUCAACCCGAGCCUUCCGUCCCUGAG,M3,RNA,40 nt,0.6,"12,808.67 Da",78.07 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of DNA damaging compounds and ultimately DNA adducts,N/A
Apta_660,UGGGAGGAGUGCUGCUCUCCAGGCACUCUUGUUGCUCGGA,M22,RNA,40 nt,0.6,"12,836.58 Da",77.90 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of DNA damaging compounds and ultimately DNA adducts,N/A
Apta_661,GGACAACATAGGAAAAAGGCTCTGCTACCGGATCCCTGTTGTATGGGCATATCTGTTGAT,HC1,DNA,60 nt,0.467,"18,553.91 Da",53.90 ¦ÌM,No QGRS found,N/A,Aptasensor,Application in microcystin detection,"Determination of the dissociation constants (KD) for aptamers. On the basis of the fluorescence recovered, saturation curves were obtained and the dissociation constants were calculated by nonlinear regression analysis"
Apta_662,GGCGCCAAACAGGACCACCATGACAATTACCCATACCACCTCATTATGCCCCATCTCCGC,AN6,DNA,60 nt,0.55,"18,167.68 Da",55.04 ¦ÌM,No QGRS found,N/A,Aptasensor,Application in microcystin detection,"Determination of the dissociation constants (KD) for aptamers. On the basis of the fluorescence recovered, saturation curves were obtained and the dissociation constants were calculated by nonlinear regression analysis"
Apta_663,CACGCACAGAAGACACCTACAGGGCCAGATCACAATCGGTTAGTGAACTCGTACGGCGCG,RC4,DNA,60 nt,0.567,"18,481.87 Da",54.11 ¦ÌM,No QGRS found,N/A,Aptasensor,Application in microcystin detection,"Determination of the dissociation constants (KD) for aptamers. On the basis of the fluorescence recovered, saturation curves were obtained and the dissociation constants were calculated by nonlinear regression analysis"
Apta_664,CACGCAACAACACAACATGCCCAGCGCCTGGAACATATCCTATGAGTTAGTCCGCCCACA,RC6,DNA,60 nt,0.533,"18,280.76 Da",54.70 ¦ÌM,No QGRS found,N/A,Aptasensor,Application in microcystin detection,"Determination of the dissociation constants (KD) for aptamers. On the basis of the fluorescence recovered, saturation curves were obtained and the dissociation constants were calculated by nonlinear regression analysis"
Apta_665,CGCCAATCTCAAAGCCCGCCACCTGCCCCTCACTGCCCACCTGTGGAATCCATGTCGCTC,RC22,DNA,60 nt,0.633,"18,118.59 Da",55.19 ¦ÌM,No QGRS found,N/A,Aptasensor,Application in microcystin detection,"Determination of the dissociation constants (KD) for aptamers. On the basis of the fluorescence recovered, saturation curves were obtained and the dissociation constants were calculated by nonlinear regression analysis"
Apta_666,TCGACCTCGCGCGAGGAGGGTGGAGGGTCGTAGAGCGCGTA,C2,DNA,41 nt,0.683,"12,813.19 Da",78.04 ¦ÌM,2,20,Target recognition,Recognition of a disaccharide analogue of moenomycin,Effect of aptamers on the antibiotic activity of moenomycin A
Apta_667,GCGGCGGTACCAGGTCAAAGGTGGGTGAGGGGACGCCAAGAGTCCCCGCGGTTACATAGAG,NaA43,DNA,61 nt,0.639,"19,035.17 Da",52.53 ¦ÌM,2,19,Aptasensor,Detection and quantification of Na+ in living cells,Rate of the initial fluorescence enhancement was calculated for different Na+ concentration up to 400 mM
Apta_668,GGAACCCAACUAGGCGUUUGAGGGGAUUCGGCCACGGUAACAACCCCUC,N,RNA,49 nt,0.592,"15,748.43 Da",63.50 ¦ÌM,2,19,Targeted binding,Binding to Flavin and Nicotinamide Redox Cofactors,Equilibrium gel filtration measurement of solution Kd's of NMN aptamer
Apta_669,AACGTGGGAGGGCGGTGGTGTTGAA,ST1,DNA,25 nt,0.6,"7,883.08 Da",126.85 ¦ÌM,2,20,Aptasensor,Recognition of Anionic Porphyrins,N/A
Apta_670,TTGCCTAACCGTGAAGGTAAAACGATTTAGTCAAACGTGGGAGGGCGGTGGTGTTGACTGATCGATTTTATTCCA,PS2,DNA,75 nt,0.453,"23,293.93 Da",42.93 ¦ÌM,2,20,Aptasensor,Recognition of Anionic Porphyrins,N/A
Apta_671,GCATCTGATCGGGTGTGGGTGGCGTAAAGG,1.12,DNA,30 nt,0.6,"9,399.03 Da",106.39 ¦ÌM,2,18,Aptasensor,Determination of Ochratoxin A,N/A
Apta_672,GGGGTGAAACGGGTCCCG,1.13,DNA,18 nt,0.722,"5,605.62 Da",178.39 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of Ochratoxin A,N/A
Apta_673,GCAGTCCTAGATCGGGTGTGGCTGGCTTGG,1.14,DNA,30 nt,0.633,"9,325.97 Da",107.23 ¦ÌM,2,20,Aptasensor,Determination of Ochratoxin A,N/A
Apta_674,GCACGATGGGGAAAGGGTCCCCCTGGGTTG,1.4,DNA,30 nt,0.667,"9,328.99 Da",107.19 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of Ochratoxin A,N/A
Apta_675,ACTGTCCGTCGGGTTTAGGGTGGCGTTCGG,2.2,DNA,30 nt,0.633,"9,316.96 Da",107.33 ¦ÌM,2,19,Aptasensor,Determination of Ochratoxin A,N/A
Apta_676,TCAGTCCCGATCAGGTGTGGGTGGCATTGG,2.3,DNA,30 nt,0.6,"9,309.97 Da",107.41 ¦ÌM,2,19,Aptasensor,Determination of Ochratoxin A,N/A
Apta_677,CCAAATGCGACGGGGCCTGTTTTAATGGGG,2.4,DNA,30 nt,0.567,"9,302.99 Da",107.49 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of Ochratoxin A,N/A
Apta_678,CGTACGGTGGGAACGGTTCCTCTTAGGGT,2.6,DNA,29 nt,0.586,"8,980.76 Da",111.35 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of Ochratoxin A,N/A
Apta_679,CAGGTGGCAGATCGGGTGTGGGTGGCCTGG,2.9,DNA,30 nt,0.7,"9,416.02 Da",106.20 ¦ÌM,2,20,Aptasensor,Determination of Ochratoxin A,N/A
Apta_680,ACATGCGACTGAGGCTCGGTTTATTGAGGG,2.1,DNA,30 nt,0.533,"9,318.00 Da",107.32 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of Ochratoxin A,N/A
Apta_681,CCTGACGATCGGGTGTGGGTTGGCTTGAGG,2.11,DNA,30 nt,0.633,"9,365.99 Da",106.77 ¦ÌM,2,19,Aptasensor,Determination of Ochratoxin A,N/A
Apta_682,CCTTGTAGATCGGGTGTGGTTTGGCGTAGG,2.12,DNA,30 nt,0.567,"9,355.99 Da",106.88 ¦ÌM,2,20,Aptasensor,Determination of Ochratoxin A,N/A
Apta_683,GCAGTACGATCGGGGGTGGGTGGATGTAGG,2.13,DNA,30 nt,0.633,"9,464.07 Da",105.66 ¦ÌM,2,20,Aptasensor,Determination of Ochratoxin A,N/A
Apta_684,GGCGGACCAAGGGGACACCACAGATGAATGTACAGTACCATGTTACTGCGCCCGTAGGTG,OA 24,DNA,60 nt,0.567,"18,583.92 Da",53.81 ¦ÌM,2,17,Aptasensor,Detection of okadaic acid (OA),N/A
Apta_685,GGGGCAACAAACACGGAAGAAAATGAATCTACATACGTGGACATATATCCTGCCGCGTG,OA 21,DNA,59 nt,0.475,"18,254.76 Da",54.78 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of okadaic acid (OA),N/A
Apta_686,GGTCACCAACAACAGGGAGCGCTACGCGAAGGGTCAATGTGACGTCATGCGGATGTGTGG,OA 34,DNA,60 nt,0.583,"18,679.96 Da",53.53 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of okadaic acid (OA),N/A
Apta_687,GGGACAGCGGAGGTCTCCCACCCACCGGCCCCTGCGGCACACCAACCTGTATGGATGCG,OA 11,DNA,59 nt,0.695,"18,089.55 Da",55.28 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of okadaic acid (OA),N/A
Apta_688,GCCATGACAACCAGAGGTACCCCCGCCCACCAGCCCCGAAGTCTGTCAGCCTAGTTGTTG,OA 32,DNA,60 nt,0.617,"18,311.72 Da",54.61 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of okadaic acid (OA),N/A
Apta_689,CCACACAACAGCCTACGTGGATACACCACATACATCCCATAACCCCGTGTCATGTGTCG,OA 22,DNA,59 nt,0.525,"17,933.53 Da",55.76 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of okadaic acid (OA),N/A
Apta_690,GGGCGAAUUCCCGAGGACCAAAUAGUACCACCCGGGAAAACAGCUAAUGCCGAAACGGAGAUUUUUUCUGCAGAAGCU,R10-B35,RNA,78 nt,0.5,"25,157.07 Da",39.75 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to 8-oxodG,Affinity and specificity of RNA R10-B35 to 8-oxodG
Apta_691,CGACGCGCGTTGGTGGTGGATGGTGTGTTACACGTGTTGT,No. 4,DNA,40 nt,0.575,"12,476.97 Da",80.15 ¦ÌM,2,20,Targeted binding,Binding to oxytetracycline (OTC),Binding of ssDNA aptamers to oxytetracycline (OTC) was performed by equilibrium dialysis as described in methods
Apta_692,ACGTTGACGCTGGTGCCCGCTTGTGGTGCGAGTGTTGTGT,No. 5,DNA,40 nt,0.6,"12,412.92 Da",80.56 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to oxytetracycline (OTC),Binding of ssDNA aptamers to oxytetracycline (OTC) was performed by equilibrium dialysis as described in methods
Apta_693,CGAGTTGAGCCGGGCGCGGTACGGGTACTGGTATGTGTGG,No. 20,DNA,40 nt,0.65,"12,520.99 Da",79.87 ¦ÌM,2,21,Targeted binding,Binding to oxytetracycline (OTC),Binding of ssDNA aptamers to oxytetracycline (OTC) was performed by equilibrium dialysis as described in methods
Apta_694,ACTCACTATGGAAGAGATGGCGACATCTCTTCTCCGAGCCGGTCGAAATAGTGAGT,N,DNA,56 nt,0.5,"17,288.10 Da",57.84 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection and quantification of lead ions in environmental,Detection of Pb(II) in Lake Michigan water
Apta_695,AUUGGAUCGGUAGUAUAGGUGAGACACUUCAUGCCUUUGUUGCAGGCUGGGGUGAAGGCGCUACAUGGCGUCUGAAA,523,RNA,77 nt,0.506,"24,906.73 Da",40.15 ¦ÌM,2,18,Aptasensor,Determination of phenylalanine,"DMS protection data in the region of A47, RNA 523"
Apta_696,GAGUGCGCCCAUUGAUAAGAGCGUAGGUUCAACGGAGUCGUAGUCGUUCUCAAGUUGACGGUGCAUUAGAGUCCU,518,RNA,75 nt,0.507,"24,175.31 Da",41.36 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of phenylalanine,"Elution of RNA 518 from ligand-Sepharose. Filled squares, Phe-Sepharose; filled circles, Oac-Sepharose"
Apta_697,CTCTCGGGACGACGGACGCTAATCTTACAAGGGCGTAGTGTATGTCGTCCC,Phenylalanine-Cp*Rh(III) sensor,DNA,51 nt,0.569,"15,707.06 Da",63.67 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to phenylalanine,"The response of sensors IV-VI at low concentrations of amino acids, representative for measurements in diluted blood or serum"
Apta_698,AGCAGCACAGAGGTCAGATGCACTCGGACCCCATTCTCCTTCCATCCCTCATCCGTCCACCCTATGCGTGCTACCGTGAA,Aptamer 9.3,DNA,80 nt,0.575,"24,336.56 Da",41.09 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of Polychlorinated biphenyls (PCBs),"Saturation curves of aptamer 9.3 to OH-PCB72 (72)-coated magnetic beads, OH-PCB106 (106)-coated magnetic beads and quenched ethanolamine (QE) magnetic beads"
Apta_699,ATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA,sgc8,DNA,41 nt,0.512,"12,634.13 Da",79.15 ¦ÌM,No QGRS found,N/A,Targeted therapy,Fluorescence signal for tumor cell imaging and diagnosis; APCs efficiently penetrated into the interior of multicellular tumor spheroids (MCTS) and caused cell damage,N/A
Apta_700,GCAGGGGCGTTCGGGGGGTACCGCTGC,GR30,DNA,27 nt,0.778,"8,414.38 Da",118.84 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Reactive Green 19,N/A
Apta_701,GTACTGGCGTTCGGGGGGTACCGCTGC,GR21,DNA,27 nt,0.704,"8,364.35 Da",119.55 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Reactive Green 19,N/A
Apta_702,TACCCGGCGTTCGGGGGGTACCGCTGC,GR31,DNA,27 nt,0.741,"8,309.32 Da",120.35 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Reactive Green 19,N/A
Apta_703,GGGCGGAUGAGACGCUUGGCGUGUGCUGUGGAGAGUCAUCCG,CTH-5,RNA,42 nt,0.643,"13,669.12 Da",73.16 ¦ÌM,No QGRS found,N/A,Target detection,Detection of S-adenosylhomocysteine,Binding specificity in the biosensor
Apta_704,GTACGAATTCACGAGGTTGCCAGCGGGGCCAGCCACTTCTGTCAGTGAATTCCTGCTCGTATATCTACTCGCCCGCCTGCGAGCATGGAGTCGGATCCTCTA,S1-11,DNA,102 nt,0.569,"31,346.99 Da",31.90 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to sialyllactose,N/A
Apta_705,CCGUAAUACGACUCACUAUAGGGGAGCUCGGUACCGAAUUCAAGGUACUCUGUGCUUGUCGAUGUGUAUUGAUGGCACUUUCGAGUCAACGAGUUGACAGAACAAGUAGUCAAGCUUUGCAGAGAGGAUCCUU,5,RNA,133 nt,0.466,"42,804.31 Da",23.36 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibition of the cell adhesion,Inhibition of the HL60 cell adhesion to E-selectin and P-selectin
Apta_706,CCGGCCAAGGGTGGGAGGGAGGGGGCCGG,Clone 73-min,DNA,29 nt,0.828,"9,155.85 Da",109.22 ¦ÌM,3,64,Targeted binding,Recognizing the fluorophore sulforhodamine B,N/A
Apta_707,GGCCUAAAACAUACCAGAUUUCGAUCUGGAGAGGUGAAGAAUUCGACCACCUAGGCCGGU,cb28 minimer,RNA,60 nt,0.5,"19,333.56 Da",51.72 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognizing the tetracycline,"Photoinduced tetracycline crosslinking to the cb28 minimer. Reverse transcription of cb28 RNA, which was UV irradiated in the presence of increasing amounts of tetracycline. G and A indicate sequencing lanes"
Apta_708,CGTACGGAATTCGCTAGCGGGCGGGGGTGCTGGGGGAATGGAGTGCTGCGTGCTGCGGGGATCCGAGCTCCACGTG,T24,DNA,76 nt,0.684,"23,767.11 Da",42.07 ¦ÌM,3,52,Target detection,Detection of TCs in pharmaceutical preparations and contaminated food products,"Binding assays with ssDNA aptamers to tetracycline (TET). The saturation curves were obtained by plotting the concentration of bound TET as a function of ssDNA concentration, and the dissociation constants (Kd) were calculated by non-linear regression analysis (n = 3)"
Apta_709,AGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACU,TCT8-4,RNA,38 nt,0.526,"12,097.19 Da",82.66 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to theophylline,The binding of TCT8-4 and mTCT8-4 RNAs to theophylline
Apta_710,GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGUCUGGAUACCAUGCAUGAUGCACCUUGGCAGUCUUACGAAACGGUAGCGAGAGCUC,AR6,RNA,94 nt,0.521,"30,366.07 Da",32.93 ¦ÌM,No QGRS found,N/A,Targeted binding,RNA switch array,N/A
Apta_711,GGCGAUACCAGCCGAAAGGCCCUUGGCAGCGUC,original (S0),RNA,33 nt,0.667,"10,621.40 Da",94.15 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to theophylline,Experimental binding affinity measurements of the theophylline-binding aptamer
Apta_712,GGCGGUGCUCGCCGAAAGGCUCCUGGAUACGUC,sequence 1 (S1),RNA,33 nt,0.667,"10,615.34 Da",94.20 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to theophylline,Experimental binding affinity measurements of the theophylline-binding aptamer
Apta_713,GGCGGUGCUGGCCGAAAGGCGCUUGGAAACGUC,sequence 2 (S2),RNA,33 nt,0.667,"10,718.43 Da",93.30 ¦ÌM,2,19,Targeted binding,Binding to theophylline,N/A
Apta_714,GGCGGUUCCUGCCGAAAGGCUCGUGGCAACGUC,sequence 3 (S3),RNA,33 nt,0.667,"10,615.34 Da",94.20 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to theophylline,N/A
Apta_715,GGCGCUGCACGCCGAAAGGCCCGUUGAAACGUC,sequence 4 (S4),RNA,33 nt,0.667,"10,621.40 Da",94.15 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to theophylline,N/A
Apta_716,GGCGCUUCAUGCCGAAAGGCCCGUUGUAACGUC,sequence 5 (S5),RNA,33 nt,0.606,"10,560.30 Da",94.69 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to theophylline,N/A
Apta_717,GGCGCAGCCCGCCGAAAGGCACGUGGAACCGUC,sequence 6 (S6),RNA,33 nt,0.727,"10,659.45 Da",93.81 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to theophylline,N/A
Apta_718,GGGUUGUGAGCUCCCGGCUCGCAUUGUGAGGUGGAGGGGGACGUGCUGCAGGUCGACGCAUGCGCCG,ApT4-A32nt-5,RNA,67 nt,0.687,"21,790.91 Da",45.89 ¦ÌM,2,21,Targeted binding,Binding to theophylline,N/A
Apta_719,GGAAUGGAUCCACAUCUACGAAGGCUUUGAAGGUGAGACCGUGCAAAUGAGGAUGGUGUGGAUGAUUAGGGUUGUCGGUUUUCACUGCAGACUUGACGAAGCUU,BA 14-2,RNA,104 nt,0.481,"33,689.93 Da",29.68 ¦ÌM,2,20,Aptasensor,Detection of the aminoglycoside antibiotic tobramycin,Effect of tobramycin on the fluorescence of BA14-2
Apta_720,GGGAGAAUUCCGACCAGAAGCUUAGUAUAGCGAGGUUUAGCUACACUCGUGCUGAUCGUUUGGUACGGGACCUGCGUGUAGCCCAUAUGUGCGUCUACAUGGAUCCUCA,J6(13),RNA,109 nt,0.514,"35,048.70 Da",28.53 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of the aminoglycoside antibiotic tobramycin,N/A
Apta_721,CTCTCGGGACGACCGCGGTAGTCTTAACCTAAAGCGGTGTCAGGTCGTCCC,Tryptophan-Cp*Rh(III) sensor,DNA,51 nt,0.608,"15,668.02 Da",63.82 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to amino acids,"The response of sensors IV-VI at low concentrations of amino acids, representative for measurements in diluted blood or serum"
Apta_722,CTCTCGGGACGACGGCCCGATCTCAGAGTAGTCGTCCC,Tyrosine-Cp*Rh(III) sensor,DNA,38 nt,0.658,"11,616.44 Da",86.08 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to amino acids,"The response of sensors IV-VI at low concentrations of amino acids, representative for measurements in diluted blood or serum"
Apta_723,GGGAGCUCAGAAUAAACGCUCAAAUCCGUGGACAGGGCGUAAGCGCCUUCGACAUGAGACACGGAUCCUGCGACGAAUUCAGC,N,RNA,83 nt,0.554,"26,818.06 Da",37.29 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to valine,N/A
Apta_724,GGGAGAGGAUACUACUGUCAUACGUUAGGCUGUAGGCGAGGUGAAAUGAGCGGUAAUAGCCUCAGCGUAGCAUAUGCAUGAAUUCGAAGCUUCGC,N,RNA,95 nt,0.495,"30,777.29 Da",32.49 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of Zn2+,Dissociation constant measurements by isocratic affinity elution in the presence of Zn ions
Apta_725,ATCCAGAGTGACGCAGCATGCTCATCCACGATTCTGGCGAATTTAGTGCCTGTCTTTTTCTCTTGGACACGGTGGCTTAGT,KHG11,DNA,81 nt,0.494,"24,912.92 Da",40.14 ¦ÌM,No QGRS found,N/A,Target recognition,Recognize targets associated with monocytic differentiation,Identification of potential aptamer candidates
Apta_726,TACCAGTGCGATGCTCAGGCCGATGTCAACTTTTTCTAACTCACTGGTTTTGCCTGACGCATTCGGTTGAC,HCH07,DNA,71 nt,0.493,"21,767.92 Da",45.94 ¦ÌM,No QGRS found,N/A,Aptasensor,Early lung cancer detection,"Specific binding of molecular aptamers to formalin-fixed, paraffin-embedded SCLC cell line tissue arrays"
Apta_727,ATACCAGCTTATTCAATTAGTCACACTTAGAGTTCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGATAGTAAGTGCAATCT,sgc8,DNA,88 nt,0.42,"27,106.40 Da",36.89 ¦ÌM,No QGRS found,N/A,Target recognition,Recognizing of target leukemia cells,Molecular recognition of CCRF-CEM cells and human bone marrow cells incubated with FITC-labeled sgc8
Apta_728,CGACCCGGCACAAACCCAGAACCATATACACGATCATTAGTCTCCTGGGCCG,cy-apt 20,DNA,52 nt,0.558,"15,856.20 Da",63.07 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of gastric cancer cell,The specific binding capacity of aptamer cy-apt 20 to gastric carcinoma cells was also assessed with flow cytometry by varying the concentration of FITC-cy-apt 20
Apta_729,AACACCGTGGAGGATAGTTCGGTGGCTGTTCAGGGTCTCCTCCCGGTG,TD05,DNA,48 nt,0.604,"14,847.49 Da",67.35 ¦ÌM,2,17,Target recognition,Specifically recognize the target lymphoma cells mixed with normal human bone marrow aspirates,Kd determination of aptamers. Flow cytometry assay was employed for the binding affinity measurement
Apta_730,ACCAAACACAGATGCAACCTGACTTCTAACGTCATTTGGTG,TC01,DNA,41 nt,0.439,"12,537.10 Da",79.76 ¦ÌM,No QGRS found,N/A,Target recognition,Specifically recognize the target lymphoma cells mixed with normal human bone marrow aspirates,Kd determination of aptamers. Flow cytometry assay was employed for the binding affinity measurement
Apta_731,AAGGAGCAGCGTGGAGGATACTCTAATTGCCGTATAAGGTCAGGGGGTTGGTTGGTTCCTAGTGCTTAGGGTGTGTCGTCGTGGT,TD08,DNA,85 nt,0.529,"26,574.95 Da",37.63 ¦ÌM,2,20,Target recognition,Specifically recognize the target lymphoma cells mixed with normal human bone marrow aspirates,Effects of trypsin (A) and proteinase K (B) digestion on the binding of TD08
Apta_732,AAGGAGCAGCGTGGAGGATAGCTGTCATCGGCTTATGTGCTTTCCAGGGTCCGTGCTGTCCGTTGTTAGGGTGTGTCGTCGTGGT,TD09,DNA,85 nt,0.565,"26,453.83 Da",37.80 ¦ÌM,No QGRS found,N/A,Target recognition,Specifically recognize the target lymphoma cells mixed with normal human bone marrow aspirates,N/A
Apta_733,TAGGCAGTGGTTTGACGTCCGCATGTTGGGAATAGCCACGCCT,TE02,DNA,43 nt,0.558,"13,290.52 Da",75.24 ¦ÌM,No QGRS found,N/A,Target recognition,Specifically recognize the target lymphoma cells mixed with normal human bone marrow aspirates,N/A
Apta_734,TCCTCGATGCACCAGTTCACCTTATTTGCTTCTTCTCTCTGTTCTGACTGGGTGCTGAGGA,TE04,DNA,61 nt,0.492,"18,635.90 Da",53.66 ¦ÌM,No QGRS found,N/A,Target recognition,Specifically recognize the target lymphoma cells mixed with normal human bone marrow aspirates,N/A
Apta_735,AGGCCCCCAGGCTCGGTGGATGCAAACACATGACTATGGGCCCGT,TE13,DNA,45 nt,0.622,"13,856.89 Da",72.17 ¦ÌM,2,17,Target recognition,Specifically recognize the target lymphoma cells mixed with normal human bone marrow aspirates,Kd determination of aptamers. Flow cytometry assay was employed for the binding affinity measurement
Apta_736,ATCGTCTGCTCCGTCCAATATGATGACACCTGCATAATTTATAGTGAGTCTTGATTCACGCTGCATTTGGTGTGAGGTCGTGC,TV08,DNA,83 nt,0.458,"25,569.35 Da",39.11 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of A549 cells,The Kds of aptamers were determined by flow cytometry
Apta_737,ATCGTCTGCTCCGTCCAATAGTGCATTGAAACTTCTGCATCCTCGTTTGGTGTGAGGTCGTGC,TV01,DNA,63 nt,0.508,"19,352.37 Da",51.67 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of A549 cells,The Kds of aptamers were determined by flow cytometry
Apta_738,ATCGTCTGCTCCGTCCAATACCTGCATATACACTTTGCATGTGGTTTGGTGTGAGGTCGTGC,TV02,DNA,62 nt,0.5,"19,063.18 Da",52.46 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of A549 cells,The Kds of aptamers were determined by flow cytometry
Apta_739,ATCGTCTGCTCCGTCCAATAGCGTGCATTGGTTTACTGCATCCGTGAAACTGGGCTTTGGTGTGAGGTCGTGC,TV03,DNA,73 nt,0.534,"22,538.38 Da",44.37 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of A549 cells,N/A
Apta_740,ATCGTCTGCTCCGTCCAATAAACCTGCATAATTTATAAGTCTAGACTGCTGCATTTGGTGTGAGGTCGTGC,TV04,DNA,71 nt,0.451,"21,839.99 Da",45.79 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of A549 cells,Flow cytometry assay for the binding capacity of the Cy5-labeled sequences TV04
Apta_741,ATCGTCTGCTCCGTCCAATAGCCTCACCCTGCATAATTTATAGACTACACTTAGGAATCGCTGCATTTGGTGTGAGGTCGTGC,TV05,DNA,83 nt,0.482,"25,468.30 Da",39.26 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of A549 cells,Flow cytometry assay for the binding capacity of the Cy5-labeled sequences TV05
Apta_742,ATCGTCTGCTCCGTCCAATAGGACCGATAGGAACCACGGACTGCATGTTTCTGCATTTGACGTGGTTTGGTGTGAGGTCGTGC,TV06,DNA,83 nt,0.53,"25,661.38 Da",38.97 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of A549 cells,N/A
Apta_743,ATCGTCTGCTCCGTCCAATATCCGAGCAAGAACTCATATTGCATTATTTATAGCTACGCGCTGCATTTGGTGTGAGGTCGTGC,TV07,DNA,83 nt,0.47,"25,523.33 Da",39.18 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of A549 cells,The Kds of aptamers were determined by flow cytometry
Apta_744,GTGGCCAGTCACTCAATTGGGTGTAGGGGTGGGGATTGTGGGTTG,S6,DNA,45 nt,0.578,"14,131.02 Da",70.77 ¦ÌM,No QGRS found,N/A,Target recognition,Recognition of subtype non-small cell lung cancer,The binding of selected aptamers to A549 cells pre-treated with trypsin
Apta_745,GGTTGCATGCCGTGGGGAGGGGGGTGGGTTTTATAGCGTACTCAG,S1,DNA,45 nt,0.6,"14,116.01 Da",70.84 ¦ÌM,3,63,Target recognition,Recognition of subtype non-small cell lung cancer,The binding of selected aptamers to A549 cells pre-treated with trypsin
Apta_746,AGAGTGGGGGGGTGGGTGGATTTGACAGGTGGCATGCTGGAGAGT,S11.a,DNA,45 nt,0.6,"14,254.11 Da",70.16 ¦ÌM,2,21,Target recognition,Recognition of subtype non-small cell lung cancer,N/A
Apta_747,TGGGGTTATTAATTTTGGGTGGGGGGGAAGATGTAGCATCCGACG,S11.b,DNA,45 nt,0.511,"14,123.05 Da",70.81 ¦ÌM,3,57,Target recognition,Recognition of subtype non-small cell lung cancer,N/A
Apta_748,AGCTTGAGGGTGGGCGGGTGGACGCGGTAGTGGTATATAGGTCGG,S11.c,DNA,45 nt,0.622,"14,190.06 Da",70.47 ¦ÌM,No QGRS found,N/A,Target recognition,Recognition of subtype non-small cell lung cancer,N/A
Apta_749,GATCGGTGGGTGGGGGGGTTGGAGATCATCCTCAGGGATTACGTC,S11.d,DNA,45 nt,0.6,"14,085.00 Da",71.00 ¦ÌM,3,54,Target recognition,Recognition of subtype non-small cell lung cancer,N/A
Apta_750,ATGCGAACAGGTGGGTGGGTTGGGTGGATTGTTCGGCTTCTTGAT,S11.e,DNA,45 nt,0.533,"14,081.00 Da",71.02 ¦ÌM,2,21,Target recognition,Recognition of subtype non-small cell lung cancer,Binding assay of S11e to A549 cells
Apta_751,GGTCGCAGATGGATTAAGTATGTGGGTGGGGGGGTGGAAGTTAAT,S11.f,DNA,45 nt,0.511,"14,212.11 Da",70.36 ¦ÌM,2,21,Target recognition,Recognition of subtype non-small cell lung cancer,N/A
Apta_752,GCTATCTTATGGAAATTTCGTGTAGGGTTTGGTGTGGCGGGGCTA,S15,DNA,45 nt,0.489,"14,039.98 Da",71.23 ¦ÌM,2,21,Target recognition,Recognition of subtype non-small cell lung cancer,The binding of selected aptamers to A549 cells pre-treated with trypsin
Apta_753,GGGCACAGACGGAAGATGAGAATTGTGGGGCTTAGTATAGTGAGGTGCGTGT,aptamer 13,DNA,52 nt,0.519,"16,348.48 Da",61.17 ¦ÌM,No QGRS found,N/A,Aptasensor,Molecular probes of HPV-associated cervical cancer cells,Binding equilibrium for aptamers and their HF cell epitopes
Apta_754,GGGCGGGGAGTAGGGAGAGGGGTTTCCATCGGCGACAGAGGAGTTATGTGTGT,aptamer 14,DNA,53 nt,0.604,"16,710.67 Da",59.84 ¦ÌM,3,62,Aptasensor,Molecular probes of HPV-associated cervical cancer cells,Binding equilibrium for aptamers and their HF cell epitopes
Apta_755,GGGGAGGGAGACACAGTCATGGAGCAGTTATTAGGGTGTACCGGGTGTAGT,aptamer 20,DNA,51 nt,0.549,"16,020.26 Da",62.42 ¦ÌM,3,48,Aptasensor,Molecular probes of HPV-associated cervical cancer cells,Binding equilibrium for aptamers and their HF cell epitopes
Apta_756,GGGGGACACGGAGGTGGTGGAAAGGCTAAGATTTGATGATGAGTAGTGTGGT,aptamer 28,DNA,52 nt,0.519,"16,428.53 Da",60.87 ¦ÌM,2,21,Aptasensor,Molecular probes of HPV-associated cervical cancer cells,Binding equilibrium for aptamers and their HF cell epitopes
Apta_757,GGTGGTGGTGGTTGTGGTGGTGG,AS1411,DNA,23 nt,0.652,"7,309.67 Da",136.81 ¦ÌM,2,21,Aptasensor,Biomedical researches,Cells detection on AS1411-PGO-I-ISE in PBS and blood samples
Apta_758,GGCUUUCGGGCUUUCGGCAACAUCAGCCCCUCAGCC,E3,RNA,36 nt,0.639,"11,412.78 Da",87.62 ¦ÌM,No QGRS found,N/A,Targeted therapy,Efficiently kills prostate cancer cells in vitro but does not affect normal prostate epithelial cells,E3 targets prostate cancer cells with nanomolar apparent affinity
Apta_759,GAGGCATACCAGCTTATTATTGGGGCCGGGGCAAGGGGGGGGTACCGTGGTAGGACAGATAGTAAGTGCAATCTGCGAA,aptamer #1-F,DNA,79 nt,0.557,"24,729.82 Da",40.44 ¦ÌM,4,82,Targeted therapy,Targeted therapy of acute myeloid leukemia,Cell-binding affinity of synthetic aptamers to cultured HEL cells at 4 ©}. Aptamer #1-F had the highest binding affinity with Kd 4.24 nM
Apta_760,AGCAGAGTTCACGACCCGATAAGGGCGATGCCGATCCCTGTGGCCGTAGGGGCAGTCCCGCTAGAGTTACATACCAATCGTCGCAG,sk6,DNA,86 nt,0.593,"26,553.97 Da",37.66 ¦ÌM,No QGRS found,N/A,Aptasensor,Probe for molecular subtyping of breast cancer,Dissociation constants (Kd) of the selected aptamers
Apta_761,AGCAGAGTTCACGACCCGATAAGGGGAAAACACATTTCGGATCTCCGTTGTCGCCCTGATACCGAGTTACATACCAATCGTCGCAG,sk1,DNA,86 nt,0.512,"26,454.96 Da",37.80 ¦ÌM,No QGRS found,N/A,Aptasensor,Probe for molecular subtyping of breast cancer,Dissociation constants (Kd) of the selected aptamers
Apta_762,AGCAGAGTTCACGACCCGATAAGGGCGATGCCGATCCCTGTGGCCGTAGGGACAGTCCCGCTAGAGTTACATACCAATCGTCGCAG,sk2,DNA,86 nt,0.581,"26,537.97 Da",37.68 ¦ÌM,No QGRS found,N/A,Aptasensor,Probe for molecular subtyping of breast cancer,Dissociation constants (Kd) of the selected aptamers
Apta_763,AGCAGAGTTCACGACCCGATAAGGGGAAAACACATTTCGGATCTCCGTTGTCGCCCTGGTACCGAGTTACATACCAATCGTCGCAG,sk3,DNA,86 nt,0.523,"26,470.96 Da",37.78 ¦ÌM,No QGRS found,N/A,Aptasensor,Probe for molecular subtyping of breast cancer,Dissociation constants (Kd) of the selected aptamers
Apta_764,AGCAGAGTTCACGACCCGATAAGGGGAAAATACATTTCGGATCTCCGTTGTCGCCCTGATACCGAGTTACATACCAATCGTCGCAG,sk4,DNA,86 nt,0.5,"26,469.97 Da",37.78 ¦ÌM,No QGRS found,N/A,Aptasensor,Probe for molecular subtyping of breast cancer,Dissociation constants (Kd) of the selected aptamers
Apta_765,AGCAGAGTTCACGACCCGATAAGGGGAAAATACATTTCGGATCTCCGTTGTCGCCCTGGTACCGAGTTACATACCAATCGTCGCAG,sk5,DNA,86 nt,0.512,"26,485.97 Da",37.76 ¦ÌM,No QGRS found,N/A,Aptasensor,Probe for molecular subtyping of breast cancer,Dissociation constants (Kd) of the selected aptamers
Apta_766,GGUUACCAGCCUUCACUGCGGACGGACAGAGAGUGCAACCUGCCGUGCCGCACCACGGUCGGUCACAC,aptamer H02,RNA,68 nt,0.647,"21,837.04 Da",45.79 ¦ÌM,No QGRS found,N/A,Aptasensor,Probe for cyto-and histofluorescence in glioblastoma,KD for the interaction between U87MG a5+ cells and aptamers H02
Apta_767,GAATTCAGTCGGACAGCGACGGTGGGAGCCCCAAATAATTCTTGCGATTATTAGTGTAAGCGGATGGACGAATATCGTCTCCC,GBM128,DNA,83 nt,0.494,"25,689.46 Da",38.93 ¦ÌM,No QGRS found,N/A,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",The binding affinity of aptamers GBM128 with U118 MG and SVGp12 cells
Apta_768,GAATTCAGTCGGACAGCGGCACTTGCGACACGTTTGTCGGGTAAATGCGTGTATTTTCTTTTCGATGGACGAATATCGTCTCCC,GBM131,DNA,84 nt,0.488,"25,908.56 Da",38.60 ¦ÌM,No QGRS found,N/A,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",The binding affinity of aptamers GBM131 with U118 MG and SVGp12 cells
Apta_769,GAATTCAGTCGGACAGCGAGTTGTTGTTAGGGTGTTGGGTTGGGGTTTTAGGGTCCCTGTCGTCGATGGACGAATATCGTCTCCC,GBM1,DNA,85 nt,0.529,"26,436.85 Da",37.83 ¦ÌM,3,62,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_770,GAATTCAGTCGGACAGCGGCATTTACATTCCATGGGAAATTTCTCAAGCGGTATTTCATTTCGATGGACGAATATCGTCTCCC,GBM7,DNA,83 nt,0.446,"25,540.37 Da",39.15 ¦ÌM,No QGRS found,N/A,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_771,GAATTCCGTCGGACAGCGGTATGCATGGGAGGTTCTGGAGGGGGTGGGTTGGCGTGCGTTCCAGATGGACGAATATCGTCTCCC,GBM10,DNA,84 nt,0.595,"26,186.68 Da",38.19 ¦ÌM,2,21,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_772,GAATTCAGTCGGACAGCGCGGTGTTGGTGGTGGGGTGGTTTGGGAATCTGTTCGGCTGGAGATGGACGAATATCGTCTCCC,GBM11,DNA,81 nt,0.568,"25,285.11 Da",39.55 ¦ÌM,2,20,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_773,GAATTCAGTCGGACAGCGGTGGTGCTTGTGTATGGGGGTGGTTGGTGGGTTTTATGCTGCTGGATGGACGAATATCGTCTCCC,GBM17,DNA,83 nt,0.542,"25,899.49 Da",38.61 ¦ÌM,2,21,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_774,GAATTCAGTCGGACAGCGAGGAAAATTTCGTTATTTTCGTTTCCGGGAACTCGGGCATTTAGAGATGGACGAATATCGTCTCCC,GBM24,DNA,84 nt,0.464,"25,974.64 Da",38.50 ¦ÌM,No QGRS found,N/A,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_775,GAATTCAGTCGGACAGCGCGGTGTTGGTGGCGGGGGTGGTTGGGGGATTTGGCTGTCCTGAGTGATGGACGAATATCGTCTCCC,GBM34,DNA,84 nt,0.595,"26,248.70 Da",38.10 ¦ÌM,2,21,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_776,AGTGGTCGAACTACACATCCTTGAACTGCGGAATTATCTAC,ADE1,DNA,41 nt,0.439,"12,568.11 Da",79.57 ¦ÌM,No QGRS found,N/A,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_777,GAGCCCTATCTCACACCGCACCCGCAAACTATCATCCTACATG,ADE2,DNA,43 nt,0.535,"12,981.37 Da",77.03 ¦ÌM,No QGRS found,N/A,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_778,GAAGACGAGCGGCGAGTGTTATTACGCTTGGAAACAACCCC,EJ4,DNA,41 nt,0.537,"12,668.16 Da",78.94 ¦ÌM,No QGRS found,N/A,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_779,TACGGGCTGGATCCACTGTTACGGCGTGTATCCGCTATCAA,EJ5,DNA,41 nt,0.537,"12,592.08 Da",79.41 ¦ÌM,No QGRS found,N/A,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_780,GAAGACGAGCGGCGAGTGTTATTACGCTTGGAAACAACCCC,EJ7,DNA,41 nt,0.537,"12,668.16 Da",78.94 ¦ÌM,No QGRS found,N/A,Target detection,"Early detection, Targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma",N/A
Apta_781,GTACGCCGCAAGACGAGTTGTGTATAAGCCGGC,JH6,DNA,33 nt,0.576,"10,203.57 Da",98.00 ¦ÌM,No QGRS found,N/A,Aptasensor,Probes for acute myelogenous leukemia detection and surface protein biomarker discovery,Determination of the aptamer binding affinities to NB4 cells
Apta_782,AGGTGTGACTCGATCTGTGGGGGTTGGGGGGTGGTTTTTCGGAA,JH19,DNA,44 nt,0.568,"13,832.83 Da",72.29 ¦ÌM,2,20,Aptasensor,Probes for acute myelogenous leukemia detection and surface protein biomarker discovery,Determination of the aptamer binding affinities to NB4 cells
Apta_783,AAGGGGTTGGGTGGGTTTATACAAATTAATTAATATTGTATGGTATATTT,K19,DNA,50 nt,0.28,"15,593.05 Da",64.13 ¦ÌM,2,19,Aptasensor,Probes for acute myelogenous leukemia detection and surface protein biomarker discovery,Determination of the aptamer binding affinities to NB4 cells
Apta_784,ATCCAGAGTGACGCAGCATTTTGACGCTTTATCCTTTTCTTATGGCGGGATAGTTTCGTGGACACGGTGGCTTAGT,U2,DNA,76 nt,0.474,"23,483.01 Da",42.58 ¦ÌM,No QGRS found,N/A,Live-cell imaging,Molecular Imaging of Glioblastoma In Vivo,Good specificity and high affinity of selected aptamers to U87-EGFRvIII cells
Apta_785,ATCCAGAGTGACGCAGCATGAATCTTTTCTTTTGGTTTTGATATTTATAGTTGGTGAATGGACACGGTGGCTTAGT,U8,DNA,76 nt,0.395,"23,560.09 Da",42.44 ¦ÌM,2,18,Live-cell imaging,Molecular Imaging of Glioblastoma In Vivo,Good specificity and high affinity of selected aptamers to U87-EGFRvIII cells
Apta_786,ATCCAGAGTGACGCAGCATTTGTATCCTATTTTGTTTATGTAATTGTCGTTGATCATGTGGACACGGTGGCTTAGT,U19,DNA,76 nt,0.408,"23,496.04 Da",42.56 ¦ÌM,No QGRS found,N/A,Live-cell imaging,Molecular Imaging of Glioblastoma In Vivo,Good specificity and high affinity of selected aptamers to U87-EGFRvIII cells
Apta_787,ATCCAGAGTGACGCAGCATTTGTTTAATATGTTTTTTAATTCCCCTTGTGGTGTGTTGTGGACACGGTGGCTTAGT,U31,DNA,76 nt,0.421,"23,503.03 Da",42.55 ¦ÌM,No QGRS found,N/A,Live-cell imaging,Molecular Imaging of Glioblastoma In Vivo,Good specificity and high affinity of selected aptamers to U87-EGFRvIII cells
Apta_788,TACCAGTGCGATGCTCAGTAACTTTGAAGGAAAGGCTACAAACTCTTCCTGACGCATTCGGTTGAC,PS1,DNA,66 nt,0.47,"20,312.04 Da",49.23 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of HL cells,Cell-binding affinity of aptamers was analyzed using a series dilution
Apta_789,TAACTTTGAAGGAAAGGCTACAAACTCTTC,PS1NP,DNA,30 nt,0.367,"9,197.98 Da",108.72 ¦ÌM,No QGRS found,N/A,Target recognition,Detection of HL cells,Cell-binding affinity of aptamers was analyzed using a series dilution
Apta_790,GGGAGACAAGAATAAACGCTCAAGAAGTGAAAATGACAGAACACAACATTCGACAGGAGGCTCACAACAGGC,MUC1-5TR-1,DNA,72 nt,0.458,"22,353.44 Da",44.74 ¦ÌM,No QGRS found,N/A,Targeted therapy,Targeted therapy of MCF7 adenocarcinoma cell,N/A
Apta_791,ATCGTCTGCTCCGTCCAATATATCAAAGGCGAATTTTGTCAAGGTGTTAAACGATAGTCCCTACCTTTGGTGTGAGGTCGTGC,Aptamer TY04,DNA,83 nt,0.458,"25,587.38 Da",39.08 ¦ÌM,No QGRS found,N/A,Targeted therapy,Aptamer TY04 inhibits the growth of multiple myeloma cells,MM.1S cells were treated with different concentrations of unselected ssDNA library (Lib) and TY04 for 96 h
Apta_792,ATACCAGCTTATTCAATTCCCAAATTGCCACCACTTACAGCATGATAACATACTACATCTTTTCATCAAGATAGTAAGTGCAATCT,Aptamer N55,DNA,86 nt,0.349,"26,238.91 Da",38.11 ¦ÌM,No QGRS found,N/A,Target recognition,Recognize inflamed human aortic endothelial cells,Dissociation plot for aptamer N55 binding to inflamed HAE cells
Apta_793,GGGAGAGAACAAUGACCUGCGGUGCCAAGCCGUCGGGUUAUGUUGAUCUCCUCAAGGACGAGUGCAUUGCAUCACGUCAGUAG,RA16,RNA,83 nt,0.542,"26,806.93 Da",37.30 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited cancer cell proliferation,"The binding curve of FITC-labeled RA16 (5-200 nM) and mean fluorescence intensities (MFIs) obtained by flow cytometry, KD = 9 ºô 2 nM. Three independent experiments were performed; all data represent means ºô SD, n = 3"
Apta_794,ATCCAGAGTGACGCAGCAAGGAGATTCGAGGGGGAAGGTTTGTTATAGGGGTTAATGGACACGGTGGCTTAGT,ZL-7,DNA,73 nt,0.507,"22,880.65 Da",43.71 ¦ÌM,2,18,Targeted therapy,Precise diagnosis and target theranostics of multidrug-resistant HCC,Quantitative analysis of the apparent dissociation constant of the ZL-7 aptamer on target HepG2/MDR cells by measuring the median fluorescence intensity after incubating with various concentrations of the FITC-labeled aptamer
Apta_795,CGCAGCAAGGAGATTCGAGGGGGAAGGTTTGTTATAGGGGTTAATGGA,ZL-7c,DNA,48 nt,0.5,"15,096.69 Da",66.24 ¦ÌM,2,18,Targeted therapy,Precise diagnosis and target theranostics of multidrug-resistant HCC,Quantification analysis of apparent Kd of truncated ZL-7c on target HepG2/MDR cells
Apta_796,GTGCTGGATGTCACCTCCACTCACCACCTCTTCTCCGCTCCTCGTCATGACACATCCAG,mApoc46,DNA,59 nt,0.576,"17,825.40 Da",56.10 ¦ÌM,No QGRS found,N/A,Targeted therapy,Molecular tools for rapid intraoperative diagnosis and In vivo imaging of serous ovarian cancer,Binding curves of mApoc46 and mApoc14 to primary SOC cells
Apta_797,GTTCGTGGTGTGCTGGATGTCACCTCCACTCACCACCTCTTCTCCGCTCCTCGTCATGACACATCCAGCAGCACGA,Apoc46,DNA,76 nt,0.579,"23,113.76 Da",43.26 ¦ÌM,No QGRS found,N/A,Targeted therapy,Molecular tools for rapid intraoperative diagnosis and In vivo imaging of serous ovarian cancer,N/A
Apta_798,GTTCGTGGTGTGCTGGATGTCGGAGATGGTCCGCTTCGTTCAACTACTACGCATTTTGACACATCCAGCAGCACGA,Apoc34,DNA,76 nt,0.526,"23,431.98 Da",42.68 ¦ÌM,2,19,Targeted therapy,Molecular tools for rapid intraoperative diagnosis and In vivo imaging of serous ovarian cancer,N/A
Apta_799,GTTCGTGGTGTGCTGGATGTCCCGTGCACGGCGCCACGTTTTCCTCTCATCCCCGATGACACATCCAGCAGCACGA,Apoc37,DNA,76 nt,0.605,"23,274.84 Da",42.96 ¦ÌM,No QGRS found,N/A,Targeted therapy,Molecular tools for rapid intraoperative diagnosis and In vivo imaging of serous ovarian cancer,N/A
Apta_800,AAGGAGCAGCGTGGAGGATATACACCGTCATCAGAGGGAGCATCTCTAGTCAGGACTGTGATGAATTAGGGTGTGTCGTCGTGGT,M3,DNA,85 nt,0.518,"26,523.97 Da",37.70 ¦ÌM,No QGRS found,N/A,Targeted binding,Against several other types of metastatic cancer cells,Binding curve of aptamer M3 with MDA-MB-231 cells
Apta_801,TGCGTGTGTAGTGTGTCTGCATGCCCCTGTAATCGCCCATGGGTAGCCTCTTAGGGATTTGGGCGG,HM69,DNA,66 nt,0.576,"20,437.02 Da",48.93 ¦ÌM,No QGRS found,N/A,Targeted therapy,Enhances bone defect repair by improving stem cell recruitment,Flow cytometry evaluation of the binding affinities to MSCs by FITC-labeled aptamers 69
Apta_802,ATGAGAAGCGTCGGTGTGGTTAAACACGGAACGAAGGTGCAGGAAGATTTGTCGATGCGGTGCCTGAGCGGGCTGGCAAGGCGCATA,Adipo-8,DNA,87 nt,0.563,"27,226.41 Da",36.73 ¦ÌM,2,18,Target recognition,Molecular recognition tool,Kd determination for adipo8
Apta_803,ATGAGAAGCGTCGGTGTGGTTACTCCGGGCACTTGATATATCGATATGGAGAATAATGCACCCTGAGCGGGCTGGCAAGGCGCATA,Adipo-1,DNA,86 nt,37.18 ×SM,"26,742.11 Da",37.39 ¦ÌM,No QGRS found,N/A,Target recognition,Molecular recognition tool,N/A
Apta_804,GCGGGATCCTATGACGCATTGACCCACAACACACTACTGTCGCTCGGTTCGAACTTCGTGCGACTGTTCCCTATAGTGAGTCGTATTAGAATTCCGC,NK2,DNA,97 nt,0.515,"29,764.03 Da",33.60 ¦ÌM,No QGRS found,N/A,Targeted therapy,New therapeutic reagent against virulent Mycobacterium tuberculosis,Isothermal titration calorimetry (ITC) measurement of aptamer (NK2)-MTB interactions. (A) aptamer (NK2)-H37Rv interaction; (B) aptamer (NK2)-BCG interaction
Apta_805,ATACCAGCTTATTCAATTAGGCGGTGCATTGTGGTTGGTAGTATACATGAGGTTTGGTTGAGACTAGTCGCAAGATATAGATAGTAAGTGCAATCT,?.1,DNA,96 nt,0.396,"29,854.14 Da",33.50 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to rat brain tumor microvessels,Cell binding of FITC-18C modified aptamers
Apta_806,GGTTGGATGTAAGGTTGGAGGGGGG,Aptamer17a,DNA,25 nt,0.6,"7,954.11 Da",125.72 ¦ÌM,2,20,Target recognition,Recognition of differentiated PC12 cells,N/A
Apta_807,GGGTCTTCCTGGACTGTCGAAAATTCAGTATCGGGAGGTTACGTATTTGGTTTATAGATAGTAA,two arm,DNA,64 nt,0.406,"19,880.76 Da",50.30 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic ligand against the pathogen-related food borne illness,Determination of the dissociation constant (Kd) for ¨ÕTwo arm¨Ù aptamer to the O157:H7 strain
Apta_808,GGGTCTTCCTGGACTGTCGAAAATTCAGTATCGGGAGG,long arm,DNA,38 nt,0.526,"11,789.57 Da",84.82 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic ligand against the pathogen-related food borne illness,Comparison of binding ability of aptamer I-1 and its truncated aptamers to O157:H7 LPS versus K12 LPS
Apta_809,GGGTACGTATTTGGTTTATAGATAGTAA,short arm,DNA,28 nt,0.321,"8,712.64 Da",114.78 ¦ÌM,No QGRS found,N/A,Aptasensor,Diagnostic ligand against the pathogen-related food borne illness,Comparison of binding ability of aptamer I-1 and its truncated aptamers to O157:H7 LPS versus K12 LPS
Apta_810,ACAGCATCCCCATGTGAACAATCGCATTGTGATTGTTACGGTTTCCGCCTCATGGACGTGCTG,TLS11a,DNA,63 nt,0.508,"19,339.38 Da",51.71 ¦ÌM,No QGRS found,N/A,Targeted therapy,Targeted Delivery,Kd determination
Apta_811,ATAGGAGTCACGACGACCAGAATCTAAAAATGGGCAAAGAAACAGTGACTCGTTGAGATACTTATGTGCGTCTACCTCTTGACTAAT,A3P,DNA,87 nt,0.414,"26,893.30 Da",37.18 ¦ÌM,No QGRS found,N/A,Target recognition,Recognition of Vibrio parahemolyticus,Binding saturation curve of aptamer A3P to V. parahemolyticus
Apta_812,ATAGGAGTCACGACGACCAGAATAGAGATATGACAGCGGGGAAGGTTAAGAGGCGCTAGGAGTATGTGCGTCTACCTCTTGACTAAT,A1P,DNA,87 nt,0.483,"27,096.38 Da",36.91 ¦ÌM,2,19,Target recognition,Recognition of Vibrio parahemolyticus,Histogram values of the percent gated fluorescence intensity above library background for individual aptamers
Apta_813,TAGAGATATGACAGCGGGGAAGGTTAAGAGGCGCTAGGAG,A1,DNA,40 nt,0.525,"12,588.11 Da",79.44 ¦ÌM,2,19,Target recognition,Recognition of Vibrio parahemolyticus,Histogram values of the percent gated fluorescence intensity above library background for individual aptamers
Apta_814,TCTAAAAATGGGCAAAGAAACAGTGACTCGTTGAGATACT,A3,DNA,40 nt,0.375,"12,385.03 Da",80.74 ¦ÌM,No QGRS found,N/A,Target recognition,Recognition of Vibrio parahemolyticus,Histogram values of the percent gated fluorescence intensity above library background for individual aptamers
Apta_815,CATCCGTCACACCTGCTCTGGCCACTAACATGGGGACCAGGTGGTGTTGGCTCCCGTATC,BT,DNA,60 nt,0.6,"18,379.74 Da",54.41 ¦ÌM,2,19,Target detection,Detection of Bacillus thuringiensis (BT) spores,N/A
Apta_816,GGGUUCACUGCAGACUUGACGAAGCUUGAGAGAUGCCCCCUGAUGUGCAUUCUUGUUGUGUUGCGGCAAUGGAUCCACAUCUACGAAUUC,S25,RNA,90 nt,0.5,"28,847.01 Da",34.67 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Salmonella Enteritidis,The binding capacity of the aptamer S25 (conc. 5 ×Sg and 30 ×Sg) to Salmonella Enteritidis was determined by flow cytometry
Apta_817,TGCGTGAGCGGTAGGCCCCTACGACCCACTGTGGTTGGGC,CCFM641-5,DNA,40 nt,0.675,"12,345.89 Da",81.00 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Bifidobacterium bifidum,Binding ability of aptamer CCFM641-5 against bifidobacterium bifidum
Apta_818,GGGCTGGCCAGATCAGACCCCGGATGATCATCCTTGTGAGAACCA,SA23,DNA,45 nt,0.578,"13,855.90 Da",72.17 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Staphylococcus aureus,Flow cytometry assay for the binding of aptamers with bacteria
Apta_819,GCGCCCTCTCACGTGGCACTCAGAGTGCCGGAAGTTCTGCGTTAT,SA20,DNA,45 nt,0.6,"13,804.83 Da",72.44 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Staphylococcus aureus,Flow cytometry assay for the binding of aptamers with bacteria
Apta_820,TCCCACGATCTCATTAGTCTGTGGATAAGCGTGGGACGTCTATGA,SA31,DNA,45 nt,0.489,"13,866.91 Da",72.11 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Staphylococcus aureus,Flow cytometry assay for the binding of aptamers with bacteria
Apta_821,CACAGTCACTCAGACGGCCGCTATTGTTGCCAGATTGCCTTTGGC,SA34,DNA,45 nt,0.556,"13,763.82 Da",72.65 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Staphylococcus aureus,Flow cytometry assay for the binding of aptamers with bacteria
Apta_822,TAGCCCTTCAACATAGTAATATCTCTGCATTCTGTGATG,hemag1P,DNA,39 nt,0.385,"11,906.68 Da",83.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Detection of Live Bacterial Cells,Binding characteristics of aptamer hemag1P as determined via flow cytometry
Apta_823,GGGATACCAGCTTATTCAATTTGATTCCATCTTCCTGGACTGTCGAAAATTCAGTATCGGGAGGTTACGTATTTGGTTTATAGATAGTAAGTGCAATCT,?-1,DNA,99 nt,0.384,"30,597.61 Da",32.68 ¦ÌM,No QGRS found,N/A,Target recognition,Diagnostic ligand against the pathogen-related food borne illness,Comparison of binding ability of RNA aptamer I-1 and its truncated aptamers to O157:H7 strain versus K12 strain. Binding capacity of each aptamer or library RNA to a specific strain is presented as relative fluorescence units to the sample without any RNA (SAHRP)
Apta_824,ATACGGGAGCCAACACCATCCCTCTTAGGATACAAAGCCAAACTGAGCCCGTGCAGAGCAGGTGTGACGGAT,BAS-6F,DNA,72 nt,0.542,"22,213.26 Da",45.02 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Bacillus Spores,N/A
Apta_825,ATACGGGAGCCAACACCACCCGTGGCCTTCACCCAGCCAGGGACCCCGTCTCTGAGAGCAGGTGTGACGGAT,BAS-3F,DNA,72 nt,0.639,"22,134.15 Da",45.18 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Bacillus Spores,N/A
Apta_826,ATCCGTCACACCTGCTCTGCACGGGCTCAGTTTGGCTTTGTATCCTAAGAGGGATGGTGTTGGCTCCCGTAT,BAS-6R,DNA,72 nt,0.542,"22,154.14 Da",45.14 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Bacillus Spores,N/A
Apta_827,ATACGGGAGCCAACACCACCCGTGGCCTTCACCCAGCCAGGGGCCCCGTCTCTGAGAGCAGGTGTGACGGAT,BAS-21/25 F,DNA,72 nt,0.653,"22,150.15 Da",45.15 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Bacillus Spores,N/A
Apta_828,ACCCCTGCATCCTTTGCTGGAGAGGAATGTATAAGGATGTTCCGGGCGTGTGGGTAAGTCAGTCTAGAGGGCCCCAGAAT,Ba,DNA,80 nt,0.538,"24,830.88 Da",40.27 ¦ÌM,2,19,Aptasensor,Rapid Single-Step Selection and Sensing,Selectivity study of Bacillus anthracis DNA capture elements (Ba DCE)
Apta_829,CCCTCCGGGGGGGTCATCGGGATACCTGGTAAGGATA,P12-31,DNA,37 nt,0.622,"11,471.36 Da",87.17 ¦ÌM,2,19,Aptasensor,Diagnosis of MNEC-borne pathologies,Binding affinity of selected pool 12 aptamers to E coli ATCC 25922
Apta_830,GACGGTGGCAGGGAAAGGGGTCGGGCATATGGCGGAGGGG,P12-17,DNA,40 nt,0.7,"12,678.11 Da",78.88 ¦ÌM,3,58,Aptasensor,Diagnosis of MNEC-borne pathologies,Binding affinity of selected pool 12 aptamers to E coli ATCC 25922
Apta_831,CCGCCCAGCGGGGGTAGGGCCGGACGTAGGAGGAGCTGCG,P12-52,DNA,40 nt,0.775,"12,494.98 Da",80.03 ¦ÌM,2,19,Aptasensor,Diagnosis of MNEC-borne pathologies,Binding affinity of selected pool 12 aptamers to E coli ATCC 25922
Apta_832,CCGGAGGTGGGTGAGGTCTGCGGCAGGCTGTGTGGGTGGACCGGAGGGGGGTGAGGTCTGCGGCAGGCTGTGTGGGTGGA,P12-55,DNA,80 nt,0.713,"25,291.04 Da",39.54 ¦ÌM,3,49,Aptasensor,Diagnosis of MNEC-borne pathologies,Binding affinity of selected pool 12 aptamers to E coli ATCC 25922
Apta_833,ATTTCGCCCCCGTGTTCCGACTGGTATCTTCACGTCTTCGAGTGT,5ˆÙ20?,DNA,45 nt,0.533,"13,711.77 Da",72.93 ¦ÌM,No QGRS found,N/A,Targeted binding,Isolation of bacteria,Binding saturation curve of aptamers
Apta_834,CGCAATACCAAAGTGGCGAGAGCGCTGTCTTGAGTGAGTGGTTGG,7ˆÙ20?,DNA,45 nt,0.556,"14,021.99 Da",71.32 ¦ÌM,No QGRS found,N/A,Targeted binding,Isolation of bacteria,Binding saturation curve of aptamers
Apta_835,TATGGCGTGGCAAGCTTGGCCCGCTTCTCAAGCATGGTTATCTAC,10ˆÙ20?,DNA,45 nt,0.533,"13,818.86 Da",72.36 ¦ÌM,No QGRS found,N/A,Targeted binding,Isolation of bacteria,Binding saturation curve of aptamers
Apta_836,TGAGCCCAAGCCCTGGTATGTTACAGTATGCTACCTCTACTTGAAGGTTGGTCGACGCGGGGCAGGTCTACTTTGGGATC,Apt-1,DNA,80 nt,0.538,"24,723.79 Da",40.45 ¦ÌM,2,18,Targeted binding,Binding to Enterohemorrhagic Escherichia coli O157:H7 (E. coli O157:H7),Histogram of the percent gated fluorescence intensity above library background for individual aptamers
Apta_837,TGAGCCCAAGCCCTGGTATGTGATCGGTGACGAGGGTGCGGGGCGGGGGGTGAGGCACAGGGCAGGTCTACTTTGGGATC,Apt-2,DNA,80 nt,0.65,"25,050.95 Da",39.92 ¦ÌM,3,62,Targeted binding,Binding to Enterohemorrhagic Escherichia coli O157:H7 (E. coli O157:H7),N/A
Apta_838,TGAGCCCAAGCCCTGGTATGTAGTAATGGTGCGTACAGGCGACGGGGTCCAGGCTGGAGGGGCAGGTCTACTTTGGGATC,Apt-3,DNA,80 nt,0.6,"24,928.90 Da",40.11 ¦ÌM,2,21,Targeted binding,Binding to Enterohemorrhagic Escherichia coli O157:H7 (E. coli O157:H7),Histogram of the percent gated fluorescence intensity above library background for individual aptamers
Apta_839,TGAGCCCAAGCCCTGGTATGAGCCCACGGAACACTGGTCGCGCCCACTGGTTTCTATATTGGCAGGTCTACTTTGGGATC,Apt-4,DNA,80 nt,0.563,"24,613.72 Da",40.63 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Enterohemorrhagic Escherichia coli O157:H7 (E. coli O157:H7),Histogram of the percent gated fluorescence intensity above library background for individual aptamers
Apta_840,TGAGCCCAAGCCCTGGTATGCGGATAACGAGGTATTCACGACTGGTCGTCAGGTATGGTTGGCAGGTCTACTTTGGGATC,Apt-5,DNA,80 nt,0.538,"24,812.85 Da",40.30 ¦ÌM,2,20,Targeted binding,Binding to Enterohemorrhagic Escherichia coli O157:H7 (E. coli O157:H7),Histogram of the percent gated fluorescence intensity above library background for individual aptamers
Apta_841,TGAGCCCAAGCCCTGGTATGGTGTGCCTGTCGTTGTATTGGTCGGTAGGGATCGGAGTGGGGCAGGTCTACTTTGGGATC,Apt-6,DNA,80 nt,0.575,"24,922.87 Da",40.12 ¦ÌM,2,21,Targeted binding,Binding to Enterohemorrhagic Escherichia coli O157:H7 (E. coli O157:H7),N/A
Apta_842,TGAGCCCAAGCCCTGGTATGTGTGGGGTCCTGGATTATGTTTAGCGTCTTTCGCAGTGGGGGCAGGTCTACTTTGGGATC,Apt-7,DNA,80 nt,0.55,"24,832.82 Da",40.27 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Enterohemorrhagic Escherichia coli O157:H7 (E. coli O157:H7),Histogram of the percent gated fluorescence intensity above library background for individual aptamers
Apta_843,TGAGCCCAAGCCCTGGTATGTCACATCCGGGTTCTTTGCGAACGCGTTTCCGCAGTCTCAGGCAGGTCTACTTTGGGATC,Apt-8,DNA,80 nt,0.563,"24,595.69 Da",40.66 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Enterohemorrhagic Escherichia coli O157:H7 (E. coli O157:H7),N/A
Apta_844,TGAGCCCAAGCCCTGGTATGTTGCGGGAGTCTAGCGGGCCACACTTTTATAGGTTCGCAGGGCAGGTCTACTTTGGGATC,Apt-9,DNA,80 nt,0.563,"24,764.80 Da",40.38 ¦ÌM,2,17,Targeted binding,Binding to Enterohemorrhagic Escherichia coli O157:H7 (E. coli O157:H7),N/A
Apta_845,CCAAACGCGCTGGTTTGGAATGCTTAGAGTTTGATCGATGCCTAA,Malaria.1,DNA,45 nt,0.467,"13,890.93 Da",71.99 ¦ÌM,No QGRS found,N/A,Targeted binding,Malaria diagnosis and surveillance,"Binding isotherm: Putative aptamer sequences were labeled at the 5©m end with [32P]. Five million cells per well were incubated with increasing concentrations of labeled sequences in bufer. Afer three washes, the amount of 32P-labeled aptamer associated with cells was determined by liquid scintillation counting. Data were normalized by fraction bound. Malaria.1, Malaria.2 and Malaria.3 bind to IEs with high afnity but the randomly generated control sequence of the same length (RDM1) shows no binding to IEs"
Apta_846,GTGCAGACAGCTAGTAGTGGTGACTTTCTGTCCAAATCAAGATAA,Malaria.2,DNA,45 nt,0.422,"13,907.97 Da",71.90 ¦ÌM,No QGRS found,N/A,Targeted binding,Malaria diagnosis and surveillance,"Binding isotherm: Putative aptamer sequences were labeled at the 5©m end with [32P]. Five million cells per well were incubated with increasing concentrations of labeled sequences in bufer. Afer three washes, the amount of 32P-labeled aptamer associated with cells was determined by liquid scintillation counting. Data were normalized by fraction bound. Malaria.1, Malaria.2 and Malaria.3 bind to IEs with high afnity but the randomly generated control sequence of the same length (RDM1) shows no binding to IEs"
Apta_847,CACTAGGATCTAGGGAAAAATCTCGTAAATACTATACTCCTGAGC,Malaria.3,DNA,45 nt,0.4,"13,820.94 Da",72.35 ¦ÌM,No QGRS found,N/A,Targeted binding,Malaria diagnosis and surveillance,"Binding isotherm: Putative aptamer sequences were labeled at the 5©m end with [32P]. Five million cells per well were incubated with increasing concentrations of labeled sequences in bufer. Afer three washes, the amount of 32P-labeled aptamer associated with cells was determined by liquid scintillation counting. Data were normalized by fraction bound. Malaria.1, Malaria.2 and Malaria.3 bind to IEs with high afnity but the randomly generated control sequence of the same length (RDM1) shows no binding to IEs"
Apta_848,CACCACGAUCACGGUUUCCCUCGCAGGUAAGGUGUAGA,Mitomer1,RNA,38 nt,0.553,"12,159.27 Da",82.24 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to mitochondria,Binding Affifinities of Truncated Mitomer2 (Short Mitomer2)
Apta_849,UCCCGAUUACUGUACAUACCUUAGCCCAUAGCUGGCUGC,Mitomer2,RNA,39 nt,0.513,"12,323.31 Da",81.15 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to mitochondria,Binding Affifinities of Truncated Mitomer2 (Short Mitomer2)
Apta_850,CACCAGTGTGTTGAGGTTTGAGCACACTGATAGAGTGTCA,SMV-19,DNA,40 nt,0.475,"12,390.97 Da",80.70 ¦ÌM,No QGRS found,N/A,Target detection,HuNoV capture and detection assays,Equilibrium dissociation curves for select aptamers
Apta_851,CCATGTTTTGTAGGTGTAATAGGTCATGTTAGGGTTTCTG,SMV-21,DNA,40 nt,0.4,"12,408.97 Da",80.59 ¦ÌM,No QGRS found,N/A,Target detection,HuNoV capture and detection assays,Equilibrium dissociation curves for select aptamers
Apta_852,CATCTGTGTGAAGACTATATGGCGCTCACATATTTCTTTC,SMV-25,DNA,40 nt,0.4,"12,226.87 Da",81.79 ¦ÌM,No QGRS found,N/A,Target detection,HuNoV capture and detection assays,Equilibrium dissociation curves for select aptamers
Apta_853,TGACCGAGTGTCTGGTCATTTTCGATGTCTGTTGTTAGGC,SMV-26,DNA,40 nt,0.475,"12,345.91 Da",81.00 ¦ÌM,No QGRS found,N/A,Target detection,HuNoV capture and detection assays,Equilibrium dissociation curves for select aptamers
Apta_854,GGGAGCUCAGAAUAAACGCUCAAGGGUAGGGAUCGUUACCCCGACAUUUUAAUGGGCCGAUGUUUCGACAUGAGGCCCGGAUCCGGC,A,RNA,87 nt,0.552,"28,091.71 Da",35.60 ¦ÌM,No QGRS found,N/A,Targeted binding,Virus inhibition,N/A
Apta_855,UCACUGUUAUCCGAUAGCAGCGCGGGAUGA,S-PS8.4,RNA,30 nt,0.533,"9,628.76 Da",103.86 ¦ÌM,No QGRS found,N/A,Target detection,Detection of salmonella enterica,Inhibition of bacterial adhesion and invasion by the RNA pools obtained at various intervals during the SELEX procedure
Apta_856,UGGGCCGGAGGUUAGCUUGCCCAUGGCAAGCAGGGCGCCACGGACCCA,SE RNA,RNA,48 nt,0.688,"15,529.31 Da",64.39 ¦ÌM,No QGRS found,N/A,Targeted binding,Protect acetylcholine receptors on human cells from the effects of these antibodies.,Binding affinity
Apta_857,GCTATGGGTGGTCTGGTTGGGATTGGCCCCGGGAGCTGGC,6H7,DNA,40 nt,0.675,"12,487.96 Da",80.08 ¦ÌM,2,21,Targeted binding,Purification of different His-tagged proteins,Variation of imidazole concentration used for protein elution. Imidazole concentrations below 1 M result in insufficient elution
Apta_858,GGCTTCAGGTTGGTCTGGTTGGGTTTGGCTCCTGTGTACG,6H5,DNA,40 nt,0.575,"12,418.92 Da",80.52 ¦ÌM,2,21,Targeted binding,Purification of different His-tagged proteins,Variation of imidazole concentration used for protein elution. Imidazole concentrations below 1 M result in insufficient elution
Apta_859,GGGAGUCUGAAGUCGGACUUGUUAUCAAUUCACUUCAGACU,9-41U22,RNA,41 nt,0.439,"13,103.76 Da",76.31 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibit the ribosome-inactivating protein,Binding curves for anti-pepocin aptamers with pepocin or gypsophilin
Apta_860,CACGGATCCTGACAAGGATGTGTGCGTTGTCGAGACCTGCGACCGGAACACTACACTGTGTGGGATGGATTTCTTTACAGTTGTGTGCAGCTCCGTCCGACTCTTCCTAGCTATGGTTCGATCAAGA,N,DNA,127 nt,0.52,"39,215.02 Da",25.50 ¦ÌM,No QGRS found,N/A,Target detection,Probes as Bacterial Indicators,Growth time required for achieving single-cell detection
Apta_861,CAGGTTGGTCTGGTTGGGTTTGGCTCCTGTGTACGCAACCTG,HMBA,DNA,42 nt,0.571,"12,990.29 Da",76.98 ¦ÌM,2,21,Target detection,Direct and universal quantitation of recombinant proteins,Direct quantification of recombinant protein from cell lysate
Apta_862,TGTGCCAAAGAGAGTGGTGGGGGGGTGGGCGGAACTCGCG,C5S,DNA,40 nt,0.675,"12,604.06 Da",79.34 ¦ÌM,2,21,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_863,CTCCTCTGACTGTAACCACGCCCAGAAACAGCACCCTTACATCGACTGGACCTTCCGCGGCATAGGTAGTCCAGAAGCC,C1L,DNA,79 nt,0.57,"24,114.45 Da",41.47 ¦ÌM,No QGRS found,N/A,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_864,CTCCTCTGACTGTAACCACGACTAGGACGCTTGGGAGGGGGGGTGGGGTGTCCGGTCGCGGCATAGGTAGTCCAGAAGCC,C3L,DNA,80 nt,0.638,"24,874.85 Da",40.20 ¦ÌM,3,64,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_865,CTCCTCTGACTGTAACCACGTGTGCCAAAGAGAGTGGTGGGGGGGTGGGCGGAACTCGCGGCATAGGTAGTCCAGAAGCC,C5L,DNA,80 nt,0.613,"24,891.89 Da",40.17 ¦ÌM,2,21,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_866,CTCCTCTGACTGTAACCACGACCGCCTTCCACCGTTCTCCACCACCCCTCAAACAACCCTGCATAGGTAGTCCAGAAGCC,C9L,DNA,80 nt,0.575,"24,194.50 Da",41.33 ¦ÌM,No QGRS found,N/A,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_867,CTCCTCTGACTGTAACCACGCCACCGAGCCTACCACATGTGACATCCCAGGACATAGCTGGCATAGGTAGTCCAGAAGCC,C10L,DNA,80 nt,0.563,"24,467.68 Da",40.87 ¦ÌM,No QGRS found,N/A,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_868,CCCAGAAACAGCACCCTTACATCGACTGGACCTTCCGCG,C1S,DNA,39 nt,0.59,"11,826.61 Da",84.56 ¦ÌM,No QGRS found,N/A,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_869,ACTAGGACGCTTGGGAGGGGGGGTGGGGTGTCCGGTCGCG,C3S,DNA,40 nt,0.725,"12,587.02 Da",79.45 ¦ÌM,3,64,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_870,CCGGGGAATCTAGGGGAGGGCGGGTGGGTCAATTGAGCCG,C4S,DNA,40 nt,0.675,"12,564.03 Da",79.59 ¦ÌM,3,64,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_871,CCAACCACACATCCTTCCATCGACATGGACCCACCGTTCC,C7S,DNA,40 nt,0.575,"12,010.74 Da",83.26 ¦ÌM,No QGRS found,N/A,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_872,ACCGCCTTCCACCGTTCTCCACCACCCCTCAAACAACCCT,C9S,DNA,40 nt,0.6,"11,906.66 Da",83.99 ¦ÌM,No QGRS found,N/A,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_873,CCACCGAGCCTACCACATGTGACATCCCAGGACATAGCTG,C10S,DNA,40 nt,0.575,"12,179.85 Da",82.10 ¦ÌM,No QGRS found,N/A,Targeted therapy,Shielding Virus from Neutralizing Antibodies,N/A
Apta_874,GGAUAAUAGCCGUAGGUUGCGAAAGCGACCCUGAUGAGCCUUAGGAUAUGUCUGGAUACCAUGCAUGAUGCACCUUGGCAGUCUUACAGAAGGACGUCGAAACGGUAGCGAGAGCUC,AR7,RNA,117 nt,0.513,"37,838.50 Da",26.43 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to FMN,N/A
Apta_875,GCCGCGACCATACAACGCAAACAACACGCCTGTACGCTTG,WKB-3,DNA,40 nt,0.575,"12,188.86 Da",82.04 ¦ÌM,No QGRS found,N/A,Target detection,Detection of antibodies to mycoplasma bovis in serum,Dose-dependent i-ELAA to determine the dissociation constant (Kd) of aptamers
Apta_876,GTTGCGAAAGACAACGAATGCTTTGCCTGCCATAATTTGC,WKB-14,DNA,40 nt,0.45,"12,294.93 Da",81.33 ¦ÌM,No QGRS found,N/A,Target detection,Detection of antibodies to mycoplasma bovis in serum,Dose-dependent i-ELAA to determine the dissociation constant (Kd) of aptamers
Apta_877,GTGCGAAGCGCCTCCACTGTACATCCACTCCTTCTGCC,WKB-51,DNA,38 nt,0.605,"11,486.37 Da",87.06 ¦ÌM,No QGRS found,N/A,Target detection,Detection of antibodies to mycoplasma bovis in serum,Dose-dependent i-ELAA to determine the dissociation constant (Kd) of aptamers
Apta_878,TCGCACATTCCGCTTCTACCGGGGGGGTCGAGCTGAGTGGATGCGAATCTGTGGGTGGGCTTCGCACACACGGACTTAC,aptamer A1,DNA,79 nt,0.608,"24,446.58 Da",40.91 ¦ÌM,3,48,Aptasensor,FO-SPR biosensing of peanut allergens in food matrices,N/A
Apta_879,GGGGGGGTGAGACATCGGGCATGTTCATGGGTGGGGGGTA,aptamer A4,DNA,40 nt,0.65,"12,650.08 Da",79.05 ¦ÌM,3,60,Aptasensor,FO-SPR biosensing of peanut allergens in food matrices,N/A
Apta_880,GCCGCACAATCGGGTTGGGCAGGGAGGGCACGTGTGGCGC,aptamer A6,DNA,40 nt,0.725,"12,484.97 Da",80.10 ¦ÌM,3,63,Aptasensor,FO-SPR biosensing of peanut allergens in food matrices,N/A
Apta_881,AGCGTCGAATACCACTACAGCCCGCACTCAACCACCGTTCCTTTGTTTAATTTTGCACATCTAATGGAGCTCGTGGTCAG,21st,DNA,80 nt,0.488,"24,459.67 Da",40.88 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Shp2 protein,Binding assay of DNA in clonal beads with Shp2 protein
Apta_882,AATAGTCTGGTTCGGTGCTTGGTGCGATGTGTTAGTCAGACTCTTGTGTG,Dapt1,DNA,50 nt,0.48,"15,530.93 Da",64.39 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to degraded protein,"Binding curves of Dapt1 to FN-toxin B pre-exposed in unformed human stool for 1, 5 and 10 days. N.D. = Not detected"
Apta_883,CGTACCGGCCAGTGATTACGACGAGACGAGCTTATGCGTATTGATGCCTAACTATCTACA,Anti-HSA Structure-switching Aptamer,DNA,60 nt,0.483,"18,458.85 Da",54.17 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to HSA,Affinity measurements of HSA-6 using a magnetic bead-based qPCR assay
Apta_884,ATACCAGCTTATTCAATTTGCACCACTTATTGTTACTAATCTGAGATAGTAAGTGCAATCT,aptamer,DNA,61 nt,0.328,"18,685.05 Da",53.52 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Pro-gastrin-Releasing Peptide (proGRP),"Binding activity of selected ssDNA with various concentrations 0 ×SM (black solid line), 0.5 ×SM (black dotted line), 1 ×SM (gray solid line), 5 ×SM (gray dotted line), and 10 ×SM (black dashed line)"
Apta_885,GGGAGAGCGGAAGCGUGCUGGGCCUGGUUGCUGUAAAAAUAGACACGAAUCUGCCGACCAUAACCCAGAGGUCGAUGGAUCCCCCC,#1,RNA,86 nt,0.581,"27,806.61 Da",35.96 ¦ÌM,2,17,Targeted binding,Selectively blocks autoantibody binding to insulin receptors on human lymphocytes,N/A
Apta_886,GGGAGACGAUAUUCGUCCAUUCGGGUGGCCCGUGUCUGAGCGGGGACGGCCACUUGAGCGCCGCUGUCCGACUGAAUUCUCGACC,2ˆÙ16?,RNA,85 nt,0.635,"27,369.20 Da",36.54 ¦ÌM,No QGRS found,N/A,Targeted binding,Function as novel drugs against African trypanosomiasis,Determination of the dissociation constant (Kd) for the binding reaction between aptamer 2-16 and MITat 1.2 cells
Apta_887,ACGCTCGGATGCCACTACAGGGGGGTGGTCCTGAGGGTGGTGTGGTTGGTTTGGTTTCCTCATGGACGTGCTGGTGAC,AGC03,DNA,78 nt,0.603,"24,321.47 Da",41.12 ¦ÌM,2,20,Targeted binding,Binding to gastric cancer cell,N/A
Apta_888,GGCGACCCCCGGGCTACCAGACAATGTACGCAGCAAGAGTGACGGTCGTACCTCGGAGTC,Aptamer clone19,DNA,60 nt,0.633,"18,505.85 Da",54.04 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Escherichia coli K88,N/A
Apta_889,ACACTCTTTTGCTCGTGTTTTTGCCTGTTACATAAAATGAATCAGTGGATGTTTCCTTCT,Aptamer clone31,DNA,60 nt,0.367,"18,367.78 Da",54.44 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Escherichia coli K88,N/A
Apta_890,GGCGGCCGTGAAATTTGCCAAATGCCGTCTTGGCTTTCGCCCAATGTATCCTGGGTGTTC,Aptamer clone7,DNA,60 nt,0.55,"18,455.79 Da",54.18 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Escherichia coli K88,N/A
Apta_891,GGAGACCGTACCATCTGTTCGTGGAAGCGCTTTGCTCGTCCATTAGCCTTGTGCTCGTGC,Aptamer clone37,DNA,60 nt,0.567,"18,431.76 Da",54.25 ¦ÌM,No QGRS found,N/A,Target detection,Detection of Escherichia coli K88,N/A
Apta_892,ACCGAGUCCAGAAGCUUGUAGUACUCAAUACUCAAGCAAGCCCAGCCCUACCAACCCCGGAGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC,T6,RNA,103 nt,0.495,"32,931.58 Da",30.37 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bind to cell adhesion receptors of trypanosoma cruzi and inhibit cell invasion,N/A
Apta_893,ACCGAGUCCAGAAGCUUGUAGUACUUAUGUCCCAUCGAACGCAGUGUAUCUUGCACCGACUCUCUGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC,L28,RNA,107 nt,0.467,"34,145.12 Da",29.29 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bind to cell adhesion receptors of trypanosoma cruzi and inhibit cell invasion,N/A
Apta_894,ACCGAGUCCAGAAGCUUGUAGUACUGACCCUUCCCGACGCACGGACCAGUGAUGCCAACCCACCCGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC,F4,RNA,107 nt,0.533,"34,201.29 Da",29.24 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bind to cell adhesion receptors of trypanosoma cruzi and inhibit cell invasion,N/A
Apta_895,ACCGAGUCCAGAAGCUUGUAGUACUACCGCAACGUUGGCGUUCGGCGUUGGCCGCGUCAUCGCUAGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC,HS6,RNA,107 nt,0.523,"34,310.24 Da",29.15 ¦ÌM,No QGRS found,N/A,Targeted therapy,Bind to cell adhesion receptors of trypanosoma cruzi and inhibit cell invasion,N/A
Apta_896,ATACGGGAGCCAACACCATAAGTCTAAAAAACTGGGAGTAAACACAATGTGTATAGAGCAGGTGTGACGGAT,seq1,DNA,72 nt,0.431,"22,387.43 Da",44.67 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,"ELASA for BCM-7. The extent of displacement of the BCM-7 peroxidase conjugate by BCM-7, BCM-5, BCM-9A1, and BCM-9A2 at fixed concentration"
Apta_897,ATACGGGAGCCAACACCACTCTTATTTCCGGAAGTGGTTCTTCAACAGAGGAATAGAGCAGGTGTGACGGAT,seq3,DNA,72 nt,0.486,"22,304.32 Da",44.83 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,"ELASA for BCM-7. The extent of displacement of the BCM-7 peroxidase conjugate by BCM-7, BCM-5, BCM-9A1, and BCM-9A2 at fixed concentration"
Apta_898,ATACGGGAGCCAACACCAACAAAACTAGCAAATTAGAGCCGTATCGGAGCCTATAGAGCAGGTGTGACGGAT,seq4,DNA,72 nt,0.486,"22,309.36 Da",44.82 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,"ELASA for BCM-7. The extent of displacement of the BCM-7 peroxidase conjugate by BCM-7, BCM-5, BCM-9A1, and BCM-9A2 at fixed concentration"
Apta_899,ATCCGTCACACCTGCTCTCGAATAGAGTATTCGATACTGACTTTATTTACCGTCTGGTGTTGGCTCCCGTAT,seq5,DNA,72 nt,0.458,"22,031.10 Da",45.39 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,"ELASA for BCM-7. The extent of displacement of the BCM-7 peroxidase conjugate by BCM-7, BCM-5, BCM-9A1, and BCM-9A2 at fixed concentration"
Apta_900,ATACGGGAGCCAACACCAAAGTAAGATCATCACCCGGACGCGGACATAATAGGAGAGCAGGTGTGACGGAT,seq6,DNA,71 nt,0.521,"22,046.18 Da",45.36 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,"ELASA for BCM-7. The extent of displacement of the BCM-7 peroxidase conjugate by BCM-7, BCM-5, BCM-9A1, and BCM-9A2 at fixed concentration"
Apta_901,ATACGGGAGCCAACACCACAAGTTGACTTGGAGGAGGGTCTAACTAGTTCGAGGAGAGCAGGTGTGACGGAT,seq7,DNA,72 nt,0.528,"22,459.40 Da",44.52 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,"ELASA for BCM-7. The extent of displacement of the BCM-7 peroxidase conjugate by BCM-7, BCM-5, BCM-9A1, and BCM-9A2 at fixed concentration"
Apta_902,ATACGGGAGCCAACACCACCAACATTATCAGAGTATGTTACTTATAGTGGTGGCAGAGCAGGTGTGACGGAT,seq8,DNA,72 nt,0.472,"22,328.34 Da",44.79 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,N/A
Apta_903,ATACGGGAGCCAACACCAGACGGTAAATAAAGTCAGTATCGATACTCTATTCGAGAGCAGGTGTGACGGAT,seq9,DNA,71 nt,0.465,"22,017.16 Da",45.42 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,N/A
Apta_904,ATACGGGAGCCAACACCAGACGGTAAATAAAGTCAGTATCGAGTACTCTATTCGAGAGCAGGTGTGACGGAT,seq10,DNA,72 nt,0.472,"22,346.37 Da",44.75 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,"ELASA for BCM-7. The extent of displacement of the BCM-7 peroxidase conjugate by BCM-7, BCM-5, BCM-9A1, and BCM-9A2 at fixed concentration"
Apta_905,ATCCGTCACACCTGCTCTTGTAGGGTTCCCACCCAATTCAGTTCCGTTAAACCATGGTGTTGGCTCCCGTAT,seqU1,DNA,72 nt,0.514,"21,962.04 Da",45.53 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,N/A
Apta_906,ATCCGTCACACCTGCTCTCCCCGGCGTCCGTTTATTAGCAGACTTTGGCGGAATTGGTGTTGGCTCCCGTAT,seqU2,DNA,72 nt,0.556,"22,050.06 Da",45.35 ¦ÌM,No QGRS found,N/A,Targeted binding,Sensing of Ø¶?Casomorphin?7,"ELASA for BCM-7. The extent of displacement of the BCM-7 peroxidase conjugate by BCM-7, BCM-5, BCM-9A1, and BCM-9A2 at fixed concentration"
Apta_907,ATACGGGAGCCAACACCACAACAAGATAAAGTATCAATCTGGTTGACGGACGTGAGAGCAGGTGTGACGGAT,seqU3,DNA,72 nt,0.486,"22,380.39 Da",44.68 ¦ÌM,2,17,Targeted binding,Sensing of Ø¶?Casomorphin?7,N/A
Apta_908,ATACGGGAGCCAACACCAATTCCGCCAAAGTCTGCTAATAAACGGACGCCGGGGAGAGCAGGTGTGACGGAT,seqU4,DNA,72 nt,0.556,"22,318.32 Da",44.81 ¦ÌM,2,20,Targeted binding,Sensing of Ø¶?Casomorphin?7,"ELASA for BCM-7. The extent of displacement of the BCM-7 peroxidase conjugate by BCM-7, BCM-5, BCM-9A1, and BCM-9A2 at fixed concentration"
Apta_909,GGGAAUUCGAGCUCGGUACCUUUACCGUAAGGCCUGUCUUCGUUUGACAGCGGCUUGUUGACCCUCCACUUUGUACCUGCUGCCAACUGCAGGCAUGCAAGCUUGG,Ø¶55,RNA,106 nt,0.547,"33,869.92 Da",29.52 ¦ÌM,No QGRS found,N/A,Target detection,Suitable tools for analytical and diagnostic purposes,N/A
Apta_910,TCACGTGCATGATAGACGGCGAAGCCGTCGAGTTGCTGTGTGCCGATGCACGTGA,N,DNA,55 nt,0.582,"17,047.91 Da",58.66 ¦ÌM,No QGRS found,N/A,Targeted therapy,Vasopressin antagonist,Equilibrium dialysis studies of mirror image aptamers
Apta_911,GGCCATTGTGGACTTCTTTGGGTAATTCAGGGGCTCGATT,C7,DNA,40 nt,0.5,"12,379.93 Da",80.78 ¦ÌM,No QGRS found,N/A,Target detection,Detection of rituximab,Titration of aptamers for heat-treated rituximab binding using ELASA
Apta_912,TAGTATGGACTTGTCTTCTTGTCAGAGTCTGGCAGCACGT,C2,DNA,40 nt,0.475,"12,323.91 Da",81.14 ¦ÌM,No QGRS found,N/A,Target detection,Detection of rituximab,Titration of aptamers for heat-treated rituximab binding using ELASA
Apta_913,GGCACTTGTTTGCTCGAACGATGGTTTGTGCTTTTGTGTT,C4,DNA,40 nt,0.45,"12,351.90 Da",80.96 ¦ÌM,No QGRS found,N/A,Target detection,Detection of rituximab,Titration of aptamers for heat-treated rituximab binding using ELASA
Apta_914,CGCTCCGTTTACTCGGTCTGCTATTGGCTTGCCTTTGTTT,C5,DNA,40 nt,0.5,"12,183.78 Da",82.08 ¦ÌM,No QGRS found,N/A,Target detection,Detection of rituximab,Titration of aptamers for heat-treated rituximab binding using ELASA
Apta_915,ACTTCGGCTAGTTAGGGGGTAGTTTAGATCGTCTCTACAT,C10,DNA,40 nt,0.45,"12,347.93 Da",80.99 ¦ÌM,No QGRS found,N/A,Target detection,Detection of rituximab,Titration of aptamers for heat-treated rituximab binding using ELASA
Apta_916,GGCGTATGCAGTTTTGTAGGGTTATCAAGGCTTGACGATT,C57,DNA,40 nt,0.45,"12,427.98 Da",80.46 ¦ÌM,No QGRS found,N/A,Target detection,Detection of rituximab,Titration of aptamers for heat-treated rituximab binding using ELASA
Apta_917,TCGATTTCCTTAGTTGTCTTCCTTAGTGAG,ABA,DNA,30 nt,0.4,"9,159.89 Da",109.17 ¦ÌM,No QGRS found,N/A,Targeted therapy,Blocks the Function of the Anti-FLAG M2 Antibody,N/A
Apta_918,TTTACTTATTCAATTCCCGTGGGAAGGCTATAGAGGGGCCAGTCTATGAATAAGTTT,Sgc-3b,DNA,57 nt,0.404,"17,627.33 Da",56.73 ¦ÌM,No QGRS found,N/A,Targeted binding,Targeted binding to selectin L protein,"Flow cytometry for validating CD62L as a target for aptamer Sgc-3b. (A) Flow cytometry assay of Jurkat E6-1 cells stained with Sgc-3b-FAM and anti-CD62L-PE FAM-labeled random DNA (L45-FAM) and IgG-PE, which do not bind to cells, were used as the negative controls. (B) Flow cytometry results to show the competition of different concentrations of Sgc-3b-FAM with 0.62 g/ml anti-CD62L-PE in binding toward Jurkat E6-1 cells. (C) Flow cytometry results to show the competition of 5 g/ml anti-CD62L-PE with 100 nM Sgc-3b-FAM in binding toward Jurkat E6-1 cells. (D) Flow cytometry assay results showed that the siRNA-mediated depletion of CD62L in Jurkat E6-1 cells led to a reduced binding of aptamer Sgc-3b, but not aptamer Sgc-4e. Binding toward anti-CD62L, Sgc-3b and Sgc-4e were assessed at 72 h after siRNA treatment, where reduced binding toward anti-CD62L indicated the successful, albeit modest, knock-down of CD62L after siRNA treatment"
Apta_919,GGAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCG,GNP DV2,DNA,65 nt,0.554,"20,258.03 Da",49.36 ¦ÌM,No QGRS found,N/A,Targeted binding,The aptamers were able to detect DV in both river water and commercial apple juice,The affinity of the developed aptamers towards the DV was measured with ITC
Apta_920,ATCCAGAGTGACGCAGCACGGCACTCACTCTTTGTTAAGTGGTCTGCTTCTTAACCTTCATCGACACGGTGGCTTA,TOV6,DNA,76 nt,0.5,"23,310.92 Da",42.90 ¦ÌM,No QGRS found,N/A,Target recognition,"Identity of the targetmolecule of aptamer TOV6 is STIP1, and by identifying the target of TOV6, a blocking effect in the metastatic process of TOV-21G could be identified",Effect of TOV6 on migration and invasion of TOV-21G cells. A 2 ×SM concentration of TOV6 has no effect on the migration ability of TOV-21G. A 2 ×SM concentration of aptamer TOV6 can prevent cell invasion to a degree equal to that of -0.05 ×SM 17-AAG with STIP1 silencing. Error bars represent the standard deviation (n =3)
Apta_921,ATCCAGAGTGACGCAGCACGAGCCAGACATCTCACACCTGTTGCATATACATTTTGCATGGACACGGTGGCTTAGT,PP3,DNA,76 nt,0.5,"23,386.99 Da",42.76 ¦ÌM,No QGRS found,N/A,Target recognition,Recognize proteins expressed on the surface of VV-infected cells,"The interaction between myc-His-tagged HA and the aptamer is reduced in the presence of glycosylation inhibitors. CV-1 cells infected in the presence of 5 ×Sg/mL tunicamycin or monensin that are N-linked and O-linked glycosylation inhibitors, respectively"
Apta_922,ATCCAGAGTGACGCAGCACACCGTTTGTATTCTGCATTGTTTTGCATTCTACATGGACACGGTGGCTTAGT,PP2,DNA,71 nt,0.465,"21,855.99 Da",45.75 ¦ÌM,No QGRS found,N/A,Target recognition,Recognize proteins expressed on the surface of VV-infected cells,Individual aptamers tested against infected and uninfected cells. (A) VV Infected HeLa cells treated with FITC-labeled aptamer PP2
Apta_923,ATCCAGAGTGACGCAGCATCGACCTCTGTGCGAGCGGGTTGCATATATATTTTGCATGGACACGGTGGCTTAGT,PP4,DNA,74 nt,0.514,"22,902.65 Da",43.66 ¦ÌM,No QGRS found,N/A,Target recognition,Recognize proteins expressed on the surface of VV-infected cells,Individual aptamers tested against infected and uninfected cells. (A) VV Infected HeLa cells treated with FITC-labeled aptamer PP4
Apta_924,GCCUUUUCGGGAUACGCGGAGGGUGGGCAA,TAFapt1,RNA,30 nt,0.633,"9,739.82 Da",102.67 ¦ÌM,2,18,Targeted therapy,"The aptamer could bind to the AML1-MTG8 fusion protein and dissociate the AML1-MTG8/DNA complex, suggesting that it can inhibit the dominant negative effects of AML1-MTG8 against normal AML1 function and serve as a potential therapeutic agent for leukemia",N/A
Apta_925,GCUCGGCCAGGUCGCGGGUGGAUGUGAGGG,TAFapt2,RNA,30 nt,0.733,"9,810.86 Da",101.93 ¦ÌM,2,19,Targeted therapy,"The aptamer could bind to the AML1-MTG8 fusion protein and dissociate the AML1-MTG8/DNA complex, suggesting that it can inhibit the dominant negative effects of AML1-MTG8 against normal AML1 function and serve as a potential therapeutic agent for leukemia",N/A
Apta_926,UCGGCAGCGGUUAGAGAGGUGGUGUGCGGG,TAFapt3,RNA,30 nt,0.667,"9,835.87 Da",101.67 ¦ÌM,2,18,Targeted therapy,"The aptamer could bind to the AML1-MTG8 fusion protein and dissociate the AML1-MTG8/DNA complex, suggesting that it can inhibit the dominant negative effects of AML1-MTG8 against normal AML1 function and serve as a potential therapeutic agent for leukemia",N/A
Apta_927,UUACAAUGAGGUGGGACGCGGGUUGUGGUG,TAFapt4,RNA,30 nt,0.567,"9,781.82 Da",102.23 ¦ÌM,2,19,Targeted therapy,"The aptamer could bind to the AML1-MTG8 fusion protein and dissociate the AML1-MTG8/DNA complex, suggesting that it can inhibit the dominant negative effects of AML1-MTG8 against normal AML1 function and serve as a potential therapeutic agent for leukemia",N/A
Apta_928,GATTGAGTAGATAGTGGTTCTGTACGTAGTGAAAGAGTGG,N5,DNA,40 nt,0.425,"12,550.08 Da",79.68 ¦ÌM,No QGRS found,N/A,Targeted therapy,"TNA aptamer N5 was specifically accumulated at the tumour site, and significantly inhibited tumour growth in vivo","The dissociation constants of TNA aptamers N5 were around 400 nM, determined by a nitrocellulose filter binding assay (n = 3)"
Apta_929,GAGTGGGATGGATAGAGAATAAGTGTGGAGTGGAAGGTGA,S42,DNA,40 nt,0.475,"12,698.18 Da",78.75 ¦ÌM,No QGRS found,N/A,Targeted therapy,"TNA aptamer S42 was specifically accumulated at the tumour site, and significantly inhibited tumour growth in vivo","The dissociation constants of TNA aptamers S42 were around 400 nM, determined by a nitrocellulose filter binding assay (n = 3)"
Apta_930,TTGCACTATGTTTTAGCTAGGGTTCCCTCCGGAGATAGTAAGTGCAA,NC3S,DNA,47 nt,0.447,"14,499.32 Da",68.97 ¦ÌM,No QGRS found,N/A,Targeted binding,Selected aptamers can specifically recognize a variety of cells expressing N-cadherin but do not bind to the negative cells,Equilibrium dissociation constant (Kd) curve of NC3S for N-cadherin cells. The standard deviations were obtained from three separate trials
Apta_931,ATACGACTCACTATTAGGGACCACATAAACATGCATCGCTCAATAACGGGATATTGTTGTGCTAGACTACTGACTACAA,M1,DNA,79 nt,0.405,"24,292.64 Da",41.16 ¦ÌM,No QGRS found,N/A,Targeted binding,M1 specifically bound to cognate target protein,"Isolated aptamers specifically recognize target proteins in Western blot. Purified proteins and E. coli cell lysates are separated on SDS-PAGE, stained with Coomassie Brilliant Blue (left) and probed with Cy5.5-labeled corresponding aptamers (right). The dissociation constants of aptamer M1 toward their cognate target proteins are determined to be in the nanomolar range by dot blot"
Apta_932,ATACGACTCACTATTAGGGATGTCCACCATATAGATCGATTTAAGTCCCTCGTTATTAATGCTAGACTACTGACTACAA,H1,DNA,79 nt,0.38,"24,224.59 Da",41.28 ¦ÌM,No QGRS found,N/A,Targeted binding,H1 specifically bound to cognate target protein,"Isolated aptamers specifically recognize target proteins in Western blot. Purified proteins and E. coli cell lysates are separated on SDS-PAGE, stained with Coomassie Brilliant Blue (left) and probed with Cy5.5-labeled corresponding aptamers (right). The dissociation constants of aptamer H1 toward their cognate target proteins are determined to be in the nanomolar range by dot blot"
Apta_933,GACGCTTACTCAGGTGTGACTCGGGGTGTAGCTCGTTATGATTCGGACAAGACTTACCTTGCGCCTCTGGGATCGAAGGACGCAGATGAAGTCTC,GVI-1,DNA,95 nt,0.537,"29,411.78 Da",34.00 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognize and bind to GCRV-infected cells,"Apparent equilibrium dissociation constant (Kd) of each aptamer binding to target GCRV-CIK cells. The concentrations of FAM-labelled aptamer candidates were diluted to 0-1,000 nM in PBS, respectively, and then incubated with target GCRV-CIK cells (5 Çß 10**5) at 4 ¨FC for 30 min. The binding fluorescence intensities of aptamer-target cells were detected by flow cytometry. Kd of each aptamer candidate was calculated according to the equation Y = BmaxX/(Kd + X) by SigmaPlot software"
Apta_934,GACGCTTACTCAGGTGTGACTCGTGAACCCACCTCAGGGCATCTTACATTTCTTCTAAGTTGTTACCATGTTTCGAAGGACGCAGATGAAGTCTC,GVI-7,DNA,95 nt,0.474,"29,199.69 Da",34.25 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognize and bind to GCRV-infected cells,"Apparent equilibrium dissociation constant (Kd) of each aptamer binding to target GCRV-CIK cells. The concentrations of FAM-labelled aptamer candidates were diluted to 0-1,000 nM in PBS, respectively, and then incubated with target GCRV-CIK cells (5 Çß 10**5) at 4¨FC for 30 min. The binding fluorescence intensities of aptamer-target cells were detected by flow cytometry. Kd of each aptamer candidate was calculated according to the equation Y = BmaxX/(Kd + X) by SigmaPlot software"
Apta_935,GACGCTTACTCAGGTGTGACTCGTCCGTCGGTTCGCCTTGCGAGTGCACGCCGCCAGCCGTTACATAAAGTCTGCCCACTCGAAGGACGCAGATGAAGTCTC,GVI-11,DNA,102 nt,0.588,"31,366.01 Da",31.88 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognize and bind to GCRV-infected cells,"Apparent equilibrium dissociation constant (Kd) of each aptamer binding to target GCRV-CIK cells. The concentrations of FAM-labelled aptamer candidates were diluted to 0-1,000 nM in PBS, respectively, and then incubated with target GCRV-CIK cells (5 Çß 10**5) at 4¨FC for 30 min. The binding fluorescence intensities of aptamer-target cells were detected by flow cytometry. Kd of each aptamer candidate was calculated according to the equation Y = BmaxX/(Kd + X) by SigmaPlot software"
Apta_936,GGAGCUCAGCCUUCACUGCGAUCACCGUGUCGGUGGCUAGUCGAUGUAUCCCGAUCACCAUUGGGGGCAAGUUUAGACAGGCACCACGGUCGGAUCCAC,SECURA-3,RNA,99 nt,0.586,"31,812.86 Da",31.43 ¦ÌM,No QGRS found,N/A,Targeted therapy,Antagonistic effect by antagonizing the interaction between PTTG1 and CXCR2,Equilibrium dissociation constant determination of the SECURA-3 RNA aptamer. The spots represent the fraction of radiolabelled RNA bound to PTTG1. Total represents the total radiolabelled RNA. Percentage represents the calculated enrichment
Apta_937,TTGCCCACAGATCTGTGGAAGCCGAACCGCGTGCTAGTCGTG,XA-A9,DNA,42 nt,0.595,"12,931.29 Da",77.33 ¦ÌM,No QGRS found,N/A,Target recognition,Demonstrated a high binding affinity and specificity to THY1 protein and the THY1 expressing cell lines,"Binding affinity of selected XAs and their equilibrium dissociation constant. Filter-binding assays were performed with the biotinylated XAs and purified THY1 protein.Saturation binding curves were generated and the equilibrium dissociation constants, Kd, were calculated from the equation Y ? Bmax X/(Kd t X), assuming a single binding site"
Apta_938,TTGCCCACCTCCCTGTGCGGGCCACAGAGCAGCAGTGTCGTG,XA-B216,DNA,42 nt,0.667,"12,868.23 Da",77.71 ¦ÌM,No QGRS found,N/A,Target recognition,Demonstrated a high binding affinity and specificity to THY1 protein and the THY1 expressing cell lines,"Binding affinity of selected XAs and their equilibrium dissociation constant. Filter-binding assays were performed with the biotinylated XAs and purified THY1 protein.Saturation binding curves were generated and the equilibrium dissociation constants, Kd, were calculated from the equation Y ? Bmax X/(Kd t X), assuming a single binding site"
Apta_939,TTGCCCACCGTACTGTGCAGGTCGAACTACAGGCACGTCGTG,XA-B217,DNA,42 nt,0.595,"12,891.26 Da",77.57 ¦ÌM,No QGRS found,N/A,Target recognition,Demonstrated a high binding affinity and specificity to THY1 protein and the THY1 expressing cell lines,"Binding affinity of selected XAs and their equilibrium dissociation constant. Filter-binding assays were performed with the biotinylated XAs and purified THY1 protein.Saturation binding curves were generated and the equilibrium dissociation constants, Kd, were calculated from the equation Y ? Bmax X/(Kd t X), assuming a single binding site"
Apta_940,TGTGCGGGGGAGGGGAGTGGCGCTGTTGGTGCGGGTATAGCGCGTGGTGT,QA-36,DNA,50 nt,0.68,"15,794.04 Da",63.32 ¦ÌM,2,20,Targeted therapy,"Inhibited STIV infection in vitro and in vivo, with aptamer QA-36 demonstrating the greatest protective effect against STIV and inhibiting STIV infection in a dose-dependent manne","Affinity of STIV-selected ssDNA aptamer interactions by ELISA. STIV was incubated with increasing concentrations of 5©m-biotinylated aptamer. After addition of streptavidin-HRP, the amount of STIV-aptamer complex was calculated and graphed as a function of aptamer concentration. The graph was fit to the equation Y = Bmax*X/(Kd + X) using SigmaPlot software. Results for each aptamer was presented as the mean ºô SD of three independent experiments"
Apta_941,CGGGTGCCTTAAAGTGTAGGTGGGAGGGGGATGATTATGTACGATCAAGT,QA-92,DNA,50 nt,0.5,"15,681.06 Da",63.77 ¦ÌM,2,20,Targeted therapy,"Inhibited STIV infection in vitro and in vivo, with aptamer QA-36 demonstrating the greatest protective effect against STIV and inhibiting STIV infection in a dose-dependent manne","Affinity of STIV-selected ssDNA aptamer interactions by ELISA. STIV was incubated with increasing concentrations of 5©m-biotinylated aptamer. After addition of streptavidin-HRP, the amount of STIV-aptamer complex was calculated and graphed as a function of aptamer concentration. The graph was fit to the equation Y = Bmax*X/(Kd + X) using SigmaPlot software. Results for each aptamer was presented as the mean ºô SD of three independent experiments"
Apta_942,AGTGGGTAAGGTCTGGTGGATTGTGGACGGGGGGCGGGGCAGTGGCTTGA,QA-12,DNA,50 nt,0.64,"15,811.08 Da",63.25 ¦ÌM,3,49,Targeted therapy,"Inhibited STIV infection in vitro and in vivo, with aptamer QA-36 demonstrating the greatest protective effect against STIV and inhibiting STIV infection in a dose-dependent manne","Affinity of STIV-selected ssDNA aptamer interactions by ELISA. STIV was incubated with increasing concentrations of 5©m-biotinylated aptamer. After addition of streptavidin-HRP, the amount of STIV-aptamer complex was calculated and graphed as a function of aptamer concentration. The graph was fit to the equation Y = Bmax*X/(Kd + X) using SigmaPlot software. Results for each aptamer was presented as the mean ºô SD of three independent experiments"
Apta_943,GAAGGTGGAGCGGTTAGGATACTAGCGAATGAAGACACGTTAGCTGATCT,QA-9,DNA,50 nt,0.48,"15,603.04 Da",64.09 ¦ÌM,2,19,Targeted therapy,"Inhibited STIV infection in vitro and in vivo, with aptamer QA-36 demonstrating the greatest protective effect against STIV and inhibiting STIV infection in a dose-dependent manne","Affinity of STIV-selected ssDNA aptamer interactions by ELISA. STIV was incubated with increasing concentrations of 5©m-biotinylated aptamer. After addition of streptavidin-HRP, the amount of STIV-aptamer complex was calculated and graphed as a function of aptamer concentration. The graph was fit to the equation Y = Bmax*X/(Kd + X) using SigmaPlot software. Results for each aptamer was presented as the mean ºô SD of three independent experiments"
Apta_944,ATACGACTCACTATTAGGGACAAAGCTGACAACCCTTTCATAATCTAACTACATTTATGTGCTAGACTACTGACTAC,G1,DNA,77 nt,0.377,"23,560.18 Da",42.44 ¦ÌM,No QGRS found,N/A,Targeted binding,G1 specifically bound to cognate target protein,"Isolated aptamers specifically recognize target proteins in Western blot. Purified proteins and E. coli cell lysates are separated on SDS-PAGE, stained with Coomassie Brilliant Blue (left) and probed with Cy5.5-labeled corresponding aptamers (right). The dissociation constants of aptamer G1 toward their cognate target proteins are determined to be in the nanomolar range by dot blot"
Apta_945,GTTAGACGCTGGACCGCGTGTGATCGGGTCAGCTGCAATT,SMZ1,DNA,40 nt,0.575,"12,383.94 Da",80.75 ¦ÌM,No QGRS found,N/A,Target recognition,"Aptasensor can be used to sensitively, selectively, and accurately detect SMZ residues in foods","The relative fluorescence intensity versus concentration of the FAM-labeled aptamers. The dissociation constants of aptamers were used to determine by nonlinear regression analysis. The relative fluorescence intensity is expressed as (F-F0), where F and F0 are the fluorescence intensity obtained with the SMZ analyte and the blank sample, respectively"
Apta_946,TACCGGGTAATATGCACACATGCTGATAGCAAGCAATGCA,SMZ5,DNA,40 nt,0.45,"12,321.97 Da",81.16 ¦ÌM,No QGRS found,N/A,Target recognition,"Aptasensor can be used to sensitively, selectively, and accurately detect SMZ residues in foods","The relative fluorescence intensity versus concentration of the FAM-labeled aptamers. The dissociation constants of aptamers were used to determine by nonlinear regression analysis. The relative fluorescence intensity is expressed as (F-F0), where F and F0 are the fluorescence intensity obtained with the SMZ analyte and the blank sample, respectively"
Apta_947,CATGGCTAGGTGTTTATTAATCCTGTAGGATTTGCGGAAT,A5,DNA,40 nt,0.4,"12,386.97 Da",80.73 ¦ÌM,No QGRS found,N/A,Targeted binding,"Binding to other cell types with varying degrees of GLUT1 expression, and selective binding to vasculature in human brain cortical tissue",Aptamer A5 affinity analysis. Flow cytometry measurements of serially diluted (0-500 nM) FAM-labeled aptamer A5 binding to high-expressing GLUT1 or GLUT1-null Caco-2 cells. The FAM-labeled scrambled aptamer was used as a negative control with the high-expressing GLUT1 Caco-2 cells. Measurements were performed in duplicate with error bars representing mean 6 SD
Apta_948,TAGGGAAGAGAAGGACATATGATACTGGCCTTGACACCCTGTTGTGGCTTGATGACAATAACATTGACTAGTACATGACCACTTGA,EF508,DNA,86 nt,0.43,"26,627.10 Da",37.56 ¦ÌM,No QGRS found,N/A,Target recognition,Aptamer EF508 exhibited high binding afnity to E. faecalis cells (KD-value: 37 nM) and successfully discriminated E. faecalis from 20 diferent Enterococcus and non-Enterococcusspp,"Binding saturation curve of aptamer EF508 to E. faecalis cells. Cells were incubated with increasing concentrations of aptamer (0, 1, 3, 10, 30, 100 and 300?nM) and measured by qPCR. Data points represent the mean of three biological replicates. A non-linear regression curve was ftted to the data using SigmaPlot version 14.0. Te dissociation constant (KD) is shown as the mean ºô SD"
Apta_949,TCCAGCACTCCACGCATAACCCCGTCCTCGGAAAGAGCGCGGGCCTGGGACGGCTACTGCCCGGATTTATGTGTTATGCGTGCGACGGTGAA,XMU3,DNA,92 nt,0.609,"28,366.10 Da",35.25 ¦ÌM,2,17,Targeted binding,"XMU3-bcd aptamer can directly regulate the cell adhesion via the ¨Jstructure-binding affinity-protein function¡Ò pathway, rather than following the Central Dogma",A) Schematic illustration of the formation of aptamer-ZNCTS-EpCAM complex. B) The binding affinity curves of XMU3-bcd aptamer with EpCAM by flow cytometry in the presence and absence of Z-NCTS
Apta_950,CACCTAATACGACTCACTATAGCGGATCCGAAGGGGGCGCGAGGTGTAAGGGTGTGGGGTGGTGGGTGGGCCTGGCTCGAACAAGCTTGC,N13,DNA,90 nt,0.611,"28,092.91 Da",35.60 ¦ÌM,3,62,Targeted binding,Binding to target proteins,EMSA and CD for specifificity study of aptamer
Apta_951,CACCTAATACGACTCACTATAGCGGATCCGAGGGGGTAGCGGGTGGGCCGGTGGATGCGGGGCGCCGGCGCCTGGCTCGAACAAGCTTGC,N53,DNA,90 nt,0.667,"27,959.80 Da",35.77 ¦ÌM,3,57,Targeted binding,Binding to target proteins,EMSA and CD for specifificity study of aptamer
Apta_952,TCACCTCATACGACTCACTATAGCGGACCCCACTCACTGCTCGGACTCTCCCCCTCCCCGCCTGGCTCGAACAAGCTTGC,NG51,DNA,80 nt,0.613,"24,193.46 Da",41.33 ¦ÌM,No QGRS found,N/A,Target recognition,Detect PfGDH with an LOD of 2.85 nM in diluted serum sample,CD measurment data curve fitting for Kd calculation
Apta_953,TCACCTCATACGACTCACTATAGCGGATCCGAGCCGGGGTGTTCTGTTGGCGGGGGCGGTGGGCGGGCTGGCTCGAACAAGCTTGC,NG3,DNA,86 nt,0.64,"26,670.98 Da",37.49 ¦ÌM,3,56,Target recognition,The aptamer could detect PfGDH with an LOD of 2.85 nM in diluted serum sample,CD measurment data curve fitting for Kd calculation
Apta_954,ATACGGGAGCCAACACCAGGACTAACATTATAAGAATTGCGAATAATCATTGGAGAGCAGGTGTGACGGAT,91,DNA,71 nt,0.437,"22,065.21 Da",45.32 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,N/A
Apta_955,ACGUAUCCCUUUUCGCGUA,EP23,RNA,19 nt,0.474,"5,935.52 Da",168.48 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Isothermal titration calorimetric analysis of the interaction of the 50-×SM aptamer solutions from EP23, A5U, or G15U, with EpCAM protein (5 ×SM) in ITC buffer at 25 ¨FC. (Top and Bottom) Raw data and binding isotherm obtained over a series of injections of aptamer into EpCAM protein. (Top) Differential power (×Scal/sec) versus time is presented in the form of integrated heat values. The data were fitted using a one binding site model"
Apta_956,ACGUUUCCCUUUUCGCGUA,A5U,RNA,19 nt,0.474,"5,912.48 Da",169.13 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Isothermal titration calorimetric analysis of the interaction of the 50-×SM aptamer solutions from EP23, A5U, or G15U, with EpCAM protein (5 ×SM) in ITC buffer at 25 ¨FC. (Top and Bottom) Raw data and binding isotherm obtained over a series of injections of aptamer into EpCAM protein. (Top) Differential power (×Scal/sec) versus time is presented in the form of integrated heat values. The data were fitted using a one binding site model"
Apta_957,ACGUAUCCCUUUUCUCGUA,G15U,RNA,19 nt,0.421,"5,896.48 Da",169.59 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to target proteins,"Isothermal titration calorimetric analysis of the interaction of the 50-×SM aptamer solutions from EP23, A5U, or G15U, with EpCAM protein (5 ×SM) in ITC buffer at 25 ¨FC. (Top and Bottom) Raw data and binding isotherm obtained over a series of injections of aptamer into EpCAM protein. (Top) Differential power (×Scal/sec) versus time is presented in the form of integrated heat values. The data were fitted using a one binding site model"
Apta_958,CGCGTGAGCGGGGAGGCGATGCCCAGGCTAACTTGACTCA,T-2,DNA,40 nt,0.65,"12,387.94 Da",80.72 ¦ÌM,No QGRS found,N/A,Aptasensor,CE-based detection validated the application feasibility of aptamer for Tg detection,N/A
Apta_959,GGACCGCTAGGTTCGTGGCTGAGATCACGCGATATCAGTA,T-1,DNA,40 nt,0.55,"12,376.95 Da",80.80 ¦ÌM,No QGRS found,N/A,Aptasensor,CE-based detection validated the application feasibility of aptamer for Tg detection,N/A
Apta_960,CCCGAGGCACGAGGGGGAACGTATCGTCATGTGCCGGCCA,T-3,DNA,40 nt,0.675,"12,372.93 Da",80.82 ¦ÌM,No QGRS found,N/A,Aptasensor,CE-based detection validated the application feasibility of aptamer for Tg detection,N/A
Apta_961,CTAGTGGGGACCTTCCAGGGTAACTGCTCGCATTCTCCAT,T-4,DNA,40 nt,0.55,"12,238.85 Da",81.71 ¦ÌM,No QGRS found,N/A,Aptasensor,CE-based detection validated the application feasibility of aptamer for Tg detection,N/A
Apta_962,CCACACCGAGATGTTGTGACGGTTCCGATTGGCAAACTGA,T-5,DNA,40 nt,0.525,"12,320.93 Da",81.16 ¦ÌM,No QGRS found,N/A,Aptasensor,CE-based detection validated the application feasibility of aptamer for Tg detection,N/A
Apta_963,TGGCGCTGCCCCTAGTCTCCGGCTGATAGCTGCTTCTTGG,T-6,DNA,40 nt,0.625,"12,237.81 Da",81.71 ¦ÌM,No QGRS found,N/A,Aptasensor,CE-based detection validated the application feasibility of aptamer for Tg detection,N/A
Apta_964,CACGAGAGGGGTGAGGTGTCGTATTAGAGGGAAGCTCCAA,T-7,DNA,40 nt,0.55,"12,515.05 Da",79.90 ¦ÌM,No QGRS found,N/A,Aptasensor,CE-based detection validated the application feasibility of aptamer for Tg detection,N/A
Apta_965,CACGGCATGTGTGGCCGGATGCCTATATCGGTCGACTGCA,T-8,DNA,40 nt,0.6,"12,328.90 Da",81.11 ¦ÌM,No QGRS found,N/A,Aptasensor,CE-based detection validated the application feasibility of aptamer for Tg detection,N/A
Apta_966,GGCCTGGTCTGTTAGCCGGGTAGCAGCCCCGGCACCTATT,No.1,DNA,40 nt,0.65,"12,280.85 Da",81.43 ¦ÌM,No QGRS found,N/A,Targeted therapy,"For masking RhD antigens on RBCs, and thus valuable for prevention or at least amelioration of RhD+-related hemolytic anemia in RhD-individuals","Binding dynamics of ssDNA aptamers to RhD+ RBCs. RhD+ RBCs (2% suspension, 100 ×Sl/well) were stained in triplicate with different concentrations (200?1,200 nM) of Alexa Fluor 488?labeled each ssDNA at 37 ©} for 60 min. After being washed, the cells were analyzed by flow cytometry. The Kd was analyzed. Data are plotted by fluorescence intensity (y?axis) against ssDNA aptamer concentrations (x-axis) using GraphPad Prism V6 software. Experiments were performed three times, and data is a mean of the triplicates. ssDNA, single-stranded DNA; Rh, Rhesus; RBCs, red blood cells; Kd, dissociation constant"
Apta_967,GGGTAGCAGCCCCGCGGAGGGTCGGCTATAAGAACCAAGA,No.2,DNA,40 nt,0.625,"12,429.99 Da",80.45 ¦ÌM,No QGRS found,N/A,Targeted therapy,"For masking RhD antigens on RBCs, and thus valuable for prevention or at least amelioration of RhD+-related hemolytic anemia in RhD-individuals","Binding dynamics of ssDNA aptamers to RhD+ RBCs. RhD+ RBCs (2% suspension, 100 ×Sl/well) were stained in triplicate with different concentrations (200?1,200 nM) of Alexa Fluor 488?labeled each ssDNA at 37 ©} for 60 min. After being washed, the cells were analyzed by flow cytometry. The Kd was analyzed. Data are plotted by fluorescence intensity (y?axis) against ssDNA aptamer concentrations (x-axis) using GraphPad Prism V6 software. Experiments were performed three times, and data is a mean of the triplicates. ssDNA, single-stranded DNA; Rh, Rhesus; RBCs, red blood cells; Kd, dissociation constant"
Apta_968,TAACACGACAGACGTTCGGAGGTCGAACCCTGACAGCGTGGGC,CD63-1,DNA,43 nt,0.605,"13,287.54 Da",75.26 ¦ÌM,No QGRS found,N/A,Targeted therapy,"CD63-1 was found to be efficient in binding CD63 positive cells, including breast cancer MDA-MB-231 cells and CD63-overexpressed HEK293T cells, with a medium binding affinity (Kd=100 nM) as assessed by flow cytometry",Analysing equilibrium dissociation constants (Kd) of CD63-1 aptamer to CD63 molecule by ELISA
Apta_969,TAACCACCCCACCTCGCTCCCGTGACACTAATGCTAATTCCAA,CD63-2,DNA,43 nt,0.512,"12,956.35 Da",77.18 ¦ÌM,No QGRS found,N/A,Targeted therapy,Binding to target proteins,Analysing equilibrium dissociation constants (Kd) of CD63-2 aptamer to CD63 molecule by ELISA
Apta_970,TTATGTAGCATTTATGAAATTTTTAAATCAATTTACTATTGGTGGTATCC,H3.17,DNA,50 nt,0.24,"15,382.93 Da",65.01 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,MST binding affinity curves for the  affinity aptamers
Apta_971,TAGTCTAGGAACGGTACGATCGTATTCCAAGGACTTTGCTGGTGGTATCC,H3.15,DNA,50 nt,0.48,"15,446.91 Da",64.74 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,MST binding affinity curves for the  affinity aptamers
Apta_972,TGACAGTACGTACTGAACTAATTTATAAGTAATTTGCTATGGTGGTATCC,H3.10,DNA,50 nt,0.34,"15,427.95 Da",64.82 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,MST binding affinity curves for the  affinity aptamers
Apta_973,TATGTAATGTTGACGTAATTTATCTCTGTGAGAATAAGCAGGTGGTATCC,H3.1,DNA,50 nt,0.36,"15,483.97 Da",64.58 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,N/A
Apta_974,CATGGTGTCAATACTATACCTTTTGCCGATGGTAACAGTTGGTGGTATCC,H3.5,DNA,50 nt,0.44,"15,396.88 Da",64.95 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,N/A
Apta_975,AGACATAGTACATAACCGATCAATGAACATTTAATTAAATGGTGGTATCC,H3.9,DNA,50 nt,0.32,"15,407.98 Da",64.90 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,N/A
Apta_976,GATGAATATCGCAATGAAATTATATATGTATAATTGGAACGGTGGTATCC,H3.12,DNA,50 nt,0.32,"15,510.02 Da",64.47 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,N/A
Apta_977,CAATCTGCTAAAACTTAAAGCCTATTAATGAAATTGTTAAGGTGGTATCC,H3.16,DNA,50 nt,0.32,"15,389.95 Da",64.98 ¦ÌM,No QGRS found,N/A,Target recognition,Binding to target proteins,N/A
Apta_978,GGCGATGAGAACGGGAGCCTGATGATACACACGAGCGATCGCTCATAAAAGCCGTGCCCG,OC2,DNA,60 nt,0.583,"18,577.92 Da",53.83 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to target proteins,Determination of affinity/dissociation constant (Kd) of from the saturation binding curve
Apta_979,ATGAGTAGTGCGGAGGGATGTGAATACTGACGCGGTCATAGTCGCTGTTGTACCATTGA,OC10,DNA,59 nt,0.492,"18,376.78 Da",54.42 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to target proteins,Determination of affinity/dissociation constant (Kd) of from the saturation binding curve
Apta_980,AACGAGCACGCTTTGTGTACAGCCACTAAATAAGGTATGTAGTCAGCACCCTCGTAAC,OC12,DNA,58 nt,0.466,"17,818.47 Da",56.12 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to target proteins,Determination of affinity/dissociation constant (Kd) of from the saturation binding curve
Apta_981,TATGGAGAGTCAATGAGTACAGTCTCGTCTCAATAACGGAGCCTCGTCCGTGCCCCCG,OC17,DNA,58 nt,0.552,"17,818.42 Da",56.12 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to target proteins,Determination of affinity/dissociation constant (Kd) of from the saturation binding curve
Apta_982,ATGACGGGGGTCTAGGCAAGTAATAACGGGGGCAAGCTTTTCTATCTCGTTCTAGGGTA,BC1,DNA,59 nt,0.492,"18,336.75 Da",54.54 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to target proteins,Determination of affinity/dissociation constant (Kd) of from the saturation binding curve
Apta_983,ATGGGAACAGAGCGGCGCAGAGACCCAATGCCACGAGTACCTGACCCTATCAACCCGTGA,BC2,DNA,60 nt,0.583,"18,466.86 Da",54.15 ¦ÌM,No QGRS found,N/A,Aptasensor,Binding to target proteins,Determination of affinity/dissociation constant (Kd) of from the saturation binding curve
Apta_984,GGGAGGACGAUGCGGCGUAUUGCGCGAGGAUUAUCCGCUCAUCGUUGUUGUUGUGCAGACGACUCGCCCGA,A15,RNA,71 nt,0.592,"22,911.55 Da",43.65 ¦ÌM,No QGRS found,N/A,Targeted therapy,Binding to target tissue,"Equal amounts of aptamers (SCAP and A15) were peripherally injected in mice (n = 3-4) and after 4 hours, total RNA was isolated. Aptamer quantitation in brain, kidney, and liver was done using one-step qRT-PCR (5 ×Sg of DNase-treated input RNA) by including 18S RNA as loading control"
Apta_985,CCAGGAGGACCCTATTCTCGTGTATCGACGAGATCCAGTG,HPA-2,DNA,40 nt,0.55,"12,296.90 Da",81.32 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect H. pylori with the naked eye for 5 min using illumination from a hand-held flashlight,Saturation curve of aptamer HPA-2
Apta_986,CGTGTATCCCCTGTGTGTTTGTACTCGGCTACTGTATCCG,Hp4,DNA,40 nt,0.525,"12,226.82 Da",81.79 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect H. pylori with the naked eye for 5 min using illumination from a hand-held flashlight,N/A
Apta_987,GTACTGTCAATTGGAAGTGGTGTTACGTTGTGTAGTCAAATCAGTGC,Apt-07S,DNA,47 nt,0.426,"14,594.38 Da",68.52 ¦ÌM,No QGRS found,N/A,Targeted binding,Apt-07S can specififically target HCC,"Binding curves of aptamer Apt-07S to two target hepatocellular carcinoma cells, HepG2 and SMMC-7721"
Apta_988,AAGGATGACTGACGACGATGGGAATGGAGAGGAAGGGGATATAGGTATGTTGGATGTAG,SP3,DNA,59 nt,0.475,"18,636.98 Da",53.66 ¦ÌM,2,21,Aptasensor,Fabricate a competitive aptasensor for sepiapterin detection,The fluorescence binding affinity curves for six sepiapterin aptamers (a plot of the aptamer concentration versus the fluorescence intensity of the eluted aptamer solution). The dissociation constants were calculated via nonlinear regression analysis of the saturation curves and the error bars represent the standard deviation of the measurements
Apta_989,ATGCGGGTACATCTCTCCAACCAGTCAAACTGCTATGATAAGACCTCATTCAACCCCGGTA,SP5,DNA,61 nt,0.475,"18,620.98 Da",53.70 ¦ÌM,No QGRS found,N/A,Aptasensor,Fabricate a competitive aptasensor for sepiapterin detection,The fluorescence binding affinity curves for six sepiapterin aptamers (a plot of the aptamer concentration versus the fluorescence intensity of the eluted aptamer solution). The dissociation constants were calculated via nonlinear regression analysis of the saturation curves and the error bars represent the standard deviation of the measurements
Apta_990,AACCCAACCCCGCACCATTAGTCTAAATTTTCGCGACGGAACACAGCAACAACTCCCCA,SP4,DNA,59 nt,0.508,"17,895.54 Da",55.88 ¦ÌM,No QGRS found,N/A,Aptasensor,Fabricate a competitive aptasensor for sepiapterin detection,The fluorescence binding affinity curves for six sepiapterin aptamers (a plot of the aptamer concentration versus the fluorescence intensity of the eluted aptamer solution). The dissociation constants were calculated via nonlinear regression analysis of the saturation curves and the error bars represent the standard deviation of the measurements
Apta_991,AGCAGTGAAGAGGCGAGAGATTTATGAGGGTAGCGTCCACATATGCCAGGATCGTGTTG,SP7,DNA,59 nt,0.508,"18,419.82 Da",54.29 ¦ÌM,No QGRS found,N/A,Aptasensor,Fabricate a competitive aptasensor for sepiapterin detection,The fluorescence binding affinity curves for six sepiapterin aptamers (a plot of the aptamer concentration versus the fluorescence intensity of the eluted aptamer solution). The dissociation constants were calculated via nonlinear regression analysis of the saturation curves and the error bars represent the standard deviation of the measurements
Apta_992,TCACTGACAGTAGGCCCATACGCACATTCAACAATCGGTAGTCCATACAACCGCGCCCCGTG,SP8,DNA,62 nt,0.548,"18,921.15 Da",52.85 ¦ÌM,No QGRS found,N/A,Aptasensor,Fabricate a competitive aptasensor for sepiapterin detection,The fluorescence binding affinity curves for six sepiapterin aptamers (a plot of the aptamer concentration versus the fluorescence intensity of the eluted aptamer solution). The dissociation constants were calculated via nonlinear regression analysis of the saturation curves and the error bars represent the standard deviation of the measurements
Apta_993,AATCCGACCACGAGAGCAGACCGACCACAGCATTATCTAAACCCATTAGTCTAGTCCTGG,SP10,DNA,60 nt,0.5,"18,350.81 Da",54.49 ¦ÌM,No QGRS found,N/A,Aptasensor,Fabricate a competitive aptasensor for sepiapterin detection,The fluorescence binding affinity curves for six sepiapterin aptamers (a plot of the aptamer concentration versus the fluorescence intensity of the eluted aptamer solution). The dissociation constants were calculated via nonlinear regression analysis of the saturation curves and the error bars represent the standard deviation of the measurements
Apta_994,GCAATGGTACGGTACTTCCGGACAGTGCTGAAAACTGTGACCCCCCAAAAGTGCACGCTACTTTGCTAA,R10C5,DNA,69 nt,0.507,"21,213.61 Da",47.14 ¦ÌM,No QGRS found,N/A,Aptasensor,Biosensor to detect Lp in real time and in situ,"Determination of the KD of the aptamers R10C5(a) and R10C1(b). Lp(lp120292) was incubated with 10-fold dilutions of the FITC-tagged aptamers and the fuorescence was measured by fow cytometry. Te number of cells displaying fuorescence above the autofuorescence were counted as bound cells, as described in Fig.?2. Te graphs show individual values of three experiments. Te equilibrium dissociation constant, KD was calculated using GraphPad Prism 7.03. Te non-linear regression (solid line) with 95% confdence interval error envelopes (dotted lines) is shown"
Apta_995,GCAATGGTACGGTACTTCCCCACCCCACGCTGCTCCCAAAAGTGCACGCTACTTTGCTAA,R10C1,DNA,60 nt,0.55,"18,260.71 Da",54.76 ¦ÌM,No QGRS found,N/A,Aptasensor,Biosensor to detect Lp in real time and in situ,"Determination of the KD of the aptamers R10C5(a) and R10C1(b). Lp(lp120292) was incubated with 10-fold dilutions of the FITC-tagged aptamers and the fuorescence was measured by fow cytometry. Te number of cells displaying fuorescence above the autofuorescence were counted as bound cells, as described in Fig.?2. Te graphs show individual values of three experiments. Te equilibrium dissociation constant, KD was calculated using GraphPad Prism 7.03. Te non-linear regression (solid line) with 95% confdence interval error envelopes (dotted lines) is shown"
Apta_996,ATAGGAGTCGACCGACCAGACAACCCTACGCGACCAACCAGATGACCTACGTGCGTCTACATCTAGACTC,Apt-1,DNA,70 nt,0.543,"21,410.75 Da",46.71 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_997,ATAGGAGTCGACCGACCAGACCCCGCCTCTCCTTTTCATGTGACACAATGGTGCGTCTACATCTAGACTC,Apt-2,DNA,70 nt,0.529,"21,380.70 Da",46.77 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_998,ATAGGAGTCGACCGACCAGACCAACCCTACGCGTACCAACCAGATGACCTACGTGCGTCTACATCTAGACTC,Apt-3,DNA,72 nt,0.542,"22,004.13 Da",45.45 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_999,ATAGGAGTCGACCGACCAGAGGACCCCGCTATCTAATTTATAGGCAATAAGTGCGTCTACATCTAGACTC,Apt-4,DNA,70 nt,0.471,"21,525.83 Da",46.46 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1000,ATAGGAGTCGACCGACCAGAACCGTTCCCATACTTCTCCAGCGATACTTAGTGCGTCTACATCTAGACTC,Apt-5,DNA,70 nt,0.5,"21,388.72 Da",46.75 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1001,ATAGGAGTCGACCGACCAGACAACCCTACGCGTACCAACCAGATGACCTACGTGCGTCTACATCTAGACTC,Apt-6,DNA,71 nt,0.535,"21,714.95 Da",46.05 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1002,ATAGGAGTCGACCGACCAGACAACCCTACGCGTACCAACCAGATGACCTACGTGCGTCTACATCTAGACTC,Apt-7,DNA,71 nt,0.535,"21,714.95 Da",46.05 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1003,ATAGGAGTCGACCGACCAGACCCCGCCTCTCCTTTCATGTGACACAATGGTGCGTCTACATCTAGACTC,Apt-8,DNA,69 nt,0.536,"21,076.50 Da",47.45 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1004,ATAGGAGTCGACCGACCAGACCCGACCTCTCTTTCACTGTGACACAATGGTGCGTCTACATCTAGACTC,Apt-9,DNA,69 nt,0.522,"21,100.53 Da",47.39 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1005,ATAGGAGTCGACCGACCAGACCCGACCTCTCCTTTCATGTGACACAATGGTGCGTCTACATCTAGACTC,Apt-10,DNA,69 nt,0.522,"21,100.53 Da",47.39 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1006,ATAGGAGTCGACCGACCAGAACTTGTCTTAGGAGGTTTACGGTGGGAATAGTGCGTCTACATCTAGACTC,Apt-11,DNA,70 nt,0.486,"21,683.90 Da",46.12 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1007,ATAGGAGTCGACCGACCAGACCCGACCTCTCTTTCATGTGACACAATGGTGCGTCTACATCTAGACTC,Apt-12,DNA,68 nt,0.515,"20,811.35 Da",48.05 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1008,ATAGGAGTCGACCGACCAGACCATTCCCACGCCAAGACCAATTTTCCCTGTGCGTCTACATCTAGACTC,Apt-13,DNA,69 nt,0.522,"21,029.49 Da",47.55 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1009,ATAGGAGTCGACCGACCAGACCAACCCTACGCTCGTACCAACCAGATGACCTACGTGGCGTCTACATCTAGACTC,Apt-14,DNA,75 nt,0.547,"22,926.71 Da",43.62 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1010,ATAGGAGTCGACCGACCAGACCGACCCTCGTCGTACCAACTGATGACCTAGTGGCGTCTACATCTAGACTC,Apt-15,DNA,71 nt,0.549,"21,752.94 Da",45.97 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibited angiogenesis through the activation of Notch signaling in vitro,"Plots for the determination of the dissociation constant (Kd). The data were fitted to the equation f = fmax*[Apt]/ ([Apt]+Kd) by the non-linear least squares method. f: complex formation rate, fmax: maximum formation rate, [Apt]: concentration of free aptamer"
Apta_1011,GCTGTGTGACTCCTGCAATGGTAGCGGGTAGGGGAGGGAGGGTGAATGGAGGATGTTCATGGCAGCTGTATCTTGTCTCC,C42 aptamer,DNA,80 nt,0.563,"25,004.94 Da",39.99 ¦ÌM,3,63,Targeted binding,Inhibited binding of PD1 to PD-L1,The Kd value was calculated using non-linear regression equation for binding of aptamers to protein-loaded beads
Apta_1012,CACATTAGGGCGGGGTACTCCTATCACGTATGGGGGCCTGT,NB1,DNA,41 nt,0.585,"12,673.12 Da",78.91 ¦ÌM,No QGRS found,N/A,Targeted therapy,G-NB3 inhibits the inactivation of activated cofactors V and VIII with IC50 values of 11.6 and 13.1 nM,"Influence of APC aptamers on the anticoagulant activity of endogenously generated APC in human plasma. Pooled normal citrated human plasma was spiked with rabbit thrombomodulin (2 U/mL) and increasing concentrations of APC aptamers. Subsequently, thrombin formation was measured using the CAT method"
Apta_1013,ATCACGTATGGGGGGCCGGCATGAGGGCCGCGCGTGACA,NB2,DNA,39 nt,0.692,"12,139.77 Da",82.37 ¦ÌM,2,19,Targeted therapy,G-NB3 inhibits the inactivation of activated cofactors V and VIII with IC50 values of 11.6 and 13.1 nM,"Influence of APC aptamers on the anticoagulant activity of endogenously generated APC in human plasma. Pooled normal citrated human plasma was spiked with rabbit thrombomodulin (2 U/mL) and increasing concentrations of APC aptamers. Subsequently, thrombin formation was measured using the CAT method"
Apta_1014,TGGGGGTTGGGTGGATAGGCTGGCGTCGGGGCAGGTCAGT,G-NB3,DNA,40 nt,0.675,"12,617.04 Da",79.26 ¦ÌM,2,20,Targeted therapy,G-NB3 inhibits the inactivation of activated cofactors V and VIII with IC50 values of 11.6 and 13.1 nM,"Influence of APC aptamers on the anticoagulant activity of endogenously generated APC in human plasma. Pooled normal citrated human plasma was spiked with rabbit thrombomodulin (2 U/mL) and increasing concentrations of APC aptamers. Subsequently, thrombin formation was measured using the CAT method"
Apta_1015,ATACCAGCTTATTCAATTGACCCGTTTCGTTCCCTCTGGGAAGTTTAGCCCAGTTGCCTGGGCGATACCAAGATAGTAAGTGCAATCT,AP-1,DNA,88 nt,0.466,"27,041.32 Da",36.98 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) protein,Kd of AP-1
Apta_1016,ATACCAGCTTATTCAATTTCTTCGCCAGTGCCAGGATCTCAGTTGGCGGTTCATTAGCTGGGTTGGTCGAAGATAGTAAGTGCAATCT,AP-2,DNA,88 nt,0.455,"27,167.39 Da",36.81 ¦ÌM,No QGRS found,N/A,Targeted binding,Inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) protein,Kd of AP-2
Apta_1017,TAGGGAATTCGTCGACGGATCCCTGCAGTTTGGTAGGGTGCGAGCAACATCAGGCACCTGCAGGTCGACGCATGCGCCG,AP32,DNA,79 nt,0.608,"24,473.62 Da",40.86 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect metronidazole in honey samples,"The saturation curves and Kd values of AP2, AP19, AP21 and AP32"
Apta_1018,ATCCCTGCAGTTTGGTAGGGTGCGAGCAACATCAGGCACCTGCAGG,AP32-1,DNA,46 nt,0.587,"14,216.11 Da",70.34 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect metronidazole in honey samples,"The saturation curves and Kd values of AP2, AP19, AP21 and AP32"
Apta_1019,ATCCCTGCAGTTTGGTAGGGTGCAGG,AP32-2,DNA,26 nt,0.577,"8,058.18 Da",124.10 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect metronidazole in honey samples,"The saturation curves and Kd values of AP2, AP19, AP21 and AP32"
Apta_1020,CTGCTTTGGTAGGGCAG,AP32-3,DNA,17 nt,0.588,"5,257.40 Da",190.21 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect metronidazole in honey samples,"The saturation curves and Kd values of AP2, AP19, AP21 and AP32"
Apta_1021,CTGTTTGGTAGGCAG,AP32-4,DNA,15 nt,0.533,"4,639.01 Da",215.56 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect metronidazole in honey samples,"The saturation curves and Kd values of AP2, AP19, AP21 and AP32"
Apta_1022,CTCCTTCAACGAAGTGGGTTCCTTCAACGAAGTGGGTCTC,CBSA-5325,DNA,40 nt,0.525,"12,262.88 Da",81.55 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of cocaine within fifteen minutes at concentrations as low as 50 nM in 10% saliva without signal amplification,ATMND binding affinity for cocaine-assembled CBSA-5325. ATMND (200 nM) fluorescence was quenched with increasing concentrations of CBSA-5325 in the presence of 1 mM cocaine. Inset: Scatchard plot of the fluorescence data. The KD was determined based on the negative reciprocal of the slope
Apta_1023,CTCCTTCAACGAAGTGGGTCTCCTTCAACGAAGTGGGTCTC,CBSA-5335,DNA,41 nt,0.537,"12,552.06 Da",79.67 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of cocaine within fifteen minutes at concentrations as low as 50 nM in 10% saliva without signal amplification,Characterization of cocaine binding affinity of CBSA-5335 and PSA using ITC
Apta_1024,GTCCAGGGTTCCAAGGTGCTTCGTGGAC,CH1S-3,DNA,28 nt,0.607,"8,636.55 Da",115.79 ¦ÌM,No QGRS found,N/A,Target recognition,Monitoring of antibody production,The Kd value of aptamer CH1S-3
Apta_1025,GAAGAGTAGATGAAACGTTTTTTCGCCCGATAAAAGGGACGTGCGTCAGACA,A2,DNA,52 nt,0.462,"16,149.40 Da",61.92 ¦ÌM,No QGRS found,N/A,Targeted therapy,Monocyte-targeted drug delivery or column selection,"Aptamer binding to human M0-, M1-, and M2-like macrophages"
Apta_1026,GGGGGGTGTATCGTTGACGAGTTGCGCGTGCGTCTCGTG,Apta 3,DNA,39 nt,0.641,"12,173.76 Da",82.14 ¦ÌM,No QGRS found,N/A,Target recognition,Specific to CEA for use as radiopharmaceuticals in colorectal cancer diagnosis,Binding saturation curves of aptamers incubated with T84 cell line. Kd was calculated using nonlinear regression with Specific Binding equation
Apta_1027,GGAGCTACGTTTAGCGAGTCCGACGCTCGGTGCCTCTTC,Apta 5,DNA,39 nt,0.615,"11,966.66 Da",83.57 ¦ÌM,No QGRS found,N/A,Target recognition,Specific to CEA for use as radiopharmaceuticals in colorectal cancer diagnosis,Binding saturation curves of aptamers incubated with T84 cell line. Kd was calculated using nonlinear regression with Specific Binding equation
Apta_1028,CTTCTGCCCGCCTCCTTCCGGCGTCCCTGCGCACTGTATAACGTACACACGATACGTGGGAGACGAGATAGGCGGACACT,M01,DNA,80 nt,0.6,"24,537.67 Da",40.75 ¦ÌM,No QGRS found,N/A,Target recognition,Detecting Mb in human serum and distinguishing acute myocardial infarction patients from healthy individuals,Characterization of selected Mb-binding aptamers
Apta_1029,CTTCTGCCCGCCTCCTTCCCGGTCGAGACCCGGGTTTACTTCCTCGGTAGTGTTCGAGGGAGACGAGATAGGCGGACACT,M02,DNA,80 nt,0.613,"24,606.68 Da",40.64 ¦ÌM,No QGRS found,N/A,Target recognition,Detecting Mb in human serum and distinguishing acute myocardial infarction patients from healthy individuals,Characterization of selected Mb-binding aptamers
Apta_1030,CTTCTGCCCGCCTCCTTCCCGGGTTACAGGATCGTAAATCTTATTCGTTGCTCGATCGGGAGACGAGATAGGCGGACACT,M03,DNA,80 nt,0.55,"24,588.70 Da",40.67 ¦ÌM,No QGRS found,N/A,Target recognition,Detecting Mb in human serum and distinguishing acute myocardial infarction patients from healthy individuals,Characterization of selected Mb-binding aptamers
Apta_1031,GGAGACCGCTTAAGCTTAAAGGAGCGGTTACGAATGCGATGACTTAGGTACCATTGCACTACGGTACCTAAACAGTTCCTTTGGATCCGAATTCGCCGC,P2MC,DNA,99 nt,0.495,"30,552.56 Da",32.73 ¦ÌM,No QGRS found,N/A,Aptasensor,Doxycycline detection,SPR binding studies
Apta_1032,TGGCAAGAGGGTGTGCTTAAGGTGGACACGGTGGCTTAG,AptHis-C,DNA,39 nt,0.564,"12,223.84 Da",81.81 ¦ÌM,2,19,Targeted binding,"AptHis-C can only specifically recognize recombinant proteins with the hexahistidine-tag in simple or complex situations, and not to those with other tags","AptHis-1, AptHis-2, AptHis-3 and AptHis-C exhibited equal binding affinity to the target peptide, but not to the blank beads"
Apta_1033,CACAGGTTCCAGGTAATACCTAAGGGTATGCTCTCGCCTATTATATGGAGCAC,S6-1b,DNA,53 nt,0.472,"16,291.47 Da",61.38 ¦ÌM,No QGRS found,N/A,Target recognition,Distinguish the molecular differences between glioma cell line SHG44 and human astrocytes,Dissociation constant of aptamer S6-1b
Apta_1034,ATGCGGATCCCGCGCGCGACCGTGTCAGCGGGGACTAGCGGTGTAGCGCGAAGCTTGCGC,HBA1,DNA,60 nt,0.7,"18,600.85 Da",53.76 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Inhibited hemagglutination, which is caused by the virus surface protein hemagglutinin",N/A
Apta_1035,ATGCGGATCCCGCGCGGGTCTGAGGAGTGCGCGGTGCCAGTGAGTGCGCGAAGCTTGCGC,HBA2,DNA,60 nt,0.7,"18,671.89 Da",53.56 ¦ÌM,2,19,Targeted therapy,"Inhibited hemagglutination, which is caused by the virus surface protein hemagglutinin",N/A
Apta_1036,ATACCAGTCTATTCAATTGGGCCCGTCCGTATGGTGGG,SL12,DNA,38 nt,0.526,"11,700.51 Da",85.47 ¦ÌM,No QGRS found,N/A,Aptasensor,Identifying high affinity aptamer sequences for the biological molecules and targeting them as antagonist for cancer cell detection,N/A
Apta_1037,ATACCAGTCTATTCAATTGG,SL1,DNA,20 nt,0.35,"6,090.97 Da",164.18 ¦ÌM,No QGRS found,N/A,Aptasensor,Identifying high affinity aptamer sequences for the biological molecules and targeting them as antagonist for cancer cell detection,N/A
Apta_1038,CCCGTCCGTATGGTGGG,SL2,DNA,17 nt,0.706,"5,218.37 Da",191.63 ¦ÌM,No QGRS found,N/A,Aptasensor,Identifying high affinity aptamer sequences for the biological molecules and targeting them as antagonist for cancer cell detection,N/A
Apta_1039,GCCCGTCCGTATGGTGGGT,SL2-A,DNA,19 nt,0.684,"5,851.77 Da",170.89 ¦ÌM,No QGRS found,N/A,Aptasensor,Identifying high affinity aptamer sequences for the biological molecules and targeting them as antagonist for cancer cell detection,N/A
Apta_1040,CAATTGGGCCCGTCCGTATGGTGGGT,SL2-B,DNA,26 nt,0.615,"8,034.16 Da",124.47 ¦ÌM,No QGRS found,N/A,Aptasensor,Identifying high affinity aptamer sequences for the biological molecules and targeting them as antagonist for cancer cell detection,Cells were incubated with different SL2-B aptamer concentrations ranging from 0 to 100 nM. The fluorescence intensity originating from the scrambled sequence at each concentration was subtracted from the fluorescence intensity of corresponding SL2-B aptamer. The actual fluorescence intensity was fitted into SigmaPlot software to determine the Kd
Apta_1041,TTGGCCCCGCGTGATCATTGAGGGGAGGAGCCGAGGCGGGTCCAAGATTG,4.6,DNA,50 nt,0.64,"15,588.96 Da",64.15 ¦ÌM,2,18,Targeted binding,Binding to histone H4 protein,N/A
Apta_1042,ATCACGATATGCCCGGCTCATCGGGGTTCAGTTGGGCGGTCACATGGAAA,4.32,DNA,50 nt,0.56,"15,466.91 Da",64.65 ¦ÌM,2,17,Targeted binding,Binding to histone H4 protein,N/A
Apta_1043,TTCAAGGCGGCGAGATTTAGTGGTTGGGAGGCTGTACGCCCTACGTGAAC,4.36,DNA,50 nt,0.56,"15,537.95 Da",64.36 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to histone H4 protein,N/A
Apta_1044,TTTAACGTAACCTGCAAGGCGGGGAGGTGCGAGCCCCGTGTGTGGCTTGC,4.58,DNA,50 nt,0.62,"15,514.91 Da",64.45 ¦ÌM,2,20,Targeted binding,Binding to histone H4 protein,N/A
Apta_1045,GGTGCTCAGGGAACTGTCTGAGGGATCAGGCTTAAGCCTGTCGAGCAGTT,4.51,DNA,50 nt,0.56,"15,537.95 Da",64.36 ¦ÌM,2,17,Targeted binding,Binding to histone H4 protein,N/A
Apta_1046,TCGCATGGAGGGCAGAGCCGCCTGCCGGGATCCGGCCCTCTTGGGCGGGC,4.65,DNA,50 nt,0.76,"15,462.84 Da",64.67 ¦ÌM,3,55,Targeted binding,Binding to histone H4 protein,N/A
Apta_1047,TAGTCCCAAGGCACATAAGGGCCGGAGGTCTAGCGTCAGGGATACAGAGA,4.57,DNA,50 nt,0.56,"15,542.99 Da",64.34 ¦ÌM,2,17,Targeted binding,Binding to histone H4 protein,N/A
Apta_1048,ATACGGGAGCCAACACCACCTGCGGAAAATCAACAACGACACACGCCACGATTCAGAGCAGGTGTGACGGAT,APB1,DNA,72 nt,0.542,"22,200.28 Da",45.04 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognition of aflflatoxin B1,N/A
Apta_1049,ATACGGGAGCCAACACCATGTACATTGTAGATTTATTTGCCCAAAACCCAAGAAGAGCAGGTGTGACGGAT,APB3,DNA,71 nt,0.451,"21,952.13 Da",45.55 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognition of aflflatoxin B1,N/A
Apta_1050,ATCCGTCACACCTGCTCTCACGTCCGTCAACCAGATTGATACTTTATCTTGTTGTGGTGTTGGCTCCCGTAT,AFAB1,DNA,72 nt,0.486,"21,983.05 Da",45.49 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognition of aflflatoxin B1,N/A
Apta_1051,ATCCGTCACACCTGCTCTATACACATTGTGTTTACTCCCAGTTTTTTAGACTTATGGTGTTGGCTCCCGTAT,AFAB2,DNA,72 nt,0.431,"21,972.06 Da",45.51 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognition of aflflatoxin B1,N/A
Apta_1052,ATCCGTCACACCTGCTCTATTCCTCTGTTGAAGAACCACTTCCGGAAATAAGAGTGGTGTTGGCTCCCGTAT,AFAB3,DNA,72 nt,0.486,"22,059.13 Da",45.33 ¦ÌM,No QGRS found,N/A,Targeted binding,Recognition of aflflatoxin B1,N/A
Apta_1053,GCCGCAAGUACGAGGGCGGCGCGCUCGACGCGGUUAGAUGAGUGUCGCCGUUUCCGAAGAUUGGCUACGCGGGG,530,RNA,74 nt,0.662,"23,021.66 Da",43.44 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of phenylalanine,N/A
Apta_1054,CUGACGUUUCGAACGUCAAAUGCGGAAGUUGUCGGAGCUAAGAAACGGGUAAUGAUGCCGUUGAUGUGAAGGCGGGCUCA,507,RNA,80 nt,0.513,"24,927.96 Da",40.12 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of phenylalanine,N/A
Apta_1055,CAAGCUUGCGGGUUGGCUUGUAACAAGAUCGCUACGUGUUGAACUCUGCAACACUGGUCGGAUAGCGUAAACGGG,527,RNA,75 nt,0.52,"23,249.88 Da",43.01 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of phenylalanine,N/A
Apta_1056,GUCAUGUUGUGUUGUGGUCCAUCCUUUUCUACGCCAGUCGAGUCUGUAGCGUGGGAGUAAACUGAACGGUCAGACAGGA,524,RNA,79 nt,0.506,"25,414.98 Da",39.35 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of phenylalanine,N/A
Apta_1057,UCUGAGGGGUUGGGGCCGCAGUCUCGUCGCCAUGGCUAACGAGGCCGGAACUAGUUUUAGCCGAAAUGAUCGAUGC,421,RNA,76 nt,0.579,"23,572.05 Da",42.42 ¦ÌM,No QGRS found,N/A,Aptasensor,Determination of phenylalanine,N/A
Apta_1058,GUAAGGCAGCUUACAAACAUUAAGGCACAG,Azo-1,RNA,30 nt,0.433,"9,666.86 Da",103.45 ¦ÌM,No QGRS found,N/A,Targeted binding,Application of photo-responsive aptamers,"Absorption spectrum of Azo-1 (0.9 ×SM) in sodium phosphate buffer (10 mM, pH 7.2) with 100 mM NaCl after irradiation by 365 nm UV light for 10 min"
Apta_1059,TCGTGACGCCGTGCAGTTACCGATACGAGCCTCGTTTTG,B01,DNA,39 nt,0.564,"11,965.67 Da",83.57 ¦ÌM,No QGRS found,N/A,Target detection,Detecting Mb in human serum and distinguishing acute myocardial infarction patients from healthy individuals,Characterization of selected B2M-binding aptamers
Apta_1060,AGCAATATTGCCCGCGCGGGGCCAACTGTCCTCACATGA,B02,DNA,39 nt,0.59,"11,937.67 Da",83.77 ¦ÌM,No QGRS found,N/A,Target detection,Detecting Mb in human serum and distinguishing acute myocardial infarction patients from healthy individuals,Characterization of selected B2M-binding aptamers
Apta_1061,TATTTATTGAATGCTGTAATTTCGCCACGCGAAAGTAGG,B03,DNA,39 nt,0.385,"12,035.77 Da",83.09 ¦ÌM,No QGRS found,N/A,Target detection,Detecting Mb in human serum and distinguishing acute myocardial infarction patients from healthy individuals,Characterization of selected B2M-binding aptamers
Apta_1062,GGGGTCTTGCAGGTCCCGTAGGAGGGGCCATTGGAGTGGGG,Apt_NDV01,DNA,41 nt,0.683,"12,875.21 Da",77.67 ¦ÌM,2,19,Target detection,Detection of NDV in poultry samples,Highly specific aptamers against NDV
Apta_1063,AACTTATCGGAGCGTGATTTCCGTCTCGCCGCTTTCCTTT,Apt_NDV02,DNA,40 nt,0.5,"12,170.80 Da",82.16 ¦ÌM,No QGRS found,N/A,Target detection,Detection of NDV in poultry samples,Highly specific aptamers against NDV
Apta_1064,CGATGGAGGACCTCCGGTTTACCGTGTCGTTTTACTCTTG,Apt_NDV03,DNA,40 nt,0.525,"12,275.86 Da",81.46 ¦ÌM,No QGRS found,N/A,Target detection,Detection of NDV in poultry samples,Highly specific aptamers against NDV
Apta_1065,CCTCGCTATGATGGAGTGCGTTTAGATCAGGGAACGGGTT,Apt_NDV04,DNA,40 nt,0.525,"12,422.97 Da",80.50 ¦ÌM,No QGRS found,N/A,Target detection,Detection of NDV in poultry samples,Highly specific aptamers against NDV
Apta_1066,CCTACGTTGGAGTGGGGTTTGCGCAGGCCGTTCTTTCCAA,Apt_NDV05,DNA,40 nt,0.575,"12,325.88 Da",81.13 ¦ÌM,No QGRS found,N/A,Target detection,Detection of NDV in poultry samples,Highly specific aptamers against NDV
Apta_1067,GCGCGGTACCGCGCTAACGGAGGTTGCGTCCGT,TEPP,DNA,33 nt,0.697,"10,187.52 Da",98.16 ¦ÌM,No QGRS found,N/A,Targeted therapy,Targeting of EpCAM-positive brain metastases,Specificity of bifunctional aptamer-DOX conjugates
Apta_1068,CGGGACAAGACAACGAACGAACAGGAAGAGAACCGGAATGCAGACGTCAGGG,AP-Cell 1,DNA,52 nt,0.558,"16,230.47 Da",61.61 ¦ÌM,No QGRS found,N/A,Target detection,Recognizing aspartate Ø¶?Hydroxylase,Affinity assay of selected aptamers using flow cytometry
Apta_1069,CCGGAGAAAAAAAACTTGATGAGCCAGGAAAACGAGGGTTGGAACGCGACTG,AP-Cell 2,DNA,52 nt,0.5,"16,226.47 Da",61.63 ¦ÌM,No QGRS found,N/A,Target detection,Recognizing aspartate Ø¶?Hydroxylase,Affinity assay of selected aptamers using flow cytometry
Apta_1070,CCGTATCGCCCAGGCAACTGGGCTAAACTTCCCAGAGGGAACGAAACCTGGG,AP-Cell 3,DNA,52 nt,0.596,"16,017.28 Da",62.43 ¦ÌM,No QGRS found,N/A,Target detection,Recognizing aspartate Ø¶?Hydroxylase,Affinity assay of selected aptamers using flow cytometry
Apta_1071,TTGAAGTGACTCCGCACTGGGTGGGTGGGAGGGTCGTGCGGCTGGTCATAGCAGGGT,A10,DNA,57 nt,0.632,"17,849.37 Da",56.02 ¦ÌM,3,64,Target detection,Detection of bPAG4 in serum samples,Binding curves of aptamer to bPAG4-coated MB
Apta_1072,TTGAAGTGACTCCCACCCCGCCCCACCGTCCTTGCCACCGTTCCGCCATAGCAGGT,A11,DNA,56 nt,0.643,"16,953.84 Da",58.98 ¦ÌM,No QGRS found,N/A,Target detection,Detection of bPAG4 in serum samples,Binding curves of aptamer to bPAG4-coated MB
Apta_1073,CTTCTGCCCGCCTCCTTCCTATTAGGGTGCTTCGCGAAGTTCATTTTACATCCCCATAGGAGACGAGATAGGCGGACACT,aptamer1 for h-Ras,DNA,80 nt,0.525,"24,507.67 Da",40.80 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Applications in cancer research, development of cancer diagnostics, and treatment of cancer",N/A
Apta_1074,CTTCTGCCCGCCTCCTTCCGCCACAGTATTATGTATCACAGTGCTTCATCTAATATGAGGAGACGAGATAGGCGGACACT,aptamer2 for h-Ras,DNA,80 nt,0.5,"24,524.71 Da",40.78 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Applications in cancer research, development of cancer diagnostics, and treatment of cancer",N/A
Apta_1075,CTTCTGCCCGCCTCCTTCCTACTAGGGTGCTTCGCGAAGTTCATTTTACATCCCCATAGGAGACGAGATAGGCGGACACT,aptamer3 for h-Ras,DNA,80 nt,0.538,"24,492.66 Da",40.83 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Applications in cancer research, development of cancer diagnostics, and treatment of cancer",N/A
Apta_1076,CTTCTGCCCGCCTCCTTCCTATTAGGGTGCTTCGCGAAGTTCATTTTACACCCCCATAGGAGACGAGATAGGCGGACACT,aptamer4 for h-Ras,DNA,80 nt,0.538,"24,492.66 Da",40.83 ¦ÌM,No QGRS found,N/A,Targeted therapy,"Applications in cancer research, development of cancer diagnostics, and treatment of cancer",N/A
Apta_1077,CCCUCCUACAUAGGG,CD133-A15,RNA,15 nt,0.6,"4,710.86 Da",212.28 ¦ÌM,No QGRS found,N/A,Targeted therapy,Aid future development of cancer stem cell targeted therapeutics and molecular imaging,Determination of equilibrium dissociation constants (KD) for the interaction of truncated clones of CD133 aptamers with CD133 positive or negative cell lines
Apta_1078,CAGAACGUAUACUAUUCUG,CD133-B19,RNA,19 nt,0.368,"6,006.61 Da",166.48 ¦ÌM,No QGRS found,N/A,Targeted therapy,Aid future development of cancer stem cell targeted therapeutics and molecular imaging,Determination of equilibrium dissociation constants (KD) for the interaction of truncated clones of CD133 aptamers with CD133 positive or negative cell lines
Apta_1079,GGGCGCUCAAUUUUUUAUUGCAUUUUUCUUUGAGCGCCC,39SGP1A,RNA,39 nt,0.436,"12,297.16 Da",81.32 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection ebolavirus infections,Specifcity of Oligonucleotides 5183 and 39SGP1A for EBOV sGP
Apta_1080,CTTACGACCCAGGGGGGTGGACAGGCGGGGGTTAGGGGGGTCGTAAG,THC1.2,DNA,47 nt,0.681,"14,787.44 Da",67.62 ¦ÌM,3,58,Targeted binding,Binding to cannabinoids,Characterization of the ligand-binding affinity of THC1.2 using ITC
Apta_1081,CTTACGACTGTGGTCGGGTGGTGGGCCTCTAGAGGGGTGTCGTAAG,XA1,DNA,46 nt,0.609,"14,365.17 Da",69.61 ¦ÌM,2,21,Targeted binding,Binding to cannabinoids,Characterization of target-binding affinity of XA1 using ITC.
Apta_1082,GGCTGGTCCGCTGGGAACAAGGGCGGGAGGGAGGGTGTGGGTGCGACAAGCGGACCAGCC,AptD2,DNA,60 nt,0.717,"18,844.01 Da",53.07 ¦ÌM,3,64,Target detection,Detection of dengue NS1 protein,Binding analysis of the UB-DNA aptamers to each DEN-NS1 by a Biacore T200 SPR system
Apta_1083,TGCTGTTGTCACCTGCCTCGTCTCCCTCGT,Tac-B1,DNA,30 nt,0.6,"9,042.79 Da",110.59 ¦ÌM,No QGRS found,N/A,Targeted binding,Capacity for internalization by cells,Evaluation of the internalization of each aptamer obtained via CE-SELEX and hybrid-type SELEX
Apta_1084,TTCCCTCCTCTGTTGTTCCCCCCTCCTCTC,Tac-B2,DNA,30 nt,0.6,"8,873.68 Da",112.69 ¦ÌM,No QGRS found,N/A,Targeted binding,Capacity for internalization by cells,Evaluation of the internalization of each aptamer obtained via CE-SELEX and hybrid-type SELEX
Apta_1085,TGGGGTGGTGGTGTGGGTGGGGGTTTGTTC,Tac-B3,DNA,30 nt,0.633,"9,499.05 Da",105.27 ¦ÌM,No QGRS found,N/A,Targeted binding,Capacity for internalization by cells,Evaluation of the internalization of each aptamer obtained via CE-SELEX and hybrid-type SELEX
Apta_1086,GCAGTTGATCCTTTGGATACCCTGG,S2,DNA,25 nt,0.52,"7,663.94 Da",130.48 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of mucin 1 (MUC 1),SWV responses of 1 mM S1 hybridized with different concentration of S2
Apta_1087,CTTACGACTCAGGCATTTTGCCGGGTAACGAAGTTACTGTCGTAAG,MA,DNA,46 nt,0.478,"14,180.11 Da",70.52 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of MDPV,ITC characterization of MA binding to MDPV
Apta_1088,ATCCAGAGTGACGCAGCATCGAGTGGCTTGTTTGTAATGTAGGGTTCCGGTCGTGGGTTGGACACGGTGGCTTAGT,aptamer-1,DNA,76 nt,0.539,"23,679.11 Da",42.23 ¦ÌM,2,20,Targeted therapy,Block S/RBD-ACE2 interactions and prevent host cell Infection,Binding assays of selected aptamers to S/RBD-virus mimics
Apta_1089,ATCCAGAGTGACGCAGCAATTACCGATGGCTTGTTTGTAATGTAGGGTTCCGTCGGATTGGACACGGTGGCTTAGT,aptamer-2,DNA,76 nt,0.5,"23,591.08 Da",42.39 ¦ÌM,2,19,Targeted therapy,Block S/RBD-ACE2 interactions and prevent host cell Infection,Binding assays of selected aptamers to S/RBD-virus mimics
Apta_1090,ATCCAGAGTGACGCAGCAGGGCTTGGGTTGGGAATAAGGATGTGGGAGGCGGCGAACATGGACACGGTGGCTTAGT,aptamer-6,DNA,76 nt,0.579,"23,839.23 Da",41.95 ¦ÌM,3,58,Targeted therapy,Block S/RBD-ACE2 interactions and prevent host cell Infection,Binding assays of selected aptamers to S/RBD-virus mimics
Apta_1091,CCATGGTAGGTATTGCTTGGTAGGGATAGTGGGCTTGATG,SP5,DNA,40 nt,0.5,"12,509.02 Da",79.94 ¦ÌM,2,17,Targeted therapy,Inhibits pseudovirus infection,"Interaction analysis of the scrambled sequence SP5sc and aptamers SP5-7 with CoV2-S, RBD, ACE2, and CoV-S"
Apta_1092,CCCATGGTAGGTATTGCTTGGTAGGGATAGTGGGCTTGATG,SP6,DNA,41 nt,0.512,"12,798.20 Da",78.14 ¦ÌM,2,17,Targeted therapy,Inhibits pseudovirus infection,"Interaction analysis of the scrambled sequence SP5sc and aptamers SP5-7 with CoV2-S, RBD, ACE2, and CoV-S"
Apta_1093,AGGAGGGTAGGTAGTGCTTGGTAGGGAAACTCCGCCGATT,SP7,DNA,40 nt,0.55,"12,497.02 Da",80.02 ¦ÌM,2,17,Targeted therapy,Inhibits pseudovirus infection,"Interaction analysis of the scrambled sequence SP5sc and aptamers SP5-7 with CoV2-S, RBD, ACE2, and CoV-S"
Apta_1094,GGAATCGTGGGTGGTAGGGTAGGGGATGCA,aptamer,DNA,30 nt,0.6,"9,488.09 Da",105.40 ¦ÌM,2,20,Aptasensor,"Fluorescence sensor for perfluorooctanoic acid, perfluoroheptanoic acid, perfluorohexanesulfonic acid detection in water",N/A
Apta_1095,CCCTGAGGGGTGATGTGAATCCTAACAGTAAGGAGGAAGG,S2,DNA,40 nt,0.525,"12,499.05 Da",80.01 ¦ÌM,No QGRS found,N/A,Aptasensor,Specific imaging of ESCC tissues,The determination of the dissociation constant (Kd) of the selected aptamers
Apta_1096,CTTCTTCGTTAGAAGCCTGTCAATGGCCAGGGGGGAGGGG,S3,DNA,40 nt,0.6,"12,448.97 Da",80.33 ¦ÌM,2,20,Aptasensor,Specific imaging of ESCC tissues,The determination of the dissociation constant (Kd) of the selected aptamers
Apta_1097,AGGCCCTACACGCCTTTTAGCGAGGGCGTTCCGTGGAGGA,S8,DNA,40 nt,0.625,"12,353.91 Da",80.95 ¦ÌM,No QGRS found,N/A,Aptasensor,Specific imaging of ESCC tissues,The determination of the dissociation constant (Kd) of the selected aptamers
Apta_1098,ATGGCCAGGGGGGAGGGG,S3-2-3,DNA,18 nt,0.778,"5,710.68 Da",175.11 ¦ÌM,2,20,Aptasensor,Specific imaging of ESCC tissues,Determination of the Kd of S3-2-3
Apta_1099,ATCCATTGCCACTGACTACCAGCCGGGTGGGTGGGGGGGTTTGCTGGTATCGCATTGTGCGAAGTCAGTCGGTCGTTAGT,aptamer SW1,DNA,80 nt,0.575,"24,851.83 Da",40.24 ¦ÌM,3,64,Aptasensor,Cancer recognition and imaging,Kd of SW1 for SMMC-7721 cells
Apta_1100,GGGAGAAUUCCGACCAGAAGGGUUAGCGGUCGUCUUAAGUAGUUUUUGGUCCUUUCCUCUCUCCUUCCUCUUCU,clone B,RNA,74 nt,0.486,"23,492.72 Da",42.57 ¦ÌM,No QGRS found,N/A,Target detection,HA recognition,N/A
Apta_1101,CCGTAATACGACTCACTATAGGTATGTGACGCGCGTCAATCGCTGTCCTACCAAGCTTTGCAGAGAGGATCCTT,C3A,DNA,74 nt,0.5,"22,735.57 Da",43.98 ¦ÌM,No QGRS found,N/A,Targeted therapy,Osteoporosis therapeutic,Michaelis-Menten plot of two different C3A concentrations for determination of mode of inhibition from representative gel data
Apta_1102,TACGACTCACTATAGGGATCCGTGACTGTACGGGCTCAGTCGTTACTTGAGAGTTGAATTCCCTTTAGTGAGGGTT,SE43,DNA,76 nt,0.474,"23,501.03 Da",42.55 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",Binding assay of SE43 with Staphylococcus epidermidis spiked in human platelet concentrates
Apta_1103,TACGACTCACTATAGGGATCCACCTATGGCAGATTGAGCCCAAGGGCTGTGCAGCGAATTCCCTTTAGTGAGGGTT,SE40,DNA,76 nt,0.513,"23,474.03 Da",42.60 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",N/A
Apta_1104,TACGACTCACTATAGGGATCCCCCCGAGTGAAGAGCAGGACAGCGGGACAGCGTCGAATTCCCTTTAGTGAGGGTT,SE42,DNA,76 nt,0.553,"23,518.06 Da",42.52 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",N/A
Apta_1105,TACGACTCACTATAGGGATCCAATGGCACAGCGCCTGGAACGTACTCTGTACCTGGAATTCCCTTTAGTGAGGGTT,SE48,DNA,76 nt,0.5,"23,408.99 Da",42.72 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",N/A
Apta_1106,TACGACTCACTATAGGGATCCTTCGCATCCGGCACGATGGCTAGGACACCCCGATGAATTCCCTTTAGTGAGGGTT,SE52,DNA,76 nt,0.526,"23,369.95 Da",42.79 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",N/A
Apta_1107,GCGCGATGGACTGTACCTTCGGCGTAACTGATATTCCTGATGATTCTGGCGAGACGTAGCACAAACCCGGTGTATA,Scrambled SE40,DNA,76 nt,0.513,"23,474.03 Da",42.60 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",N/A
Apta_1108,GTGCTTAGGTGCAGAACGCACACACGCTCGGTATGACGTGTTCGCTACGGTATAATTGCAGGCGCGAGCACAACAG,Scrambled SE42,DNA,76 nt,0.553,"23,518.06 Da",42.52 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",N/A
Apta_1109,GGTATGTGTCGTTGATCTGGATATCTATGCCTAATGCTCGTAGGCGACTGTTCGGATAGTAACGTTGACCGCATAC,Scrambled SE43,DNA,76 nt,0.474,"23,501.03 Da",42.55 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",N/A
Apta_1110,GTTGACGGATCCCTATTGCAGTGCTTGAGAGAGACCTCGCGTATATTTCGGAAGACCACGTGTAATGCCCCTAACT,Scrambled SE48,DNA,76 nt,0.5,"23,408.99 Da",42.72 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",N/A
Apta_1111,GTGCGTCGCATGATCGCGATTAGTGCGACCATGTACGATTCTCACGACAACGACACTGTACTTGAGGACTGTCTCC,Scrambled SE52,DNA,76 nt,0.526,"23,369.95 Da",42.79 ¦ÌM,No QGRS found,N/A,Target detection,"Capture, detect  or remove S. epidermidis contaminant from platelet concentrates",N/A
Apta_1112,ATCCAGAGTGACGCAGCAGGGCACATTGTTCACACACAGATCACATTACGGAAAACACAACTACACGAAATGTCGTTGGTGGCCC,OS-7.9,DNA,85 nt,0.494,"26,176.82 Da",38.20 ¦ÌM,No QGRS found,N/A,Targeted therapy,"OS-7.9 could recognize a common protein expressed in these cancer cells, possibly becoming a potential molecular probe for early diagnosis and targeted therapies for metastatic disease",Binding curve of OS-7.9 aptamer to target MG-63 cells and negative control MC3T3-E1 cells
Apta_1113,CCGCCCAAATCCCTAAGAGCACAAACACCAAACACAACCACCCCAACCAGACACACTACACACGCA,DB99,DNA,66 nt,0.53,"19,941.89 Da",50.15 ¦ÌM,No QGRS found,N/A,Targeted therapy,Precise treatment of NB,Flow cytometry evaluation of the binding affinity of DB99 to GD2+ cells
Apta_1114,TAATACGACTCACTATAGGGAGACCCAAGCCGATTTATTTTGTGCAGCTTTTGTTCCCTTTAGTGAGGGTTAATT3,G5›¥3N.4,DNA,75 nt,0.4,"23,104.82 Da",43.28 ¦ÌM,No QGRS found,N/A,Target detection,Detection of papillomavirus infection and cervical cancer,Hill plot showing the KD for the G5a3N.4 interaction with purified HPV-16 E7 protein
Apta_1115,CGTACGGAATTCGCTAGCGGTGACGGACGTGGGGTGCACGAAGGGAGGGGATCCGAGCTCCACGTG,G35,DNA,66 nt,0.652,"20,607.15 Da",48.53 ¦ÌM,2,18,Targeted binding,Binding to nampt,"The dose dependent saturation plots for Nampt binding to aptamer sequences G35, G40 and G55 obtained by SPR assay"
Apta_1116,CGTACGGAATTCGCTAGCCGGGGTGGGAACCAGTCTTGCGCGGGTGACGGATCCGAGCTCCACGTG,G40,DNA,66 nt,0.652,"20,469.05 Da",48.85 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to nampt,"The dose dependent saturation plots for Nampt binding to aptamer sequences G35, G40 and G55 obtained by SPR assay"
Apta_1117,CGTACGGAATTCGCTAGCGGACTGGAGTCTAGACCGGGTAGCTGTGGTGGATCCGAGCTCCACGTG,G55,DNA,66 nt,0.606,"20,483.07 Da",48.82 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to nampt,"The dose dependent saturation plots for Nampt binding to aptamer sequences G35, G40 and G55 obtained by SPR assay"
Apta_1118,GGGAATGGATCCACATCTACGAATTCATCAGGGCTAAAGAGTGCAGAGTTACTTAGTTCACTGCAGACTTGACGAAGCTT,clone 1,DNA,80 nt,0.45,"24,749.89 Da",40.40 ¦ÌM,No QGRS found,N/A,Target detection,Detection and Quantitation of Proteins,Fluorescence data showing the reactivity of the three anti-lysozyme aptamer clones after 10 min of washing
Apta_1119,GGGAATGGATCCACATCTACGAATTCGGTTGTGAAGATTGGGAGCGTCGTGGCTACTTCACTGCAGACTTGACGAAGCTT,clone 3,DNA,80 nt,0.5,"24,804.87 Da",40.31 ¦ÌM,No QGRS found,N/A,Target detection,Detection and Quantitation of Proteins,Fluorescence data showing the reactivity of the three anti-lysozyme aptamer clones after 10 min of washing
Apta_1120,GGGAATGGATCCACATCTACGAATTCGGAATGAGTGCCCTGCAAGCGAGGGCTAGCTTCACTGCAGACTTGACGAAGCTT,clone 6,DNA,80 nt,0.525,"24,752.86 Da",40.40 ¦ÌM,No QGRS found,N/A,Target detection,Detection and Quantitation of Proteins,Fluorescence data showing the reactivity of the three anti-lysozyme aptamer clones after 10 min of washing
Apta_1121,GACAGCGUGCCUAGAAGUCCAAGCUUAAAUAACCACGCUCGACAAGC,S132B-C22,RNA,47 nt,0.511,"15,073.09 Da",66.34 ¦ÌM,No QGRS found,N/A,Targeted therapy,Reverse the symptom caused by BoNT/A,Binding specificity and affinity of aptmers
Apta_1122,ACAACCCGGAACAACGUCUAACAGUGUACCAUAACCCGGCAUUCA,S132B-C12,RNA,45 nt,0.489,"14,342.65 Da",69.72 ¦ÌM,No QGRS found,N/A,Targeted therapy,Reverse the symptom caused by BoNT/A,Binding specificity and affinity of aptmers
Apta_1123,AUUCGGGCCCAGGAACCAACUAUAUAAAUGUCCCGAAUGCUUCGACG,S132B-C11,RNA,47 nt,0.489,"15,027.99 Da",66.54 ¦ÌM,No QGRS found,N/A,Targeted therapy,Reverse the symptom caused by BoNT/A,Binding specificity and affinity of aptmers
Apta_1124,GGGCGAAUUCGGGUUGGAUAGUAGGCGCAUAUGGCAUCUUCGUGGUUGUGUAUUGCCCUUUAGUGAGGGUUAAUU,2©m-O-methyl modified RNA aptamer,RNA,75 nt,0.48,"24,205.19 Da",41.31 ¦ÌM,2,19,Target detection,Detection of p53,N/A
Apta_1125,TCGGGCGAGTCGTCTGGGGAGGTCAGAACGAAAGGCCCGCATCGTCCTCCC,Aptamer 14,DNA,51 nt,0.667,"15,743.06 Da",63.52 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibition of vascular smooth muscle cell (VSMC) proliferation,Binding of selected RNA aptamers to vascular smooth muscle cells in culture
Apta_1126,TCGGGCGAGTCGTCTGCGGGCGGATAGACTACGACACCGCATCGTCCTCCC,Aptamer 51,DNA,51 nt,0.667,"15,654.00 Da",63.88 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibition of vascular smooth muscle cell (VSMC) proliferation,Binding of selected RNA aptamers to vascular smooth muscle cells in culture
Apta_1127,TCGGGCGAGTCGTCTGCGAGGCAACAAGCTCGTAATCCGCATCGTCCTCCC,Aptamer NSC,DNA,51 nt,0.627,"15,612.99 Da",64.05 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibition of vascular smooth muscle cell (VSMC) proliferation,Binding of selected RNA aptamers to vascular smooth muscle cells in culture
Apta_1128,GCCGAGATTGCACTTACTATCTCAATAGGGTAAAAAAAAAAAGTTGGTCCTATGGGTGGGTTGTTCAGTAATTGAATAAGCTGGTATGCGC,A04,DNA,91 nt,0.407,"28,277.16 Da",35.36 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,Binding isotherms for aptamer
Apta_1129,GCCGAGATTGCACTTACTATCTGATGTTATTGTGTTTATTGGAATTTAAAGTATATGGGATGTTTGGTTAGTAATTGAATAAGCTGGTATGCGC,A07,DNA,94 nt,0.351,"29,213.73 Da",34.23 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,Binding isotherms for aptamer
Apta_1130,GCCGAGATTGCACTTACTATCTATTAGGAATAAGGTATGAATAGAGATGTATAAGTTGTGTGGACGGTGTAATTGAATAAGCTGGTATGCGC,A10,DNA,92 nt,0.391,"28,676.41 Da",34.87 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,Binding isotherms for aptamer
Apta_1131,GCCGAGATTGCACTTACTATCTCAAGAAGGGTAGTAAGAGGAGTGGGTGATTATGGGTAAGTTGTATGAGGTAATTGAATAAGCTGGTATGCGC,B02,DNA,94 nt,0.436,"29,400.84 Da",34.01 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,Binding isotherms for aptamer
Apta_1132,GCCGAGATTGCACTTACTATCTGAAAGGGTGGAGATTGATAGGTATAGAGAAACGATAAGGGGGTGTAGAGTAATTGAATAAGCTGGTATGCGC,B17,DNA,94 nt,0.436,"29,427.88 Da",33.98 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,N/A
Apta_1133,GCCGAGATTGCACTTACTATCTAAAGAAGAGTAGTAAGAGGCGTGGGTGATTATGGGTAAGTTGTATGAGGTAATTGAATAAGCTGGTATGCGC,B29,DNA,94 nt,0.426,"29,384.85 Da",34.03 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,Binding isotherms for aptamer
Apta_1134,GCCGAGATTGCACTTACTATCTGTTGAGGGAAGAAGTGGTGTAATGTGGAATAATTGTTGTAATAGTAATTGATAAGCTGGTATGCGC,C06,DNA,88 nt,0.398,"27,447.61 Da",36.43 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,Binding isotherms for aptamer
Apta_1135,GCCGAGATTGCACTTACTATCTCATCAATAAAGATTATAGGGTGAAGGTGATAGTAGGTGGTATATAGGGTAATTGAATAAGCTGGTATGCGC,C07,DNA,93 nt,0.398,"28,974.60 Da",34.51 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,N/A
Apta_1136,GCCGAGATTGCACTTACTATCTAAAGAAAGGTAGTAAGAGTGGGTGATTATGGGTAAGTTGTATGAGGTAATTGAATAAGCTGGTATGCGC,C14,DNA,91 nt,0.407,"28,437.25 Da",35.17 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,Binding isotherms for aptamer
Apta_1137,GCCGAGATTGCACTTACTATCTCAAGAAGAGTAGTAAGAGGAGTGGGTGGTTATGAGTAAGTTGTATGTGGTAATTGAATAAGCTGGTATGCGC,C22,DNA,94 nt,0.426,"29,375.83 Da",34.04 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,Binding isotherms for aptamer
Apta_1138,GCAGTGTGGGCGAATCTATGCGTACCGTTCGATATCGTG,DNA aptamer,DNA,39 nt,0.538,"12,069.74 Da",82.85 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,N/A
Apta_1139,AATAGGGTAAAAAAAAAAAGTTGGTCCTATG,A04T.2,DNA,31 nt,0.29,"9,648.29 Da",103.65 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to targets,Binding isotherms for aptamer
Apta_1140,UAGUGUGAGAGCCGUGAGUGAAAGGCCGCGACAAAGAUCGGA,I-2,RNA,42 nt,0.548,"13,714.27 Da",72.92 ¦ÌM,No QGRS found,N/A,Target detection,Disease Diagnosis,Determination of the dissociation constant (Kd) for the aptamer to the OmpC protein
Apta_1141,ACGAGUCUGGUCCUUCCUUUGACGACUAUUGUUUGGUAUCGAUCAACAACAA,PNDA-1,RNA,52 nt,0.423,"16,536.77 Da",60.47 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibits breast cancer growth and metastasis,Binding affinities were determined using 32P-labeled PNDAs and varying hPN concentrations
Apta_1142,ACGAGUCACACGUUGAUGACUGGAUGGUAGUUAAAGAGGGUGGGGCAACAA,PNDA-2,RNA,51 nt,0.49,"16,616.96 Da",60.18 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibits breast cancer growth and metastasis,Binding affinities were determined using 32P-labeled PNDAs and varying hPN concentrations
Apta_1143,ACGAGUUGUCGCAUGUGCGGUUCAGUCUGGUCCUUCAGCACCGUACAACAA,PNDA-3,RNA,51 nt,0.529,"16,299.67 Da",61.35 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibits breast cancer growth and metastasis,Binding affinities were determined using 32P-labeled PNDAs and varying hPN concentrations
Apta_1144,ACGAGUCUGGUCCUUCCUCCCUAAUUGCUGUUGAGGUAUCGGCUACAACAA,PNDA-4,RNA,51 nt,0.49,"16,221.59 Da",61.65 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibits breast cancer growth and metastasis,Binding affinities were determined using 32P-labeled PNDAs and varying hPN concentrations
Apta_1145,ACTGCTAGAGATTTTCCACAT,21-mer aptamer,DNA,21 nt,0.381,"6,380.16 Da",156.74 ¦ÌM,No QGRS found,N/A,Target detection,Detection of aflflatoxin M1,N/A
Apta_1146,GGGACAGGGAGTGCGCTGCTCCCC,Antibac1,DNA,24 nt,0.75,"7,395.75 Da",135.21 ¦ÌM,No QGRS found,N/A,Aptasensor,Bacterial infections identification,Antibac1 saturation curves
Apta_1147,GGGGACTAGAGGACTTGTGCGGCC,Antibac2,DNA,24 nt,0.667,"7,474.81 Da",133.78 ¦ÌM,No QGRS found,N/A,Aptasensor,Bacterial infections identification,Antibac2 saturation curves
Apta_1148,CCGTCTTCCAGACAAGAGTGCAGGG,DNA aptamer,DNA,25 nt,0.6,"7,691.97 Da",130.01 ¦ÌM,No QGRS found,N/A,Target detection,VEGF recognition,N/A
Apta_1149,ATCATGGTGGGTATCGGCACTCGTTGGTTGAT,M6b-M14,DNA,32 nt,0.5,"9,917.37 Da",100.83 ¦ÌM,2,17,Target detection,Recognize lysine,Binding curve of M6b-M14 to PSL determined by static adsorption method
Apta_1150,CTAAGCAGGAAGGTATGGATTGGTTGCATTAG,M13a,DNA,32 nt,0.438,"9,983.45 Da",100.17 ¦ÌM,2,20,Target detection,Recognize lysine,Binding curve of M13a to PSL determined by static adsorption method
Apta_1151,GGGAATTCGAGCTCGGTACCATCTGTGTAAGGGGTAAGGGGTGGGGGTGGGTACGTCTAGCTGCAGGCATGCAAGCTTGG,10.1,DNA,80 nt,0.588,"25,063.98 Da",39.90 ¦ÌM,3,63,Target detection,Daunorubicin detection,N/A
Apta_1152,GACAAGGATAAATCCTTCAATGAAGTGGGTCACTCATCTGTGA,aptamer against cocaine,DNA,43 nt,0.419,"13,274.57 Da",75.33 ¦ÌM,No QGRS found,N/A,Target detection,Detection of cocaine,N/A
Apta_1153,TATTTTTATATTTGTTTGACAGTCGCTTGCTTGTGTAGGCGTT,GE54,DNA,43 nt,0.349,"13,247.50 Da",75.49 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit the replication of RABV,The inhibition of non-RABV viral infections by aptamers in vitro
Apta_1154,TTAATTTTTTGATCTTTGATTGTTTTATTTTTTTTATTGTTTGTG,GE58,DNA,45 nt,0.156,"13,815.88 Da",72.38 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit the replication of RABV,The inhibition of non-RABV viral infections by aptamers in vitro
Apta_1155,TAGTTTTATTTGTTCATTTTGTGTATTGTTTTGA,GTE33,DNA,34 nt,0.206,"10,460.74 Da",95.60 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit the replication of RABV,The inhibition of non-RABV viral infections by aptamers in vitro
Apta_1156,TTCTGGTGTGGTAACTCATGTATCGGTCGTGGGGGTCGTGGCATT,GT1,DNA,45 nt,0.533,"13,991.93 Da",71.47 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit the replication of RABV,The inhibition of non-RABV viral infections by aptamers in vitro
Apta_1157,ACCTTGTACTGGTTACCTTGGCTAAAAAAAAAAAAAAAAAAAAAGTAAGCCGAAGCCATTACGTTTAGC,LS Circle Template,DNA,69 nt,0.333,"21,301.79 Da",46.94 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin,N/A
Apta_1158,CCAGTACAAGGTGCTAAACGTAAT,LS Primer,DNA,24 nt,0.417,"7,369.80 Da",135.69 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin,N/A
Apta_1159,TGGGATACTGAACGGATGCCTTACAAAAAAAAAAAAAAAAAAAAACCTTATAGTTGTTGATTCCACCCG,SC Circle Template,DNA,69 nt,0.333,"21,301.79 Da",46.94 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin,N/A
Apta_1160,TTCAGTATCCCACGGGTGGAATCA,SC Primer,DNA,24 nt,0.5,"7,352.76 Da",136.00 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin,N/A
Apta_1161,TAGCCAAGGTAACCAGTACAAGGTGCTAAACGTAATGGCTTCGGCTTAC,LS Aptamer,DNA,49 nt,0.469,"15,113.73 Da",66.16 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin,N/A
Apta_1162,AGAGGCTACAGCGATAAGTCGACATTGCTGACCGTACCTAGTAATACGT,SC Aptamer,DNA,49 nt,0.469,"15,113.73 Da",33.17 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibit L-selectin,N/A
Apta_1163,GUCUCUGUGUGCGCCAGAGAACACUGGGGCAGAUAUGGGCCAGCACAGAAUGAGGCCC,RNA1,RNA,58 nt,0.603,"18,784.24 Da",53.24 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to dopamine,N/A
Apta_1164,GTCTCTGTGTGCGCCAGAGAACACTGGGGCAGATATGGGCCAGCACAGAATGAGGCCC,DNA1,DNA,58 nt,0.603,"17,982.52 Da",55.61 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to dopamine,N/A
Apta_1165,GGAUCCCGACUGGCGAGAGCCAGGUAACGAAUGGAUCC,Malachite Green aptamer,RNA,38 nt,0.605,"12,300.41 Da",81.30 ¦ÌM,No QGRS found,N/A,Live-cell imaging,Real-time detection of tagged proteins,Emission spectra of MG with and without excess MG aptamer
Apta_1166,GAUGUAACUGAAUGAAAUGGUGAAGGACGGGUCCAGUAGGCUGC,Spinach2,RNA,44 nt,0.5,"14,327.58 Da",69.80 ¦ÌM,2,18,Live-cell imaging,Dynamic localizations,Emission spectra of Spinach and Spinach2
Apta_1167,GGCGCGAGGAAGGAGGUCUGAGGAGGUCACUGCGCC,Corn,RNA,36 nt,0.694,"11,777.09 Da",84.91 ¦ÌM,2,21,Live-cell imaging,Designing selfassembling RNA nanostructures,Binding of ThT to Corn
Apta_1168,GCGACUACGGUGAGGGUCGGGUCCAGUAGCUUCGGCUACUGUUGAGUAGAGUGUGGGCUCCGUAGUCGC,iSpinach,RNA,69 nt,0.609,"22,333.19 Da",44.78 ¦ÌM,No QGRS found,N/A,Live-cell imaging,Dynamic localizations,Transcription efficiency of the genes coding for iSpinach and its D5 variants
Apta_1169,TTTTTTTTTTTCAGCACCGACCTTGTGCTTTGGGAGTGCTGGTCCAAGGGCGTTAATGGACA,Cov2-1C,DNA,62 nt,0.468,"19,133.23 Da",52.27 ¦ÌM,2,20,Targeted therapy,Inhibits SARS-CoV?2 Infection and suppresses mutational escape,RBD neutralization efficiency of candidate sequences and aptamer cocktail
Apta_1170,TTTTTTTTTTTATCCAGAGTGACGCAGCATTTCATCGGGTCCAAAAGGGGCTGCTCGGGATTGCGGATATGGACACGT,Cov2-4C,DNA,78 nt,0.474,"24,134.43 Da",41.43 ¦ÌM,2,19,Targeted therapy,Inhibits SARS-CoV?2 Infection and suppresses mutational escape,RBD neutralization efficiency of candidate sequences and aptamer cocktail
Apta_1171,TTTTTTTTTTTCGCAGCACCCAAGAACAAGGACTGCTTAGGATTGCGATAGGTTCGG,Cov2-6C3,DNA,57 nt,0.439,"17,579.28 Da",56.89 ¦ÌM,2,17,Targeted therapy,Inhibits SARS-CoV?2 Infection and suppresses mutational escape,RBD neutralization efficiency of candidate sequences and aptamer cocktail
Apta_1172,GACGCCACTGACTACCCCAGTATCTCTTCAACGCGTATTGAAGTCAGTCGGTCGTCA,W5,DNA,57 nt,0.526,"17,424.17 Da",57.39 ¦ÌM,No QGRS found,N/A,Target detection,Detect glioma stem cells,Dissociation constant of the aptamer W5 to glioma stem cells
Apta_1173,TTGACTTGCCACTGACTACCCCAGTATCTCTTCAACGCTATGGTGCATGTACTACGTATTGAAGTCAGTCGGTCGTCATC,W5-7,DNA,80 nt,0.475,"24,496.68 Da",40.82 ¦ÌM,No QGRS found,N/A,Target detection,Detect glioma stem cells,Dissociation constant of the aptamer W5-7 to glioma stem cells
Apta_1174,ATGAGAGCGTCGGTGTGGTAAGTATGATATCGGTGTTTATGGTGTCTGTCTTCATACTCTTGCTGTAGGAGGGTGCGGAAGTA,WYZ-41,DNA,83 nt,0.47,"25,905.54 Da",38.60 ¦ÌM,No QGRS found,N/A,Targeted therapy,Diagnosis and effective therapy of glioma,Kd of full-length and truncated aptamers for T98G cells
Apta_1175,ATGAGAGCGTCGGTGTGGTATCCTACTCGTGATATCGGTGTTTATGGTGTCTGTCTTCATGTAGGAGGGTGCGGAAGTA,WYZ-50,DNA,79 nt,0.494,"24,630.72 Da",40.60 ¦ÌM,No QGRS found,N/A,Targeted therapy,Diagnosis and effective therapy of glioma,Kd of full-length and truncated aptamers for T98G cells
Apta_1176,AGTATGATATCGGTGTTTATGGTGTCTGTCTTCATACT,WYZ-41a,DNA,38 nt,0.368,"11,710.53 Da",85.39 ¦ÌM,No QGRS found,N/A,Targeted therapy,Diagnosis and effective therapy of glioma,Kd of full-length and truncated aptamers for T98G cells
Apta_1177,TCCTACTCGTGATATCGGTGTTTATGGTGTCTGTCTTCATGTAGGA,WYZ-50a,DNA,46 nt,0.435,"14,174.08 Da",70.55 ¦ÌM,No QGRS found,N/A,Targeted therapy,Diagnosis and effective therapy of glioma,Kd of full-length and truncated aptamers for T98G cells
Apta_1178,AGCGTCGAATACCACTACAGGGGATGCGAAGTTCCGCGGTCGAGTATATGATACATCCATCTAATGGAGCTCGTGGTCAG,AY-3,DNA,80 nt,0.513,"24,767.87 Da",40.37 ¦ÌM,No QGRS found,N/A,Targeted therapy,Inhibiting the coactivation of AIB1,Determination of the dissociation constant of the enriched pool to flag-AIB1-CID beads
Apta_1179,GAATTCAGTCGGACAGCGAAGTAGTTTTCCTTCTAACCTAAGAACCCGCGGCAGTTTAATGTAGATGGACGAATACGTCTCCC,LXL-1,DNA,83 nt,0.47,"25,568.40 Da",39.11 ¦ÌM,No QGRS found,N/A,Target detection,Recognition and tissue imaging,Dissociation constant of selected aptamers for MDA-MB-231
Apta_1180,GAATTCAGTCGGACAGCGCAATTGTGGTTCTTACCCTATCCCTTGTGTTTGGCGTTCGTTGCGATGGACGAATATCGTCTCCC,LXL-4,DNA,83 nt,0.506,"25,522.29 Da",39.18 ¦ÌM,No QGRS found,N/A,Target detection,Recognition and tissue imaging,Dissociation constant of selected aptamers for MDA-MB-231
Apta_1181,GAATTCAGTCGGACAGCGTAGTAAGAATCTGTTTCTGGTCCTAGTCTTGCTTGTGTTTCCTGATGGACGAATATCGTCTCCC,LXL-7,DNA,82 nt,0.463,"25,256.15 Da",39.59 ¦ÌM,No QGRS found,N/A,Target detection,Recognition and tissue imaging,Dissociation constant of selected aptamers for MDA-MB-231
Apta_1182,GAATTCAGTCGGACAGCGTCAGTCGTCCCTTTATGCTTGGTGCTCACCGTCTGAATTTCTTCAGATGGACGAATATCGTCTCCC,LXL-9,DNA,84 nt,0.5,"25,764.46 Da",38.81 ¦ÌM,No QGRS found,N/A,Target detection,Recognition and tissue imaging,Dissociation constant of selected aptamers for MDA-MB-231
Apta_1183,GAATTCAGTCGGACAGCGGCGTGAGTCTTTTGCGGTGGCTCGGGTTCGAATATCTACGACCTTGATGGACGAATATCGTCTCCC,LXL-14,DNA,84 nt,0.536,"25,959.57 Da",38.52 ¦ÌM,No QGRS found,N/A,Target detection,Recognition and tissue imaging,Dissociation constant of selected aptamers for MDA-MB-231
Apta_1184,GAATTCAGTCGGACAGCGTAATCCCTTGTGTTTGACGTTCGAAGATTATTTCTATCTTTTAGGATGGACGAATATCGTCTCCC,LXL-37,DNA,83 nt,0.422,"25,552.37 Da",39.14 ¦ÌM,No QGRS found,N/A,Target detection,Recognition and tissue imaging,Dissociation constant of selected aptamers for MDA-MB-231
Apta_1185,CAGGGGGTTTTGGTGGGGGGGGCTGGGTTGTCTTGGGGGTGGGCT,SH-HJ24,DNA,45 nt,0.689,"14,251.04 Da",70.17 ¦ÌM,4,76,Targeted binding,Binding to shp2,Typical force curves of dual-labeled G-quadruplex in solution
Apta_1186,AGGGGGTTTTGGTGGGGGGGGCTGGGTTGTCTTGGGGGTGGGCT,SH-HJ24-bio,DNA,44 nt,0.682,"13,961.86 Da",71.62 ¦ÌM,4,76,Targeted binding,Binding to shp2,Typical force curves of dual-labeled G-quadruplex in solution
Apta_1187,TGTACCGTCTGAGCGATTCGTACTTTATTCGGGAAGGGTATCAGCGGGGTTCAACAAGCCAGTCAGTGTTAAGGAGTGC,R12.45,DNA,79 nt,0.506,"24,531.69 Da",40.76 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to atrazine,ITC analysis of binding affinity between R12.45 Trunc
Apta_1188,CGGGCGGGGCGTGGGGTGTTGGAGTGGAGGGCGGGGCGGC,S-10,DNA,40 nt,0.825,"12,709.07 Da",78.68 ¦ÌM,3,57,Target detection,Detect S. pyogenes in the cooked chicken,N/A
Apta_1189,GCGGGCGGGGGGAGGGCGGCCGTGGGCTGCGAGTGGGAGG,S-12,DNA,40 nt,0.85,"12,703.07 Da",78.72 ¦ÌM,3,63,Target detection,Detect S. pyogenes in the cooked chicken,N/A
Apta_1190,TTCAGGGCGGGGTAAACGGGAGGTGGGGGGGGCTTGGGAC,S-26,DNA,40 nt,0.7,"12,660.08 Da",78.99 ¦ÌM,3,64,Target detection,Detect S. pyogenes in the cooked chicken,N/A
Apta_1191,TAATACTACCAACTTCTTTGCCTGGCGTAAGTAACAGTCA,S-28,DNA,40 nt,0.4,"12,213.89 Da",81.87 ¦ÌM,No QGRS found,N/A,Target detection,Detect S. pyogenes in the cooked chicken,N/A
Apta_1192,CTTTCTGTCCTTCCGTCACATCCCACGCATTCTCCACAT,DBP-1,DNA,39 nt,0.513,"11,675.50 Da",85.65 ¦ÌM,No QGRS found,N/A,Target detection,Selective detection of bis(2-ethylhexyl) phthalate,Affinity measurements of DBP-1 by qPCR-based assays
Apta_1193,GGGTTGGAGGTGGAGGGGAGTTGAGG,HGFap1,DNA,26 nt,0.654,"8,308.33 Da",120.36 ¦ÌM,No QGRS found,N/A,Target detection,Detect hepatocyte growth factor,SPR sensorgram of PQSs bound to HGF or HBEGF protein
Apta_1194,GGGAGAGGTGGGAGCGGGGCCAGGG,HGFap2,DNA,25 nt,0.8,"7,959.10 Da",125.64 ¦ÌM,3,62,Target detection,Detect hepatocyte growth factor,SPR sensorgram of PQSs bound to HGF or HBEGF protein
Apta_1195,GGGGTTGGGGGGAGGCGGGGAATGGGGG,HGFap3,DNA,28 nt,0.786,"8,992.74 Da",111.20 ¦ÌM,4,84,Target detection,Detect hepatocyte growth factor,SPR sensorgram of PQSs bound to HGF or HBEGF protein
Apta_1196,GGGGGATGGGGG,HBEGFap1,DNA,12 nt,0.833,"3,847.49 Da",259.91 ¦ÌM,2,20,Target detection,Detect hepatocyte growth factor,SPR sensorgram of PQSs bound to HGF or HBEGF protein
Apta_1197,GGGGGCATGGGGG,HBEGFap2,DNA,13 nt,0.846,"4,136.68 Da",241.74 ¦ÌM,2,19,Target detection,Detect hepatocyte growth factor,SPR sensorgram of PQSs bound to HGF or HBEGF protein
Apta_1198,CTTTTAAGAACCGGACGAACTAGAATATTATATTTT,T10-7.t5,DNA,36 nt,0.278,"11,056.17 Da",90.45 ¦ÌM,No QGRS found,N/A,Target detection,Molecular recognition,Binding isotherm obtained for ATP
Apta_1199,CCCTGCGGGGCTGCCCGATATGTGTCCAAGTGGTG,Aptamer 1,DNA,35 nt,0.657,"10,795.90 Da",92.63 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,Binding saturation curve of Aptamer 1 to the target H37Rv
Apta_1200,GGCACACAGGACTATACAGTGTTGCAGTGTTGCTG,Aptamer 2,DNA,35 nt,0.514,"10,826.97 Da",92.36 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1201,CCCTGCGGGGCTGCCCGATATGTGTCCAAGTGGTG,Aptamer 3,DNA,35 nt,0.657,"10,795.90 Da",92.63 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1202,CCCTGCGGGGCTGCCCGATATGTGTCCAAGTGGTG,Aptamer 4,DNA,35 nt,0.657,"10,795.90 Da",92.63 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1203,CCCTGCGGGGCTACCCGATATGTGTCCGAGTGGTG,Aptamer 5,DNA,35 nt,0.657,"10,795.90 Da",92.63 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1204,GGCACGATGTGGCTACATCGATCGCGGTACTGGTG,Aptamer 6,DNA,35 nt,0.6,"10,843.95 Da",92.22 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1205,GGCAGGTGGTGTTGGTTGGTTGTGCGTGGAGTTGG,Aptamer 7,DNA,35 nt,0.6,"11,048.04 Da",90.51 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1206,GGCAGCAGCAATGTAACACTGTGTGTATGTGTTGG,Aptamer 8,DNA,35 nt,0.486,"10,882.00 Da",91.89 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1207,CCCTGCGGGGCTGCCCGATATGTGTCCAAGTGGTG,Aptamer 9,DNA,35 nt,0.657,"10,795.90 Da",92.63 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1208,CCCTGCGGGGCTGCCCGATATGTGTCCAGGTGGTG,Aptamer 10,DNA,35 nt,0.686,"10,811.90 Da",92.49 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1209,GGCACGATGTGGCTACATCGATCGCGGTACTGGTG,Aptamer 11,DNA,35 nt,0.6,"10,843.95 Da",92.22 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1210,GGGGAGGCAGTGTGTTGTGTCGTGTGTGTGCTTGG,Aptamer 12,DNA,35 nt,0.6,"11,008.02 Da",90.84 ¦ÌM,No QGRS found,N/A,Target detection,Detection of H37Rv in clinical diagnosis,N/A
Apta_1211,ACUAGCCUCAUCAGCUCAUGUGCCCCUCCGCCUGGAUCAC,Seq1,RNA,40 nt,0.6,"12,602.49 Da",79.35 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to angiopoietin-2,N/A
Apta_1212,CTGTTCTCGGTCGCGACCTATCTGGTCGTCGCCGCGCTCGTGTTCGGAACGCTCATCGCGTTCGGGCTCGGCG,Eppc6,DNA,73 nt,0.671,"22,414.23 Da",44.61 ¦ÌM,No QGRS found,N/A,Target detection,Recognize prostate cancer cells and tissues,Binding curves
Apta_1213,GGACTTGAAGAAAAGGGCGACACGCGAAGTCGATGTCGCGTCTGCCTGAAGTCA,Eppc14,DNA,54 nt,0.556,"16,769.77 Da",59.63 ¦ÌM,No QGRS found,N/A,Target detection,Recognize prostate cancer cells and tissues,Binding curves
Apta_1214,GTCCATTATTCTGGTAGCGTTGAACAACATTCAACACGCC,Apta 5A,DNA,40 nt,0.45,"12,214.88 Da",81.87 ¦ÌM,No QGRS found,N/A,Aptasensor,Develop a cross-reactive aptasensor,N/A
Apta_1215,GTCGAATCAGCACCTCTGCATAGGTTACGTTTATACTGCG,Apta 6A,DNA,40 nt,0.475,"12,261.89 Da",81.55 ¦ÌM,No QGRS found,N/A,Aptasensor,Develop a cross-reactive aptasensor,N/A
Apta_1216,AGCGTCCTCTGCATAGTGATTTACGCTATGTGTACAGTGC,Apta 8A,DNA,40 nt,0.475,"12,292.90 Da",81.35 ¦ÌM,No QGRS found,N/A,Aptasensor,Develop a cross-reactive aptasensor,N/A
Apta_1217,ATACGAGCTTGTTCAATACGAAGGGATGCCGTTTGGGCCCAAGTTCGGCATAGTGTGGTGATAGTAAGAGCAATC,E2,DNA,75 nt,0.48,"23,312.94 Da",42.89 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of estradiol,Determination of the dissociation constant
Apta_1218,CGACACCACACAGCAGTAAGCACTACAACATAGTGGTCTAGACTATCTCGGGCCGGTG,ATX4,DNA,58 nt,0.534,"17,829.46 Da",56.09 ¦ÌM,No QGRS found,N/A,Aptasensor,Aptasensor for neurotoxin anatoxin-a,N/A
Apta_1219,GCGCAGAACCGACAGCAAAACGGAAGTCCACCACGACTATTGGTGCCCAATCTACCGTA,ATX2,DNA,59 nt,0.542,"18,096.64 Da",55.26 ¦ÌM,No QGRS found,N/A,Aptasensor,Aptasensor for neurotoxin anatoxin-a,N/A
Apta_1220,TGGCGACAAGAAGACGTACAAACACGCACCAGGCCGGAGTGGAGTATTCTGAGGTCGG,ATX8,DNA,58 nt,0.569,"18,039.58 Da",55.43 ¦ÌM,No QGRS found,N/A,Aptasensor,Aptasensor for neurotoxin anatoxin-a,N/A
Apta_1221,GGAGGCGCCAACUGAAUGAACGAGUUGAAAUGCGGAUCAAGUUACUGCUUCGGCAGUACCUAGUGGGAAAAGUUCUUGGGUCCGUAACUAGUCGCGUCAC,JX1,RNA,100 nt,0.51,"32,304.18 Da",30.96 ¦ÌM,No QGRS found,N/A,Target detection,Detection of benzylguanine,Binding affinity of the JX1-6 aptamers for Atto488-bG as measured by FP
Apta_1222,GGAGGCGCCAACUGAAUGAAACCGUGCUAAGGAGUUGGACUCCGCUGCUUCGGCAGAGCGAUAUAGUGCCAGCUGAUACAUCCGUAACUAGUCGCGUCAC,JX2,RNA,100 nt,0.55,"32,237.18 Da",31.02 ¦ÌM,No QGRS found,N/A,Target detection,Detection of benzylguanine,Binding affinity of the JX1-6 aptamers for Atto488-bG as measured by FP
Apta_1223,GGAGGCGCCAACUGAAUGAAAGGUUACGCUUCAACGCCGUGCAGCUGCUUCGGCAGGCUUGUGAGUACAUGGCCCAUUGAUCCGUAACUAGUCGCGUCAC,JX3,RNA,100 nt,0.56,"32,167.08 Da",31.09 ¦ÌM,No QGRS found,N/A,Target detection,Detection of benzylguanine,Binding affinity of the JX1-6 aptamers for Atto488-bG as measured by FP
Apta_1224,GGAGGCGCCAACUGAAUGAAUGUUCUGGAUCUGCUAGAGACUAUCUGCUUCGGCAGCACUCUCCGUUAACAACACGUACAUCCGUAACUAGUCGCGUCAC,JX4,RNA,100 nt,0.51,"32,000.97 Da",31.25 ¦ÌM,No QGRS found,N/A,Target detection,Detection of benzylguanine,Binding affinity of the JX1-6 aptamers for Atto488-bG as measured by FP
Apta_1225,GGAGGCGCCAACUGAAUGAAAGAGGUAACGAAAGAUGAUUGUGCCUGCUUCGGCAGUACAACUUCUCGGAUAAAUGAUUAUCCGUAACUAGUCGCGUCAC,JX5,RNA,100 nt,0.47,"32,240.19 Da",31.02 ¦ÌM,No QGRS found,N/A,Target detection,Detection of benzylguanine,Binding affinity of the JX1-6 aptamers for Atto488-bG as measured by FP
Apta_1226,GGAGGCGCCAACUGAAUGAAGGUGUAUUUCAGUUAAAGAACUUGCUGCUUCGGCAGCGUUCUGAGUUACUAGUCCAAUAAUCCGUAACUAGUCGCGUCAC,JX6,RNA,100 nt,0.47,"32,108.00 Da",31.14 ¦ÌM,No QGRS found,N/A,Target detection,Detection of benzylguanine,Binding affinity of the JX1-6 aptamers for Atto488-bG as measured by FP
Apta_1227,CACACCAAACACACAAGTGGACCCTGACGCATGGATAGGGTGACGGTATACGCGGGCATG,BT 1,DNA,60 nt,0.567,"18,561.92 Da",53.87 ¦ÌM,2,19,Aptasensor,Detection of BTX-2 in food samples,N/A
Apta_1228,GGCCACCAAACCACACCGTCGCAACCGCGAGAACCGAAGTAGTGATCATGTCCCTGCGTG,BT 10,DNA,60 nt,0.6,"18,393.80 Da",54.37 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of BTX-2 in food samples,N/A
Apta_1229,CACGGGCAGAGGGATAGGTTGTTGACGGGGCTGGTGGGTGGGTGCGCTCGCGCTATCGTGG,BT 5,DNA,61 nt,0.672,"19,142.17 Da",52.24 ¦ÌM,3,58,Aptasensor,Detection of BTX-2 in food samples,N/A
Apta_1230,GGCGATAGGCAGTGTTGCGGGGTCGGAGAGCGAGGTAATAGCGTGTATGGGTGCTGTGTG,BT 3,DNA,60 nt,0.6,"18,900.05 Da",52.91 ¦ÌM,2,17,Aptasensor,Detection of BTX-2 in food samples,N/A
Apta_1231,ACCACCGGCCCGAGATAGTCTAGACCACTATGTTGTTGTGCTTACTGCTGTGTGGTGTGG,BT 31,DNA,60 nt,0.533,"18,519.83 Da",54.00 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of BTX-2 in food samples,N/A
Apta_1232,GGCCACACAAACAACATGACAACACGTCTCACATAACGCCCACGTGCTGCCGCCTCATCG,BT 22,DNA,60 nt,0.567,"18,241.73 Da",54.82 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of BTX-2 in food samples,N/A
Apta_1233,TCACGAGAGAGCGAGAGCGCCCCCCCACCACAGCCGTCACCACCCTATTCCTCTGCCGTTG,BT 9,DNA,61 nt,0.656,"18,521.85 Da",53.99 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of BTX-2 in food samples,N/A
Apta_1234,TGTACCGTCTGAGCGATTCGTACTGTGGGCACCAATCGTACCCAATACTTGCGAATCAGCCAGTCAGTGTTAAGGAGTGC,R13.2,DNA,80 nt,0.513,"24,669.79 Da",40.54 ¦ÌM,No QGRS found,N/A,Aptasensor,Recognition specific for bromacil,Affinity binding assays of R13.2
Apta_1235,TGTACCGTCTGAGCGATTCGTACGATCGGGTCGGGGTCTATTTTAGGGCCATTTGGCAGCCAGTCAGTGTTAAGGAGTGC,R13.26,DNA,80 nt,0.538,"24,834.84 Da",40.27 ¦ÌM,2,18,Aptasensor,Recognition specific for bromacil,N/A
Apta_1236,GGACTGTTGTGGTATTATTTTTGGTTGTGC,Cd-4,DNA,30 nt,0.4,"9,310.98 Da",107.40 ¦ÌM,No QGRS found,N/A,Aptasensor,Recovery of cadmium from polluted samples,The relationship between fluorescence intensities and concentration of FAM-labelled Cd-4 aptamer
Apta_1237,GGGGTTGTGTGGGGAGTTTGTCCTGTTGTG,Cd-1,DNA,30 nt,0.567,"9,418.01 Da",106.18 ¦ÌM,No QGRS found,N/A,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1238,GGTTTTGTGTTTGTGTTTTGTGGTTGTTGT,Cd-2,DNA,30 nt,0.367,"9,338.97 Da",107.08 ¦ÌM,No QGRS found,N/A,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1239,GGTGGATGGGGATGCTTTGTTAGTTTGTGC,Cd-3,DNA,30 nt,0.5,"9,386.02 Da",106.54 ¦ÌM,2,19,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1240,GGAGTAGTGGGGATTGTGGTGTATGTTGTC,Cd-5,DNA,30 nt,0.5,"9,435.05 Da",105.99 ¦ÌM,2,17,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1241,GGTGTGGAGTGGTGTGTGTTGTTGTTTGTC,Cd-6,DNA,30 nt,0.5,"9,408.01 Da",106.29 ¦ÌM,2,17,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1242,GGAGCGATTAGTAGTGGTCTTGTCTTTTGC,Cd-7,DNA,30 nt,0.467,"9,289.97 Da",107.64 ¦ÌM,No QGRS found,N/A,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1243,GGTGTTGTTGTTGGCTAGTTTGTTGTGGGC,Cd-8,DNA,30 nt,0.5,"9,367.99 Da",106.75 ¦ÌM,No QGRS found,N/A,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1244,GGAGATGTCAGTTGTGTGTGTGGTTATGGC,Cd-9,DNA,30 nt,0.5,"9,395.03 Da",106.44 ¦ÌM,No QGRS found,N/A,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1245,AGTGTGAAGTGGTGTGTGTTGTTGTTTGTC,Cd-10,DNA,30 nt,0.433,"9,376.01 Da",106.66 ¦ÌM,No QGRS found,N/A,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1246,GGAGATGTATGAGCGGGTGTTTGTGTTTGC,Cd-11,DNA,30 nt,0.5,"9,395.03 Da",106.44 ¦ÌM,No QGRS found,N/A,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1247,GGTGGTTGCTGTTGTTTGTGGTTGGTGTGC,Cd-12,DNA,30 nt,0.533,"9,383.99 Da",106.56 ¦ÌM,No QGRS found,N/A,Aptasensor,Recovery of cadmium from polluted samples,N/A
Apta_1248,GGGUGACUUUUCCCUCAGGCUCCUGUGAAGCAACCGAAUGGACUGAAAUGAAACCGCCC,Dano-I,RNA,59 nt,0.542,"18,916.28 Da",52.86 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection and sensing of danofloxacin,N/A
Apta_1249,AAUCGGCCCAAUUUUACCUUCGGACUUCAGUAUCUAGUGUGGCUUUAAAUCAUAGC,Dano-II,RNA,56 nt,0.411,"17,783.49 Da",56.23 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection and sensing of danofloxacin,N/A
Apta_1250,ATACCAGCTTATTCAATTAGCCCGGTATTGAGGTCGATCTCTTATCCTATGGCTTGTCCCCCATGGCTCGGTTATATCCAGATAGTAAGTGCAATCT,Aptamer # 3_19,DNA,97 nt,0.443,"29,758.05 Da",33.60 ¦ÌM,No QGRS found,N/A,Target detection,Detection of kanamycin A,Determination of dissociation constants by fluorescence detection using the bead assay
Apta_1251,ATACCAGCTTATTCAATTGGTGGTAGGATGGGCTCGATCGAGGTCTTCAGTCGGCTCGGTTTAGTTTATGTTCTCCTGTAGATAGTAAGTGCAATCT,Aptamer # 3_7,DNA,97 nt,0.443,"30,020.19 Da",33.31 ¦ÌM,No QGRS found,N/A,Target detection,Detection of kanamycin A,Determination of dissociation constants by fluorescence detection using the bead assay
Apta_1252,ATACCAGCTTATTCAATTATGCGGGGATGAGGCTTGATCTGTGGCTCTGATCCATGATCAGTCGTCTTACGTGCGGTCCAGATAGTAAGTGCAATCT,Aptamer # 11_76,DNA,97 nt,0.464,"29,968.17 Da",33.37 ¦ÌM,No QGRS found,N/A,Target detection,Detection of kanamycin A,Determination of dissociation constants by fluorescence detection using the bead assay
Apta_1253,ATACCAGCTTATTCAATTCAGGGCGGTATGAGGCTCGATCAAGGTCGGAGCGAGAATTTTTTCGCGGAGTCGGCTGGATCAGATAGTAAGTGCAATCT,Aptamer # 13_82,DNA,98 nt,0.48,"30,429.47 Da",32.86 ¦ÌM,No QGRS found,N/A,Target detection,Detection of kanamycin A,Determination of dissociation constants by fluorescence detection using the bead assay
Apta_1254,GGCAGTGTGGGCGAATCTATGCGTACCGTTCGATATCGTG,A08,DNA,40 nt,0.55,"12,398.95 Da",80.65 ¦ÌM,No QGRS found,N/A,Target detection,OTA detection in food samples,Binding elution assay
Apta_1255,GGCGCATGATCATTCGGTGGGTAAGGTGGTGGTAACGTTG,B08,DNA,40 nt,0.55,"12,519.02 Da",79.88 ¦ÌM,No QGRS found,N/A,Target detection,OTA detection in food samples,Binding isotherm for aptamer B08 with OTA obtained using the magnetic beads-based isocratic elution assay
Apta_1256,GATCGGGTGTGGGTGGCGTAAAGGGAGCATCGGACA,1.12.2,DNA,36 nt,0.611,"11,311.26 Da",88.41 ¦ÌM,2,20,Target detection,OTA detection in food samples,Binding isotherm for aptamer 1.12.2 with OTA obtained using the magnetic beads-based isocratic elution assay
Apta_1257,CGACGCACAGTCGCTGGTGCGTACCTGGTTGCCGTTGTGT,OTC3,DNA,40 nt,0.625,"12,326.87 Da",81.12 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of oxytetracycline in milk,"Binding affinities of the aptamers OTC3, OTC6, OTC9, and OTC16"
Apta_1258,GGCGAAGGAGTCATGTAGGTGTGGTCGAGACCGCTGTGCT,OTC6,DNA,40 nt,0.6,"12,489.00 Da",80.07 ¦ÌM,2,17,Aptasensor,Detection of oxytetracycline in milk,"Binding affinities of the aptamers OTC3, OTC6, OTC9, and OTC16"
Apta_1259,GGCGCGGCATGGTGTGGACTCCAGGCGGTAGGGATGTCGT,OTC9,DNA,40 nt,0.675,"12,505.98 Da",79.96 ¦ÌM,2,21,Aptasensor,Detection of oxytetracycline in milk,"Binding affinities of the aptamers OTC3, OTC6, OTC9, and OTC16"
Apta_1260,GAAAGGGACGTTCCAAGTTCGTATAAGCAGTCCTGTGCGT,OTC16,DNA,40 nt,0.5,"12,375.96 Da",80.80 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of oxytetracycline in milk,"Binding affinities of the aptamers OTC3, OTC6, OTC9, and OTC16"
Apta_1261,GGGCGGACGCTAGGTGGTGATGCTGTGCTACACGTGTTGT,DNA01,DNA,40 nt,0.6,"12,470.97 Da",80.19 ¦ÌM,2,17,Targeted binding,Aptamer-based recovery strategy,Binding affinity of the selected aptamers (DNA01·ªDNA04) to palladium ion was examined in equilibrium dialysis-based binding assays
Apta_1262,ACAAGGGGTGCAGGGGTCCGCGATTGTGACTGTGTGTGCG,DNA02,DNA,40 nt,0.625,"12,505.00 Da",79.97 ¦ÌM,No QGRS found,N/A,Targeted binding,Aptamer-based recovery strategy,Binding affinity of the selected aptamers (DNA01·ªDNA04) to palladium ion was examined in equilibrium dialysis-based binding assays
Apta_1263,CCCCGCTGCCCGTGTTCCGTCCTCCCTTGCTGTGTGTGCG,DNA04,DNA,40 nt,0.7,"12,125.71 Da",82.47 ¦ÌM,No QGRS found,N/A,Targeted binding,Aptamer-based recovery strategy,Binding affinity of the selected aptamers (DNA01·ªDNA04) to palladium ion was examined in equilibrium dialysis-based binding assays
Apta_1264,CAACGATCGTACCACAGTACCCACCCACCAGCCCCAACATCATGCCCATGCGTCGGTGTG,P4G11,DNA,60 nt,0.6,"18,224.69 Da",54.87 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of progesterone,Binding affinity assays between ssDNA aptamers and progesterone
Apta_1265,CACGCACACAACAGCCAATAATGTATAACGCTGTCCACTGTGTGGTGTCCCCCGCGTCG,P4G06,DNA,59 nt,0.559,"18,036.56 Da",55.44 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of progesterone,N/A
Apta_1266,GCATCACACACCGATACTCACCCGCCTGATTAACATTAGCCCACCGCCCACCCCCGCTGC,P4G13,DNA,60 nt,0.617,"18,080.59 Da",55.31 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of progesterone,Binding affinity assays between ssDNA aptamers and progesterone
Apta_1267,GGCACGGCAAAGGGGTACAGCCTACCGAACCGTGGCTGTAAGGGTGGTTGTGGTGTG,P4G04,DNA,57 nt,0.614,"17,811.38 Da",56.14 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of progesterone,N/A
Apta_1268,CACACACGCAGCAAGGTCGTCGATACAAAACGTATCGACCCGTCACAGACTGCCCCGGGT,P4G03,DNA,60 nt,0.583,"18,377.80 Da",54.41 ¦ÌM,No QGRS found,N/A,Aptasensor,Detection of progesterone,N/A
Apta_1269,TAGCACACAACCCTTTGATTGGGATATCTCATCCCTCG,Seq.2,DNA,38 nt,0.474,"11,548.44 Da",86.59 ¦ÌM,No QGRS found,N/A,Aptasensor,Biosensors for T-2 detection,Binding saturation curves and determination of the dissociation constants (Kd) of aptamers
Apta_1270,GTATATCAAGCATCGCGTGTTTACACATGCGAGAGGTGAA,Seq.16,DNA,40 nt,0.45,"12,383.99 Da",80.75 ¦ÌM,No QGRS found,N/A,Aptasensor,Biosensors for T-2 detection,Binding saturation curves and determination of the dissociation constants (Kd) of aptamers
Apta_1271,ACCACAGCCAGTAAGTCCCGTAGGCCCTGGTTGGGCTGTT,Seq.6,DNA,40 nt,0.6,"12,288.88 Da",81.37 ¦ÌM,No QGRS found,N/A,Aptasensor,Biosensors for T-2 detection,Binding saturation curves and determination of the dissociation constants (Kd) of aptamers
Apta_1272,TCCGTGTATAGGTCGGGTCTCTTGCCAACTGATTCGTTGAAAAGTATAGCCCCGCAGGG,CLSE1201,DNA,59 nt,0.525,"18,208.66 Da",54.92 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1273,TCCCTCCTGTTGGTTTGGGATGGTGGCGACTATCTGATTGTTTGACTCCCCGTAGGGG,CLSE1203,DNA,58 nt,0.552,"17,915.42 Da",55.82 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1274,GACTTCGTCGTCTTTAGACTAGCAGTTAGGGTTTACGATTGTGGAGTTAGCCCCCAGGG,CLSE1205,DNA,59 nt,0.508,"18,254.68 Da",54.78 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1275,CAAGTACAAACTTCCATCGCACCTCTTGCTCCCCGCGAGGGG,CLSE1208,DNA,42 nt,0.595,"12,780.21 Da",78.25 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1276,TCAATGGGATGTTAGTATGCAAAGATATTCTGTTCAGTGTGTGCCCAGGCCCCCAGGG,CLSE1206,DNA,58 nt,0.5,"17,943.50 Da",55.73 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1277,TCCGTGGTACGGTTACTCGTTCCTTATGTATGTTGCTACAATGGATTGCGTCCCCAGGG,CLSE1231,DNA,59 nt,0.508,"18,156.60 Da",55.08 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1278,CCATGATTCAACTTTACTGGTCTTGTCTTGGCTAGTCGTGTGTCATTCCCTAAGG,CLSE1215,DNA,55 nt,0.455,"16,854.79 Da",59.33 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1279,TTCCAAGACCTGACCGTAATCGTCAAATGTGTTATTGGAGGGGGACTAGCCCCCGGAGGG,CLSE1214,DNA,60 nt,0.55,"18,580.90 Da",53.82 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1280,TCATATCCTTCTTGGTATCATTGCGTCATTTAGTCATTCATGTTATTCCCGAGGG,CLSE1220,DNA,55 nt,0.4,"16,828.79 Da",59.42 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1281,CACACCTTGACTTTCTTCTTTTTGAAGTTGAACCTGTTGTACTAGTGTTACCCCTAGGG,CLSE1213,DNA,59 nt,0.424,"18,049.57 Da",55.40 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1282,TCCTCTCACACATCTTATCCCCTAGGG,CLSE803,DNA,27 nt,0.519,"8,106.23 Da",123.36 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1283,TACTGATGCAGGGTAATGCTTCTGTGTTTGTTCTTCATCATTAACGGCCGCGTCTGGCGG,CLSE1216,DNA,60 nt,0.5,"18,500.82 Da",54.05 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1284,ACCTGTTATGTTTGAGAGAGGGTAGTCAATAGTGTTATGCCCGCTTCCCCCCTTTGGGGG,CLSE1219,DNA,60 nt,0.517,"18,534.85 Da",53.95 ¦ÌM,No QGRS found,N/A,Aptasensor,Detect tobramycin in label-free surface,N/A
Apta_1285,AGGAACCTTCTCTTCCTCTATTTTTTAATTCTGTCTACCCT,1Z22,DNA,41 nt,0.366,"12,367.96 Da",80.85 ¦ÌM,No QGRS found,N/A,Target detection,Recognizing zearalenone,N/A
Apta_1286,CTATACGTATTCTAACTTGTTACGTATTGGTCTCTTATTG,2Z14,DNA,40 nt,0.325,"12,222.87 Da",81.81 ¦ÌM,No QGRS found,N/A,Target detection,Recognizing zearalenone,N/A
Apta_1287,GCCCGCATGCCGTCAAGCAATGTTAATCTTGTTTTGATTTCG,3Z35,DNA,42 nt,0.452,"12,861.26 Da",77.75 ¦ÌM,No QGRS found,N/A,Target detection,Recognizing zearalenone,N/A
Apta_1288,GGCGCACUGGCGCUGCGCCUUCGGGCGCCAAUCGUAGCGUGUCGGCGCC,pepper,RNA,49 nt,0.755,"15,756.36 Da",63.47 ¦ÌM,No QGRS found,N/A,Live-cell imaging,Live imaging of cellular RNAs,N/A
Apta_1289,GGGAGAGGAUACUACACGUGGAAAAACCAACAAAUUGGGAAAAAUGUUAAGGGUCCACUUCAUGCCAUUGCAUGUAGCAGAAGCUUCCG,N11,RNA,89 nt,0.449,"28,782.22 Da",34.74 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to Ni2+,N/A
Apta_1290,GCGCGAGAAACGGUCACUAGAAUAGUGGGCCGUCAUGCUAACGCCUCUUUCGGUGUUGGGGAAUAUUGGCCAAUCGAGU,529,RNA,79 nt,0.532,"25,499.12 Da",39.22 ¦ÌM,1,15,Targeted binding,Binding to phenylalanine,N/A
Apta_1291,CGTACGGAATTCGCTAGCCCCCCGGCAGGCCACGGCTTGGGTTGGTCCCACTGCGCGTGGATCCGAGCTCCACGTG,T20,DNA,76 nt,0.684,"23,366.87 Da",42.80 ¦ÌM,1,20,Targeted binding,Binding to tetracyclines,N/A
Apta_1292,GGCACGUGUAUUACCCUAGUGGUCGACGUGCC,XBA,RNA,32 nt,0.594,"10,232.08 Da",97.73 ¦ÌM,No QGRS found,N/A,Targeted binding,Binding to xanthine,N/A
Apta_1293,ATCCAGAGTGACGCAGCATGCCCTAGTTACTACTACTCTTTTTAGCAAACGCCCTCGCTTTGGACACGGTGGCTTAGT,KH1C12,DNA,78 nt,0.5,"23,913.30 Da",41.82 ¦ÌM,No QGRS found,N/A,Target recognition,Molecular analysis of leukemia and its subcategories,N/A
